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VIII. Abstract 
 The biosynthesis of the plant hormones strigolactone and abscisic acid is, in part, 
controlled by a family of enzymes known as the carotenoid cleavage dioxygenases (CCDs), 
which perform an oxidative cleavage reaction on a carotenoid substrate (9’-cis-neoxanthin for 
abscisic acid and 9-cis-β-carotene and 9-cis-β-apo-10’-carotenal for strigolactone) to form 
apocarotenoids, which are metabolised to the functional phytohormone. Phenotypic effects on 
seed dormancy and shoot branching have been observed in Arabidopsis thaliana and Zea mays 
on the application of a selection of hydroxamic acids based inhibitors, designed to inhibit 
CCDs, whereby application of the inhibitor to the plant result in a decrease in the time take 
for germination (abscisic acid mediated) or an increase in the number of lateral shoot branches 
(strigolactone mediated). However, the biochemical basis of these phenotypes is not 
understood. 
            In the present thesis, carotenoid cleavage dioxygenases from the abscisic acid 
biosynthesis pathway (9’-cis-epoxycarotenoid cleavage dioxygenases (NCED)) and 
strigolactone biosynthesis pathway (CCD7 and CCD8) were produced in vitro and assayed 
for inhibition against the hydroxamic acid inhibitors. The results show that Z. mays NCED is 
indeed inhibited by the hydroxamic acid inhibitors (D2: greater than 95% inhibition at 100 
µM) in a time dependent fashion, indicating that inhibition of NCED is the basis of the seed 
germination phenotype. On the strigolactone biosynthesis pathway, recombinant A. thaliana 
CCD7 is not inhibited by the hydroxamic acids. However, recombinant A. thaliana CCD8 is 
inhibited by hydroxamic acids that show shoot branching phenotypes (D6 53% inhibition at 
10 μM), suggesting that inhibition of CCD8 is the basis of the shoot branching phenotype. 
Structure activity relationships have also been performed to identify the key features of the 
hydroxamic acids required to inhibit each enzyme. 
            The biochemistry of several CCDs has also been investigated, along with that of the 
enzyme Dwarf27, an isomerase enzyme required for the isomerisation of all-trans-β-carotene 
to 9-cis-β-carotene on the strigolactone biosynthesis pathway. Investigations indicate that 
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Dwarf27 from Oryza sativa could be a novel iron-sulfur protein which isomerises β-carotene 
via a one electron transfer to or from the β-carotene substrate. D27 is also inhibited to some 
extent by certain hydroxamic acids (e.g. 41% by D30 at 100 µM). Biochemical 
characterisation of A. thaliana CCD8 provides evidence for a two-step mechanism involving 
acid-base catalysis, and evidence is obtained for an active site cysteine residue. A possible 
mechanism for the double oxidative cleavage reaction catalysed by CCD8 is proposed. 
            These results provide an insight into the biochemistry of the biosynthesis of the 
phytohormones abscisic acid and strigolactone and demonstrate that enzymes on the 
biosynthesis pathways of these hormones can be selectively inhibited using a chemical 
genetics approach. This has potential to aid the development of novel agrochemical 
compounds which could influence these processes to improve plant architecture and crop 
yield. 
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Chapter One: Introduction 
1.1 Carotenoids 
Carotenoids are C40 polyene terpenoids biosynthesised by phototrophic organisms 
such as plants, algae and certain bacteria (Walter & Strack 2011). Carotenoids are essential 
metabolites, so mammals must obtain carotenoids through their diet, mostly in the form of β-
carotene (pro-vitamin A) and lycopene. To date, over 700 different carotenoids have been 
identified, which can be divided into two groups: Carotenoids which have an entirely 
hydrocarbon skeleton are termed carotenes, such as β-carotene (Figure 1.1), whilst those 
which are oxygenated are termed xanthophylls, such as neoxanthin (Figure 1.1). Xanthophylls 
which contain an epoxide group, such as neoxanthin, are termed epoxycarotenoids. Although 
structurally different, all carotenoids share the same polyene backbone.  
The conjugated system of π electrons in carotenoids means that the energy of 
transition between the π and π* bonding and anti-bonding orbitals is low (Williams & Fleming 
1995). As a result, carotenoids absorb in the high energy end of the UV-Vis spectrum (350-
500nm), resulting in their yellow, red and orange colours. Carotenoids are found as accessory 
pigments in photosynthesis, where they can act as light harvesting pigments - whereby they 
absorb solar light energy and pass this energy onto chlorophyll by singlet-singlet excitation 
transfer (Cogdell & Frank 1987). In addition, carotenoids can quench triplet-chlorophyll, 
preventing the formation of the highly toxic singlet-oxygen (1O2) species. In a similar way, 
 
Figure 1.1 – Structures of the carotenoids lycopene and β-carotene and the epoxycarotenoid 
9’-cis-neoxanthin. 
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carotenoids also act as antioxidants (Foote & Penny 1968). The highly conjugated nature of 
carotenoids results in a low lying π* state, which renders the molecule susceptible to reactions 
with radicals. The resultant radical, which is resonance stabilised by the conjugation of the 
polyene backbone of the carotenoid, prevents the radical from causing oxidative damage 
(Burton 1989).  
Carotenoids also have an ecological role as coloured pigments. The yellow and orange 
colours such as those produced by lutein and β-carotene respectively, are important in 
attracting pollinating insects to plants (Schaefer et al. 2004). Carotenoids have been reported 
to function in many other roles, such as reinforcing bacterial cell membranes and altering 
membrane properties (Rottem & Markowitz 1979, Britton et al. 2008). Due to the hydrophobic 
nature of carotenoids, it is not unexpected to find them localised to membranes. 
1.2 Apocarotenoids 
Carotenoids can be broken down via oxidative cleavage into smaller molecules known 
as apocarotenoids or norisoprenoids. The cleavage of carotenoids can occur either specifically 
or non-specifically. The non-specific cleavage of carotenoids occurs via either photo- or 
chemical oxidation. The specific cleavage of apocarotenoids, however, occurs via the action 
of a family of enzymes known as the carotenoid cleavage dioxygenases (CCDs). These 
apocarotenoids may be biologically active in their own right, or may be precursors to other 
biologically active molecules.  
Apocarotenoids and their derivatives play a wide variety of different roles within 
biological systems. Possibly the most well studied apocarotenoid is retinal, one of the three 
forms of vitamin A (the other two being retinol and retinoic acid). Retinal, is produced by the 
symmetrical cleavage of β-carotene by the enzyme β-carotene oxygenase I (BCOI) and is the 
visual pigment in the rod cells of mammals, where it is bound via a Schiff base linkage to a 
lysine residue in a G-protein coupled receptor, called opsin. On exposure to light, 11-cis-
retinilidene undergoes an 11-cis to all-trans isomerisation, which initiates the visual cascade, 
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allowing vision (Figure 1.2) (Moiseyev et al. 2005, Jin et al. 2007, Wald 1968). 
Apocarotenoids also have roles as signalling molecules. For example, in plants, the signalling 
molecules strigolactone and abscisic acid are apocarotenoid derived molecules (Figure 1.3) 
(Umehara et al. 2008, Gomez-Roldan et al. 2008, Von-Lintig & Vogt 2000, Nambara & 
Marion-Poll 2005). Other biological roles of apocarotenoids have also been reported. For 
example, retinoic acid has been shown to have signalling properties in the immune system and 
in growth and development (Lampert et al. 2003, Spilianakis et al. 2005).  
 
Figure 1.3 – Chemical structures of the phytohormones strigolactone and abscisic acid.  
 
Figure 1.2 – Schematic representation of the visual pathway in mammals starting from β-carotene. 
The position of cleavage on β-carotene is indicated with a red line. 
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In many cases, apocarotenoids also have similar roles as carotenoids. Apocarotenoids 
are located in the thylakoid membrane of cyanobacteria and plants, acting as photosynthesis 
accessory pigments and as photoprotective compounds (Winterhalter & Straubinger 2000, 
Walter et al. 2010). Finally, examples of apocarotenoids acting as scent and aroma compounds 
have been reported, as have examples of apocarotenoids acting as colour pigments 
(Winterhalter & Straubinger 2000). Similarly, the volatile C13 apocarotenoid β–ionone is 
involved in the aroma of wine and tobacco (Walter et al. 2010, Winterhalter & Rouseff 2001). 
1.3 Carotenoid Cleavage Dioxygenases 
Carotenoid cleavage dioxygenases are a large family of non-heme iron (II) dependent 
enzymes which catalyse the oxidative cleavage of a double bond on the polyene backbone of 
carotenoids to produce two apocarotenoid products. Depending upon the position of cleavage 
on the backbone, this results in either aldehyde or ketone products being produced. As 
discussed, apocarotenoid and apocarotenoid derived molecules form important signalling 
molecules in plants and mammals. There is some debate within the literature as to whether 
CCDs are technically dioxygenases or monooxygenases, and as a result the names carotenoid 
cleavage dioxygenase and carotenoid cleavage oxygenase (CCO) are often used 
interchangeably. Here, however, the term CCD will be used.  
Since the 1930s it has been known that β-carotene was the precursor to retinal. In vivo 
experiments in rats showed the production of retinal from β-carotene, which was proposed to 
occur through cleavage of the central 15,15’ double bond. (Moore 1930, Karrer et al. 1930). 
Using cell extracts from rat liver and intestines, it was further shown in 1965 that this cleavage 
was the result of enzymatic activity of an enzyme termed β-carotene oxygenase (Goodman & 
Huang 1965, Olson & Hayaishi 1965). The gene encoding β-carotene oxygenase was not 
identified until the early 2000s, when it was shown to have sequence similarity with a plant 
gene termed vp14, which encodes the NCED1 enzyme from Zea mays. (von-Lintig & Vogt 
2000, Wyss et al. 2000, Schwartz et al. 2007). Subsequently, large scale genomic sequencing 
has allowed the identification of large numbers of putative CCDs across all taxa (Auldridge et 
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al 2006b). However, in only a few cases are the biochemical functions of these enzymes 
understood. 
 Although they can exhibit substrate promiscuity, CCDs show high regio- and stereo-
specificity for specific double bonds on carotenoid and apocarotenoid substrates. The regio-
specificity of CCDs refers to the position on the carotenoid backbone where the CCD enzyme 
cuts. An enzyme with 9,10 cleavage specificity, for example, will cut between carbons 9 and 
10 (or 9’ and 10’) (Figure 1.4).  
To date, the majority of CCDs enzymes identified have been in plants, where they are 
involved in the biosynthesis of the signalling molecules strigolactone and abscisic acid. Within 
Arabidopsis thaliana (thale cress) nine distinct CCDs have been identified: CCD1, CCD4, 
CCD7, CCD8, NCED2, NCED3, NCED5, NCED6 and NCED9 (Neill et al. 1998, Tan et al. 
2003, Sorefan et al. 2003, Booker et al. 2004). CCDs in other plant species are named 
according to homology to the A. thaliana enzymes. Only CCD1, 4, 7, 8 and NCEDs are found 
in all plants, which have varying numbers of NCEDs. For example, A. thaliana and Z. mays 
have five NCEDs, whereas Solanum lycopersicum (tomato) has only two. However, additional 
CCD enzymes may be found in certain plants. For example, zeaxanthin cleavage dioxygenase 
is found in Crocus sativus (crocus) and lycopene cleavage oxygenase is found in Bixa orellana 
 
Figure 1.4 – Carbon numbering assignments for carotenoids, as represented on the structure of β-
carotene in the cleavage reaction catalysed by CCD1. The position of cleavage on β-carotene is 
indicated with a red line. 
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(bixa) (Bouvier et al. 2003). The plant CCD enzymes CCD1, CCD4, CCD7, CCD8 and 
NCEDs are discussed in more detail below.  
In mammals, two CCD enzymes have been identified, termed β-carotene oxygenase I 
(BCOI) and β-carotene oxygenase II (BCOII) (Redmond et al. 2001, Yan et al. 2001, Kiefer 
et al. 2001). BCOI, identified in Homo sapiens and Mus musculus, is required for the 15,15’ 
cleavage of β-carotene to produce retinal, which is required for vision. BCOII on the other 
hand, also identified in H. sapiens and M. musculus, has been shown to catalyse the 9,10 
cleavage of β-carotene and lycopene. However, the biological role of BCOII remains 
unknown. A third protein with sequence similarity to the CCD family is also present in 
mammals. Retinal pigment epithelium 65 kDa protein (RPE65) is an iron dependent enzyme 
which is structurally related to the CCDs (Moiseyev et al. 2006). However, RPE65 does not 
catalyse the cleavage of carotenoid or apocarotenoids. Instead, RPE65 is required for the 
isomerisation of all-trans-retinyl ester to 11-cis-retinol in the visual cycle (Figure 1.2). RPE65 
is discussed in more detail in Section 1.7.  
NinaB is a CCD enzyme identified from Galleria mellonella (great wax moth) and is 
similar to BCOI in that is required for the biosynthesis of retinal (Oberhauser et al. 2008). 
However, NinaB is interesting in that it also appears to catalyse the isomerisation of the 
apocarotenoid products (Figure 1.5). NinaB has been shown to be able to catalyse the cleavage 
 
Figure 1.5 – Isomerisation and cleavage reaction of β-carotene catalysed by G. mellonella NinaB. 
The all-trans-retinal isomer is formed in preference to the 11-cis isomer. The position of cleavage 
on β-carotene is indicated with a red line. 
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of a range of carotenes and epoxycarotenoids structurally related to β-carotene to all-trans and 
11-cis retinal. 
Many CCD enzymes have been identified in bacteria. One of the first bacterial CCDs 
to be investigated was the cyanobacterial apocarotenoid cleavage oxygenase (ACO) from 
Synechocystis sp. PCC 6803 (Ruch et al. 2005). ACO is involved in the biosynthesis of retinal 
from the substrate all-trans-β-apo-8’-carotenal via a 15,15’ cleavage reaction (Figure 1.6). In 
vitro experiments show that ACO is selective for all-trans substrates and will accept 
oxygenated derivatives of the β-apo-8’-carotenal substrate, but will not cleave either β-
carotene or lycopene. Changes in the chain length of the substrate from that of the natural β-
apo-8-carotenal alter the rate of the cleavage reaction. If the length of the substrate was either 
increased or decreased then the reaction rate falls. 
Other bacterial CCDs have also been identified in Mycobacterium tuberculosis and 
Novosphingobium aromaticivorans (Scherzinger et al. 2010, Kim et al. 2012). The 
M.  tuberculosis CCD is somewhat interesting in that it only cleaves carotenoids with terminal 
cyclic groups at both the 15,15’ and 13,14 positions (Kim et al. 2012). This regio-promiscuity 
is somewhat unusual for the CCD family. It could be reasoned that the terminal cycle group 
is required for binding, and that the active site architecture is such that it provides only a loose 
fit of the substrate within the active site. A fungal CCD, termed CarX has also been identified 
in Gibberella fujikuroi (Prado-Cabrero et al. 2007).  
 
Figure 1.6 – Cleavage reaction of all-trans-β-apo-8’-carotenal to retinal and (2E, 4E, 6E)-2,6-
dimethylocta-2,4,6-trienedial. The position of cleavage on all-trans-β-apo-8’-carotenal is indicated 
with a red line. 
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1.4 Structural Aspects of CCDs 
To date, two CCD enzymes have been crystallised. These structures belong to 
Synechocystis sp. PCC 6803 ACO (PDB: 2B1W) and to Z. mays VP14 (PDB: 3NPE) (Figure 
1.7) (Kloer et al. 2005, Messing et al. 2010). A third structure, belonging to Bos taurus RPE65 
has also been reported (PDB: 3FSN) (Kiser et al. 2009). Although RPE65 does not catalyse 
the cleavage of carotenoids, it shares both sequence and structural similarity with the CCD 
family. Analysis of the structures of ACO, VP14 and RPE65 reveals that CCDs have a 
 
Figure 1.7 – Structures of the CCD enzymes Zea mays VP14 (PDB: 3NPE) and Synechocystis sp. 
ACO (PDB: 2B1W), and the retinyl isomerase Bos taurus RPE65 (PDB: 3FSN). β-sheet blades are 
numbered in orange. 
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conserved 7 bladed β propeller motif (Figure 1.7). The blades of this β-propeller consist of 4 
to 5 β sheets arranged in an antiparallel fashion. At the base of the β-propeller sits the catalytic 
iron centre, buried deep within the enzyme, most likely to prevent escape of radical species 
which could damage the cell.  
The iron (II) centre is chelated by four histidine residues from the innermost blades 
of the β propellers in an octahedral fashion (Figure 1.8). Surrounding this are second shell 
glutamate or aspartate residues which are partially conserved. The tetradentate co-ordination 
state is unusual for non-heme iron enzymes, which usually have tridentate coordination by 
 
Figure 1.8 – Active site structures of the CCD enzymes Z. mays VP14 and Synechocystis sp. ACO 
and the retinyl isomerase Bos taurus RPE65. The four histidine residues coordinating the iron are 
strictly conserved, whilst the second shell residues are semi conserved. In VP14, water and oxygen 
have been modelled into the active site (not observed crystallographically). The putative β-apo-8’-
carotenal substrate is also shown in the Synechocystis structure, positioned 4.7 Å below the iron. 
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histidine, glutamate or aspartate residues. Where there is tetradentate coordination, such as in 
the case of the intradiol protochatechuate 3,4-dioxygenase from Pseudomonas putida, the 
coordination is performed by a variety of ligands (Ohlendorf et al. 1988). For the P. putida 
protochatechuate dioxygenase this is by two histidine residues and two tyrosine residues. Only 
a handful of enzymes are known to have tetradentate coordination by four histidine residues, 
such as superoxide reductase (Gilmor et al. 1997). Sequence alignment of the CCD enzyme 
BtRPE65 (Q28175) CTETNF TAHPH SYVHSFG NLFHHIN NTYEDHE YPSEPIF VTFHGLF 
HsRPE65 (Q16518) CTETNF TAHPH SYVHSFG NLFHHIN NTYEDNG YPSEPIF VTFHGLF 
HsBCO2  (Q9BYV7) CTETNF TAHPH SYYHSFG VTFHQIN NAFEDQG YPSEPVF YGFHGTF 
HsBCO1  (Q9HAY6) TSETNY TSHPH SYYHSFG VVFHHVN NAYEEDG WPAEPLF MDLHGLF 
ZmNCED1 (O24592) MSEDDL IAHPK TMIHDFA FCFHLWN NAWEDEA FGGEPCF FGFHGTF 
ZmCCD1  (Q45VT7) LSEADK TAHPK VMMHDFA FIFHNAN NAWEEGD FGSEAIF YGFHAFF 
AtNCED9 (Q9M9F5) MSEDDL IAHPK TMIHDFA FCFHLWN NSWEEPE YGGEPLF YGFHGTF 
AtNCED3 (Q9LRR7) MSEDDL IAHPK TMMHDFA FCFHLWN NAWEEPE YGGEPLF YGFHGTF 
AtNCED5 (Q9C6Z1) MSEDDL IAHPK TMMHDFA FCFHLWN NAWESPE YGGEPFF YGFHGTF 
AtNCED2 (O49505) MSEDDL IAHPK TMIHDFA FCFHLWN NAWESPE YGGEPFF YGFHGTF 
AtNCED6 (Q9LRM7) MSEDDL IAHPK TMIHDFA FCFHLWN NAWEERT FGGEPCF YGFHGTF 
AtCCD4  (O49675) LGESDL TAHPK SFLHDFA NIIHAIN NAWDEDD YGGEPFF YGFHGLF 
AtCCD1  (O65572) LQEADK TAHPK IMMHDFA FIFHNAN NAWEEED YGSEAIY YGFHALF 
AtCCD7  (Q7XJM2) LWEGGE LSHYK MMIHDWA WLIHSGN NAYETRE FVGEPMF ICVHSFY 
AtCCD8  (Q8VY26) LTETQK SAHPI GWVHSFA VTFHFIN NAYEEDK IPSEPFF YGLHGCW 
S.ACO   (P74334) LWEGGQ SAHPR AFIHDFA FVFHHAN NAFEEN- FAGEPIF YPLHGSW 
DmNinaB (Q9NKW9) FTETPF TSHPH GYMHTFG FYLHIIN NCFERDG YPSEPIF KCLHGWF 
LeCCD1a (Q6E4P5) LSEADK TAHPK IMMHDFA FIFHNAN NAWEEGD FGSEAVF YGFHAFF 
PsNCED2 (Q8LP16) MSEDDI IAHPK TMMHDFA FCFHLWN NAWEEPE FGGEPLF YGFHGTF 
PsNCED3 (Q8LP15) MSEDDL IAHPK TMIHDFA FCFHLWN NAWEEPE FGGEPFF YGFHGTF 
PaNCED1 (Q9AXZ3) MSEDDL IAHPK TMIHDFV FCFHLWT TAWEEPE YGGEPYF YGFHGTF 
PaNCED3 (Q9AXZ4) MSEDDL IAHPK TMIHDFA FCFHLWN NAWEEPE FGGEPYF YGFHGTF 
LeNCED2 (C5H805) MSEDDV IAHPK TMMHDFA FCFHLWN NAWEEPE YGGEPLF YGFHGTF 
BoLCO   (Q7OYP8) LCEYDL TAHPK SFVHDFA NMVHVVN NAWEEEG FGGEPFF YGFHGLF 
CsZCD   (Q84K96) LCEYDL TAHPK SFVHDFA NMVHVVN NAWEEEG FGGEPFF YGFHGLF 
PsCCD1  (Q8LP17) LSEGDK TAHPK VMMHDFA FIFHNAN NAWEEED FGSEAVY YGFHAFF 
MtCCO   (O06785) LVEAGV TAHPQ PMMHSFS YVYHPLN NAYSECR LIGEMVF MGFHGNW 
MmBCO2  (Q99NF1) STETNF TAHPH SYYHSFG LTYHQIN NAFEDQG YPSEPVF YGFHGTF 
MmBCO1  (Q9JJS6) TTETNY TSHPH SYYHSFG VVFHHVN NAYEEDG WPAEPLF LDLHGLF 
NaCCO   (Q2GA76) MKEDSP TAHPK CMMHDFG FASHVLN NAWQEGT SLQEPCF FGLHGNW 
PpLSD   (Q53353) MKEDSP CAHPK CMMHDFG FVGHVMN NAFNDGT AIQEPCF QGLHGNW 
LeNCED1 (O24023) MSEDDL IAHPK TMMHDFA FCFHLWN NAWEEAE YGGEPLF YGFHGTF 
GfCarX  (Q5GN50) TCESGP TGHPK RMMHDFG CIFHTAN NTWDSQS YAQEPRF YGLHGTW 
 
Figure 1.9 – Partial T-Coffee (Notredame et al. 2000) sequence alignment of carotenoid cleavage 
dioxygenases showing conserved histidine residues (orange) and semi-conserved second shell 
residues (red). Conflicts from the consensus are in blue. Accession numbers are shown in brackets. 
Bt – Bos taurus; Hs – Homo sapiens; Zm - Zea mays; At – Arabidopsis thaliana; S. – Synechocystis 
sp.; Dm – Drosophilia melanogaster; Le – Solanum lycopersicum; Ps – Pisum sativum; Pa – Persea 
americana; Bo – Bixa orellana; Cs – Crocus sativum; Mt – Mycobacterium tuberculosis; Mm – 
Mus musculus; Na – Novosphingobium aromaticivorans; Pp – Pseudomonas paucimobilis; Gf - 
Gibberella fujikuroi. A full sequence alignment is provided in appendix 10.1 
. 
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family shows that the four histidine residues required for iron coordination are strictly 
conserved across the family (Figure 1.9). Since tetradentate coordination leaves only two 
vacant sites for catalysis, it is reasonable to assume that the tetradentate coordination is 
essential for the CCD enzyme family. The crystal structure of ACO in the absence of iron 
shows that the histidine ligands and second shell residues remain in the same position, 
suggesting a rigid structure. The second shell residues may either participate in catalysis or 
modulate the redox potential of the iron. 
Within the structures of CCD enzyme there are two tunnels. The first tunnel runs from 
the surface of the enzyme to the active site (Figure 1.10). This tunnel is lined with polar 
residues and is believed to be required for delivering oxygen to the active site. The second 
tunnel is a long hydrophobic tunnel which runs perpendicular to the axis of the β-propeller 
 
Figure 1.10 – Cross-section of the CCD enzymes Zea mays VP14 and Synechocystis sp. ACO and 
the retinyl isomerase Bos taurus RPE65 showing the substrate binding tunnels. Tunnel entrances 
and exits are shown with orange arrows. The location of the catalytic iron centre is shown with blue 
arrows (iron is only visible in ACO due to orientation of structures) as an orange sphere. Tunnel 
entrances are located next to hydrophobic regions, allowing substrate extraction from the 
membrane. Purple patches represent β-sheet blades. 
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from the surface of the enzyme to the catalytic iron at the centre (Figure 1.10). At the iron 
centre, the tunnel turns 90° and exits the enzyme parallel to the β-propeller. This is the 
substrate binding tunnel and is required to deliver the carotenoid substrate to the active site. 
Analysis of the VP14 structure shows that the carotenoid substrate is held in place by non-
specific hydrophobic van der Waals interactions with leucine, valine and isoleucine residues 
within the binding tunnel (Messing et al. 2010). Additionally, the cleavage site is surrounded 
by three phenylalanine residues. These phenylalanine residues, along with additional non-
specific hydrophobic interactions from methionine, leucine, valine, tryptophan and proline 
residues aid in the binding of the substrate. Mutation of the analogous three phenylalanine 
residues which surround the cleavage site in the structurally related Z. mays CCD1 enzyme to 
alanine residues results in a decrease in activity by up to 30%, suggesting that the residues are 
indeed important for substrate binding. From modelling with the ACO structure, it appears 
that the length of the tunnel before it turns to exit the enzyme and the size of the opening to 
the tunnel on the surface of the enzyme helps to dictate substrate specificity (Kloer et al. 2005). 
A small opening blocks the bulky terminal cyclic groups on carotenoids from entering the 
active site. This essentially turns the tunnel into a ruler, with the opening acting as a stopper, 
ensuring the correct double bond is positioned for cleavage. 
 In their original 2005 paper on the structure of ACO, Kloer et al. crystallised ACO 
in the presence of apocarotenoid substrates, and assigned electron density observed within the 
active site of the enzyme to a carotenoid substrate bound within the active site (Kloer et al. 
2005). Interestingly, this electron density did not give a straight linear chain as would be 
expected for a carotenoid (Sui et al. 2013). Instead, it was proposed that the carotenoid had 
undergone isomerisation upon binding to the enzyme. As a result, analysis of the structure 
produced by Kloer et al. suggested that the bound substrate is positioned approximately 5.0 Å 
from the iron (Figure 1.8). This would imply that the interaction between the substrate and the 
activated oxygen species would occur distal to the iron (II) centre, with the activated oxygen 
species sitting between the iron and substrate. However, Sui et al., crystallising ACO in the 
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presence of a wide variety of different surfactants and in the absence of carotenoids or 
apocarotenoids, have observed the same electron density within the active site (Sui et al. 
2014). Consequently the electron density within the active site may in fact be due to either 
detergent or ordered water molecules sitting within the hydrophobic active site. Hence the 
geometry of the carotenoid substrate within the active site is still uncertain.  
Within the VP14 crystal structure, the two remaining coordination sites-on the iron 
centre are proposed to be occupied by water and dioxygen, which is bound in a side on fashion 
(Messing et al. 2010). In the ACO crystal structure no other ligands were reported on the iron 
other than the four histidine residues. Given the observations from the VP14 structure, it is 
reasonable to hypothesise that the oxygen binds to the iron in a side on fashion, sitting between 
the iron and the carotenoid substrate.  
Structural analysis also reveals that both the Vp14 and ACO enzymes are targeted to 
the membrane. In Vp14, an α-helical domain, consisting of two long antiparallel α-helices 
lined with non-polar alanine, phenylalanine and leucine residues, targets the enzyme to the 
active site (Figure 1.11). Given the hydrophobicity of the 9’-cis-neoxanthin substrate, which 
is likely to reside within the plastid membrane, this would allow the enzyme easy access to 
 
Figure 1.11 – Crystal structures of the CCD enzymes Z. mays VP14 and Synechocystis sp. ACO 
showing hydrophobic patches required for membrane association and access to carotenoid and 
apocarotenoid substrates. 
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the substrate, whilst preventing the substrate from entering the polar cytosol. A similar 
hydrophobic path is found on the surface of ACO (Figure 1.11). Here the patch is lined with 
leucine and phenylalanine residues, which are predicted to allow the enzyme to dip into the 
membrane and access substrate. Given that ACO acts on apocarotenoids, which are more polar 
due to the presence of either an aldehyde or ketone from a subsequent cleavage, it seems 
reasonable that ACO can access either substrates from either the cytosol or the membrane 
(Kloer et al. 2005, Messing et al. 2010). 
Sequence alignment of CCDs shows that they are related to another family of enzymes 
known as lignostilbene dioxygenases (LSD) (Figure 1.9) (Kamoda & Saburi 1993). LSD 
enzymes are found in bacteria and are required for the cleavage of lignostilbene into two 
equivalents of vanillin, which may be involved in the breakdown of lignin (Figure 1.12) (Bugg 
et al. 2011). Sequence alignment shows that LSD contains the four conserved histidine 
residues and second shell glutamine residues which are found in the CCD family (Tan et al. 
1997). LSD is known to be an iron dependent enzyme and given the sequence similarity 
between the enzymes it is possible that they share a common ancestor and catalytic 
mechanism.  
 
 
Figure 1.12 – Representation of the breakdown of lignostilbene to vanillin, which may be involved 
in the lignin degradation pathway performed by bacteria and fungi. 
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1.5 Plant Carotenoid Cleavage Dioxygenases: Biochemical Roles 
1.5.1 Carotenoid Cleavage Dioxygenase 1 (CCD1) 
The carotenoid cleavage dioxygenase 1 (CCD1) enzyme subfamily is unusual 
amongst the plant CCDs, as it is the only CCD not to be localised to the plastids within the 
plant cell (Bouvier et al. 2005). Originally identified in A. thaliana, AtCCD1 is a cytosolic 
enzyme, which catalyses the cleavage of the 9,10 or 9’,10’ bond in β-carotene to give a C13 
ketone (β-ionone) and a C27 aldehyde (Figure 1.13) (Schwartz et al. 2001). Other CCD1 
enzymes have been identified, based on sequence similarity to AtCCD1 (Schwartz et al. 
1997). CCD1 enzymes have been identified in Cucumis melo (melon), S. lycopersicum, Oryza 
sativa (rice), Coffea arabica (coffee), Vitis vinifera (grape), C. medica (citrus fruit), Fragaria 
ananassa (strawberry) and Rosa damascena (rose) (Idbah et al. 2006, Simkin et al. 2004, Ilg 
et al. 2009, Simkin et al. 2009, Mathieu et al. 2005, Kato et al. 2006, Garcia-Limones et al. 
2008, Huang et al. 2009). 
In A. thaliana, CCD1 has been shown to be expressed in high levels in flowers and 
siliques (Auldridge et al. 2006a). This supports the idea that one of the roles of CCD1 is the 
biosynthesis of aroma volatiles such as β-ionone, required for attracting pollinating insects. 
The expression of A. thaliana CCD1 has also been shown to be brought about by drought 
stress, suggesting that CCD1 may have a role in the plant drought tolerance response (Neill et 
al. 1998). 
 
Figure 1.13 – Cleavage reaction of β-carotene to β-ionone and β-apo-10’-carotenal catalysed by 
CCD1. The position of cleavage on β-carotene is indicated with a red line. 
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Interestingly, all members of the CCD1 enzyme family identified to date have a high 
degree of sequence similarity, indicating shared substrate specificities (Tan et al. 1997, Idbah 
et al. 2006). The CCD1 enzyme family shows a high degree of substrate promiscuity, with 
9,10 cleavage activity having also been reported against numerous carotenoids including, 
lycopene, 9’-cis and all-trans-violoxanthin, 9’-cis-neoxanthin and apocarotenoids including 
all-trans-β-apo-8’-carotenal (Figure 1.14) (Schwartz et al. 2001, Auldridge et al. 2006a, 
Schmidt et al. 2006). In addition to 9,10 cleavage, 5,6 and 5’,6’ cleavage has been reported in 
vitro on the substrate lycopene. However, this has not been shown in vivo (Vogel et al. 2008).  
Deletion of the gene encoding CCD1 in A. thaliana does not result in a change in plant 
phenotype, indicating that in plants it is likely that CCD1 is not the sole enzyme responsible 
for the cleavage of β-carotene (Auldridge et al. 2006a). Suppression of CCD1 by RNA 
interference (RNAi) in planta results in only a 50% loss of C13 (β-ionone) apocarotenoid levels 
(Floss et al. 2008). In addition, the CCD7 enzyme has also been shown to catalyse a 
9,10/9’,10’ cleavage of β-carotene to give β-ionone, and a C27 apocarotenoid (Schwartz et al. 
2004). It is likely, due to the hydrophobicity of the β-carotene substrate, that CCD7 
predominantly catalyses the cleavage of β-carotene in or around the plastid membranes. CCD1 
is then able to act on the more polar C27 apocarotenoid in the cytosol, catalysing a 9,10 
 
Figure 1.14 – Cleavage positions of CCD1 on the carotenoid substrates lycopene, violaxanthin, 9’-
cis-neoxanthin and the apocarotenoid β-apo-8’-carotenal. 
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cleavage to give a second equivalent of β-ionone and a C14 dialdehyde. CCD1 is important for 
the biosynthesis of C13 and C14 apocarotenoids in the roots, such as β-ionone and mycorradicin, 
which form important plant pigments and volatiles (Bouvier et al. 2005) (Figure 1.15). The 
possibility also exists that CCD1 acts on other C27 apocarotenoids, derived from carotenoids 
other than β-carotene, leading to other apocarotenoids. 
1.5.2 Carotenoid Cleavage Dioxygenase 4 (CCD4) 
 The carotenoid cleavage dioxygenase 4 family of CCDs is possibly the least explored 
member of the CCD family. Little is known about the in planta roles of CCD4 or its 
biochemistry. RNAi silencing of the CCD4 gene in Chysanthemum morifolium 
(chrysanthemum) resulted in no phenotypic changes other than decolourisation of petals from 
white to yellow (Ohmiya et al. 2006). Further in planta experiments using RNAi in Solanum 
tuberosum (potato) resulted in increased levels of violoxanthin, indicating that violoxanthin 
may be the natural substrate in vivo (Campbell et al. 2010).  Phenotypic effects were observed 
on heat sprouting and tubers, suggesting that the CCD4 cleavage product may be involved in 
development of potato tubers.   
 In vivo experiments with β-carotene, cis-ζ-carotene (Figure 1.16) and lycopene 
accumulating Escherichia coli revealed that CCD4 from Malus domestica (apple), C. 
morifolium, R. damascena, Osmanthus fragrens (osmanthus) and A. thaliana were only able 
to cleave β-carotene at the 9,10 / 9’,10’ position, producing β-ionone and β-apo-10-carotenal  
(Huang et al. 2009, Rubio et al. 2008). In vitro, CCD4 enzymes from A. thaliana and R. 
damascena were both able to cleave β-apo-8’-carotenal at the 9,10 / 9’,10’ position to produce 
 
Figure 1.15 – Structures of the aroma volatiles mycorradicin and β-ionone. 
 
Figure 1.16 – Structure of ζ-carotene. 
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β-ionone. Given the difference in in vitro specificity, it is possible the different CCD orthologs 
from different species act on different substrates in planta. 
1.5.3 Carotenoid Cleavage Dioxygenase 7 and 8 – Strigolactone Biosynthesis 
 CCD7 and CCD8 are often discussed together since both are involved in the 
biosynthesis of the plant signalling molecule strigolactone. The existence of strigolactone has 
been known for some time, as it is involved in rhizosphere signalling in plants. However, it 
was not until recently that strigolactone was identified as a phytohormone which acts to inhibit 
lateral shoot branching in plants (Akiyama et al. 2005, Gomez-Roldan et al. 2008, Umehara 
et al. 2008, Brewer et al. 2013). Currently, only the details of the initial stages of strigolactone 
biosynthesis are known. 
Analysis of More Axillary Branching (max, i.e. more shoot branching) mutants and 
Ramosous mutants (rms) of A. thaliana and Pisum sativum (garden pea) respectively led to 
the identification of max/rms genes required for the biosynthesis of a then-unknown hormone 
(Turnbull et al. 2002, Beveridge 2000, Beveridge et al. 1996, Morris et al. 2001). The product 
of max3 and max4 was found to be graft transmissible, indicating that the product of the max 
pathway was a signalling molecule (Leyser 2005, Dun et al. 2006). Initially max4/rms1 was 
identified as a carotenoid cleavage dioxygenase (CCD8), however, its biochemical function 
remained unknown (Sorefan et al. 2003). In vivo experiments by Auldridge et al. suggested 
CCD8 was capable of cleaving the carotenes lycopene, zeaxanthin (Figure 1.17) and β-
carotene (Auldridge et al. 2006). Subsequently max3/rms2 was shown to code for a carotenoid 
cleavage dioxygenase, termed CCD7, and was shown to cleave β- and ζ-carotene in vivo 
(Booker et al. 2004). In vitro biochemical characterisation by Schwartz et al. on the gene 
 
Figure 1.17 – Structures of zeaxanthin and lutein. 
  Chapter One: Introduction 
Page | 19  
 
products of max3/max4 (A. thaliana CCD7 and CCD8 respectively) showed that CCD7 was 
indeed able to cleave all-trans-β-carotene at the 9,10/9’,10’ position to produce 
all-trans-β-apo-10-carotenal (a C27 aldehyde) and that CCD8 then cleaved β-apo-10-carotenal 
to produce β-apo-13-carotenal (a C18 ketone) (Figure 1.18) (Schwartz et al. 2004). The 
β-apo-13-carotenal was then proposed to be converted to strigolactone via an unknown 
process in the remainder of the pathway. Further in vitro experiments by Alder et al. with 
A. thaliana and O. sativa CCD8 corroborated the findings of Schwartz (Alder et al. 2008).  
Genetic knockout experiments by Lin et al. in O. sativa led to the identification of 
another enzyme on the strigolactone biosynthesis pathway (Lin et al. 2009). The enzyme, 
Dwarf27 (D27, due to the fact that gene knockout mutants display a dwarf phenotype) was 
shown to be an iron containing enzyme of unknown function which acted upstream of max1, 
a cytochrome P450. The homologue of D27 has subsequently been identified in Arabidopsis 
(Waters et al. 2012). D27 does not share sequence similarity with the CCD enzyme family, 
nor to any other protein of known function. As such, the role of the iron in D27 remained 
unknown, as did the catalytic mechanism of the enzyme.  Experiments by Alder et al. have 
identified D27 as an isomerase, which converts the all-trans isomer of β-carotene to 9-cis-β-
 
Figure 1.18 – Initial proposal for the start of the biosynthetic route to strigolactone, via the formation 
of β-apo-13-carotenal produced by the sequential action of CCD7 and CCD8. 
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carotene (Alder et al. 2012). The 9-cis-β-carotene is then cleaved by CCD7 at the 9’,10’ 
position to produce 9-cis-β-apo-10’-carotenal, which is then converted to a compound named 
carlactone by CCD8 (Figure 1.19). Carlactone is then converted by the rest of the strigolactone 
biosynthesis pathway to strigolactone, an unknown process which is known to include at least 
one P450 oxidase (max1) (Booker et al. 2005, Lazar & Goodman 2006). The CCD8 reaction 
is most unusual for a CCD as it appears to catalyse two sequential cleavage reactions on the 
same substrate. 
Experiments by Alder and co-workers show that CCD7 cleaves 9-cis-β-carotene 10 
fold faster than it does the all-trans isomer. CCD7 has also been shown to cleave the 9-cis 
isomers of zeaxanthin and lutein (Bruno et al. 2014). Two groups have also recently reported 
that the P450 MAX directly catalyses the conversion of carlactone into strigolactone (5-deoxy-
strigol) (Zhang et al. 2014, Abe et al. 2014). Unknown enzymes can then subsequently further 
oxidise 5-deoxy-strigol to produce other functional strigolactones.  
 
Figure 1.19 – Current proposed biosynthetic route from all-trans-β-carotene to carlactone, an 
intermediate on the strigolactone biosynthesis which is converted to strigolactone through an 
unknown process. The position of isomerisation on all-trans-β-carotene is indicated with a red 
arrow. The positions of cleavage in 9-cis-β-carotene and 9-cis-β-apo-10’-carotenal are indicated 
with red lines. 
  Chapter One: Introduction 
Page | 21  
 
1.5.4 9’-cis-Epoxycarotenoid Dioxygenases (NCEDs) – Abscisic Acid Biosynthesis 
Abscisic acid is a plant hormone which is involved in a number of different plant 
processes such as secondary seed dormancy and drought tolerance (Taylor et al. 2005, Iuchi 
et al. 2001, Nambara & Marion-Poll 2005). NCED1 from Z. mays was the first CCD enzyme 
to be biochemically characterised. A vivaporous seed mutant from Z. mays was discovered to 
be deficient in abscisic acid biosynthesis. The mutant was found to contain a lesion in the vp14 
gene, which codes for a protein with sequence similarity to the lignostilbene dioxygenase 
enzyme family (Schwartz et al. 1997). Genetic investigations have shown that, in A. thaliana 
at least, there are five isoforms of the NCED enzyme, termed NCED2, NCED3, NCED5, 
NCED6 and NCED9. However, the localisation of these isoforms within the plant varies, as 
does their roles in controlling plant biological processes (Tan et al. 2003, Lefebvre et al. 2006). 
A. thaliana NCED2 and NCED3 are localised in the roots and reproductive tissues, whereas 
A. thaliana NCED5, NCED6 and NCED9 are localised solely in reproductive tissues. The 
presence of all NCEDs within the reproductive tissue, and the fact they are expressed during 
early plant growth is consistent with NCED playing a role in controlling development (Tan et 
al. 2003, Lefebvre et al. 2006). In Arabidopsis, NCED6 and NCED9 are the most important 
NCEDs for seed ABA content (Kucera et al. 2005). In addition to the control of development, 
NCEDs control seed germination and plant responses to drought through the action of ABA 
(Finch-Savage & Leubner-Metzger 2006). 
The biosynthesis of abscisic acid begins with 9’-cis-neoxanthin, which is produced 
via a series of enzymatic reactions from β-carotene to produce all-trans-neoxanthin (Taylor et 
al. 2005, Walter & Strack 2011). An unknown isomerase activity then selectively isomerises 
the 9’,10’ double bond in a reaction which appears analogous to that performed by D27 in the 
strigolactone biosynthesis pathway. NCED then catalyses the 11’,12’ cleavage of 
9’-cis-neoxanthin to a C25 aldehyde and xanthoxin (Figure 1.20) (Tan et al. 1997). The NCED 
cleavage reaction is the rate limiting step on the abscisic acid biosynthesis pathway. Xanthoxin 
is then reduced by a short chain alcohol dehydrogenase known as xanthoxin dehydrogenase 
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(ABA2) to abscisic aldehyde, which is then finally oxidised to abscisic acid by abscisic acid 
oxidase (AAO3) (Gonzalez-Guzman et al. 2002, Burbidge et al. 1999). 
Biochemical investigations with Z. mays VP14 have shown that it is selective for the 
9-cis isomers of the epoxycarotenoids violoxanthin, neoxanthin and luteoxanthin and is 
targeted to chloroplast membranes in the cell (Tan et al. 2001, Schwartz et al. 2003). VP14 
shows no activity towards the all-trans isomers.  
 1.6 Mechanisms of CCD Cleavage 
 There is some debate within the literature with regards to the mechanism of cleavage 
by carotenoid cleavage dioxygenases. Primarily debate surrounds whether CCDs perform a 
monooxygenase or dioxygenase cleavage of the carotenoid. However, mechanistic studies are 
limited to a small number of examples performed on Z. mays NCED1, mammalian BCO and 
 
Figure 1.20 – Biosynthetic route from all-trans-β-carotene to abscisic acid. The rate limiting step, 
the cleavage of 9’-cis-neoxanthin, is catalysed by NCED. 
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A. thaliana CCD1. Early 18O2 labelling experiments with Z. mays NCED1 suggested a 
dioxygen mechanism, with almost 100% labelling of abscisic acid in the carboxylic acid 
position (Zeevaart et al. 1989). Subsequent 17O2 labelling studies by Leuenberger et al. with 
mammalian BCO gave only 50% incorporation of 17O into the retinal products (Leuenberger 
et al. 2001). Consequentially this was interpreted as a monooxygenase mechanism, 
contradicting the findings of work on Z. mays. Labelling studies using A. thaliana CCD1, 
however, again showed 100% incorporation of 18O into the β-ionone and β-apo-10’-carotenal 
products (Schmidt et al. 2006). Re-interpretation of the work by Leuenberger suggested that 
the apparent 50% incorporation on 17O could be due to exchange of isotopically labelled 
oxygen with unlabelled oxygen in bulk water, as samples were left for 24 hours before 
analysis. Aldehydes are reactive species and can exchange rapidly with water. Beyond 
labelling experiments, there is no other experimental data in the literature pertaining to the 
CCD cleavage mechanism. 
It is likely that activation of molecular oxygen in the CCD enzyme reaction occurs via 
single electron transfer from Fe (II) to oxygen to generate superoxide, as can be deduced by 
analogy to other non-heme iron dependent enzymes such as extradiol catechol dioxygenases 
or 2-oxo-glutarate dependent dioxygenases (Bugg 2003, Bugg & Ramaswamy 2008). Attack 
of superoxide on the carotenoid backbone would create a radical intermediate (Figure 1.21) 
which would be stabilised via conjugation along the polyene backbone. Subsequent one 
electron transfer back to the Fe (III) would restore the resting state Fe (II) and create a similarly 
highly stabilised secondary or tertiary cation, depending upon the position of cleavage. 
Although no evidence exists for the formation of a cation, it is consistent with inhibition of 
Vigna unguiculata (cowpea) and A. thaliana NCED3 by abamine (Figure 1.21 and Section 
1.8). At physiological pH, the tertiary amine of abamine is likely to be protonated, resulting 
in a tertiary amine cation. This cation would mimic the substrate cation and bind to the active 
site, inhibiting the cleavage reaction.  
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 Following formation of the secondary cation, one of three reactions is possible 
(Figures 1.22 and 1.23). Firstly, the oxygen anion could ring close onto the cation to form a 
highly strained four membered dioxetane ring (path one). Breakdown of the dioxetane would 
result in the two aldehyde products (Schmidt et al. 2006, Harrison & Bugg 2013). The second 
possible mechanism involves nucleophilic attack of water on the carbocation (path two) 
followed by a Criegee rearrangement. This would result in a secondary carbocation which 
would be quenched by iron (II) hydroxide. A similar mechanism is proposed to occur in the 
extradiol catechol dioxygenases and the resulting hemi-acetal would break down to form the 
two aldehyde products (Bugg 2003). A third possible mechanism, the monooxygenase 
mechanism (Figure 1.23), also exists, whereby an epoxide forms following formation of the 
carbocation (Leuenberger et al. 2001). Formation of the epoxide would result in a high energy 
iron (IV) intermediate and attack on the epoxide by water would result in the formation of an 
α,β-diol, which breaks down to form the two aldehyde products.  
 Without detailed mechanistic data it is very difficult to distinguish between the 
possible mechanisms. Labelling experiments with 18O2 strongly suggest a dioxygen 
mechanism, incorporating both atoms of oxygen from O2. However, whether that mechanism 
proceeds through a dioxetane intermediate or Criegee intermediate is unknown. It was noted 
in the crystal structure of VP14 that there is a lack of acidic and basic residues within the 
active site, which would lend support for a dioxetane mechanism (Messing et al. 2010). 
However, in the case of 9,10 cleavage reactions, formation of the dioxetane would require 
attack on a tertiary cation, which could present a steric challenge for the enzyme. In addition 
to this, dioxetane formation in catalysis is very rare. Very few enzymes are known to proceed 
 
Figure 1.21 – Structures of the protonated abamine and the secondary substrate cation formed during 
carotenoid cleavage. 
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through a dioxetane mechanism as formation of a dioxetane ring is an unfavourable 
endothermic process. Vitamin K-dependent carboxylase and firefly luciferase are two 
examples of enzymes whose mechanisms are known to proceed through dioxetane 
intermediates (Suttie 1985, Dowd et al. 1994, McCapra 1976, Franks & Brick 1996).  
The Criegee rearrangement mechanism, however, requires the addition of water, so 
18O2 experiments would result in either one or two atoms of 18O being incorporated depending 
upon the direction of the final C-O cleavage step. Only the dioxetane mechanism would 
 
Figure 1.22 – Proposed dioxygen cleavage mechanisms for CCDs based upon the NCED catalysed 
cleavage of 9’-cis-neoxanthin. Path one involves the formation of a dioxetane intermediate which 
breaks down to form two aldehyde products. Path two, however, utilises a Criegee rearrangement 
(which can also proceed in the reverse direction). Figure adapted from Harrison & Bugg 2013. 
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guarantee incorporation of both atoms from molecular oxygen. Another issue is the source of 
water to attack the substrate cation, which could be provided via the semi conserved second 
shell glutamic acid residues participating in catalysis, possibly by deprotonating water. This 
could arise through the iron cofactor acting as a Lewis acid. The sixth ligand on the iron (II), 
most likely water, would have its pKa lowered to between 7-10. A proton this acidic could 
then be abstracted by one of the second shell glutamate residues, allowing participation in 
catalysis. A metal cofactor acting as a Lewis acid is not unprecedented. In the 
carboxypeptidase active site the zinc cofactor decreases the pKa of bound water allowing 
deprotonation by a glutamate ligand (Christianson & Lipscomb 1989). If this were the case it 
would lend support for the Criegee rearrangement.  
 As discussed, there is a high degree of sequence similarity between the carotenoid 
cleavage dioxygenases and the lignostilbene dioxygenases. Labelling studies using 18O2 on 
two lignostilbene dioxygenases identified from Novosphingomonas aromaticivorans have 
shown only 50% incorporation of the 18O label into the products, suggesting a monooxygenase 
mechanism for these lignostilbene dioxygenases (Marasco & Schmidt-Dannert 2008). In 
addition, the LSDs assayed showed no activity against carotenoids or apocarotenoids. The 
inability of LSD to cleave carotenoids is unsurprising, given how CCDs tend to cleave 
substrates of similar structures (Wirtz et al. 2001). However, the observation of a 
monooxygenase mechanism is interesting. It is entirely possible that the reaction is proceeding 
via a dioxygenase mechanism, but with a Criegee rearrangement, which eliminates the other 
18O label. Such a mechanism would explain why only 50% labelling is observed.  
 
Figure 1.23 – Possible monooxygenase cleavage mechanism of carotenoids by CCDs, proposed by 
Leuenberger et al. (Leuenberger et al. 2001). Figure from Harrison & Bugg 2013. 
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 Computational studies have been performed examining the thermodynamics of 
possible CCD cleavages (Borowski et al. 2008). Such studies, which examine the lowest 
energy routes through the reaction, suggest that energetically the dioxetane intermediate is 
more likely than the epoxide intermediate. However, the study did not examine the possible 
Criegee rearrangement, so such a mechanism cannot be discounted.  
 Little insight into carotenoid cleavage is provided by model chemistry. To date, only 
one model complex, involving a ruthenium porphyrin, has been demonstrated (French et al. 
2000). The ruthenium complex has been shown to cleave β-carotene to two equivalents of 
retinal in the presence of t-butyl hydroperoxide.  
1.7 Carotenoid Isomerisation 
  In addition to carotenoid cleavage activity, another role of CCDs has emerged; the 
isomerisation of carotenoid substrates. The enzyme RPE65, which shares sequence similarity 
to the CCD enzyme family, although not strictly a CCD, isomerises all-trans-retinyl esters to 
11-cis retinol (Oberhauser et al. 2008). Debate surrounds the proposed mechanism of 
isomerisation by RPE65. It was initially proposed by Deigner et al. (before the discovery of 
RPE65) that isomerisation occurred through an enzyme active site nucleophile specifically 
attacking the 11,12 double bond of all-trans-retinyl ester, eliminating a carboxylate (Deigner 
et al. 1989). This removes the double bond character at the 11,12 double bond allowing  
isomerisation (Figure 1.24). Attack on the terminal double bond by water eliminates the active 
site base and forms the 11-cis-retinal. Several issues with this mechanism were raised by 
McBee et al. including the breaking a highly stable conjugated double bond system through 
nucleophilic attack and addition of water to conjugated double bond system (McBee et al. 
2000). 
  A second mechanism involving a carbocation mediated mechanism was proposed by 
McBee et al. (McBee et al. 2000). Here retinol is protonated by an active site acid, resulting 
in elimination of water and the formation of a primary cation, which is delocalised along the  
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conjugated system. This results in a loss of double bond character, allowing isomerisation. 
Addition of water to the cation re-establishes the conjugated system and forms the 11-cis-
retinol (Figure 1.25). Further evidence in support of the cation mediated mechanism was 
provided by Redmond et al. following the discovery of RPE65 (Redmond et al. 2010). It was 
observed in vitro that RPE65 was a leaky enzyme, producing the 13-cis isomer of retinal in 
addition to the 11-cis isomer, which is consistent with a carbocation mediated mechanism. 
Mutations which removed aromaticity in the active site all resulted in a decrease in activity, 
consistent with a loss of cation stabilisation.  
 
Figure 1.24 – Proposed isomerisation mechanism of all-trans-retinol to 11-cis-retinal involving 
attack of an active site base specifically on the 11,12 double bond of all-trans-retnyl-ester, resulting 
in the loss of polyene double bond character, allowing isomerisation. Attack of water on the terminal 
alkene reforms the polyene system and eliminates the active site base.  
 
Figure 1.25 – Proposed isomerisation mechanism of all-trans-retinol to 11-cis-retinal involving the 
formation of a substrate cation, resulting in a loss of double bond character, allowing free rotation 
of the delocalised polyene backbone. 
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  18O labelling studies by Kiser et al. with H2O18 revealed that the oxygen on the retinol 
originated from bulk water (Kiser et al. 2009). Consequentially it was proposed that 
isomerisation of the all-trans-retinyl ester by RPE65 occurs through an O-alkyl cleavage 
reaction (Figure 1.26) (Kiser et al. 2012). The ferrous iron acts as a Lewis acid, coordinating 
the ester moiety and delocalising electron density towards the carbonyl. This results in 
cleavage of C-O of the ester, forming a primary carbocation which is delocalised along the 
polyene backbone. Delocalisation of the cation results in a loss of double bond character, 
allowing free rotation of the of the C-C bonds. Attack of water on the terminus of the 
carotenoid cation results in formation of 11-cis-retinal. Although unusual, iron is known to act 
as a Lewis acid, a feature which is likely enhanced by coordination to four uncharged histidine 
ligands (Sanvoisin et al. 1995). Aromatic residues within the active site have been shown to 
mediate the isomerisation reaction to ensure the formation of the 11-cis product and modulate 
the progression of the reaction (Chander et al. 2012).  
  Isomerisation has also been observed in the CCD NinaB from G. mellonella, which 
not only cleaves carotenoids but also forms isomerised cleavage products (Oberhauser et al. 
2008). In this case there is no ester moiety with which the carotenoid substrate can bind to the 
iron. As a result, the question arises as to how is NinaB able to catalyse an isomerisation 
reaction? Examination of the carotenoid cleavage mechanism provides some possible answers 
(Figure 1.27) (Harrison & Bugg 2013). Following the formation of the substrate radical or 
 
Figure 1.26 – Current accepted mechanism for the isomerisation of all-trans-retinyl ester to 11-cis-
retinol in which ferrous iron acts a Lewis acid, causing ester hydrolysis. Free rotation can occur in 
the subsequent cation before attack of water forms the 11-cis-retinol product. 
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cation the double bond character of the carotenoid is lost. Just as in the case of the RPE65 
isomerisation, at this point free rotation of the C-C bonds on the backbone is allowed. The 
reaction can then either proceed to completion, resulting in the formation of the two isomerised 
oxidised products, or reverse, since formation of the substrate radical is reversible thus 
forming the isomerised carotenoid. Radical mediated isomerisation is precedented in non-
heme iron (II) dioxygenase chemistry. The cis-trans isomerisation of cycloproyl analogues 
was observed by Spence et al. with the extradiol cleavage dioxygenases MhpB from 
Escherichia coli and Alcaligenes eutrophus (Spence et al. 1996). In the case of NinaB it is 
likely that isomerisation occurs during the cleavage reaction. 
  It was suggested by Kloer et al. that the Synechocystis sp. ACO was also able to 
perform isomerisation reactions (Kloer et al. 2005). Electron density observed within the 
active site was assumed to belong to an isomerised carotenoid substrate. However, this 
electron density has since been shown not to be due to a bound carotenoid substrate and ACO 
has been shown not to catalyse isomerisation reactions (Sui et al. 2014).  
 
Figure 1.27 – Possible mechanism for the isomerisation of carotenoids. Following formation of the 
secondary radical, double bond character is lost, allowing free rotation and isomerisation. Reversal 
of the steps would then result in the isomerised carotenoid product.  
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  Two other enzymes not belonging to the carotenoid cleavage dioxygenases enzyme 
family have also been shown to catalyse carotenoid cleavage. The first of these to be identified 
was prolycopene isomerase (CRTISO), first identified in S. lycopersicum and subsequently in 
A. thaliana (Isaacson et al. 2002, Park et al. 2002). Prolycopene isomerase is responsible for 
the isomerisation of 7,9/7’,9’-cis-phytoene to all-trans-phytoene, the final step in the 
biosynthesis of all-trans-phytoene in plants. Prolycopene isomerase has been shown to contain 
a flavin adenine dinucleotide (FAD(H)) or nicotinamide adenine dinucleotide (NAD(H)) 
cofactor binding domain (Isaacson et al. 2004). Prolycopene isomerase from S. lycopersicum 
activity has been found to be dependent upon reducing conditions and upon the presence of 
cytoplasmic extracts. CTRISO is inactive in the purified form without the addition of 
cytoplasmic components from lysed E. coli (Isaacson et al. 2004) It has been suggested that 
CRTISO receives an electron from complex I (NADH ubiquinone oxidoreductase) in the 
electron transport chain and uses this electron to break the conjugation of 7,9/7’,9’-cis-
phytoene, thus allowing isomerisation. The electron is then passed onto complex II (succinate 
ubiquinone oxidoreductase). This proposed mechanism is consistent with the observation that 
CRTISO is dependent upon other cytosolic materials, however, it does not explain the function 
of the FAD(H)/NAD(H) binding domain or suggest how electron transfer is mediated by 
CRTISO.  
  The second enzyme, Dwarf27 first identified in O. sativa and subsequently in A. 
thaliana, is required for the isomerisation of all-trans-β-carotene to 9-cis-β-carotene in the 
biosynthesis of strigolactone (see Section 1.5.3) (Lin et al. 2009, Alder et al. 2012, Waters et 
al. 2012). Interestingly D27 shows no sequence similarity to prolycopene isomerase, nor does 
it contain an FAD(H) binding domain like prolycopene isomerase. D27 has, however, been 
shown to contain 1.7 moles of iron for every one mole of protein. Currently the mechanisms 
of isomerisation by both prolycopene isomerase and Dwarf27 remain unknown. 
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1.8 Inhibition of Carotenoid Cleavage Dioxygenases 
  Within the literature there are several different examples of small molecule 
compounds which inhibit carotenoid biosynthesis and subsequently apocarotenoid production 
(Bramley 1993). One of the most well-known compounds is norflurazon (Figure 1.28), which 
inhibits the enzyme phytoene desaturase (Bartels & Watson 1978). However, these 
compounds all act high up on the carotenoid biosynthesis pathway. As a result, these 
compounds are non-specific, inhibiting almost all carotenoid and apocarotenoid mediated 
processes. However, over the last decade, several different CCD specific inhibitors have been 
identified. The first CCD specific inhibitor identified was nordihydroguaiaretic acid (NDGA), 
originally developed as a lipoxygenase inhibitor which is known to inhibit ABA biosynthesis 
(Creelman et al. 1992). NDGA was shown to inhibit V. unguiculata NCED1 in vitro by 80% 
at 100 µM (Han et al. 2004a, Han et al. 2004b). Given the structure of NDGA (Figure 1.29), 
it is likely it inhibits by acting as a substrate analogue. Binding to the active site and blocking 
carotenoid access.   
  A second NCED inhibitor was subsequently developed, abamine (Figure 1.29) (Han 
et al. 2004a). Abamine is a tertiary amine compound with a Ki of 38.8 µM in vitro against V. 
unguiculata NCED1. At physiological pH, it is likely that the tertiary amine of abamine will 
be protonated. This tertiary amine cation could then inhibit the CCD enzyme by mimicking 
the cation which is believed to form during the cleavage of carotenoids by CCDs (see Section 
1.6). Interestingly abamine shows some selectivity towards NCEDs. Abamine has been shown 
to inhibit S. lycopersicum CCD1 in vitro by 35% at 100 µM (Sergeant et al. 2009). A second 
generation abamine inhibitor, known as abamineSG, has been developed (Figure 1.29) 
(Kitahata et al. 2006). AbamineSG is very similar to abamine, however, it contains a longer 
 
Figure 1.28 – Chemical structure of norflurazon. 
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ester moiety, most likely increasing the affinity with which the molecule can bind to the 
hydrophobic active site with. In vitro against V. unguiculata NCED1 a Ki of 18.5 µM was 
reported. In planta both abamine and abamineSG inhibit ABA biosynthesis.  
  A family of sesquiterpene like compounds have also been shown to inhibit CCD 
cleavages and lead to reductions of ABA levels in planta (Figure 1.29) (Boyd et al. 2009). 
Boyd et al. have reported almost 100% inhibition of A. thaliana NCED3 in vitro by some 
sesquiterpene like inhibitors at 100 µM. However, the sesquiterpene like compounds are less 
effective than abamine and abamineSG, with the most effective compound having a modest 
Ki of 93 µM. Being sesquiterpene like compounds, these inhibitors are proposed to inhibit 
NCED via a mechanism similar to that of NDGA. 
  Despite several compounds being shown to be effective inhibitors of NCED, only one 
class of compounds have been shown to inhibit other CCD enzymes. Hydroxamic acids are 
known iron chelators which have been shown to be effective at inhibiting S. lycopersicum 
CCD1a. In vitro at 100 µM, 100% inhibition is seen by some members of the hydroxamic 
family, and IC50 values lower than <1 µM are reported (Sergeant el al. 2009). The hydroxamic 
acids are believed to inhibit CCDs by binding to the active site iron, blocking carotenoid 
 
Figure 1.29 – Structures of the four classes of small molecule CCD inhibitors.   
  Chapter One: Introduction 
Page | 34  
 
access to the active site. It is proposed that by varying the aryl-N length (Figure 1.29), the 
specificity of the hydroxamic acids can be altered (Figure 1.29 and see Chapters 2 and 3 for a 
complete list of hydroxamic acid inhibitors). However, against S. lycopersicum NCED1 in 
vitro at most 33% inhibition at 100 µM was observed. This is somewhat lower than the 
inhibition seen for abamine, abamineSG and the sesquiterpene like compounds, and also lower 
than the inhibition seen against CCD1. Differences in active site architecture could well 
explain the differences in the levels of inhibition observed. In vivo against A. thaliana CCD7 
weak inhibition (less than 50% inhibition at 100 µM) has been seen by the hydroxamic acids. 
However, low inhibition here may be due to poor uptake of the inhibitor by E. coli. 
Additionally, against M. musculus BCOI and BCOII in vivo at 100 µM less than 30% 
inhibition was recorded. Given that BCOI is a 15,15’ cleavage enzyme, a lack of inhibition is 
expected. However, BCOII has 9,10/9’,10’ β-carotene cleavage specificity like CCD1. As a 
result, inhibition levels similar to CCD1 would be expected for BCOII. This could suggest a 
different mechanism of inhibition. However, poor uptake into E. coli is the likely cause of the 
poor inhibition observed. 
  In planta, phenotypic effects on shoot branching and seed germination have been seen 
in the presence of several members of the hydroxamic acid inhibitor family (Figure 1.30)  
(Sergeant et al. 2009, Sergeant et al. unpublished). For example, the compound D4 (Table 
1.1) when applied to seeds can partially overcome the osmotic inhibition of germination. 
Effects on seed germination are believed to be mediated through inhibition of NCED. NCED 
is the rate limiting step in the biosynthesis of ABA, which induces secondary seed dormancy, 
preventing seed germination (Finch-Savage & Leubner-Metzger 2006). Effects on shoot 
branching have also been observed (Sergeant et al. 2009). When compound D6 (Table 1.1) is 
applied to wild type A. thaliana, there is a two fold increase in the number of shoot branches 
produced (Figure 1.30). Mediation of the shoot branching phenotype is thought to occur 
through inhibition of CCD7 and/or CCD8, which controls the biosynthesis of strigolactone, a 
phytohormone which inhibits shoot branching in plants (Gomez-Roldan et al. 2008, Umehara 
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et al. 2008). Additionally, with the hydroxamic acids F1 and F2 (Table 1.1), phytotoxic effects 
on A. thaliana have been observed which can be observed through bleaching of the plants  
(Figure 1.31) (Sergeant et al. 2013). This phytotoxicity effect has been shown to occur 
partially through inhibition of metalloenzyme p-hydroxy-phenylpyruvate dioxygenase, a 
known herbicide target (Sergeant et al. 2013). However, studies indicate that a second, 
unknown enzyme, is also involved. One hydroxamic acid, D15 (Table 1.1), has also been 
shown to effect lateral root branching in A. thaliana (Figure 1.30) (Van Norman et al. 2014). 
The biochemical target of this inhibitor is unknown and is believed to constitute a new role 
for carotenoids in planta. 
 
Figure 1.30 – In planta phenotypes observed in A. thaliana on addition of hydroxamic acid 
inhibitors. Figures A and B show lateral root branches in wild type (Columbia-0) A. thaliana 
without (A) and with (B) the application of 125 µM D15. Absence of lateral roots in the presence 
of D15 suggest inhibition of a carotenoid derived molecule. Figures C and D show shoot branching 
in wild type (Columbia-0) A. thaliana without (C) and with (D) 100 µM D6. Increased shoot 
branching in the presence of compound D6 suggests inhibition of strigolactone biosynthesis. Images 
from Van Norman et al. 2014 and Sergeant et al. 2009. 
 
Figure 1.31 – Bleaching observed on wild type (Columbia-0) A. thaliana in the presence of 100 
µM compound F1. Image from Sergeant et al. 2013. 
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 Inhibitors of lignostilbene dioxygenases have been reported. Han et al. have shown that 
(Z)-1-(4-hydroxyphenyl)-1-fluoro-2-phenylethene (Figure 1.32) is a competitive inhibitor in 
vitro of lignostilbene-α,β-dioxygenase (LSD) from P. paucimobilis, with a Ki of 0.98 µM (Han 
et al. 2002). Effective inhibition of LSD was found to result from polarisation of the double 
bond, with the fluorine in the Z configuration, which limits delocalisation of electrons. 
Additionally, a 4-hydroxy group was also required for inhibition and is proposed to be 
essential for binding of the substrate with the active site of the enzyme. However, when tested 
in vitro against A. thaliana NCED3, (Z)-1-(4-hydroxyphenyl)-1-fluoro-2-phenylethene 
showed no inhibition, which is proposed to be due to a lack of binding of the inhibitor to the 
NCED active site. Han et al. have also reported the inhibition of LSD by N-benzylideneaniline 
Phenotype 
Species 
Observed in 
Mediated 
by? 
Inhibitor Structure 
S
ee
d
 
G
er
m
in
at
io
n
 
Arabidopsis 
thaliana, Z. 
mays 
NCED D4 
 
S
h
o
o
t 
B
ra
n
ch
in
g
 
Arabidopsis 
thaliana 
D27 or 
CCD7 or 
CCD8 
D6 
 
B
le
ac
h
in
g
 
Arabidopsis 
thaliana 
HPPD 
and 
unknown 
target 
F1 
 
F2 
 
L
at
er
al
 r
o
o
t 
B
ra
n
ch
in
g
 
Arabidopsis 
thaliana 
Unknown D15 
 
Table 1.1 – Summary of phenotypic effects observed in planta on addition of hydroxamic inhibitors 
to A. thaliana and Z. mays and the enzymes believed to be involved in mediation of the phenotype. 
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and N-benzylaniline derived compounds (Han et al. 2004b). In vitro against P. paucimobilis 
LSD the compounds N-(4-Hydroxybenzylidene)-3-methoxyaniline and N-(4-hydroxybenzyl)-
3-methoxyaniline (Figure 1.33) were shown to have IC50 values of 0.3 µM and 10 µM 
respectively. However, neither compound was effective in vitro against A. thaliana NCED3.  
1.9 Aims 
 By 2050 it is projected that the world population will have reached 9.5 billion people, 
straining world food production resources (United Nations World Population Prospects, 2012 
Revision). It is therefore of paramount importance to maximise land use efficiency, ensuring 
high yielding crops are produced. Many of the factors which can lead to crop failure or low 
yields are due to abiotic stress (non-living factors), such as temperature and water levels 
(Mendelsohn 2007). Abiotic stress management seeks to control these factors to ensure high 
crop yields. For example, secondary seed dormancy in plants is controlled by the hormone 
abscisic acid, the levels of which in seeds can vary according to several factors including 
osmotic potential and temperature (Finch-Savage & Leubner-Metzger 2006). It is proposed 
that abscisic acid levels in seeds can be controlled through a chemical genetics approach which 
lowers abscisic acid levels ensuring crops could be planted with a high certainty of 
germination, reducing crop failure and increasing yields.  
CCD enzymes are vital for the biosynthesis of the phytohormones abscisic acid and 
strigolactone which control many important plant process. As a result, much work has been 
conducted in order to understand the biochemical roles that CCDs play in different organisms. 
 
Figure 1.32 – Structures of the lignostilbene dioxygenases inhibitors (Z)-1-(4-hydroxyphenyl)-1-
fluoro-2-phenylethene, N-(4-Hydroxybenzylidene)-3-methoxyaniline and N-(4-hydroxybenzyl)-3-
methoxyaniline 
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One such method, in addition to knock-out mutants, is to use inhibit enzymes with small 
molecules, such as the inhibitors described in Section 1.8. In order to understand the pathways 
which control the biosynthesis of these important phytohormones, a detailed understanding of 
the targets of the small molecule interventions and the mechanisms of the enzymes is required. 
In particular, the mechanisms of carotenoid cleavage dioxygenases, which catalyse the rate 
limiting steps in strigolactone and abscisic acid biosynthesis.  
 The aim of this project, the results of which are described in the coming chapters, is 
to understand the biochemical basis for the phenotypic effects observed. Previously published 
studies have only studied the tomato CCD1a and NCED1 enzymes in vitro (Sergeant et al. 
2009). Expanding the in vitro study to explore the enzymes of the strigolactone biosynthesis 
pathway and to study seed germination phenotypes observed in more detail will be of benefit 
for the development of potential agrochemical compounds. In planta data detailed effects on 
seed germination and shoot branching in the presence of hydroxamic acids does not 
completely correlate with in vitro data. Understanding the biochemical basis of these 
phenotypes, the mechanisms of the enzymes involved along with detailed structure-activity 
relationships, is required in order to develop new effective inhibitors. A selective inhibitor for 
each of the CCD enzymes would aid in understanding the molecular basis for the seed 
germination and shoot branching activities. 
 The specific aims of the project are as follows: 
 CCD1:  
 Obtain structure activity relationship data of hydroxamic acid inhibitors versus S. 
lycopersicum CCD1a. 
 Develop a method for the purification of S. lycopersicum CCD1a. 
 NCED:  
 Obtain structure activity relationship data of hydroxamic acid inhibitors versus S. 
lycopersicum NCED1. 
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 Express and assay Z. mays NCED1, 2, 3A, 3B and 9 versus compounds D2 and D4. 
 Clone and express A. thaliana ABA2 enzyme and develop a high throughput assay 
for the screening of potential inhibitors against NCED. 
 D27 / CCD7:   
 Obtain structure activity relationship data of hydroxamic acid inhibitors versus A. 
thaliana CCD7. 
 Clone and express the D27 isomerase from O. sativa, perform structure activity 
relationship analysis versus the hydroxamic acid inhibitors and perform initial 
mechanistic investigations.  
 CCD8:  
 Obtain structure activity relationship data of hydroxamic acid inhibitors versus A. 
thaliana CCD8. 
 Investigate the mechanism of A. thaliana CCD8. 
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Chapter Two: Expression, Purification and 
Inhibition of Solanum lycopersicum Carotenoid 
Cleavage Dioxygenase 1a 
2.1 Introduction 
First identified in Arabidopsis thaliana (thale cress), carotenoid cleavage dioxygenase 
1 (CCD1) is a cytosolic CCD enzyme responsible for the production of the volatiles β–ionone 
and geranylacetone (Figure 2.1) (Schwartz et al. 2001). Many orthologs of A. thaliana CCD1 
have been identified in many different plant species including Solanum lycopersicum 
(tomato), Rosa damascena (rose) and Cucumis melo (melon) (Simkin et al. 2004, Huang et 
al. 2009, Ibdah et al. 2006). CCD1 has been shown to accept a wide variety of different 
carotenoid, epoxycarotenoid and apocarotenoid substrates, such as β–carotene, lycopene and 
β-apo-8’-carotenal (Auldridge et al. 2006, Schwartz et al. 2001). Despite this high substrate 
promiscuity, CCD1 shows a high selectivity for the 9,10/9’,10’ double bond of these substrates 
both in vitro and in planta. In vitro experiments have also shown the formation of products 
resulting from a 5,6/5,6’ cleavage of lycopene. However, these products have not been 
observed in vivo or in planta (Vogel et al. 2008). 
Due to its substrate promiscuity, CCD1 can be assayed via a continuous assay with 
the substrate all-trans-β-apo-8’-carotenal (Figure 2.2) (Sergeant et al. 2009). Although the 
cytosolic nature of CCD1 makes it easier to study than its plastid located cousins, many 
authors have found purification of CCD1 difficult due to instability and the formation of 
 
Figure 2.1 – Structures of the aroma volatiles β-ionone and geranyl acetone. 
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inclusion bodies (Schmidt et al. 2006). In their 2009 paper, Sergeant et al. report the assay of 
several hydroxamic acid based inhibitors against S. lycopersicum CCD1 (Sergeant et al. 
2009). However, a complete structure activity relationship study of the hydroxamic acids 
against LeCCD1a has not been performed. 
This chapter describes work on the development of novel purification techniques for 
LeCCD1a. In addition, the structure activity relationship of the hydroxamic acids towards 
LeCCD1a is also detailed. 
2.2 Purification and Assays of S. lycopersicum CCD1a 
Little biochemical information on the CCDs has been reported in the literature, with 
the bulk of knowledge on the CCD enzyme family coming from in vivo and in planta studies. 
The successful purification of CCD enzymes by affinity chromatography such as glutathione 
S-transferase (GST) tagged purification and N-His6 tagged purification has been reported 
(Alder et al. 2008, Messing et al. 2010). Some members of the CCD1 enzyme family, such as 
A. thaliana CCD1, can form inclusion bodies during purification, thus leading to a loss of 
activity of the purified enzyme (Schmidt et al. 2006). This may be due to the presence of 
hydrophobic patches on the surfaces of CCD enzymes which are required for association with 
the lipid membranes, as demonstrated with the crystal structures of Synechocystis sp. 
apocarotenoid cleavage oxygenase (ACO) and Zea mays VP14 (Kloer et al. 2005, Messing et 
al. 2010). In addition, by analogy to other dioxygenases such as the catechol dioxygenases, 
 
Figure 2.2 – Cleavage reaction performed by CCD1 on the all-trans-β-apo-8’-carotenal substrate. 
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the catalytic cycle of the CCD is likely to involve highly reactive species such as oxygen 
radicals (Bugg 2003, Bugg & Ramaswamy 2008). These intermediates can act non-
specifically to attack residues of the enzyme active site, resulting in denaturation of the 
enzyme and causing a loss of enzyme activity. Air oxidation of the catalytic iron (II) over time 
to iron (III) could also result in a loss of enzyme activity if the cleavage mechanism begins 
with iron (II), as is predicted (Harrison & Bugg 2013).  
Two LeCCD1a plasmids were provided by Dr Andrew Thompson (Cranfield 
University), pGEX-4T-1-LeCCD1a (GST-LeCCD1a) and pET-14b-LeCCD1a (N-His6-
LeCCD1) (accession number AY576001). Initial experiments into the purification of 
LeCCD1a were attempted via glutathione-S-transferase tag purification. GST tag purification 
was used in preference to N-His6 tag purification due to the presence of the iron cofactor 
within the enzyme active site. However, the GST tag is rather bulky, adding a molecular 
weight of approximately 30.0 kDa to the overall mass of the protein being purified, which 
risks interfering sterically with the catalytic activity of the enzyme. 
The pGEX-LeCCD1a plasmid was used to transform pRosetta BL21 E. coli and the 
LeCCD1a enzyme was overproduced by addition of 1 mM IPTG followed by growth for 16 
hours at 16º C (Sergeant et al. 2009). In order to help overcome non-specific binding of 
cytosolic components, GST resin was incubated for at least one hour with cell lysate at 4º C. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) of eluted fractions 
showed the presence of purified protein, which was subsequently concentrated and assayed 
(Figure 2.3). Cleavage of the orange all-trans-β-apo-8’-carotenal by LeCCD1a results in the 
formation of a light yellow / green colour as the substrate is consumed (Figure 2.4). Initial 
assays with purified LeCCD1a (≈100 ng) in the presence of all-trans-β-apo-8’-carotenal 
(3 µg), however, showed neither a decrease in absorbance nor visual colour change versus 
time, indicating a loss of activity within the purified protein. Upon repeating, some samples 
showed only a minor decrease in absorbance at 485 nm, along with a slight decolouration of 
the reaction mixture upon visual inspection. However, the level of activity shown by these 
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purified samples, 0.36 µM min-1 was both lower than the cell lysate and significantly lower 
than would be expected for a purified sample. Control experiments with cell lysate containing 
the LeCCD1a protein overexpressed (≈50 µg total protein) showed an activity of 8.9 µM min-
1, with a visual colour change and decrease in absorbance (Figure 2.4). Additional controls 
with boiled enzyme and assays in the absence of the enzyme all failed to produce a decrease 
in absorbance at 485m. These results suggested that enzyme activity was lost during the 
purification process. 
 The purification of non-heme iron dependent enzymes has been reported whereby the 
iron cofactor is first removed from the enzyme in the cell lysate (Bugg 1993). The apo-enzyme 
is then purified before the iron is added back into the enzyme via an iron salt, restoring enzyme 
activity. By removing the catalytic iron centre, the enzyme can be purified before the protein 
is deactivated. Hence several changes were made to the purification technique. Firstly, 10% 
(v/v) glycerol, which is known to aid the stability of dioxygenases, and 0.1% Triton X-100 
were added to the assay buffer to aid protein stability and prevent the aggregation of the 
protein due to potential hydrophobic patches (Bugg 2003). The reducing agent 2-
mercaptoethanol was added to ensure that any iron present was kept in the iron (II) state. Iron 
 
Figure 2.3 – 8% SDS-PAGE gel of fractions from the purification of glutathione tagged LeCCD1a. 
1 – Ladder; 2 – Total soluble protein; 3 – Flow through; 4 – Wash fraction 1; 5 – Wash fraction 10; 
6 – Wash fraction 20; 7 – Elution fraction 1; 8 – Elution fraction 2; 9 – Elution fraction 3; 10 – 
Elution fraction 4. Molecular weights of ladder are in kDa. Molecular weight for GST-LeCCD1a: 
87.86 kDa (calculated from sequence). 
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was removed via the addition of 10mM 1, 10-phenanthroline to the cell lysate prior to 
purification, chelating the iron from the active site. Addition of 1, 10-phenanthroline was 
accompanied by the appearance of a red colour in the lysate, indicating iron chelation. It was 
hoped that removal of the iron would allow the apoenzyme to be stored for long periods 
at -80º C without loss of activity. LeCCD1a was purified as before and elution fractions 
containing the enzyme, as determined by SDS-PAGE gel electrophoresis, were pooled and 
concentrated. Purified LeCCD1a was then reactivated by the addition of 1 mM iron sulfate 
and 1mM BME. Enzymatic assay with purified enzyme showed activity characteristic of the 
LeCCD1a enzyme (Figure 2.5). 
By comparison, the activity of the purified enzyme, 3.9 µM min-1, appears to be lower 
than that of the cell lysate. This is most likely due to incomplete reactivation of the enzyme. 
It is also possible that the iron cofactor is required for maintaining the structure of the protein. 
In the absence of this cofactor, a percentage of the protein in the sample could have denatured, 
 
 
Figure 2.4 – A: Absorbance change at 485 nm shown after incubation of all-trans-β-apo-8’-
carotenal with cell free extract containing overproduced LeCCD1a enzyme. B: Colour change 
observed on incubation of LeCCD1a with all-trans-β-apo-8’-carotenal. 
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leading to the decreased activity. This method of purification has been subsequently used for 
the purification of S. lycopersicum LeNCED1 and Z. mays NCEDs as detailed in Chapter 3.  
2.3 Structure-Activity Relationship of Hydroxamic Acid CCD Inhibitors 
towards S. lycopersicum CCD1a 
Novel hydroxamic acid based inhibitors of carotenoid cleavage dioxygenases were 
first reported by Sergeant et al. in 2009. However, since the publication of these compounds, 
subsequent inhibitors have been developed, and a complete structure-activity profile has not 
been performed. Inhibition data of the hydroxamic acid and abamine CCD inhibitors against 
LeCCD1a is shown in Tables 2.1-2.5 (some data reproduced from Sergeant et al. 2009, 
marked with ‘*’, Sergeant et al. 2013, marked with ‘‡’ and Van Norman et al. 2014, marked 
with’!’). Representative data from an inhibition assay is shown in Figure 2.6. In addition to 
the hydroxamic acids, a selection of other compounds have also be assayed for inhibition 
against LeCCD1a. In particular, abamine compounds, first developed by Han et al. for the 
inhibition of Vigna unguiculata (cowpea) NCED (Han et al. 2004), and thiosemicarbazones 
(provided by Louisa Noffke and Prof. Peter Sadler, University of Warwick Chemistry, 
represented in Figure 2.7), which are known iron chelators used in medicine (Yu et al. 2009). 
 
Figure 2.5 – A: Absorbance change at 485 nm shown after incubation of all-trans-β-apo-8’-
carotenal with purified apo-LeCCD1a enzyme reconstituted with iron (II) sulfate. B: Control 
reaction with E. coli cell lysate with empty pGEX-4T-1 vector. 
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IC50 values reported are based on assays using cell free extract, therefore the total 
concentration of LeCCD1a is unknown. As such, exact comparison of data with other enzymes 
is not possible. 
Most interestingly, the thiosemicarbazones show no inhibition towards CCD1. The 
thiosemicarbazones assayed contain phenyl groups and π systems similar to the hydroxamic 
acid and abamine inhibitors, bearing a resemblance in particular to D12 and D13, which 
showed 26% and 46% inhibition respectively against LeCCD1a at 100 μM. 
Thiosemicarbazones are known iron chelators, and as such, it was expected that these 
thiosemicarbazones would show activity against LeCCD1a (Yu et al. 2009). However, despite 
this, none of the compounds showed any inhibition at 100 μM. This suggests that the CCD 
enzymes are not susceptible to all metal chelators, and there is a specific element of the 
 
Figure 2.7 – Representative structure of thiosemicarbazones assayed. 
 
Figure 2.6 – Absorbance change at 485 nm for control cleavage reaction of LeCCD1a with all-
trans-β-apo-8’-carotenal and for the same reaction in the presence of the inhibitor F7 at 100 µM. 
Control reaction is normal enzyme assay of LeCCD1a with all-trans-β-apo-8’-carotenal. 
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hydroxamic acids which aids inhibition, or that the iron binding affinity of the 
thiosemicarbazones is lower than that of the hydroxamic acids. Hydroxamic acids have a pKa 
around physiological pH (Green et al. 1958). As such, at assay conditions (pH 7.4) the N-
alkoxy of the hydroxamic acid may well be deprotonated, resulting in a hydroxamic anion 
which could enhance binding to the metal with respect to the thiosemicarbazones (Figure 2.8). 
Oxidation of the iron (II) to iron (III) is then subsequently likely to enhance the binding of the 
hydroxamic to the iron (Sergeant et al. 2013) (see Chapter 3.5). 
The abamine based compounds assayed were all less effective than the hydroxamic 
acids. Abamine showed only 49% inhibition at 100 μM, comparable to the effect seen against 
V. unguiculata NCED. Compounds E1 to E4, based on the structure of abamine, vary in the 
length of the alkyl chain connecting the methyl ester to tertiary amine, which should increase 
the overall hydrophobicity of the inhibitor and potentially aid binding in the hydrophobic 
active site. However, increased chain length also increases the risk of steric clashes within the 
active site. In addition, the E series compounds have para substituted methoxy group on the 
phenyl ring as opposed to a dimethoxy substituted ring at the meta and para positions as in the 
case of abamine. The inhibitors E1 to E4 all showed 0% inhibition at 100 μM. The lack of 
inhibition shown by the E series compounds against LeCCD1a is quite surprising, given that 
abamine showed almost 50% inhibition. In abamine, the presence of two methoxy groups will 
increase the electron density in the phenyl group, due to the electron donating effects of 
methoxy groups, thus enhancing any potential π-π stacking interactions. Decreased inhibition 
 
Figure 2.8 – Representation of deprotonation of hydroxamic acids at pH > 7.4, resulting in a 
hydroxamic acid anion which may aid binding to the active site iron (II). 
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for the E series compounds would have been expected, given the fact that the decreased 
electron density in the phenyl group would have weakened π-π stacking interactions. 
However, some inhibition would still have been expected. This was not observed, and the 
reasons for the absence of any inhibition are unknown. 
Without a doubt, the most effective inhibitors are D1 to D7. These compounds all 
show greater than 95% inhibition at 100 μM. D1, D2 and D3 have the lowest IC50 values at 
0.9, 0.8 and 0.8 μM respectively. Hydroxyl groups on the terminal aromatic ring appear to 
increase the affinity for binding. The effect of these hydroxyl groups could be two-fold, 
through either a hydrogen bonding interaction within the active site, or increased donation of 
electron density into the phenyl ring, as discussed previously. Given the hydrophobicity of the 
carotenoid substrates, it is likely through increased electron density in the aromatic ring.  In 
the case of D16 and D17, there is the added possibility that there is a steric effect brought 
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-- 90 20 
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-- 47 N/A 
E1 
 
1 0 N/A 
E2 2 0 N/A 
E3 3 0 N/A 
E4 4 0 N/A 
Table 2.1 – Inhibition data for hydroxamic acid compounds abamine, B1, B2 and E1-4 versus 
LeCCD1a. Compound marked with ‘*’ previously published in Sergeant et al. 2009. 
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about by the bulky O-acetyl and O-butyl para substituents, causing a decrease in the inhibition 
seen. 
Inhibitors D8, D14, and D15 all show less inhibition against LeCCD1a. These 
compounds have an increased alkyl chain length connecting the carbonyl of the hydroxamic 
acid to a phenyl group (ethylene linker as opposed to a methylene linker). This increased linker 
could be preventing the optimal alignment of the phenyl group for a π-π stacking interaction.  
The exception here is D9, which shows almost complete inhibition even with the ethylene 
linker. The IC50 of D9 (10 μM) is almost 10 times higher than D1-D3. Para fluorination of the 
phenyl group on the hydroxylamine has little to no effect. 
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4-Hydroxy H >95 0.9 
D2* 4-Hydroxy F >95 0.8 
D3* 3,4-Dihydroxy F >95 0.8 
D4* 4-Methoxy F >95 2.5 
D5* 3,4-Dimethoxy H >95 8.0 
D6* 3,4-Dimethoxy F >95 9.0 
D7* 4-Methoxy F >95 3.0 
D16 4-O-Butyl H 25 N/A 
D17 4-Acetyl H 24 N/A 
D8* 
 
3,4-Dimethoxy H 61 N/A 
D9* 4-Methoxy H >95 10.0 
D14 3,4-Dimethoxy F N/A N/A 
D15! 4-Methoxy F 70 10.0 
D10* 
 
3,4-Dimethoxy --- 65 N/A 
D11* 4-Methoxy --- 53 N/A 
Table 2.2 – Inhibition data for hydroxamic acid compounds D1-D11 and D14-D16 versus 
LeCCD1a. Compounds marked with ‘*’ previously published in Sergeant et al. 2009. Compound 
marked with ‘!’ previously published in Van Norman et al. 2014. 
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Inhibitors D10-D13, D20 and D21 lack phenyl groups on the N-alkoxy terminal of the 
hydroxamic acid. D10 and D11 both have a saturated eight carbon chain, and show moderate 
inhibition of LeCCD1a at 100 µM, possibly due to a loss of π-π stacking interactions. 
Compounds D12 and D13 have a protonated N-alkoxy hydroxamic acid. Unsurprisingly, both 
D12 and D13 show poor inhibition against LeCCD1a, most likely due to a loss of hydrophobic 
interactions. The inhibitors D20 and D21 have a carboxylate on the N-alkoxy of the 
hydroxamic acid, but neither showed good inhibition. Given the pKa of aliphatic carboxylic 
acids is around 5.0, it is probable that at the reaction pH (pH 7.4) the carboxylic acid will be 
deprotonated to a carboxylate anion. This anion is unlikely to bind well within an active site 
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--- >95 1.0 
Table 2.3 – Inhibition data for hydroxamic acid compounds D12-D13, D20-D21 and D30-D31 
versus LeCCD1a. Compounds marked with ‘*’ previously published in Sergeant et al. 2009. 
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designed for hydrophobic substrates, likely resulting in the lower levels of inhibition observed. 
It would be interesting to observe what effect, if any, replacing the carboxylate on D21 with 
benzyl moiety would have. One would expect that the increased π-π staking capabilities of a 
napthyl group would lead to an effective inhibitor. 
Inhibitors D30, D31 and D32 all have long geranyl chains. These geranyl chains 
mimick the hydrophobic nature of the carotenoid chain and show greater than 90% inhibition 
at 100 µM. This inhibition data suggests that the positioning of the geranyl chain (either on 
the N-alkoxy or carboxylate of the hydroxamic acid) is irrelevant. This raises the question as 
to what the orientation of the inhibitors is within the active site. Do they bind with the N-
alkoxy terminus first, or the carboxylate terminus first? D30 and D31 both have IC50 values 
of 1.0 µM, comparable to D1, D2 and D3. The ‘H’ series, H1-H4, are somewhat similar to the 
D30-D32, with long hydrophobic chains, no doubt aiding their binding within the active site. 
These compounds all show approximately 80% inhibition at 100 μM.  
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81 10.0 
Table 2.4 – Inhibition data for hydroxamic acid compounds H1-H4 versus LeCCD1a. Bn represents 
a benzyl group (CH2Ph). 
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Inhibitors F1, F2, F6 and F7 all also show greater than 95% inhibition at 100 μM, yet 
lack a connector between the carboxylate of the hydroxamic acid and the phenyl group. F6 
and F7, which are substituted at the meta position, show comparable activity to F1 and F2, 
which are substituted at the para position. Inhibitors F3 and F4, differ from F1 and F2 in that 
they are additionally substituted at the meta position with an additional methoxy group. Both 
inhibitors gave less than 50% inhibition at 100 µM. Given how F1, F2, F6 and F7 all showed 
>95% inhibition with meta or para substitutions, it is intriguing why the dimethoxy substituted 
inhibitors would be less effective. This indicates that some sort of interaction at the three 
position is important. Interestingly though, a 3-amino or 3-chloro group increases activity 
heavily. Again, the presence of a 4-fluoro-phenyl group makes little difference. Inhibition 
data, in the form of percentage activity of enzyme in the presence of inhibitor is summarised 
in Figure 2.9. 
Clearly there is a complex series of interactions within the active site that are required 
for optimal inhibitor binding. Additionally, several other matters complicate the analysis. For 
example, it is unknown in which orientation the inhibitors bind. Messing et al. showed that Z. 
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4-Methoxy H >95 2 
F2*‡ 4-Methoxy F >95 2.5 
F3* 3,4-Dimethoxy H 50 N/A 
F4* 3,4-Dimethoxy F 0 N/A 
F5‡ 3-Chloro H 0 N/A 
F6‡ 3-Amino H >95 <1 
F7 3-Bromo H >95 <1 
F8‡ 
3-Chloro-4-
Methoxy 
H 30 N/A 
Table 2.5 – Inhibition data for hydroxamic acid compounds F1-F8 versus LeCCD1a. Compounds 
marked with ‘*’ previously published in Sergeant et al. 2009. Compounds marked with an ‘‡’ 
previously published in Sergeant et al. 2013. 
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mays Vp14 and Z. mays CCD1 from maize contained a high degree of sequence similarity 
(Messing et al. 2010). Using this data, they were able to model the structure of the ZmCCD1 
enzyme. There is a high degree of sequence similarity between Vp14, ZmCCD1 (33% 
identity) and LeCCD1a  (41% similarity). Using the active site model they produced (Figure 
2.10, sequence alignment is shown in Figure 2.11), it is possible to interpret some of the data 
obtained from these inhibitors. The majority of the substrate binding tunnel consists of non-
polar residues.  However, three other key pieces of information can be taken from the active 
site. Firstly, the presence of at least two charged residues which are in close proximity to the 
metal centre, secondly, the fact that the active site tunnel appears to turn once it has passed 
the iron centre and thirdly, the presence of a small aperture before the metal centre. 
Figure 2.9 – Summary of inhibition data for hydroxamic acids against LeCCD1a. 
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Figure 2.10 – Modelling of 9’-cis-neoxanthin (pink) and all-trans-β-apo-8’-carotenal (green) 
within the active site of ZmNCED1 (A) and ZmCCD1 (B). Figure taken from Messing et al. 2010. 
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The tertiary amines abamine and E1-E4 are all sterically bulky. The active site of 
LeCCD1a is likely to be linear due to the all-trans nature of the carotenoid substrate, 
restricting the binding of the abamines into the active site. It is possible that the hydroxyl 
groups of D1, D2, D3 and D4 are interacting with the positively charged groups located near 
the active site. The fact that D4-D8 all show higher IC50 values than D1-D3 seems to confirm 
the presence of some sort of polar-charged interaction, since ethers are less polar than alcohols. 
ZmNCED1            MQGLAPPTSVSIHRHLPARSRARASNSVRFSPRAVSSVPPAECLQAPFHKPVADLPAPSR 
ZmCCD1             ------------------------------------------------------MGTEAE 
LeCCD1a            ------------------------------------------------------MG---R 
                                                                         :    . 
ZmNCED1            KPAAIAVPGHAAAPRKAEGGKKQLNLF--QRAAAAALDAFEEGFVANVLERPHGLPSTAD 
ZmCCD1             QPD--------MDSHRNDGVVVVPAPRPRKGLASWALDLLESLAVRL-------GHDKTK 
LeCCD1a            KED--------DGVERIEGGVVVVNPKPRRGITAKAIDLLEWGIVKL-------MHDSSK 
                   :             .: :*          :  :: *:* :*   *           ..:. 
ZmNCED1            PAVQIAGNFAPV-GERPPVHELPVSGRIPPFIDGVYARNGANPCFDPVAGHHLFDGDGMV 
ZmCCD1             PLHWLSGNFAPVVEETPPAPNLTVRGHLPECLNGEFVRVGPNPKFAPVAGYHWFDGDGMI 
LeCCD1a            PLHYLQGNFAPT-DETPPLNDLVVQGHLPECLNGEFVRVGPNPKFAPVAGYHWFDGDGMI 
                   *   : *****.  * **  :* * *::*  ::* :.* * ** * ****:* ******: 
ZmNCED1            HALRIRNGAAESYACRFTETARLRQERAIGRPVFPKAIGELHGHSGIARLALFYARAACG 
ZmCCD1             HAMRIKDGKA-TYVSRYVKTARLKQEEYFGGAKFMK-IGDLKGFFGLFMVQMQQLRKKFK 
LeCCD1a            HGLRIKDGKA-TYVSRYVRTSRLKQEEFFGGAKFMK-VGDLKGLFGLFTVYMQMLRTKLK 
                   *.:**::* * :*..*:..*:**:**. :*   * * :*:*:*  *:  : :   *     
ZmNCED1            LVDPSAGTGVANAGLVYFNGRLLAMSEDDLPYHVRVADDGDLETVGRYDFDGQLGCAMIA 
ZmCCD1             VLDFTYGFGTANTALIYHHGKLMALSEADKPYVVKVLEDGDLQTLGLLDYDKRLKHSFTA 
LeCCD1a            VLDISYGNSTANTALVYHHGKLLALSEADKPYALKVLEDGDLQTLGMLDYDKRLTHSFTA 
                   ::* : * ..**:.*:*..*:*:*:** * ** ::* :****:*:*  *:* :*  :: * 
ZmNCED1            HPKLDPATGELHALSYDVIKRPYLKYFYFRPDGTKSDDVEIPLEQPTMIHDFAITENLVV 
ZmCCD1             HPKVDPFTDEMFTFGYSH-EPPYCTYRVINKEGAMLDPVPITIPESVMMHDFAITENYSI 
LeCCD1a            HPKVDAVTGEMFTFGYAH-TPPYITYRVISKDGIMQDPVPITIPEPIMMHDFAITENYAI 
                   ***:*  * *:.::.*     ** .*  :  :*   * * * : :  *:********  : 
ZmNCED1            VPDHQVVFKLQEMLRGGSP-VVLDKEKTSRFGVLPKHAADASEMAWVDVPDCFCFHLWNA 
ZmCCD1             FMDLPLLFRPKEMVKNGEFIYKFDPTKKGRFGILPRYAKDDKLIRWFQLPNCFIFHNANA 
LeCCD1a            MMDLPLCFRPKEMVKKNKLAFTFDATKKARFGVLPRYANNEALIRWFELPNCFIFHNANA 
                   . *  : *: :**::  .    :*  *..***:**::* :   : *.::*:** **  ** 
ZmNCED1            WEDEATGEVVVIGSCMTPA---DSI---FNESDERLESVLTEIRLDARTGRSTRRAVLPP 
ZmCCD1             WEEGDE---VVLITCRLENPDLDKVNGYQSDKLENFGNELYEMRFNMKTGAASQKQLS-- 
LeCCD1a            WEEGDE---VVLITCRLVNPDLDMVNGAVKEKLENFCNELYEMRFNMKSGAASQKKLS-- 
                   **:      **: :*       * :    .:. *.: . * *:*:: ::* :::: :    
ZmNCED1            SQQVNLEVGMVNRNLLGRETRYAYLAVAEPWPKVSGFAKVDLSTG-------------EL 
ZmCCD1             --VSAVDFPRVNESYTGRKQRYVYCTILDSIAKVTGIIKFDLHAEPESGVKVLEVGGNVQ 
LeCCD1a            --ESAVDFPRINENYTGRKQRYVYGTTLNSIAKVTGVIKFDLHAEPETGKSQLEVGGNVQ 
                        ::.  :*..  **: **.* :  :   **:*. *.** :                 
ZmNCED1            TKFEYGEGRFGGEPCFVPMDPAAAHPRGEDDGYVLTFVHDERAGTSELLVVNAADMRLE- 
ZmCCD1             GIYDLGPGRFGSEAIFVPKHPGV--SGEEDDGYLIFFVHDENTGKSEVNVIDAKTMSADP 
LeCCD1a            GIFDLGPGRFGSEAVFVPSRPGT--EREEDDGYLIFFVHDENTGKSAVNVIDAKTMSAEP 
                     :: * ****.*  ***  *..     *****:: *****.:*.* : *::*  *  :  
ZmNCED1            -ATVQLPSRVPFGFHGTFITGQELEAQAA-- 
ZmCCD1             VAVVELPNRVPYGFHAFFVTEDQLARQAEGQ 
LeCCD1a            VAVVELPKRVPYGFHAFFVTEEQIQEQAKL- 
                    *.*:**.***:***. *:* :::  **    
Figure 2.11 – Sequence alignment of ZmNCED1, ZmCCD1 and LeCCD1a using ClustalΩ (Goujon 
et al. 2010, Sievers et al. 2011). Accession numbers: ZmNCED1 - O24592; ZmCCD1 - Q45VT7; 
LeCCD1a - Q6E4P5. Conserved histidine residues are shown in red. 
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The increased chain length of D8, D9, D14 and D15 may position the aromatic ring in such a  
position that it interferes with the aperture close to the active site. This would result in the 
decreased binding affinities seen. The increased chain length on D30, D31 and D32 potentially 
increases the hydrophobic interaction within the active site, resulting in their high levels of 
inhibition. This would also explain the respectable levels of inhibition reported for the ‘H’ 
series.  
Although the ‘F’ series compounds F1 and F2 both lack a hydroxyl group, it is 
possible that the absence of an alkyl chain connecting the C-terminus of the hydroxamic acid 
with the phenyl group consolidates a hydrophobic interaction, maximising binding. Halogen-
oxygen interactions in biological systems are known (Auffinger et al. 2004). As such, it 
appears likely that the excellent data observed for F5 and F6 inhibiting LeCCD1a is due to 
these moieties interacting favourable with one of the polar residues within the active site. 
However, F5 and F8, both with meta halogen substitutions would have been expected to 
behave in a similar way. It is possible that the meta methoxy groups are too large for the three 
position on the phenyl group in F3 and F4, sterically clashing with residues of the active site. 
The lower activity seen by D20 and D21 is somewhat surprising, given that the carboxyl group 
might have been expected to interact with one of the polar residues within the active site. 
Without a definitive crystal structure of either ZmCCD1, or more importantly 
LeCCD1a, it is very difficult to assign accurate structure activity relationships based on the 
data here. A crystal structure with bound substrate or inhibitor would also help to explain 
possible discrepancies in the data observed.  
2.4 Conclusions 
 It has been possible to purify the CCD1a enzyme from S. lycopersicum in the absence 
of the catalytic metal cofactor, as indicated by SDS-PAGE analysis. However, protein mass 
spectrometry would be required to definitively illustrate the purification of the native and apo-
proteins. Reactivated apo-LeCCD1a has been shown to be able to retain catalytic activity.  
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From the structure activity data obtained for the LeCCD1a enzyme it is possible to 
elucidate which features of the hydroxamic acids are required for optimal activity against 
LeCCD1a. The key features of the inhibition assays are summarised in Figure 2.12. 
Hydroxamic acids were more potent inhibitors of LeCCD1a mediated carotenoid cleavage 
than abamines and thiosemicarbazones. One of the key features observed is that an element of 
hydrophobicity is required in the inhibitors, which is unsurprising given the hydrophobic 
nature of the substrates the enzyme utilises. Inhibitors which maximise this hydrophobicity,  
but are not sterically bulky are better inhibitors. Truncated hydroxamic acids with no groups  
on the N-alkoxy of the hydroxamic acid and carboxylate groups reduced inhibition, as did 
large bulky substitutions on the phenyl group of the carboxylate terminal of the hydroxamic 
acids. Hydroxyl and methoxy substitutions also lead to higher levels of inhibition, likely 
through promoting π-π stacking interactions in the active site. In vitro, no difference in 
inhibition was observed for the fluorine substituted inhibitors.  
2.5 Future Work 
 It would be of great interest to perform mechanistic studies on the CCD1 enzyme. 
Since CCD1 is a cytosolic enzyme, it is more amenable to spectroscopic studies. As a result, 
it would be interesting to investigate whether the enzymatic mechanism proceeds through a 
 
Figure 2.12 – Key features of hydroxamic acid compounds required for the inhibition of LeCCD1a. 
 
Chain length important:
Methylene > ethylene.
Phenyl group required.
Geranyl units also accepted.
Element of hydrophobicity required.
OH groups 
favoured. 
OMe also 
accepted. 
Hydroxamic acid preferential.
Abamines and thiosemicarbazones 
less effective.
CH2Ph optimal.
Indicates 
hydrophobicity 
required.
Increased hydrophobicity 
associated with increase in 
activity. Phenyl can be 
replaced with geranyl unit. 
Amine and carboxylate show 
little activity.
Hydrogen or 
fluorine 
substitution 
accepted.
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dioxetane intermediate or through a Criegee rearrangement. In addition, there is no 
mechanistic proof that the CCD enzymes proceed through a carbocation intermediate. It would 
be possible to use a series of substituted stilbene derivatives to probe the existence of this 
intermediate, since different substitutions would have either electron donating or electron 
withdrawing effects, which would influence the stability of the carbocation and hence the rate 
of the cleavage reaction (Figure 2.13). Given that CCD1 is a relatively promiscuous enzyme, 
it would be hoped that stilbenes and stilbene derivatives would be accepted by the enzyme.  
 Iron is a common cofactor in oxygenase and dioxygenase enzymes (Bugg 2003). The 
consecutive and readily accessible oxidation states of iron make it ideal for the activation of 
molecular oxygen to superoxide. Other transition metals however, are also able to perform 
such a task. Manganese dependent oxygenases, for example, use a manganese (II) cofactor to 
activate molecular oxygen (Gibello et al. 1994, Whiting et al. 1996, Que et al. 1981) whilst 
quercetin 2,3-dioxygenase is the only known copper (II) dependent dioxygenases (Oka & 
Simpson 1971, Hund et al. 1999). Recently, Fielding and co-workers demonstrated that in the 
homoprotocatechuate 2,3-dioxygenase from Brevibacterium fuscum the catalytic iron (II) 
cofactor can be replaced with either manganese (II) or cobalt (II) with retention of activity 
(Fielding et al. 2011). In fact, in the presence of the cobalt (II) cofactor, the catalytic activity 
of the enzyme is enhanced and it would be interesting to see whether CCD1 could utilise other 
transition metal elements in its active site. Uptake of metals into the active site may be a 
Figure 2.13 – Structures of trans-stilbene derivatives which could be used to probe the mechanism 
of LeCCD1a. 
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problem as such an alternative method for producing CCD1 enzyme substituted with other 
metals would be required, such as growing E. coli in minimal media, in the absence of iron. 
Adding in other metal salts, such as manganese (II) sulfate, when overproducing CCD1 would 
ideally force the incorporation of other metal ions into the active site. The incorporation of 
these metals could then be confirmed by Inductively Coupled Plasma Optical Emission 
Spectroscopy (ICP-OES) or by ultraviolet-visible spectroscopy by the addition of a metal 
chelator. 
 Finally, as with all the CCD enzymes, the development of an inhibitor which is 
selective for solely the CCD1 enzyme would be desirable. A selective inhibitor for CCD1 
would allow the roles of CCD1 in planta to be observed through phenotypic effects on plants. 
The inhibitors developed and assayed here could be used to probe the roles of CCDs in other 
organisms, such as in bacteria and mammals. 
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Chapter Three: Expression, Inhibition and Assays of 
9’-cis-Epoxycarotenoid Cleavage Dioxygenases 
(NCED) from Solanum lycopersicum and Zea mays 
3.1 Introduction 
 The enzyme 9’-cis-epoxycarotenoid cleavage dioxygenase 1 (NCED1, Vp14) from 
Zea mays (maize) was the first biochemically characterised carotenoid cleavage enzyme 
(Schwartz et al. 1997). Homologues of NCED have been found in a wide variety of different 
plant species such as Arabidopsis thaliana and Solanum lycopersicum (Tan et al. 2003, 
Burbidge et al. 1997). There are varying numbers of NCED homologues in different species. 
In S. lycopersicum there are only two NCEDs. However, in Z. mays and A. thaliana there are 
five different NCED homologues (Tan et al. 2003, Lefebvre et al. 2006). 
 The rate limiting step in the biosynthesis of the plant signalling hormone abscisic acid 
is catalysed by 9’-cis-epoxycarotenoid cleavage dioxygenases, which catalyse the selective 
oxidative cleavage of the 11’,12’ double bond in 9’-cis-neoxanthin or 9’-cis-violoxanthin to 
give a C25 aldehyde product and a second aldehyde called xanthoxin (Figure 3.1) (Taylor et 
al. 2005). NCEDs are selective solely for the 9’-cis isomer of violoxanthin and neoxanthin 
and show no activity against all-trans substrates (Schwartz et al. 2003). Assays of NCED are 
stopped and low throughput, requiring quantification of products by HPLC. Nevertheless, with 
these methods, a KM for NCED1 from Z. mays has been reported of 27 µM for 9’-cis-
neoxanthin and 58 µM for 9’-cis-violaxanthin (Schwartz et al. 2003). 
 The work within this chapter describes the use of low throughput assays for 
performing structure activity analysis of hydroxamic acid inhibitors against S. lycopersicum 
NCED1 and Z. mays NCED homologues. In addition development of high throughput assays 
for the screening of compounds against Z. mays NCED1 is described. Coupled assay work 
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was performed in partial collaboration with Dr David Brocklehurst (Syngenta, Jealott’s Hill) 
and undertaken partially at Syngenta Jealott’s Hill. 
3.2 Expression and HPLC Assays of S. lycopersicum NCED1 
 The natural substrate for NCEDs, 9’-cis-neoxanthin is unstable, and susceptible to 
light, pH, temperature and oxygen. This high degree of sensitivity is due to the functional 
groups within the enzyme, such as the epoxide, allene and conjugated double bonds. 9’-cis-
neoxanthin is available commercially, but the cost was too high for the planned study. As a 
result 9’-cis-neoxanthin was extracted from spinach leaves, which have a high natural 
abundance of neoxanthin (Tonucci et al. 1995). 9’-cis-neoxanthin was extracted from fresh 
spinach using previously reported methods (Sergeant et al. 2009). Initial attempts to 
characterise the 9’-cis-neoxanthin via thin layered chromatography (TLC), as published, 
proved inconclusive (Schwartz et al. 1997). However, the absorbance maxima in the 
ultraviolet-visible (UV-Vis) spectra of 9’-cis-neoxanthin and all-trans-neoxanthin have been 
reported (Table 3.1) (Britton 1985, Cholnokey et al. 1969). As such, it was possible to 
characterise the 9’-cis-neoxanthin via its characteristic UV-Vis spectra. The purified 9’-cis-
Figure 3.1 – Schematic representation of the NCED catalysed 11’,12’ cleavage of 9’-cis-neoxanthin 
to xanthoxin and C25 aldehyde. 
 
All-trans-
neoxanthin 
(Literature) 
9’-cis-
neoxanthin 
(Literature) 
Purified 9’-cis-
neoxanthin 
Authentic 9’-cis-
neoxanthin 
(CaroteNature) 
Absorbance 
maxima (nm) 
467 467 465 466 
440 439 439 437 
415 416 417 414 
 
Table 3.1 - Absorbance maxima recorded for purified 9’-cis-neoxanthin compared with literature 
values for all-trans-neoxanthin and 9’-cis-neoxanthin (Britton 1985, Cholnokey et al. 1969).  
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neoxanthin was found to absorb at 417, 439 and 465 nm (Figure 3.2). Authentic 9’-cis-
neoxanthin from CaroteNature (Switzerland, provided by Dr David Brocklehurst, Syngenta, 
Jealott’s Hill) was analysed by UV-Vis spectroscopy. The spectra of the authentic sample 
matched with that of the 9’-cis-neoxanthin purified from spinach, with λMAX values of 414, 
437 and 466 nm (Figure 3.2). Additionally, comparison of authentic 9’-cis-neoxanthin and 
purified 9’-cis-neoxanthin by HPLC showed that both had identical retention times (Figure 
3.3). Using Beer-Lambert’s law and authentic 9’-cis-neoxanthin, a molar extinction 
coefficient of 1.33 x 105 M-1 cm-1 was calculated for 9’-cis-neoxanthin (Beer 1852). The slight 
discrepancies between the literature values reported for 9’-cis-neoxanthin are likely due to cis-
trans isomerisation of other alkenes on the polyene backbone or solvent effects. It was found 
that fresh spinach was required for assays. Spinach more than one day old gave a low yield of 
9’-cis-neoxanthin and was not turned over by the enzyme. 
 Investigations into LeNCED1 involved the use of pGEX-4T-1-LeNCED1 pRosetta 
BL21 E. coli (GST-LeNCED1) provided by Dr Andrew Thompson (Cranfield) (accession 
number O24023). Cell free extract containing overproduced glutathione-S-transferase (GST) 
tagged LeNCED1 was prepared according to the method of Sergeant et al. 2009 and a band 
 
Figure 3.2 – A: Absorbance spectra of purified and authentic 9’-cis-neoxanthin. B: Obtained HRMS 
of purified 9’-cis-neoxanthin. C: Predicted HRMS spectrum. Peaks at m/z 603.4108, 604.4143 and 
605.4166 in (B) are due to polyethylene glycol contamination. 
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of the correct molecular weight was visible via sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) (Figure 3.4) (Sergeant et al. 2009). As with the LeCCD1a 
enzyme, cell free extract was used in preference to purified enzyme due to the instability of 
the enzyme.  
Given that cell free extract containing overproduced LeNCED1 was used for the 
assays, it was not possible to determine the exact concentration of LeNCED1 present in the 
assays. However, approximately 100 µg of total E. coli lysate was added to each assay. A 2:1 
(v/v) excess of cell lysate (from 3 mL of cell free extract prepared from a 500 mL culture of 
E. coli) containing overproduced GST-LeNCED1 to 9’-cis-neoxanthin was required to allow 
the reaction to proceed to 50% completion. Each assay contained approximately 60 µM of 9’-
cis-neoxanthin (purified from spinach). Upon incubation of LeNCED1 with 9’-cis-neoxanthin 
 
Figure 3.3 – HPLC chromatogram of authentic 9’-cis-neoxanthin (CaroteNature, A) and 
9’-cis-neoxanthin purified from spinach (B). 9’-cis-neoxanthin is the main peak in both 
chromatographs.  
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for 20 minutes at 25° C, a product peak at 6.5 minutes was observed at 440 nm, corresponding   
to that reported by Sergeant et al. 2009 (Figure 3.5A). Integration of the product and substrate 
peaks observed in the HPLC chromatogram was used to follow the course of the reaction. 
A variety of other different strains encoding the LeNCED1 enzyme were obtained 
from Dr Andrew Thompson (Cranfield University) (Table 3.2). All constructs gave similar or 
 
Figure 3.4 – 8% SDS-PAGE gel showing overproduced GST-LeNCED1 fusion in the cell free 
extract from pRosetta pGEX-LeNCED1 BL21 E. coli. 1 – Ladder; 2 – Non-induced control (NIC); 
3 – Cell free extract from E. coli induced with IPTG. Molecular weights of ladder are in kDa. 
Molecular weight of GST-tagged LeNCED1: 93.9 kDa (calculated from sequence). Mass 
spectrometry analysis would be required to definitively confirm the presence of LeNCED1.                                                                                                                                    
1 2 3
250
130
100
70
55
35
25
15
LeNCED-GST Fusion
Construct 
Enzyme 
Expressed 
Features of strain 
pGEX-4T-1-LeNCED1 
BL21 
GST-LeNCED1 Normal BL21 
pGEX-4T-1-LeNCED1 
pRosetta BL21 
GST-LeNCED1 
Contains Rosetta plasmid coding for 
expression of rare codons 
p14b-LeNCED1 BL21 
N-His6-
LeNCED1 
Normal BL21 
pGEX-4T-1-LeNCED1 
Origami 
GST-LeNCED1 
E. coli K-12 strain lacking thioredoxin 
reductase and glutathione reductase to 
enhance disufide bond formation. 
pGEX-4T-1-LeNCED1 
Gami 
GST-LeNCED1 
Origami host strain containing the pRosetta 
plasmid 
Table 3.2 – Comparison of the E. coli strains expressing LeNCED1 tested and the features provided 
by each strain (Bessette et al. 1999, Kane 1995, Merck Millipore Ltd 2012). 
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lower expression, and as such, all subsequent experiments were conducted with the pGEX- 
LeNCED1 pRosetta BL21 construct.  
 
Figure 3.5 – HPLC chromatogram of LeNCED1 catalysed cleavage of 9’-cis-neoxanthin (A) and 
9’-cis-neoxanthin (B). C25 aldehyde peak can be seen eluting at 6.5 minutes in the chromatogram 
of the enzyme catalysed reaction, consistent with the observations of Sergeant et al. 2009. (C) Time 
dependent increase in the magnitude of the peak at 6.2 minutes is consistent with an enzyme 
catalysed reaction. (D) UV absorption spectrum of the peak at 6.2 minutes gives a λMAX of 414 nm, 
similar to the theoretical value of 411 nm for the C25 aldehyde (Williams & Fleming 1995). High 
resolution mass spectrometry would be required for a definitive assignment of the peak at 6.2 
minutes. 
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3.3 Structure Activity Relationship of Hydroxamic Acid CCD Inhibitors 
Towards S. lycopersicum NCED 
All assays with LeNCED1 were conducted in a total volume of 200 µL with inhibitors 
at 100 µM. Percentage inhibition was calculated by working out the percentage conversion 
for each reaction from integration of the substrate and the product peaks for each assay at 440 
nm. An example chromatogram comparing the inhibited and un-inhibited assays is shown in 
Figure 3.6. 
Inhibition data of the hydroxamic acids and abamine CCD inhibitors against 
LeNCED1 is shown in tables 3.3-3.7 (some data reproduced from Sergeant et al. 2009, marked 
with ‘*’, and Van Norman et al. 2014, marked with’!’). Although some inhibition was 
observed, neither the hydroxamic acids nor the abamines are effective inhibitors against 
 
Figure 3.6 – HPLC chromatogram of 9’-cis-neoxanthin control (top, A), LeNCED1 catalysed 
cleavage of 9’-cis-neoxanthin in the absence (middle, B, 71% conversion) and presence (bottom, 
C, 50% conversion) of 100 µM D30. Additional peaks in chromatograph are believed to be other 
carotenoids co-purified from spinach. 
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LeNCED1. Within the literature, three classes of compound have previously been shown to 
be inhibitors of NCED; nordihydroguaiaretic acid (NDGA), the tertiary amines abamine and 
abamineSG and the sesquiterpene based compounds (Han et al. 2004, N. Kitahata et al. 2006, 
Boyd et al. 2009 respectively). Against Vigna unguiculata (cowpea) NCED, abamine showed 
approximately 50% inhibition at 100 µM and abamineSG showed 80% inhibition of the same 
enzyme at 100 µM. However, against LeNCED1 abamine showed only 20% inhibition 
(Sergeant et al. 2009). Derivatives of abamine (compounds E1-E4) showed levels of inhibition 
similar to abamine itself. It is not clear why the levels of inhibition for the same compound 
are so different for homologues of the same enzyme, which have 70.1% identity.  
Within the compounds of the D series it is difficult to observe any trends within the 
data. Compounds D1-D7, D16 and D17 are all structurally similar, with a methylene bridge 
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-- 20 
B1* 
 
-- 5 
B2 
 
-- 13 
E1 
 
1 16 
E2 2 17 
E3 3 22 
E4 4 9 
Table 3.3 – Inhibition data for hydroxamic acid compounds A1, B1, B2 and E1-4 versus LeNCED1. 
Compound marked with ‘*’ previously published in Sergeant et al. 2009. 
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between the carbonyl of the hydroxamic acid and the terminal phenyl group. A para substituted 
fluorine on the phenyl group attached to the N-alkoxy of the hydroxamic acid offers no change 
in the level of inhibition. If the para hydroxyl (D1, D2) is substituted with a methoxy group, a 
slight increase in inhibition is observed. Given the similarity between the inhibition of D1, D2 
(para hydroxyl – hydrogen bond donor) and D4 (para methoxy – hydrogen bond acceptor), 
there is unlikely to be a hydrogen bonding interaction within the active site. Interestingly, 
dihydroxylation of the carbonyl phenyl group results in a sharp decrease in inhibition to only 
4%. This is unexpected, given that hydroxyl groups would donate electron density into the 
aromatic ring, increasing any π-π stacking interaction. Similarly, with dimethoxylation, the 
inhibitory effects are perturbed. This suggests there is a steric effect in play at the meta 
position. However, with compound D7, which has a 3,4-methylenedioxy substitution, the level 
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4-Hydroxy H 27 
D2* 4-Hydroxy F 29 
D3* 3,4-Dihydroxy F 4 
D4* 4-Methoxy F 33 
D5* 3,4-Dimethoxy H 8 
D6* 3,4-Dimethoxy F 18 
D7* 4-Methoxy F 33 
D16 4-o-Butyl H 14 
D17 4-Acetyl H 20 
D8* 
 
3,4-Dimethoxy H 40 
D9* 4-Methoxy H 27 
D14 3,4-Dimethoxy F N/A 
D15! 4-Methoxy F 24 
D10* 
 
3,4-Dimethoxy --- 14 
D11* 4-Methoxy --- 15 
Table 3.4 – Inhibition data for hydroxamic acid compounds D1-D11 and D14-D16 versus 
LeNCED1. Compounds marked with an asterisk previously published in Sergeant et al. 2009. 
Compound marked with ‘!’ previously published in Van Norman et al. 2014. 
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of inhibition reported is equal to that of D1, D2 and D4. The mediocre levels of inhibition seen 
for D16 and D17, 14% and 20% respectively, are most likely due to a steric effect of the bulky 
O-butyl and O-acetyl groups. 
The inhibitors D8, D9, D14 and D15 are structurally similar to D4, D5 and D6, save 
for the presence of an ethylene bridge between carbonyl and the phenyl group. The presence 
of this ethylene linker appears to negate the negative effects of meta hydroxylation and 
methoxylation. D8, which is 3,4-dimethoxy substituted, reported 40% inhibition at 100 µM, 
the second highest of all the hydroxamic acids tested. The additional chain length may well 
be positioning the methoxy groups such that they avoid a steric clash, or possibly such that 
they act as a hydrogen bond acceptor to a backbone amide. 
Replacement of the N-alkoxy terminal phenyl group (D10, D11) or its removal (D12, 
D13) has little effect on the levels of inhibition seen. This suggests that the coordination of 
the hydroxamic acid moiety and possibly π-π stacking of the carbonyl phenyl group is most 
important for inhibition. The inhibitors D20 and D21 have a carboxylate group on the 
N-alkoxy of the hydroxamic acid and show modest levels of inhibition. There is possibly a 
hydrogen bonding or electrostatic interaction involving the carboxylate. The inhibition shown 
by D21 certainly suggests that the carboxylate is not detrimental to inhibition. In the case of 
D21, the napthyl group could provide additional π-π stacking interactions within the active 
site of the enzyme.  
The inhibitor D30 shows the highest level of inhibition, 42%, at 100 µM. However, 
two related compounds, D31 and D32 show quite poor inhibition, only 10% at 100 µM. The 
inhibitors D30, D31 and D32 all have geranyl units on either the N-alkoxy or carbonyl of the 
hydroxamic acid. In compounds D31 and D32 there is an alkene conjugated to the carbonyl 
group of the hydroxamic acid. In D30, this alkene is one carbon unit further away from the 
hydroxamic acid and it is on the N-alkoxy terminus of the hydroxamic acid, preventing any 
conjugation. This lack of conjugation allows free rotation around the carbon-nitrogen σ bond. 
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This increase in flexibility may well allow the inhibitor to maximise interactions with the 
active site, aiding inhibition.  
Within the F series of compounds, no inhibition greater than 7% was recorded. 
Compounds in the F series lack a methylene or ethylene linker between the carbonyl moiety 
of the hydroxamic acid and the phenyl group. One could propose that this lack of a methylene 
or ethylene bridge prevents the phenyl group from aligning a π-π stacking interaction or other 
favourable interaction within the active site. Halogen or amino groups substituted onto the 
meta position of the phenyl group have little effect on inhibition. Given the electron 
withdrawing effects of halogens, it would be expected that F5 and F7 would show no 
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3,4-Dimethoxy 11 
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4-Methoxy 22 
D21 Napthyl 39 
D30 
 
--- 42 
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Table 3.5 – Inhibition data for hydroxamic acid compounds D12-D13, D20-D21 and D30-D31 
versus LeNCED1. Compounds marked with an asterisk previously published in Sergeant et al. 
2009. 
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inhibition, not more inhibition. The electron donating effect of the amino group on F6 is 
possibly helping to improve the inhibition seen by the compound. 
Compounds in the ‘H’ series showed more effective inhibition, generally around 25% 
at 100 µM. The H series compounds are sterically quite bulky, and contain many π-bonding 
systems, which may aid their binding to the enzyme. Compound B2, which is structurally 
similar to the H series compounds, showed similar levels of inhibition at 100 µM. It may also 
be that the increased chain length aids the flexibility of the inhibitors. Given the NCED is 
selective for the 9-cis isomer of 9’-cis-neoxanthin, it may be that the most effective inhibitors 
in fact mimic this geometrical feature.  
 The magnitude of the difference between the most effective of the hydroxamic acids 
against LeNCED1 and the least effective is not great, and does not allow for strong 
conclusions to be made on the aspect of structure activity relationships (Figure 3.7). One of 
the clear trend that emerges from this data is that compounds with longer chain lengths appear 
to show greater inhibition. This could be because these longer chained compounds are 
maximising hydrophobic binding within the active site of LeNCED1. Looking at the active 
site of Z. mays  Vp14, a related NCED enzyme which shares significant sequence homology 
(66% identity of LeNCED1 with Vp14) (see Figure 1.9,  Section 1.4) in Figure 3.8, it can be 
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F1* 
 
4-Methoxy H 0 
F2* 4-Methoxy F 0 
F3* 3,4-Dimethoxy H 2 
F4* 3,4-Dimethoxy F 0 
F5 3-Chloro H 5 
F6 3-Amino H 7 
F7 3-Bromo H 4 
F8 3-Chloro-4-Methoxy H 0 
Table 3.6 – Inhibition data for hydroxamic acid compounds F1-F8 versus LeNCED1. Compounds 
marked with an asterisk previously published in Sergeant et al. 2009. 
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seen that there are a significant number of hydrophobic residues within the active site  
(Messing et al. 2010). However, there are several exceptions to this trend. B2, for example, a 
long chain hydroxamic acid, shows low inhibition against LeNCED1. Given the structural 
similarities between D30, D31 and D32, it is interesting that D31 and D32 showed lower 
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24 
H3 
 
26 
H4 
 
24 
Table 3.7 – Inhibition data for hydroxamic acid compounds H1-H4 versus LeNCED1. Bn 
represents a benzyl group (CH2Ph). 
 
 
Figure 3.7 – Summary of inhibition shown by hydroxamic acids against cell free extract containing 
overproduced LeNCED1. 
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inhibition than D30. In addition, D10 and D11 both showed weak inhibition despite having a 
long aliphatic chain.  
One particular concern with performing assays with cell free extract is non-specific 
binding of the inhibitor molecules to other soluble proteins within the cell free extract. 
However, given that cell free extract was used for in vitro assays for LeCCD1a (see Chapter 
2.2), and inhibition of greater than 95% was recorded for several inhibitors, it seems unlikely 
that this is the cause of the low levels of inhibition seen. It seems more likely that the specific 
geometry and features of the NCED active site are preventing inhibition. 
3.4 Expression and Assays of Z. mays NCEDs versus Inhibitors D2 and 
D4 
When assayed in planta against A. thaliana, the hydroxamic acids D2 and D4 (Figure 
3.9) exhibit phenotypic effects on seed germination, whereby application of the compounds 
D2 and D4 to the seed decreases the time taken for the seed to germinate (Sergeant et al. 
unpublished). Seed germination is controlled by the plant signalling hormone abscisic acid, 
 
Figure 3.8 – Active site structure of Z. mays VP14 with docked 9’-cis-violoxanthin (purple) and 
β–apo-8’-carotenal (green) showing the polarities of residues found within the active site. Figure 
taken from Messing et al. (2010). 
 
 
Figure 3.9 – Structures of the hydroxamic acid inhibitors D2 and D4. 
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the biosynthesis of which is controlled by NCED (Taylor et al. 2005). However, within 
Arabidopsis, and other plant species in fact, there are multiple NCED homologs, and it is 
unknown which NCED enzyme, or enzymes, are the cause of the observed phenotype (Tan et 
al. 2003, Lefebvre et al. 2006). Z. mays is a commercially important crop which has five 
different NCED homologues termed ZmNCED1, 2, 3A, 3B and 9 (Chandler 2014). In an 
attempt to identify which NCED homologue is responsible for the observed phenotype and to 
aid in the development of a specific NCED inhibitor, it was decided to express the Z. mays 
NCED enzymes and to assay them against the two more effective hydroxamic acid inhibitors, 
D2 and D4 (provided by Syngenta). In addition, there is not a strong correlation between the 
levels of inhibition seen in vitro against S. lycopersicum NCED1 and the in planta effect on 
seed germination.  
 The Z. mays NCEDs were cloned by Jake Chandler (Cranfield University) from 
Z. mays cDNA into the pGEX-4T-1 vector (Chandler 2014). The ZmNCEDs were then used 
to transform E. coli BL21 and expressed (Figure 3.10). Sequences of the five ZmNCEDs are 
shown in appendix 11.2. Three ZmNCEDs, ZmNCED1, 3A and 3B expressed moderately 
well, considering the codon bias difference between Z. mays and E. coli (Tuller et al. 2010, 
Burgess-Brown et al. 2008). A fourth, ZmNCED2, expressed at a low level, however, there 
was enough protein present to allow for an assay. For the fifth NCED, ZmNCED9, no protein 
band was visible at all. ZmNCED9 was then expressed in pRosetta BL21 E. coli in an attempt 
to enhance the expression, since the pRosetta plasmid codes for rare codons which are not 
usually required for gene expression in E. coli (Kudla et al. 2009, Fu et al. 2007, Kane 1995).  
 Using cell free extracts containing overexpressed ZmNCED, the inhibitors D2 and D4 
were assayed at 100 µM concentrations. Assays were conducted as described for 
S. lycopersicum NCED1 and the products were examined by HPLC as described for 
S. lycopersicum NCED1. Inhibition data for ZmNCED1, 2, 3A and 3B is shown in Figure 
3.11.  Despite also being expressed in pRosetta BL21 E. coli strains no turnover of the 
9’-cis-neoxanthin substrate was observed with the cell free extract. Against NCED1, 2, 3A 
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and 3B both D2 and D4 showed 20-40% inhibition, apart from D2 versus ZmNCED2, which 
showed approximately 65% inhibition. However, if one particular isozyme was responsible 
for the observed phenotype at 1 mM concentration in planta, then one might expect greater 
than 90% inhibition for that enzyme at 100 µM of inhibitor in vitro, but that effect was not 
observed. The expression levels of the different NCEDs vary between different plant tissues, 
and as such, given the  phenotypes observed in planta, it was expected there would be different 
levels of inhibition observed in vitro (Tan et al. 2003, Lefebvre et al. 2006). This was not 
apparent and further work may be required to solubilise ZmNCED9 and to observe what levels 
of inhibition this enzyme shows against compounds D2 and D4.  
 
Figure 3.10 – Top: 8% SDS-PAGE analysis of the production of Z. mays enzymes NCED1 (orange 
box), 2 (blue box), 3A (green box), 3B (purple box) and 9 (red box) expressed in E. coli BL21. 
Thick band between 70 and 100 kDa marker corresponds to the overproduced NCED. 1 – Ladder; 
2 -  ZmNCED1 non-induced control (NIC); 3 – ZmNCED1 total protein (TP); 4 – ZmNCED1 total 
soluble protein (TSP); 5 – ZmNCED2 NIC; 6 – ZmNCED2 TP; 7 – ZmNCED2 TSP; 8 – 
ZmNCED3A NIC; 9 – ZmNCED3A TP; 10 – ZmNCED3A TSP; 11 – ZmNCED3B NIC; 12 - 
ZmNCED3B TP; 13 – ZmNCED3B TSP; 14 – ZmNCED9 NIC; 15 – ZmNCED9 TP; 16 – 
ZmNCED9 TSP. Molecular weights of GST-NCEDs (calculated from sequence); 1: 89.2 kDa; 2: 
86.9 kDa; 3A: 83.3 kDa; 3B: 83.0 kDa; 9: 89.0 kDa. Molecular weights of ladder are in kDa. Mass 
spectrometry would be required to definitely confirm the production of each protein. Bottom: 
Western blot analysis of ZmNCED1 elution fractions following GST purification visualised with 
anti-GST-HRP conjugate using BioRad ChemiDoc imaging instrument. 
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3.5 Time-Dependent Inhibition of Z. mays NCED1 
 When ZmNCED1 was expressed and purified for the purposes of the development of 
a coupled NCED-ABA2 assay (see Chapter 3.6), it was discovered that pre-incubation of 
inhibitors with cell free extract containing overexpressed ZmNCED1, prior to the addition of 
the substrate, resulted in different levels of inhibition than was observed without pre-
incubation. In samples that were pre-incubated, almost 100% inhibition of the enzyme was 
observed (Figure 3.12). Conversely, in samples without pre-incubation, inhibition levels of 
less than 40% were seen (Figure 3.12). On the basis of these observations, Z. mays NCED1 
 
Figure 3.12 – Comparison of percentage inhibition observed at 100 µM D2 versus cell free extract 
containing over produced ZmNCED1 with and without pre-incubation of D2.  
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Figure 3.11 – Percentage inhibitions shown by the hydroxamic acid inhibitors D2 and D4 against 
Z. mays NCED1, NCED2, NCED3A, NCED3B, NCED9 and S. lycopersicum NCED1. Error bars 
represent standard deviation of inhibition between replicates. 
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was purified via the same method as reported for S. lycopersicum CCD1. Reactivated Z. mays 
NCED1 was shown to effectively turn over 9’-cis-neoxanthin to xanthoxin and the C25 
aldehyde via HPLC. However, when D2 was pre-incubated with the enzyme for different 
lengths of time, either 30, 20 or 10 minutes, no turnover was observed (Figure 3.13). Partial 
inhibition was seen when D2 was added simultaneously with the substrate. This time 
dependent inhibition effect has been seen with hydroxamic acid inhibitors of p-hydroxy-
phenylpyruvate dioxygenase (HPPD) (Sergeant et al. 2013). In this case the ‘F-series’ 
inhibitors were shown to inhibit HPPD to a greater extent on pre-incubation of the inhibitor 
with the enzyme. This effect was speculated to be due to oxidation of the Fe (II)-HA complex 
to Fe (III)-HA (where HA represents the hydroxamic acid). Fe (III) would bind the 
hydroxamic acid more strongly, thus resulting in the increased levels of inhibition observed 
(Sergeant et al. 2013).   
Given the effect of pre-incubation of the hydroxamic acids D2 and D4 with 
ZmNCED1 it appears that the biochemical basis of the seed germination phenotype observed 
in Z. mays is due to inhibition of one or more NCED isozymes. Interestingly, however, when 
the inhibitors abamine and abamineSG (provided by Syngenta) are assayed against 
ZmNCED1 using the same time dependent incubation method, only 20% inhibition is 
observed at 100 µM (Figure 3.14). This is interesting, given that abamine and abamineSG 
 
Figure 3.13 – Comparison of percentage conversion of 9’-cis-neoxanthin to C25 aldehyde by 
ZmNCED1 following pre-incubation of ZmNCED1 with compound D2 for various lengths of time. 
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have been shown to inhibit stomatal closure, ABA induced gene expression of RD29B (a gene 
with an ABA response element which encodes the LEA protein in A. thaliana) and osmotic 
induced ABA accumulation in planta in A. thaliana (Han et al. 2004, Kitahata et al. 2006). 
AbamineSG has additionally been shown to inhibit seedling growth in A. thaliana (Kitahata 
et al. 2006). As with the hydroxamic acids, complete inhibition would be expected at 100 µM 
in vitro if these phenotypes were the result of NCED inhibition in planta. This would suggest 
that there is perhaps an additional target for these compounds. Some hydroxamic acids (D12 
and D13) have been shown to inhibit other iron-dependent dioxygenases such as the E. coli 
catechol dioxygenase MhpB and HPPD (Sergeant et al. 2013, Sainsbury 2014). As such, the 
hydroxamic acids could be inhibiting another non-heme oxygenase enzyme resulting in the 
observed phenotype. 
3.6 Development of a Coupled NCED-ABA2 Assay 
The rate limiting step in the biosynthesis of ABA is the 11’,12’ cleavage of 
9’-cis-neoxanthin catalysed by NCED (Taylor et al. 2005). As explained in Section 3.2, the 
NCED enzyme and its 9’-cis-neoxanthin substrate present many problems when being 
assayed. HPLC assays, required for the study of NCED, require significantly more time for 
sample preparation, data collection and analysis. As a result, this makes the screening of large 
collections of compounds rather difficult and time consuming. To this end, it is necessary to 
 
Figure 3.14 – Comparison of percentage inhibition observed for abamine, abamineSG, D2 and D4 
at 100 µM against ZmNCED1 following 10 minute pre-incubation of ZmNCED1 with inhibitor 
prior to the addition of 9’-cis-neoxanthin.  
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develop a high throughput assay for the screening of compounds for inhibition of NCED in 
order to identify an effective and selective NCED inhibitor.  
Xanthoxin is, along with the C25 aldehyde, produced upon NCED cleavage of 9’-cis-
neoxanthin (Figure 3.15). Xanthoxin is a conjugated aldehyde which is oxidised to abscisic 
aldehyde by ABA2, also known as xanthoxin dehydrogenase, the next enzyme on the ABA 
biosynthesis pathway (Figure 3.15) (González-Guzmán et al. 2002, Cheng et al. 2002). The 
enzyme abscisic aldehyde oxidase (AAo3) then catalyses the final step in the biosynthesis of 
abscisic acid (Seo et al. 2000). ABA2 is an alcohol dehydrogenase and belongs to a family of 
enzymes known as the short chain dehydrogenases (González-Guzmán et al. 2002, Cheng et 
al. 2002). The oxidation of xanthoxin by ABA2 is a nicotinamide adenine dinucleotide (NAD) 
dependent process, and as such the reaction can be monitored by the change in absorbance or 
fluorescence at 340 nm or 440 nm respectively as reduced NAD (NADH) is produced. If 
ABA2 were coupled to NCED, then as NCED produces xanthoxin, it should be oxidised by 
the ABA2, resulting in the production of NADH, which can be monitored continuously. The 
reported KM for ABA2, of 19 µM, is lower than reported KM values for NCEDs (49 µM, 27 
 
Figure 3.15 – Biosynthetic route from 9’-cis-neoxanthin to the signalling hormone abscisic acid. 
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µM and 24 µM for V. unguiculata NCED, Z. mays NCED1 and A. thaliana NCED3 
respectively (Han et al. 2004, Schwartz et al. 2003, Boyd et al. 2009). 
 To this end, the A. thaliana ABA2 gene sequence was codon optimised for expression 
in E. coli, and the codon optimised gene was purchased from Genscript (see Appendix 10.3 
for the optimised gene sequence. Accession number of wild type ABA2 gene: BT003412). 
The ABA2 gene was cloned from the pUC57 vector into a pET-200 expression vector with an 
N-His6 fusion tag and the AtABA2 gene fusion product was expressed in BL21 E. coli and 
purified by nickel affinity chromatography (Figure 3.16). Work by González-Guzmán et al. 
has shown that ABA2 will also oxidise a range of other alcohols, including 
3, 3, 5-trimethylcyclohexanol (González-Guzmán et al. 2002). As such 
3, 3, 5-trimethylcyclohexanol was used as a control to test the activity of AtABA2 in vitro. 
Upon the addition of 100 µM 3, 3, 5-trimethylcycohexanol in the presence of 100 µM NAD+ 
and 36 µg mL-1 AtABA2 there was an increase in absorbance at 340 nm, indicating AtABA2 
activity (Figure 3.17A). Additionally, NADH production was confirmed by fluorescence 
under the same conditions (Figure 3.17B). A time dependent increase in emission at 440 nm 
 
Figure 3.16 – SDS-PAGE gel of N-His6-AtABA2 purification. Lane 1 – Ladder; 2 – Non-induced 
E. coli cell pellet; 3 - Induced pET-200-AtABA2 E. coli cell pellet; 4 – Elution fraction 1; 5 - Elution 
fraction 3. Molecular weights of the ladder are in kDa. Molecular weight of N-His6-AtABA2 
(calculated from sequence): 34.4 kDa. Mass spectrometry would be required to definitively confirm 
expression of AtABA2. 
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can be observed for the AtABA2 catalysed reaction. Assays in the presence of boiled, 
denatured enzyme and in the absence of NAD showed no turnover (data not shown). 
Initial experiments towards the coupled assay involved using cell free extract 
containing overproduced S. lycopersicum NCED1. It was found that upon the addition of the 
cell free extract containing overproduced LeNCED1 to 100 µM NAD+, 36 µg mL-1 AtABA2  
and 40 µM 9’-cis-neoxanthin there was an increase in absorbance at 340 nm, consistent with 
the apparent oxidation of xanthoxin by ABA2 (Figure 3.18A). However, subsequent 
experiments showed inconsistent results and controls with cell-free extract without 
 
 
Figure 3.17 – Changes in absorbance (A) and fluorescence (B) seen for the AtABA2 catalysed 
oxidation of 3,3,5-trimethylcyclohexanol (D). (C) ABA2 control reaction in the absence of NAD 
indicates reaction is dependent upon NAD+ and an NAD+ dependent enzyme. Ex – Excitation 
wavelength; Em: Emission wavelength. 
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overproduced LeNCED1 also caused an increase in absorbance at 340 nm. It was noticed that 
upon the addition of the 9’-cis-neoxanthin extract to the assay mixture there was an increase 
in absorbance which continued after the addition of the cell free extract (Figure 3.18B). These 
results suggested that the increase in absorbance was not due to xanthoxin oxidation by ABA2. 
The upwards drift begins before the addition of ABA2, suggesting it was not due to NAD(H). 
The possibility that the ABA2 was oxidising the ethanol that is required to solubilise the 9’-
cis-neoxanthin was considered. However, this was deemed unlikely since experiments by 
Gonzalez-Guzman et al show that AtABA2 does not oxidise ethanol (González-Guzmán et 
al. 2002). The data suggests that something in the 9’-cis-neoxanthin extract, the AtABA2 or 
 
 
Figure 3.18 – Changes in absorbance at 340 nm during coupled assay development. Top graph, A, 
shows initial attempts towards the development of the coupled assay with an increase in absorbance 
at 340 nm seen on addition of cell free extract containing over-produced LeNCED1. Bottom graph, 
B, shows the increase in absorbance observed upon the addition of 9’-cis-neoxanthin extract to the 
assay. 
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the cell lysate was causing a reaction. As a result of the upward drift in absorbance, it was 
decided to attempt to prepare crude purification samples of the NCED enzyme.  
A crude purification of Z. mays NCED1 was performed in order to eliminate factors 
in the cell free extract which could interfere with the assay. ZmNCED1 was chosen instead of 
LeNCED1 since its purification has been reported in the literature, although its activity was 
not reported after purification (Messing et al. 2010). Purification of both native (with the iron 
cofactor within the enzyme) and apo-ZmNCED1 (where the iron has been extract via the 
addition of 1 mM 1, 10–phenanthroline) by glutathione affinity chromatography was 
performed (via the procedure detailed in Chapter 2.2). The purified proteins were assayed via 
HPLC under the same conditions as Chapter 3.2. This showed the presence of the C25 product, 
indicating that the ZmNCED1 was active after purification (as seen in Figure 3.5). Due to the 
crude nature of the purification and the presence of non-specifically bound proteins in the 
eluted protein fractions, as can be seen by SDS-PAGE gel electrophoresis (for example Figure 
3.4), the concentration of ZmNCED1 is unknown, although approximately 50 µg of protein 
was added to assays. By comparison with HPLC assays involving cell free extract containing 
over produced ZmNCED1, the activity of the enzyme is diminished after purification. Upon 
addition of purified native enzyme (5 µL of crude purification elution to a total volume of 200 
µL), there was a decrease in absorbance, indicating that the assay was not functional (Figure 
3.19A). It is also not clear what would cause this drop in absorbance. When apo-ZmNCED1 
was reactivated by the addition of 1.25 mM iron (II)  sulphate  and  5 mM 2-mercaptoethanol 
(BME), an increase in absorbance was observed at 340 nm on the addition of the reactivated 
ZmNCED1 (5 µL of crude purification elution to a total volume of 200 µL) to the assay 
(Figure 3.19B). Control experiments with boiled enzyme and in the presence of 100 mM 
EDTA both failed to produce an increase in absorbance at 340 nm (Figure 3.19C and Figure 
3.19D). However, control experiments in the absence of NAD resulted in an increase in 
absorbance at 340 nm (Figure 3.19E). As such, it was not possible to discern whether the 
ABA2 enzyme was active or not and the  cause  of this  observation  remains  unknown.  One  
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Figure 3.19 – UV chromatograms at 340 nm of NCED-ABA2 coupled assay. Top left, A: coupled 
assay with purified native ZmNCED1. 1 – addition of 100 µM NAD+; 2 – addition of 35 µg mL-1 
AtABA2; 3 – addition of 5 µL 9’-cis-neoxanthin extract; 4 – addition of 5 µL purified native 
ZmNCED1. Top right, B: coupled assay with reactivated purified apo-ZmNCED1. 5 - addition of 
100 µM NAD+; 6 – addition of 35 µg mL-1 AtABA2; 7 – addition of 5 µL 9’-cis-neoxanthin extract; 
8 – addition of 5 µL reactivated purified apo-ZmNCED1. Middle left, C: coupled assay in the 
presence of EDTA. 9 – addition of 100 µM NAD+, 35 µg mL-1 AtABA2 and 5 µL 9’-cis-neoxanthin 
extract; 10 - addition of 5 µL reactivated purified apo-ZmNCED1; 11 – addition of 5 mM EDTA. 
Middle right, D: coupled assay with boiled reactivated purified apo-ZmNCED1. 12 - addition of 100 
µM NAD+, 35 µg mL-1 AtABA2 and 5 µL 9’-cis-neoxanthin extract; 13 – addition of 5µL boiled 
reactivated purified apo-ZmNCED1. Bottom, E: coupled assay in the absence of NAD+. 14 – 
addition of 35 µg mL-1 AtABA2 and 5 µL 9’-cis-neoxanthin extract; 15 – addition of 5 µL reactivated 
purified aop-ZmNCED1. 
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possible explanation for the results observed is that ABA2 is oxidising the 9’-cis-neoxanthin 
directly before xanthoxin is produced from 9’-cis-neoxanthin. This is possible, given that 
structurally there is no difference between the portion of the ABA2 substrate that is oxidised 
between xanthoxin and 9’-cis-neoxanthin, but Figure 3.19E shows that the increase in 
absorbance is not due to NAD+ dependent enzyme activity. 
Since it was speculated that interference in the assay was coming from the crude 9’-
cis-neoxanthin preparation, authentic, pure 9’-cis-neoxanthin from CaroteNature was 
obtained and used. Using a continuous UV assay at 340 nm, 25 µM 9’-cis-neoxanthin was 
added to a sample containing 5 µg mL-1 purified ABA2 and 100 µM NAD+. Upon addition of 
the NCED there was no significant increase in the absorbance but a small increase of 0.002 
AU was recorded over 15 minutes. However, considering the molar extinction coefficient of 
NADH is 6220 M-1 cm-1, and that the 9’-cis-neoxanthin is used at a final concentration of 25 
µM in the assays, then an increase in absorbance of 0.15 AU at 340 nm would be expected for 
the coupled assay, given there is a 1:1:1 ratio between the stoichiometry of 9’-cis-neoxanthin, 
xanthoxin and NAD(H) required for the reaction. Hence the observed absorbance change 
would correspond to only a 1.3% turnover of 9’-cis-neoxanthin. Considering the abscisic acid 
biosynthesis pathway, it is reasonable to assume that ABA2 would not oxidise 9’-cis-
neoxanthin, as if ABA2 were able to oxidise 9’-cis-neoxanthin, then the ABA biosynthesis 
pathway would have evolved the ABA2 to act before the NCED cleavage step. In addition 
given the hydrophobic nature of 9’-cis-neoxanthin, which is membrane associated, ABA2 
would also have had to evolve to act on a hydrophobic substrate at the interface of membranes. 
Given the highly soluble cytosolic nature of ABA2 this seems unlikely. On the other hand, 
structurally, oxidised 9’-cis-neoxanthin would not be dissimilar to 9-cis-neoxanthin, as 
discussed above. 
 Using pure 9’-cis-neoxanthin and purified ZmNCED, the coupled assay was repeated 
and the change in absorbance at 340 nm was recorded. In the presence of 100 µM NAD+, 5 
µg mL-1 ABA2, 25 µM 9’-cis-neoxanthin and 54 µg mL-1 of protein containing NCED there 
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was an increase in absorbance at 340 nm, However, control experiments also showed increases 
in absorbance by the same magnitude (Figure 3.20). Only one control, NAD, 9’-cis- 
neoxanthin and NCED showed no increase in absorbance. Repeating the assay with cell free 
extract containing over produced NCED in order to compensate for a possible low 
concentration of NCED had no effect.  
As already mentioned, the fluorescence signal of NADH can be monitored at 440 nm 
which is significantly more sensitive than that of the absorbance signal. However, it was not 
possible to use NADH fluorescence to monitor the reaction, since the emission of NADH, 440 
nm, overlaps with the absorption of the 9’-cis-neoxanthin, which is also 440 nm. As such, any 
signal produced from the reduction of NAD would be quenched by 9’-cis-neoxanthin. The 
fluorescence of carotenoids has been reported (Frank & Christensen 2008), but the quantum 
yield of the fluorescence signal is low, and as such it is unlikely that any signal could be 
detected and discerned from a no doubt overlapping signal from the C25 product. The 
fluorescence of NADH can be used for control experiments in the absence of 9’-cis-
neoxanthin. Accordingly, a series of controls in the absence of 9’-cis-neoxanthin were run in 
 
NAD+ + + + + 
AtABA2 + + +  
9’-cis-neoxanthin +  + + 
ZmNCED1 + +  + 
 
Figure 3.20 – Changes in absorbance associated with reduction of NAD+ shown by the full coupled 
assay (A) and controls (B-D) at 340 nm. Error bars represent standard deviation between replicates. 
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order to determine if either ABA2 or NCED were reacting in some way to reduce NAD. As 
can be seen in Figure 3.21, none of the control assays showed any significant change in 
fluorescence at an emission of 440 nm. As such, these components, either on their own or 
reacting together, are not producing reduced NADH. The result of this is that background 
absorbance at 340 nm must be either due to 9’-cis-neoxanthin or another unknown factor. 
 In general, assays followed the same pattern shown in Figure 3.20, whereby the 
absorbance change shown by the controls is equal to that of the full coupled assay. In an 
attempt to overcome this background absorbance several changes were made to the assay, 
such as increasing the concentration of NCED used, pre-incubation of NCED with 9’-cis-
neoxanthin and the removal of factors which were found to cause high background, such as 
catalase. It is interesting to note that the control without 9’-cis-neoxanthin had a lower 
absorbance change than the controls with 9’-cis-neoxanthin (Figure 3.20). This suggests that 
9’-cis-neoxanthin is causing the absorbance change seen through a non-enzyme catalysed 
process.  
The production of NADH can, however, be monitored using an NAD(P)H-Glo kit 
(Promega). With this system, the NADH is re-oxidised by a third enzyme, a reductase. This 
 
Figure 3.21 – Changes in fluorescence observed at 440 nm for control reactions in the AtABA2-
ZmNCED1 coupled assay. Concentrations of 100 µM NAD+, 5 µg mL-1 ABA2, 25 µM 9’-cis-
neoxanthin and 54 µg mL-1 NCED were used for the assays. 
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reductase reduces a substrate to produce luciferin, which is then used by a luciferase enzyme 
to produce a light signal (Figure 3.22). This signal can then be quantified as the amount of 
light produced is proportional to the amount of NADH present in the sample. In addition, the 
NAD(P)H system is sensitive to a concentration of 0.15 µM of NADH (Promega Ltd 2014).  
A concentration of 25 µM of 9’-cis-neoxanthin was used in the assays and even if neither 
ABA2 and NCED worked at optimal rates, then a signal should still be observed with the 
NAD(P)H kit. When analysed with the NAD(P)H Glo kit, it was seen that both the coupled 
assay and the controls all showed high luminescence, suggesting that NADH is being 
produced in the control reactions (Figure 3.23). However, this contradicts the observations of 
the control reactions performed using fluorescence, which suggested that the noise at 340 nm 
was not due to NADH. 
It is possible that NAD+ was present somehow in either the 9’-cis-neoxanthin extract, 
AtABA2 or ZmNCED1, but it is unlikely that the NAD+ was carried through the purification 
of ABA2 or NCED, since it is bound only loosely by enzymes. It was noted in early 
experiments that there was some slight precipitation in the assays, which may have interfered 
with readings. However, this precipitation was eliminated through the use of cleaner 
preparations, meaning that it could not be the cause of the high background readings. In 
addition, ABA2 was further purified to eliminate other proteins which may interfere with the 
assays, but again this had no effect on the assay. 
 
Figure 3.22 – Schematic of the NAD(P)H-Glo Kit (Promega) used to detect the NADH production 
from the ABA2 enzyme. The reductase substrate is a proprietary substrate provided within the kit. 
The luciferin detection reagent provided contains a luciferase enzyme and adenosine triphosphate 
(ATP). 
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It is clear that there are inconsistencies across the assay which render the assay 
unreliable at this moment. Possible solutions include obtaining completely pure samples of 
ABA2 and NCED in order to totally remove competition from contaminating non-specifically 
bound proteins which may be inhibiting the assay. Low turnover of NCED may also be a 
problem and repeating the experiment with a high concentration of NCED to ensure complete 
turnover of 9’-cis-neoxanthin by NCED, thus overcoming any background, may be a 
possibility. 
3.7 Conclusions 
It is difficult to draw any firm conclusions on what features of the hydroxamic acids 
are required for inhibition of NCEDs (summarised in Figure 3.24). It is, however, interesting 
to note the time dependent inhibition observed with compounds D2 and D4 against 
ZmNCED1. It is entirely possible that the weak inhibition data seen against LeNCED1 is due 
to a lack of pre-incubation. This would in part explain why there is a discrepancy between in 
 
Buffer + + + + + + + + 
Catalase  +  +     
NAD+   + + + + + + 
AtABA2     + + +  
9’-cis-
neoxanthin 
    +  + + 
ZmNCED1     + +  + 
 
Figure 3.23 – Changes in luminescence seen for controls and full coupled assay using the NAD(P)H 
Glo kit measuring NADH production. 
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planta data, which suggests inhibition of ABA mediated processes, and the in vitro data shown 
above. Poor inhibition by compounds abamine and abamineSG, which inhibit ABA mediated 
process in planta, may suggest an additional target is involved in planta. 
 The apparent lack of any difference in inhibition between the five NCEDs in Z. mays 
is understandable given the magnitude of the sequence similarity between the homologues. 
Given that the different NCEDs are expressed at different stages of plant development, in 
order to develop a commercial NCED inhibitor it would be necessary to develop a specific 
NCED inhibitor. However, since time dependent inhibition of ZmNCED1 has been shown, 
there could well be a difference in inhibition between the different ZmNCED homologs 
towards D2 and D4. 
 Finally, attempts to develop a method for the high throughput assay of NCED by 
coupling to the enzyme ABA2 were ultimately unsuccessful. Although the activity of each 
enzyme can be shown individually, upon addition of the two enzymes there is a significant 
amount of background, making it impossible to separate any actual reading from that 
background. Unfortunately, despite many experiments, the causes of the high background 
readings in the measurements remains unknown.  
 
Figure 3.24 – Summary of the in vitro structure activity relationship data of hydroxamic acid 
compounds against cell free extract containing over produced LeNCED1. 
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3.8 Future Work 
 Given the time dependent inhibition effect of hydroxamic acids in vitro towards Vp14, 
it would be of interest to assay the library of hydroxamic acids against ZmNCED1 and 
LeNCED1 and obtain IC50 values in order to discern structure activity relationships, which 
would aid in the development of selective NCED inhibitors. 
Further development of new inhibitors is required to ascertain whether any of the 
structure activity features highlighted here hold true. A crystal structure with bound inhibitor 
would be invaluable for this endeavour. It would be interesting to investigate whether the 
hydroxyl groups and epoxide on 9-cis-neoxanthin are required for binding. In addition to this, 
it is known that NCED only accepts 9-cis substrates and developing an inhibitor which mimics 
this could be an interesting avenue of investigation. This may be why the longer chained 
inhibitors are more effective, as free σ bond rotation may allow the inhibitor to access 
conformations thus allowing it to mimic the cis double bond of the 9-cis substrates.  
 Experiments with Oryza sativa Dwarf27 have shown that D27 does not isomerise 
9’-cis-neoxanthin to the all-trans isomer (see Chapter 4). Identifying the elusive neoxanthin 
isomerase, NCEI, would be of interest. A BLAST search reveals there are three homologs of 
D27 in A. thaliana, one of which may be the neoxanthin isomerase. 
 Finally, further work in developing a coupled assay would be beneficial, although 
potential problem is the low activity of the purified NCED. If the activity of the NCED can be 
increased, then it may be possible to discern a signal above the background of the reaction. 
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Chapter Four: Expression, Inhibition, Assays and 
Mechanistic Studies of Oryza sativa Dwarf27 (D27) 
4.1 Introduction 
 The biosynthesis of strigolactone begins with all-trans-β-carotene, which is 
isomerised by an isomerase enzyme termed Dwarf27, or D27, to yield 9-cis-β-carotene (Figure 
4.1). The isomerised β-carotene is then first cleaved by carotenoid cleavage dioxygenases 7 at 
the 9’,10’ position to give one equivalent each of β-ionone and 9-cis-β-apo-10’-carotenal. The 
9-cis-β-apo-10’-carotenal is then cleaved by the second CCD in the pathway, CCD8, to 
produce a compound known as carlactone (Alder at al. 2012). 
 In planta, phenotypic effects on shoot branching have been observed with the 
application of hydroxamic acids, in particular D2, D4, D5 and D6, to the model organism 
Arabidopsis thaliana (Sergeant et al. 2009). Given that this class of hydroxamic acids has 
been shown to inhibit CCDs, it is likely the cause of this observed shoot branching phenotype 
 
Figure 4.1 – Schematic of the biosynthetic pathway from all-trans-β-carotene to carlactone 
catalysed by D27, CCD7 and CCD8. 
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is the inhibition of either CCD7 or CCD8. Interestingly, the enzyme D27 is an iron containing 
enzyme (Lin et al. 2009). The role of iron is unknown, and possible isomerisation mechanisms 
involving a catalytic iron centre can be postulated (Chapter 1.7). The possibility of inhibition 
of D27 by hydroxamic acids cannot be ignored. Expression of D27 was therefore of interest 
for both generation of substrates for CCD7 and CCD8, and for enzyme inhibition assays. 
 The work detailed within this chapter describes the cloning of the enzyme D27, 
inhibition assays of hydroxamic acids towards D27 and mechanistic studies of D27. Cloning 
of D27 into the pGEX-4T-1 and pMAL-c5e vector and initial in vitro assays were performed 
by MChem project student Sophie Newgas. 
4.2 Cloning and Expression of O. sativa Dwarf27  
 The cDNA of full length Oryza sativa Dwarf27 (herein termed OsD27.1) was 
obtained from the Genbank database and the synthetic DNA sequence was sequence  
optimised for expression in E. coli and purchased from Genscript (Lin et al. 2009) (See 
Appendix 10.4 for optimised sequence. Wild type accession number: FJ641055). The D27 
genomic DNA was cloned from the pUC-57-Kan-OsD27.1 plasmid into a pET-151 expression 
vector via TOPO cloning.  
 Expression of N-His6-OsD27.1 was induced with 1 mM IPTG and cultures were 
allowed to incubate overnight at 20º C. Following purification via nickel affinity 
chromatography there was no band corresponding to the N-His6-OsD27.1 protein in the total 
soluble protein fraction following SDS-PAGE analysis. However, a band corresponding 
N-His6-OsD27.1 was present in the total protein fraction (Figure 4.2).  Attempts to refold the 
protein using 6 M guanidinium hydrochloride and dialysis were unsuccessful. Induction at 
different temperatures (16° C and 25° C) with different concentrations of IPTG (500 µM and 
250 µM) also failed to produce soluble OsD27 protein.  
 Analysis of the sequence of OsD27 using the UniProt database reveals that the first 
40 amino acids of D27 correspond to a potential chloroplast transit peptide. Consequently, the 
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first 120 base pairs were cloned out of OsD27 (OsD27ΔTP (termed D27.2)). OsD27.1 and 
OsD27.2 were subsequently cloned into the pMAL-c5e and the pGEX-4T-1 expression 
vectors as well as the pET-151 expression vector to give the maltose binding protein (MBP), 
glutathione-S-transferase (GST) and N-His6 tagged recombinant proteins. The large soluble 
nature of the GST and MBP tags was predicted to aid the solubility of D27. The expression of 
the MBP, GST and N-His6 tagged OsD27.1 and OsD27.2 was tested in the presence and 
absence of the pBB541 plasmid. The pBB541 plasmid was obtained from Addgene (de Marco 
2007) and contains the genes groES and groEL, coding for the GroES and GroEL proteins. 
GroES and GroEL are chaparones from E. coli which, when overproduced in conjunction with 
a protein, aid the correct folding of that particular protein. This helps to ensure solubility and 
prevent aggregation of that protein.  
 A summary of the results from the expression tests is presented in Table 4.1. In all 
cases protein over production was induced with 1 mM IPTG and cultures were incubated for 
16 hours at 20° C. All cloning experiments were performed successfully and results confirmed 
by sequencing. Only the MBP-OsD27.1 protein construct failed to express, the reasons for 
which are unknown. Removal of the transit peptide failed to improve the solubility of N-His6 
 
Figure 4.2 – 12% SDS-PAGE gel showing overproduced N-His6-OsD27.1 in the insoluble total 
protein fraction (lane 3) from pET-151-OsD27.1 BL21 E. coli. 1 – Ladder; 2 – Non-induced control; 
3 – Total protein; 4 – Total soluble protein from E. coli induced with IPTG (cell free extract); 5 – 6 
M Guanidinium hydrochloride fraction; 6 – 5 µL Dialysed protein; 7 – 25 µL Dialysed protein; 8 – 
20 µL Insoluble pellet following dialysis; 9 - 5 µL Insoluble pellet following dialysis. Molecular 
weights of ladder are in KDa. Molecular weight of N-His6 tagged OsD27.1: 34.9 kDa (calculated 
from sequence).                                                                     
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tagged OsD27. Expression of either N-His6-OsD27.1 or N-His6-D27.2 did not result in soluble 
protein unless the GroES/EL chaperones were co-expressed. GST-OsD27.1 was also found to 
be soluble and active. In all cases, the level of soluble protein was low (Figure 4.3). For in 
vivo work, the N-His6 tagged OsD27.1 protein was used, whilst for in vitro work, either GST 
tagged OsD27.1 in the presence of GroES/EL or N-His6 tagged OsD27.2 in the presence of 
GroES/EL was used.  
Construct 
N-His6-
OsD27.1 
N-His6-
OsD27.1 
N-His6-
OsD27.2 
N-His6-
OsD27.2 
GST-
OsD27.1* 
GST-
OsD27.1 
MBP-
OsD27.1* 
(+) pBB541 
Plasmid? 
(-) (+) (-) (+) (-) (+) (-) 
Expression? Y Y Y Y Y Y N 
Soluble? N Y N Y Y Y - 
Active? - N - Y Y Y - 
Table 4.1 – Summary of expression constructs tested for expression of the OsD27 protein. 
Constructs marked with ‘*’ were prepared by Sophie Newgas. OsD27.2 lacks the 120 amino acid 
transit peptide. 
 
Figure 4.3 – A: 10% SDS-PAGE gel showing overproduced GST-OsD27.1 from pGEX-4T-1-
OsD27.1 BL21 E. coli following Coomassie staining. 1 – Ladder; 2 – Total soluble protein; 3 – 
Unbound protein; 4 – Elution fraction 1; 5 – Elution fraction 2; 6 – Elution fraction 3; 7 – Elution 
fraction 4; 8 – Elution fraction 5. B: 10% SDS-PAGE gel showing overproduced N-His6-OsD27.2 
from pET-151-OsD27.2 BL21 E. coli following Coomassie staining. 8 – Ladder; 9 – Non-induced 
control; 10 – Total protein; 11 – Total soluble protein; 12 – Flow through; 13 – Elution fraction; 14 
– Concentrated elution fraction. Molecular weights of ladder are in kDa. Molecular weight of GST 
tagged OsD27.2: 57.1 kDa. Molecular weight of N-His6 tagged OsD27.2: 30.4 kDa. Mass 
spectrometry would be required to definitively confirm the presence of the OsD27 protein.                                                                                                         
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4.3 Identification of β-Carotene Isomers via HPLC 
 Isomers of β-carotene can be identified via UV-visible spectroscopy due to the 
differences in the λMAX values which result from isomerisation of the double bond backbone. 
Since the λMAX values are overlapping, the isomerisation reaction cannot be assayed 
continuously. Table 4.2 summarises λMAX values reported in the literature for 9-cis-β-carotene 
and all-trans-β-carotene.  
 In order to differentiate between isomers of β-carotene, a hydrophobic C30 reversed 
phase HPLC column is required (Figure 4.4). The high hydrophobicity of the C30 column 
 
 
Figure 4.4 – Comparison of HPLC chromatograms at room temperature and 4° C for the separation 
and analysis of β-carotene and its isomers. 
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Emenhiser et 
al. 1995 
Tsukida et al. 
1982 
Alder et al. 
2012 
Experimentally 
observed 
Absorbance maxima 
for all-trans (nm) 
450 450 453 452 
Absorbance maxima 
for 9-cis (nm) 
444 445 447 448 
Table 4.2 – Comparison of λMAX values in the literature for all-trans-β-carotene and 
9-cis-β-carotene to those obtained experimentally in this project. 
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allows isomers of β-carotene to be separated using a suitable solvent system (Sharpless et al. 
1996). It was noticed in order for complete separation of peaks, it was essential to operate the 
column at a temperature of 0º C. When the column is operated at room temperature, peaks 
with close retention times co-elute, thus preventing separation of certain isomers. However, 
at a lower temperature, the retention and interaction of the isomers with the column is 
increased, allowing separation of the isomers (Figure 4.4).  
Analysis of the peaks at 23.9 minutes and 24.5 minutes showed that the first peak had 
λMAX values at 452 nm and 476 nm (Figure 4.5). The second peak on the other hand had λMAX 
values at 448 nm and 474 nm (Figure 4.5). These values are in agreement with those reported 
in the literature for all-trans-β-carotene and 9-cis-β-carotene respectively (Tsukida et al. 1982, 
Emenhiser et al. 1995, Alder et al. 2012). In addition to this, cis-isomers of β-carotene have a 
 
 
Figure 4.5 – Comparison of the UV absorption spectra of 9-cis-β-carotene (A, left), all-trans-β-
carotene (B, right) and 15-cis-β-carotene (C, bottom). 
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cis peak between 320 and 350 nm, 343 nm in the case of 9-cis-β-carotene. The wavelength of 
this cis peak can be used to identify β-carotene isomers (Tsukida et al. 1982). Using these 
techniques, the peak at 23.9 minutes was identified as belonging to the all-trans-isomer and 
the peak at 24.5 minutes was assigned to the 9-cis isomer. The peak at 21.6 minutes was 
identified as belonging to the 15-cis isomer of β-carotene via its UV absorbance profile (Figure 
4.5). It should be noted, however, that comparison to synthetic authentic standards would be 
required for unambiguous assignment of the β-carotene isomers.  
4.4 In vivo assays of O. sativa Dwarf27 
For assays of OsD27, β-carotene was extracted using 6 M pyridinium acetate pH 5.5, 
as discussed in Section 5.3. Analysis was performed using a C30 reversed phase column as 
described above. Due to the low solubility of OsD27.1 and OsD27.2, in vivo assays of OsD27 
were attempted using a β-carotene accumulating strain of E. coli, pAC-BETA BL21 E. coli, 
which contains the pAC-BETA plasmid (obtained from Dr Andrew Thompson (Cranfield 
University)), which produces β-carotene when induced with 100 µM IPTG. Chemically 
competent pAC-BETA BL21 E. coli was prepared and transformed with the pET-151-
OsD27.1 plasmid. Although the N-His6-OsD27.1 was insoluble in vitro, it was suspected that 
in vivo a large proportion of the protein would remain soluble. The two strains of E. coli, pAC-
BETA BL21 E. coli and pAC-BETA pET-151-OsD27.1 BL21 E. coli were grown to OD600 = 
0.6 AU and induced with 100 µM IPTG.  
 After incubation for 16 hours at 20º C, the cells were collected by centrifugation and 
lysed via the action of lysozyme and sonication. Reaction products and unreacted substrate  
were extracted with 6 M pyridinium acetate and n-butanol extraction. Analysis showed that in 
the presence of pET-151-OsD27.1 the ratio of all-trans-β-carotene to 9-cis-β-carotene was 
smaller than with respect to the control (pAC-BETA in the absence of D27) (Figure 4.6) 
indicating that in vivo D27 isomerises all-trans-β-carotene to the 9-cis isomer. In vivo 
isomerisation was additionally performed with pGEX-4T-1-OsD27.1, demonstrating the 
activity of the construct.  
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 In order to test whether the hydroxamic acids were able to inhibit D27, in vivo cultures 
of pAC-BETA BL21 E. coli and pAC-BETA pET-151-OsD27.1 BL21 E. coli were prepared 
as before in the presence of 100 µM D4 (Figure 4.7). Unfortunately, on analysis it was found 
there was no difference in the ratio of all-trans-β-carotene to 9-cis-β-carotene in the presence 
and absence of D4. This is by no means conclusive proof that hydroxamic acids do not inhibit 
OsD27, given that it is possible that D4 is simply not taken up into the cell by E. coli. On the 
basis that the in vivo data showed activity of the pGEX-4T-1-OsD27.1, in vitro experiments 
were attempted.  
 
Figure 4.6 – Comparison of the ratio of all-trans-β-carotene to 9-cis-β-carotene produced by E. 
coli expressing the pAC-BETA β-carotene producing plasmid in the presence and absence of a 
plasmid expressing the D27 β-carotene isomerase. Lower ratio of all-trans to 9-cis-β-carotene 
indicates there is proportionally more 9-cis-β-carotene and hence isomerisation has occurred. 
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Figure 4.7 – Comparison of the ratio of all-trans-β-carotene to 9-cis-β-carotene produced by E. coli 
expressing the pAC-BETA β-carotene producing plasmid in the presence and absence of a plasmid 
expressing the D27 β-carotene isomerase and in the presence and absence of 100 µM D4. 
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4.5 In vitro assays of O. sativa Dwarf27 
 Initial in vitro assays with GST-D27.1 were performed by Sophie Newgas. In these 
experiments, partially purified GST-OsD27.1 (50 µg total protein) was used with commercial 
β-carotene (99% all-trans isomer, 40 µM). Assays were incubated at 20° C in the dark for 2 
hours. Following analysis by HPLC it could be seen that there was only a very small change 
in the ratio of all-trans-β-carotene to 9-cis-β-carotene with respect to the control, indicating 
that little or no reaction had taken place (Figure 4.8). Moreover, it was observed that this small 
change in the ratio of β-carotene isomers could be due to non-specific isomerisation. When a 
geometrically pure solution of all-trans-β-carotene was obtained following purification via 
HPLC and carried through the assay in absence of OsD27.1, then reanalysed, new peaks 
corresponding to the 15-cis and 9-cis isomers were present (Figure 4.9).  
 Isomerisation of a solution of all-trans-β-carotene by iodine under UV light results in 
a mixture of different geometrical isomers in equilibrium (See chapter 5.3). Analysis of these 
isomers via HPLC gives an equilibrium constant (Keq), defined by Equation 4.1, of 0.53 for 
the equilibrium of all-trans-β-carotene and 9-cis-β-carotene. D27 is catalysing a homologous 
 
Figure 4.8 – Comparison of the ratio of all-trans-β-carotene to 9-cis-β-carotene in the presence and 
absence of OsD27.1. 
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Equation 4.1 – Equation for the calculation of the equilibrium constant for the isomerisation of 9-
cis-β-carotene and all-trans-β-carotene. 
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reaction to that of iodine with UV light. It would be expected that following incubation of all-
trans-β-carotene with D27, the β-carotene solution should reach a similar equilibrium. 
However, this was apparently not the case.  
 Due to the low activity of OsD27 and the inaccuracies of observing the isomerisation 
reaction due to competing non-specific isomerisation, and to confirm that D27 was active, 
D27 was coupled to the second enzyme on the strigolactone biosynthesis pathway, CCD7  
(assays of AtCCD7.2 are discussed in Chapter 5). Incubation of all-trans-β-carotene with 
CCD7 failed to produce a peak corresponding to the 9-cis-β-apo-10-caroteal product of the 
CCD7 reaction (Figure 4.10). However, when D27 is incubated with AtCCD7.2 and all-trans-
β-carotene, a peak correspond to the 9-cis-β-apo-10’-carotenal, the product of the CCD7 
reaction, becomes apparent (Figure 4.10 and 4.11). This confirms that the D27 is active and 
 
 
Figure 4.9 – Comparison of purified all-trans-β-carotene immediately following purification via 
HPLC (A, top), and following exposure to assay conditions (B, bottom). Non-specific, non-enzyme 
catalysed isomerisation occurs as a background reaction. 
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does catalyse the isomerisation of all-trans-β-carotene to the 9-cis isomer. However, it raises 
the question as to why D27 does not appear to catalyse the isomerisation on its own?  
 It was investigated as to whether D27 could catalyse the reverse reaction, the 
isomerisation of 9-cis-β-carotene to all-trans-β-carotene. When D27 is incubated with a 
 
 
Figure 4.10 – HPLC chromatogram of products from the incubation of all-trans-β-carotene with 
AtCCD7.2 (A, top) and of all-trans-β-carotene with OsD27 and AtCCD7.2 (B, bottom).  
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Figure 4.11 – Percentage conversion of 9-cis-β-carotene to 9-cis-β-apo-10’-carotenal. In the 
absence of the isomerase OsD27.1, there is less than 5% conversion of all-trans-β-carotene by 
AtCCD7.2. However, when AtCCD7.2 is incubated with all-trans-β-carotene and OsD27.1 the level 
of conversion increases above that observed when AtCCD7.2 is incubated with 9-cis-β-carotene. 
9-cis-β-apo-10’-carotenal was identified by mass spectrometry (see Chapter 5). 
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solution of β-carotene containing predominantly the 9-cis-isomer, and the products analysed 
it can be seen that there is a significant increase in the levels of all-trans-β-carotene present 
(Figure 4.12). The amount of all-trans-β-carotene increases until an equilibrium between the 
β-carotene isomers is reached (Figure 4.13). Following incubation of D27 with 9-cis-β-
carotene, the Keq of the isomers equals 0.49, similar to that of the non-enzyme catalysed iodine 
isomerisation.  
 Consequentially, the question becomes why is D27 not catalysing the forward reaction 
to completion? There are two possible solutions to this question. The first, inactivation of the 
enzyme, is unlikely, given that the D27 has been shown to be active. The second is product 
inhibition. Given that the 9-cis isomer is thermodynamically higher in energy than the all-
trans isomer due to the favourable overlap of the π orbitals in the all-trans state and decreased 
steric interactions (Niedzwiedzki et al. 2009), it is likely that the enzyme binds the 9-cis isomer 
 
 
Figure 4.12 – Incubation of 9-cis-β-carotene in the absence (A) and presence (B) of OsD27.1. 
Following incubation of 9-cis-β-carotene with OsD27.1 the 15-cis and all-trans isomers of 
β-carotene are visible, indicating that the reverse isomerisation reaction is favoured and the enzyme 
is not selective for solely the all-trans and 9-cis isomers of β-carotene. 
 
-10
10
30
50
70
90
110
130
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 (
4
7
5
 n
m
) 
(m
A
U
)
Time (Minutes)
A: 9-cis-β-carotene
all-trans-β-carotene
9-cis-β-carotene
-10
-5
0
5
10
15
20
25
30
35
0 5 10 15 20 25 30
A
b
so
rb
an
ce
 (
4
7
5
 n
m
) 
(m
A
U
)
Time (Minutes)
B: 9-cis-β-carotene (+) OsD27.1
15-cis-β-carotene
all-trans-β-carotene
9-cis-β-
carotene
  Chapter Four: D27 
Page | 103  
 
more tightly than the all-trans isomer. If so, the forward reaction forms a higher affinity 
product, which might lead to product inhibition. In the presence of CCD7, the 9-cis-β-carotene 
product would be readily removed, thus ensuring that the effective concentration of 9-cis-β-
carotene in the reaction solution remains low, preventing product inhibition of D27. In the 
reverse reaction (9-cis to all-trans), the formation of lower affinity all-trans-β-carotene would 
not cause product inhibition.   
 A KM of 0.26 µM was determined for OsD27 for 9-cis-β-carotene at pH 6.4 at 25° C, 
a very low KM value. Additionally, a kcat of 34 s-1 was calculated for the same reaction under 
the same conditions. However, due to poor efficiency of the forward isomerisation reaction, it 
was not possible to calculate either KM or kcat for OsD27 with all-trans-β-carotene. Despite 
this, the low KM value for the reverse reaction implies that D27 does bind 9-cis-β-carotene 
with a high affinity, supporting the hypothesis of product inhibition by 9-cis-β-carotene in the 
forward reaction. Consequentially, this would imply that the KM for the forward reaction, the 
isomerisation of all-trans-β-carotene, is higher than that of the reverse reaction. As such, since 
the Keq of the reaction can also be defined by Equation 4.2, it must therefore follow that the 
kcat of the forward reaction must be of a similar magnitude to that of the KM, since the product 
of kcat / KM for the forward reaction must equal roughly 1 to give a Keq of 0.5. This is supported 
by the observation that when D27 is coupled to CCD7 with all-trans-β-carotene there are 
 
Figure 4.13 – Time course experiment of OsD27 in the presence of 9-cis-β-carotene. The reaction 
proceeds until an equilibrium is reached between the isomers of β-carotene. 
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higher levels of 9-cis-β-apo-10’-carotenal formation than when CCD7 is incubated with 9-cis-
β-carotene alone.  
 The 15-cis isomer can also be identified following incubation of 9-cis-β-carotene with 
D27 (Figure 4.12). The presence of the 15-cis isomer suggests that D27 is not 100% 
regiospecific, which could indicate that the isomerisation occurs through either a radical or 
cation mediated process, similar to the RPE65 isomerase, whereby loss of double bond 
character allows free rotation of the polyene backbone. An isomerisation reaction which 
utilises a covalent intermediate is unlikely to produce side products. Moreover it suggest that 
more than one bond can be isomerised by D27. However, the caveat with this data is that D27 
catalysed isomerisation is competing with nonspecific thermal and UV catalysed 
isomerisation, and it is difficult to distinguish between the two using these assay methods.  
 Given the propensity of β-carotene to favour the all-trans isomer and that in vitro D27 
activity is low, it is likely that in vivo, CCD7 and D27 are localised together. This would allow 
CCD7 to immediately cleave any 9-cis-β-carotene produced by D27. Removal of 9-cis-β-
carotene would then prevent substrate inhibition of D27 and drive D27 to continue to 
isomerise all-trans-β-carotene to maintain the equilibrium of isomers.  
4.6 Mechanistic Studies O. sativa Dwarf27 
During these investigations, several questions regarding the mechanism by which D27 
isomerises β-carotene became apparent, primarily by what mechanism does D27 isomerise 
β-carotene? D27 does not share any sequence similarity to the all-trans-retinyl ester isomerase, 
RPE65. In fact, analysis of D27 shows it is not related to any protein of known function. What 
is more, the isomerisation of retinol by RPE65 is dependent upon the ester moiety of the 
all-trans-retinyl ester, which is cleaved by the Lewis acidity of iron to create a substrate cation, 
𝐾eq=
(
𝑘cat
𝐾M
)
Forward
(
𝑘cat
𝐾M
)
Reverse
 
Equation 4.2 – Equation for the calculation of the equilibrium constant for the isomerisation of 9-
cis-β-carotene and all-trans-β-carotene via KM and kcat values. 
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which can then isomerise (Kiser et al. 2012). Since β-carotene would be unable to interact 
with iron in a similar way with D27, this mechanism seems unlikely. As such, it is likely 
isomerisation occurs through a novel mechanism. For these assays, the isomerisation of 
9-cis-β-carotene to all-trans-β-carotene was observed due to reasons outlined in Section 4.5. 
A pH rate profile of D27 was performed to determine if any acid/base catalysis occurs 
in the mechanism of D27. Incubation of D27 with 9-cis-β-carotene at different pH revealed 
little variation in the rate of isomerisation of 9-cis-β-carotene to all-trans-β-carotene versus 
pH (Figure 4.14). As such, it is unlikely that there is any acid-base catalysis in the 
isomerisation of D27. This would therefore suggest a mechanism of isomerisation that is 
mediated by electron transfer to or from the carotenoid substrate. Removal or addition of an 
electron would create either a substrate radical cation or anion (Figure 4.17). This would break 
the conjugated double bond system and allow free rotation of the β-carotene. This hypothesis 
is supported by the observation that D27 is not regiospecific, producing isomers of β-carotene 
other than 9-cis or all-trans. The production of the 15-cis isomer can be clearly seen following 
incubation of 9-cis-β-carotene with OsD27 (Figure 4.12). A mechanism involving a covalent 
intermediate, similar to that suggested by Deigner et al. for the isomerisation of all-trans-
retinol by RPE65 (Chapter 1.7, Figure 1.24), would be significantly less likely to produce side 
products (Deigner et al. 1989). 
 
Figure 4.14 – pH rate profile of GST-OsD27.1, showing no significant variation in the rate of the 
D27 catalysed isomerisation of 9-cis-β-carotene to all-trans-β-carotene. 
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As discussed in Chapter 1.7, isomerisation of β-carotene could proceed through a 
mechanism whereby oxygen is used to create a substrate cation or radical (Figure 1.24). 
Formation of this intermediate results in a loss of double character, which allows free rotation 
and subsequent isomerisation (Harrison & Bugg 2013). In order to investigate whether D27 
proceeds through this oxygen dependent mechanism, the isomerisation reaction was 
performed under an atmosphere of nitrogen gas following thorough degassing of the enzyme 
and buffers. Subsequent analysis of the reaction products revealed that the reaction occurred 
identically as under aerobic conditions (Figure 4.15). Moreover, a mechanism involving 
dioxygen might also be expected to produce the cleavage product, 9-cis-β-apo-10’-carotenal, 
in addition to the isomerised β-carotene. However, no such cleavage products are observed. 
Consequentially, these observations seem to rule out this mechanism. 
 
 
Figure 4.15 – HPLC chromatogram following incubation of 9-cis-β-carotene with OsD27 in the 
presence of oxygen (A, top) and absence of oxygen (B, bottom). 
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The enzyme prolycopene isomerase (CRTISO) is an isomerase required for the 
isomerisation of 7,9/9’,7’-tetra-cis-lycopene to all-trans-lycopene (Isaacson et al. 2004). 
Although the mechanism of CRTISO is also unknown, experiments by Isaacson et al. have 
shown that purified CRTISO is inactive in vitro. CRTISO activity is only present upon the 
addition of bacterial cell free extract. Further experiments suggested CRTISO may require the 
presence of the respiratory transport chain proteins complex I (NADH ubiquinone 
oxidoreductase) and complex II (succinate ubiquinone oxidoreductase), indicating that 
isomerisation of 7,9/9’,7’-tetra-cis-lycopene is a redox process, obtaining electrons from 
complex I before passing them to complex II (Isaacson et al. 2004). However, there is no 
direct evidence for this mechanism. Moreover, this raises the question of how does CRTISO 
mediate this electron transfer? CRTISO has been shown to contain a cofactor binding domain 
and as such, other possible mechanisms of isomerisation could be postulated, involving 
electron transfer to or from a redox active cofactor such as FAD(H) or NAD(P)(H). The 
resulting carotenoid cation, anion or radical would then be able to isomerise due to the loss of 
double bond character (Figure 4.16).  
Therefore, although sequence alignment showed that D27 is not related to CRTISO 
(data not shown) we therefore considered the possibility that D27 may contain a redox cofactor 
such as an iron sulfur cluster. It was reported by Lin et al. that D27 contains 1.7 moles of iron 
per mole of protein (Lin et al. 2009). If it assumed that there is in fact actually two moles of 
iron per mole of protein, then two possibilities exist. Either a di-nuclear [FeFe] centre or an 
[2Fe2S] cluster. Di-iron [FeFe] centres are commonly found in hydrogenase enzymes and are 
linked to an electron donor, such as an iron sulfur cluster or ferrodoxin (Ferraro et al. 2005). 
 
Figure 4.16 – Schematic of possible mechanism for the isomerisation of 4,7/4’,7’-tetra-cis-
lycopene to all-trans-lycopene by CRTISO. 
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It seems unlikely that D27 contains an [FeFe] centre for two reasons. Firstly, D27 is not 
dependent on the presence of a second protein, such as a ferrodoxin, and secondly, if D27 
contained an iron sulfur cluster in addition to an [FeFe] centre, then the ratio of iron to protein 
would be higher than two to one. As such, the presence of a [2Fe2S] centre seems possible, 
performing a reaction similar to that shown in Figure 4.17, where the iron sulfur cluster 
mediates either the addition or abstraction of an electron to or from the carotenoid, resulting 
in a radical anion or cation which can then isomerise.  
In order to investigate the presence of an [2Fe2S] cluster, GST-OsD27.1 was assayed 
in the presence of the 100 µM sodium dithionite, 100 µM sodium dithionite/pyridine, 100 µM 
2-mercaptoethanol and 100 µM hydrogen peroxide. In the presence of each of these redox 
 
Figure 4.17 – Possible isomerisation mechanisms for the isomerisation of β-carotene by D27. 
Formation of either the substrate radical anion or radical cation would result in either an oxidised 
or reduced iron sulfur cluster. The resulting loss of conjugation in the substrate would allow free 
rotation of the newly formed σ bond. Reversal of the movement of the electron would reform the 
iron sulfur cluster and result in isomerised substrate. Mechanism involving a radical anion is more 
likely given the difficulties involved in abstraction of an electron from a conjugated system. 
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agents D27 was still active. D27 showed slightly higher activity in the presence of reducing 
agents than in the presence of hydrogen peroxide (Figure 4.18). However, the difference in 
the level of activity is not so significant as to constitute the presence of an iron sulfur cluster. 
Given the lack of variation in activity in the presence of oxidants and reductants, and given 
that D27 is active in aerobic conditions, if an [2Fe2S] cluster is present in D27, then it must 
be buried deep within the enzyme. This would render the cluster stable and protect it from 
denaturation by cytosolic components.  This is consistent with the observation that D27 was 
still active in the presence of 100 µM of the metal chelators EDTA and 1, 10-phenanthroline. 
Commonly in proteins containing iron sulfur clusters the cluster is located on the exterior of 
the enzyme to allow electron transfer from the cluster to a second protein. Such is the case 
with Rieske dioxygenases, where a reductase is required to reduce a ferredoxin protein, which 
transfers an electron to an oxygenase, which performs catlaysis (Ferraro et al. 2005). In these 
cases, the solvent exposed iron-sulfur cluster of the ferredoxin is susceptible to oxidation, 
which can deactivate the iron sulfur protein (Orme-Johnson & Orme-Johnson 1978). It would 
be logical in the case of D27 for the cluster to be located on the interior of the enzyme, as this 
would allow the active site architecture of the enzyme to control the geometry of the isomer 
 
Figure 4.18 – Graph showing the ratio of all-trans-β-carotene to 9-cis-β-carotene following 
incubation of 9-cis-β-carotene with OsD27.2 in the presence of 100 µM hydrogen peroxide (H2O2), 
100 µM 2-mercaptoethanol (BME), 100 µM sodium dithionite and 100 µM sodium dithionite and 
pyridine. 
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produced. If the cluster was located on the exterior of the enzyme then no such control of the 
reaction would be possible, leading to a larger number of isomers being produced. As it is, 
although D27 is not regiospecific, it is predominantly selective for the 9-cis and all-trans 
isomers of β-carotene. 
The UV absorption spectrum of D27 was recorded and found to be consistent with 
that recorded by Lin et al, with a distinct absorption band present at 422 nm and a small 
shoulder  peak at 368 nm (Figure 4.19) (Lin et al. 2009). It is very difficult to discern the type 
of iron sulfur cluster present based on optical spectra. The absorption spectrum obtained for 
D27 is not consistent with plant type [2Fe2S] ferredoxins, which have additional absorption 
maxima at 280 nm, 330 nm, 420 nm and 460 nm (Ohme-Johnson 1973). Similarly other 
[2Fe2S] proteins have been shown to have absorption maxima at different positions (Table 
4.3) (Palmer & Sands 1966, Tagawa & Arnon 1968, Fee et al. 1983). The shape of absorption 
spectra for D27 is itself, however, similar to that of NADH-quinone oxidoreductase from 
Thermus thermophiles, which has an absorption maxima at 410 nm for an [4Fe4S]2+ cluster 
(Nakamaru-Ogiso et al. 2001). Calculation of the extinction coefficient at 422 nm for the D27 
peak reveals   a molar extinction coefficient of 6800 M-1 cm-1, which is consistent with [2Fe2S] 
 
Figure 4.19 – UV spectra of OsD27.2 (blue) and OsD27.2 in the presence of 100 µM silver (I) 
acetate (orange). Upon the addition of silver acetate there is a reduction in the intensity of the peaks 
at 368 nm and 422 nm. 
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(Ohme-Johnson 1973, Nakamaru-Ogiso et al. 2001). It appears likely, therefore, the iron 
sulfur cluster would be of the [2Fe2S] type. 
Addition of 100 µM hydrogen peroxide, 100 µM 2-mercaptoethanol and 100 µM 
sodium dithionite did not affect the appearance of the peak at 422 nm. Lin et al. observed a 
reduction in the intensity of the peak at 422 nm in OsD27 protein in the presence of sodium 
dithionite (Lin et al. 2009). Addition of 100 µM silver (I) acetate, however, was found to cause 
a loss of intensity in the peak at 422 nm (Figure 4.19). Additionally, assays of OsD27 in the 
presence of 100 µM silver (I) acetate resulted in inhibition of enzyme activity. Interestingly, 
however, incubations in the presence of 100 µM lead (II) acetate did not result in a loss of 
activity. Silver (I) ions have been shown to destroy [4Fe4S] clusters in iron sulfur dehydratase 
enzymes in E. coli by displacing the iron from the cysteine ligands (Xu & Imlay 2012). 
Sodium dithionite similarly is known to quench iron sulfur clusters and demonstrates that the 
cofactor in D27 is redox active (Nakamaru-Ogiso et al. 2001). Taken together, the loss of a 
peak at 422 nm in the UV spectrum in the presence of silver (I) acetate and sodium dithionite 
is consistent with the presence of an iron sulfur cluster. 
 Cluster Type λMAX (nm) 
Extinction coefficient 
(M-1 cm-1) 
Reference 
Plant type ferrodoxins 
(Spinacia oleracea) 
[2Fe2S] 
280, 330, 420, 
460 
- 
Palmer & 
Sands 1966 
Higher Plant [2Fe2S] [2Fe2S] 325, 420, 465 8000 
Tagawa & 
Arnon 1968 
T. thermophilus Rieske 
iron sulfur cluster 
[2Fe2S] 380, 425, 550 - Fee et al. 1983 
T. thermophilus 
NADH-quinone 
oxidoreductase 
[4Fe4S]2+ 410 13300 – 15000 
Nakamaru-
Ogiso et al. 
2001 
O. sativa D27 ? 368, 422 6800 - 
Table 4.3 – Comparison of λMAX values and extinction coefficients of selected different iron sulfur 
clusters from iron sulfur proteins. The dominant peak in the UV spectra for each protein is 
highlighted in bold.  
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In conclusion, these observations provide some evidence of the presence of an iron 
sulfur cluster, possibly of the [2Fe2S] type (Figure 4.20). The oxidation state of the cluster is 
also unknown and due to the availability of only small amounts of enzyme, we were unable 
to perform further experiments, such as cyclic voltammetry. Further experimentation is 
required to ascertain the definitive presence of a cluster and the resting oxidation state of the 
cluster.  
A BLAST search using the full length OsD27 sequence reveals a number of related 
unidentified proteins. Subsequent sequence alignment (Figure 4.21) of these proteins reveals 
large areas of conserved sequence between these proteins. This suggests that the structure of 
this region is essential for enzyme function. Within this highly conserved region it is possible 
to identify six conserved cysteine residues (Cys198, Cys206, Cys210, Cys214, Cys241 and Cys260 in 
O. sativa), which could potentially ligate an iron sulfur cluster.  
4.7 Inhibition Assays of O. sativa Dwarf27 
 Sergeant et al. reported an in planta phenotypic effect of hydroxamic acids 
(compounds D2, D4, D5 and D6) on shoot branching in Arabidopsis thaliana (Sergeant et al. 
2009). Shoot branching in plants is known to be mediated through the action of the 
phytohormone strigolactone (Gomez-Roldan et al. 2008, Umehara et al. 2008). The complete 
biosynthetic pathway of strigolactone is unknown. However, the first three enzymes in the 
biosynthetic pathway are known: Dwarf27, carotenoid cleavage dioxygenase 7 and carotenoid 
cleavage dioxygenases 8. Although hydroxamic acids are designed to target the carotenoid 
cleavage dioxygenases, it was decided to test the hydroxamic acids in vitro against D27 in 
order to investigate whether the hydroxamic acids affect D27 and to discern the selectivity of 
the hydroxamic acids towards the different enzymes of the strigolactone biosynthesis pathway. 
To this end, OsD27.2 was screened against the hydroxamic acids (structures shown in tables 
 
Figure 4.20 – Possible structure of the putative D27 active site [2Fe2S] iron sulfur cluster. The 
oxidation state of the cluster is unknown. 
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2.1-2.5 and 3.3-3.7). The hydroxamic acids D12H and D13H (synthesised by Paul Sainsbury), 
abamine(SG) (provided by Syngenta) and nordihydroguaiaretic acid (Sigma) were also 
assayed at 100 µM (Figure 4.22). All inhibitors were assayed at a final concentration of 
100 µM in the presence of 50 µg total protein containing D27 and 20 µM 9-cis-β-carotene. 
All incubations were performed for 20 minutes at 25° C in the dark.   
C7AU21_OsD27* METTTLVLLLPHGGAG---------GVRPAAAATAKRSYV--MRR---CSTVRAVMARPQEAPASA 
J3N995_ObD27  METTALVLHLPRGDL-----------WRPAGATTMKQSYV--RRRRSCCPTVRAIMASPQEAPAKE 
W5I4N5_TaD27  MEATALVLL-PHSHSGLTARAPPCVGGRGVS-CVTKKSYV--RRIK-RSSTVRGVMARPQEATLAR 
K7LH46_GmD27  MEAKL-VAQCKSPTLS-----------------------LAHRKPK-HPCVVVGVLARPVDEISG- 
K4CUK1_SlD27  MEANL-VLSYQSFSKV-S--------MRN----IKINTYYKYNKLA-YP-STCCVLTKPPHN---- 
Q7XA78_AtD27* MNTKL-SLSQTKIFTF-------------TTWFNDTRSGL--DRRSSISPTL---CSKPVYSGK-- 
cons          *::.                                       :            : *        
 
C7AU21_OsD27* P-AKKTETAAMMSTVQTETAAAPPATVYRDSWFDKLAIGYLSRNLQEASGLKNE--KDGYESLIDA 
J3N995_ObD27  KTAVASTETAMVTTTVTR--TAAPATVYRDNWFDKLAIGYLSRNLQEASGLKNE--KDGYESLIDA 
W5I4N5_TaD27  VPAPAPTRPV-----RETAAATTTTTVYHDTWFDNLAIGYLSRKLQEASGIKNG--KHGYQGLIEA 
K7LH46_GmD27  -------------------EARKTNHVYKDGLFDRITINYLSKCVQEATGLRNN--KSGYESLVDA 
K4CUK1_SlD27  -------------------NHSSNCHVYKDNWFDHLAINHLSQSIQATTGLRNK--KSGYEGFVEA 
Q7XA78_AtD27* --LKAAKETA-----RIETSNTKN-ASIEDSFFSKIAINYLSKNLQDAAGISSSSKSTDYDRLVDT 
cons                                      .*  *..::*.:**: :* ::*: .   . .*: :::: 
 
C7AU21_OsD27* ALAISRIFSLDKQSEIVTQALERALPSYILTM----------------------IKVMMPPSRFSR 
J3N995_ObD27  ALAISRIFSLDKQSEIVTRALEIAFPSYILTMRRD-GFFIIISYLNFDWDFCLQIKVMMPPSRLSR 
W5I4N5_TaD27  AVTISRIFRLDTQCEIVASALERAMPSYIVTMGKQYKCLYFLPGFWFDRILFGQIKVMMPPSRFSR 
K7LH46_GmD27  ATVASQRFSPVEQHQLVIQSLDRAFPKPMLLL----------------------IRKLLPPSKFAR 
K4CUK1_SlD27  ARVVYVNFNSTHQANLVIESLQRAFPKPILSL----------------------VKMLLPESKWAR 
Q7XA78_AtD27* ATRVSRNFDTKQQHEFVLSSLDRALPTVISSL----------------------IKMAFPPSKVSR 
cons          *      *    * ::*  :*: *:*. :  :                      ::  :* *: :* 
 
C7AU21_OsD27* EYFAAFTTIFFPWLVGPCEVMESEVEGRKEKNVVYIPKCR------FLESTNCVGMCTNLCKIPCQ 
J3N995_ObD27  EYFAAFTTIFFPWLVGPCEVMESEVDGRKEKNVVYIPKCR------FLESTNCVGMCTNLCKIPCE 
W5I4N5_TaD27  EYFAAFTTIFFPWLVGPCEVRESEVDGTREKNVVYIPKCR------FLESTNCVGMCTNLCKIPSQ 
K7LH46_GmD27  KLFAVFTTLFFAWLVGPSEVRESEVEGRRERNVVHIKKCRWGRLPRFLEGTNCVGMCINLCKLPSQ 
K4CUK1_SlD27  EYCAIFTTIFFPWLVGPCEVKESEFNGRKENNVVHIKKCR------FLEETNCVGMCTNLCKMPSQ 
Q7XA78_AtD27* ELFALFTTISFAWLVGPSEVRETEVNGRKEKSVVYIEKCR------FLEQSNCVGMCTHICKIPSQ 
cons          :  * ***: *.*****.** *:*.:* :*..**:* ***      *** :****** ::**:*.: 
 
C7AU21_OsD27* KFIQDSLGMKVYMSPNFEDMSCEMIFGQQPPE--DDPALKQPCFRTKCVA---------------- 
J3N995_ObD27  KFIQDSLGMNVYMSPNFEDMSCEMIFGQQPPE--DDPAFKQPCLRTKCIA---------------- 
W5I4N5_TaD27  KFMQDSLGVSVYMSPNFEDMSCEMIFGQQPPE--DDPALKQPCFST-------------------- 
K7LH46_GmD27  SFIKDSLGISVNMVPNFDDMSCEMIFGQDPPESTDDPALKQPCFKL-CKA---------------- 
K4CUK1_SlD27  LFIKDTLGISVNMVPNFDDMSCEMIFGQDPPPLDKDPAFRQPCYKL-CNFFIYHNYFRKKHIILVM 
Q7XA78_AtD27* IFIKNSLGMPIYMEPDFNDLSCKMMFGREPPEIEDDPAMKQPCFEF-CKS---------------- 
cons           *::::**: : * *:*:*:**:*:**::**   .***::***                        
 
C7AU21_OsD27* -----------KQNHGVNC-----------SI          BAD AVG GOOD 
J3N995_ObD27  -----------QQNHGVNC-----------ST 
W5I4N5_TaD27  -------------------------------K 
K7LH46_GmD27  -----------KRSHGTNCL---------VIN 
K4CUK1_SlD27  PEYVLLHAGKLNNKHQADCNSQIKKKDHLEIS 
Q7XA78_AtD27* -----------NKSYGV-------------KH 
cons                                           
 
Figure 4.21 – T-Coffee sequence alignment of OsD27 against selected random hits from a BLAST 
search. Conserved cysteine residues are highlighted in red. Ob – Oryza brachyantha (wild rice); Ta 
– Triticum aestivum (wheat); Gm – Glycine max (soybean) *functionally characterised enzyme. 
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 None of the hydroxamic acids tested showed complete inhibition of OsD27.2 at 100 
µM. However, some hydroxamic acids, as well as NDGA, did show some inhibition (Figure 
4.23, Tables 4.4 and 4.5). In addition, no inhibition of D27 activity was reported for abamine 
or abamineSG at 100 µM. These data are unsurprising, given that OsD27 is suspected to be 
an iron sulfur protein. Since hydroxamic acid activity would likely result from hydroxamic 
acid chelation to the active site iron, thus blocking substrate access, it is likely that the 
hydroxamic acids are not chelating to any active site iron in the CCDs. This could be due to 
the architecture of the iron sulfur cluster. If the iron is coordinated by two bridging sulfur 
atoms and 4 cysteine residues (Figure 4.19), then this may not provide any free coordination 
sites onto which the hydroxamic acid can coordinate, thus preventing inhibition of the enzyme. 
 
Figure 4.22 – Structures of additional inhibitors screened against OsD27.2– D12H, D13H, 
nordihydroguaiaretic acid (NDGA) and abamineSG.  
 
Figure 4.23 – Percentage activity of OsD27.2 isomerisation of 9-cis-β-carotene in the presence of 
hydroxamic acid inhibitors. 
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It has been observed that hydroxamic acids bind with a greater affinity to iron (III) (Sergeant 
et al. 2013). Since it is unknown what oxidation state the iron is in, it is possible that the 
hydroxamic acids are binding to D27, but with an affinity too low to induce inhibition. 
Similarly it may well be that the active site architecture precludes the hydroxamic acids from 
binding.  
 Compounds D30, D31 and D32 all showed approximately 33% to 42% inhibition of 
OsD27.2 at 100 µM. These compounds are terpenoid-like, mimicking the terpenoid structure 
of the carotenoid substrates. It is possible that this architecture allows D30, D31 and D32 to 
bind to the active site without necessarily chelating the active site iron. Similarly, B2 and H1 
are a longer compounds compared to other members of the hydroxamic acid inhibitors. 
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D12H 
 
--- 40.0 
D20 
 
4-Methoxy 25.5 
D21 Napthyl 33.3 
D30 
 
--- 41.4 
D31 
 
--- 38.1 
D32 
 
--- 33.3 
Table 4.4 – Inhibition data for hydroxamic acid compounds D12H, D20-D21 and D30-D31 versus 
OsD27. 
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Likewise, they could be inhibiting D27 through non-specific binding in the active site. Both 
D20 and D21 showed some inhibition of OsD27.2, 25% and 33% respectively. Both D20 and 
D21 have carboxylate groups, which are likely to be deprotonated at reaction pH (pH 6.4). 
These carboxylate groups could be interacting with residues in the active site or to the iron 
sulfur cluster itself, blocking the active site and resulting in inhibition. D17 also exhibited a 
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D17 
 
--- --- 8.0 
B2 
 
--- --- 39.7 
H2 
 
--- --- 9.4 
N
D
G
A
 
 
--- --- 41.8 
F1 
 
4-Methoxy H 10.4 
F2 4-Methoxy F 15.5 
F3 
3,4-
Dimethoxy 
H 9.1 
F4 
3,4-
Dimethoxy 
F 24.5 
F5 3-Chloro H 21.3 
F6 3-Amino H 7.0 
F7 3-Bromo H 18.0 
F8 
3-Chloro-
4-Methoxy 
H 15.0 
Table 4.5 – Inhibition data for hydroxamic acid compounds F1-F8 versus OsD27. Bn represents a 
benzyl group (CH2Ph). 
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small level of inhibition, although based on the inhibition observed with other members of the 
hydroxamic acid inhibitors, it is not clear why D17 would show inhibition. As such, it appears 
that larger hydroxamic acids are better inhibitors of D27 through non-specific binding to the 
D27 active site. 
 However, inhibition was also observed for all members of the ‘F’ series compounds 
and D12H. Compounds F1 – F8 and D12H are small compounds which showed between 7% 
and 24% (for F1 – F8) and 40% (for D12H) inhibition of D27, in contradiction to the 
observation that larger hydroxamic acids showed inhibition. However, it is possible that an 
inverse effect is occurring, whereby the small nature of these compounds allows them access 
to a small binding pocket within the active site, blocking substrate access and inhibiting the 
enzyme. It is interesting that whilst D12H showed inhibition, there was no inhibition by D12, 
D13 and D13H, which are structurally related compounds. Likewise, it is unlikely that 
inhibition is the result of chelation by the hydroxamic moiety, and is more likely due to non-
specific interactions within the active site of the enzyme.   
 The compound NDGA showed 42% inhibition against OsD27.2. NDGA is similar to 
B2, D30, D31 and D32 in that it is a long molecule. However, NDGA also contains two 
catechols. These catechols may bind to the iron sulfur cluster, resulting in enzyme inhibition. 
 A number of quinone based compounds have been shown to have inhibitory effects 
on electron transport chains, which use iron sulfur clusters to mediate electron transfer. These 
quinones inhibit these proteins by inhibiting electron transfer (Matsuura et al. 1982). Based 
on this, 2-hydroxy-3-methyl-1,4-napthoquinone (Sigma) (Figure 4.24) was purchased and 
 
Figure 4.24 – Structure of 2-hydroxy-3-methyl-1,4-napthoquinone. 
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assayed against OsD27.2 at 100 µM. 2-hydroxy-3-methyl-1,4-napthoquinone is a member of 
a family of quinones which have been shown to inhibit electron transfer in electron transport 
chains. However, no inhibition was observed. This absence of inhibition does not indicate an 
absence of an iron sulfur cluster, as the lack of inhibition may well be due to inability of the 
3-alkyl-2-hydroxy-1,4-napthoquinone to enter the active site of the enzyme. 
 Only one compound was found to fully inhibit OsD27.2 isomerisation of 
9-cis-β-carotene to all-trans-β-carotene: silver (I) acetate. Inhibition by silver (I) acetate likely 
arises due to displacement of iron in the active site iron sulfur cluster by silver. Interestingly 
lead (II) acetate did not inhibit the activity of OsD27.2. The reasons for this are unknown, but 
could be due to the larger size of the lead ion.  
4.8 Conclusions 
 On the basis of the data obtained and observations in the literature, D27 is a putative 
iron sulfur enzyme containing an [2Fe2S] iron sulfur cluster. D27 is sparingly soluble, 
indicating that it is a membrane associated protein, which is to be expected given the 
hydrophobic nature of the carotenoid substrates which are found localised within membranes. 
Given that D27 is active independent of any cofactors or other cytosolic components this 
indicates D27 is not dependent upon electron transport chain proteins like CRTISO or redox 
cofactors such as NAD(H) or FAD(H). However, the data obtained do not allow for a 
definitive assignment of the presence of such an iron sulfur cluster, and additional experiments 
will be required to demonstrate the presence of an iron sulfur cluster. D27 appears to exhibit 
substrate inhibition by 9-cis-β-carotene, formed from the isomerisation of 
all-trans-β-carotene.  
The isomerisation of 9-cis-β-carotene to all-trans-β-carotene by D27 is only partially 
inhibited by the action of the hydroxamic acid inhibitors in vitro, and it is not possible to 
discern any definitive structure-activity relationships from those compounds that do show 
some inhibition. Moreover, no inhibition was seen for compounds D2, D4, D5 and D6, which 
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exhibit a shoot branching phenotype in planta. These results suggest that the effects on shoot 
branching must be due to the inhibition of another target, most likely CCD7 or CCD8. 
4.9 Future Work 
 D27 is a remarkable enzyme which catalyses a highly specific isomerisation reaction 
with remarkable precision via an unusual enzymatic mechanism. Elucidation of this 
mechanism would be of wider interest and, assuming the presence of an iron sulfur cluster, 
would demonstrate a novel function of an iron sulfur protein. A key experiment for 
determining the presence of such an iron sulfur cluster would be cyclic voltammetry, which 
would reveal whether a redox process is occurring during the isomerisation of β-carotene by 
D27. Additionally, mass spectrometry of the native protein would also aid in this endeavour. 
Upon the treatment of an iron sulfur protein with mild acid, the iron sulfur cluster should break 
down due to competition for the cysteine ligands from protons. This breakdown of the iron 
sulfur cluster could be detected by a change in mass. Site directed mutagenesis of conserved 
key cysteine residues could also be used to identify whether the cysteine residues are required 
for catalysis. Mossbauer spectroscopy and EPR spectroscopy could also be used to identify 
the presence of an iron sulfur and help to identify the type of cluster present.  
 It would be enlightening to examine the preference of D27 for different carotenoids. 
As has been discussed previously in Chapter 3, the biosynthesis of the hormone abscisic acid 
requires isomerisation of all-trans-neoxanthin to 9’-cis-neoxanthin. As of yet, the enzyme or 
activity which performs this function has yet to be identified. A BLAST search on the UniProt 
database reveals that there are four orthologs of D27 present in A. thaliana (Entry numbers: 
Q7XA78, Q9SGU7, F4HZB1 and Q8W4C4) with 53%, 38% 49% and 32% similarity to 
OsD27 respectively. It is entirely probable that one of these homologs could have different 
substrate specificity. Developing a D27 specific inhibitor would aid in this, and would allow 
additional phenotypes mediated by these types of enzymes to be identified.  
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Chapter Five: Expression and Inhibition of 
Arabidopsis thaliana Carotenoid Cleavage 
Dioxygenase 7 (CCD7) 
5.1 Introduction 
 Carotenoid cleavage dioxygenases 7 (CCD7) is the second enzyme on the committed 
biosynthesis pathway of strigolactone, cleaving 9-cis-β-carotene to 9-cis-β-apo-10’-carotenal 
(Alder et al. 2012) (Figure 5.1). CCD7 will also cleave the all-trans isomer of β-carotene, 
albeit ten fold less efficiently. The 9-cis isomer is reported to be the preferred natural substrate 
for the enzyme (Alder et al. 2012). The CCD7 cleavage product, 9-cis-β-apo-10’-carotenal, is 
then converted by CCD8 to carlactone and subsequently by a number of other enzymes to 
strigolactone. CCD7 has also been shown to cleave the 9-cis isomers of zeaxanthin and lutein 
(Bruno et al. 2014). Other than this, there is little other biochemical information known about 
CCD7. 
 The work detailed within this chapter describes the expression of Arabidopsis 
thaliana CCD7 and assays of A. thaliana CCD7 against hydroxamic acid inhibitors to 
determine the biochemical basis of observed in planta phenotypes in the presence of 
 
Figure 5.1 – Schematic of the cleavage reaction catalysed by CCD7. 
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hydroxamic acids. Work on the development of the AtCCD7 assays was completed in 
conjunction with Erasmus project student Flora Descombes.  
5.2 Expression of A. thaliana CCD7  
 Two constructs, pGEX-AtCCD7.1 (full length CCD7 gene) and pGEX-AtCCD7.2 
(truncated gene lacking the first 93 base pairs corresponding to a chloroplast transit peptide), 
both with a GST fusion tag, were obtained from Dr Andrew Thompson (Cranfield University) 
(CCD7 accession number: NM_130064. The sequence of construct used differs slightly from 
that of the wild type and the sequence of CCD7 used is shown in Appendix 10.5). Both 
plasmids were transformed into competent pRosetta BL21 E. coli and the GST-AtCCD7.1 and 
GST-AtCCD7.2 fusion proteins were produced following induction with 100 µM IPTG at A600 
= 0.6 AU, and grown overnight at 20° C. However, following sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the cell free extract and fractions 
following glutathione-S-transferase (GST) tagged purification, no protein was visible in either 
the total protein or elution fractions. Varying the temperature of protein induction and the 
concentration of IPTG present did not result in the appearance of a band of molecular weight 
which would correspond to either AtCCD7.1 or AtCCD7.2 (95.9 and 92.6 kDa respectively). 
At this point, given the tendency of signal peptide sequences to cause aggregation and interfere 
with protein expression, only work on AtCCD7.2 was continued (Singh et al. 2013).  
 The pBB541 plasmid (see Chapter 4.2) was used to transform competent pRosetta 
BL21 E. coli. The resulting transformant was then made chemically competent via the method 
of Inoue and the pGEX-ATCC7.2 plasmid was subsequently used to transform the pRosetta 
pBB541 BL21 E. coli (Inoue et al. 1990). Upon co-expression of GroES and GroEL with 
AtCCD7.2 a band of the correct molecular weight, 92.6 kDa, was visible in the SDS-PAGE 
gel (Figure 5.2). 
 The glutathione-S-transferase tagged AtCCD7.2 fusion protein was purified by 
glutathione affinity chromatography and the partially purified enzyme was used for assays 
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(Figure 5.2). Due to the low expression of AtCCD7.2 further purification was not attempted 
and the partially purified protein was used as described following desalting from purification 
elution buffer.  
5.3 Assays of A. thaliana CCD7 
 Initially, assays were attempted by Flora Descombes with commercially available 
all-trans-β-carotene and cell free extract containing overproduced AtCCD7.2. In these assays 
all-trans-β-carotene was solubilised in 4% (v/v) Triton X-100 in ethanol and added to a final 
concentration of 40 µM. The reaction was allowed to proceed for two hours in the light. 
Following extraction into ethyl acetate the products were analysed via C30 reversed phase 
HPLC at room temperature (as described in Chapter 4). These initial assays showed no 
turnover of the β-carotene to the apocarotenoid product (Figure 5.3). Given the impurity of 
9-cis-β-carotene in commercial all-trans-β-carotene (as discussed in Section 4.3), and the fact 
that reactions were incubated for two hours in the light to allow light mediated isomerisation 
of all-trans-β-carotene to 9-cis-β-carotene, it was expected that turnover would have been 
observed despite the ten fold slower reaction of CCD7 with all-trans-β-carotene over 9-cis-β-
carotene. 
 
Figure 5.2 – 8% SDS-PAGE gel showing the overproduction of A. thaliana CCD7.2 from pGEX-
AtCCD7.1 pRosetta pBB541 BL21 E. coli. 1 – Ladder; 2 – Total protein; 3 – Total soluble protein; 
4 – Elution fraction following concentration of protein. Molecular weights of ladder are in kDa. 
Molecular weight of GST tagged AtCCD7.2: 95.9 kDa (calculated from sequence). Mass 
spectrometry would be required to definitively prove the presence of the AtCCD7 protein. 
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 For assays with 9’-cis-epoxycarotenoid cleavage dioxygenases (NCED), using the 
9’-cis-neoxanthin substrate, the products are extracted into ethyl acetate (Chapter 3). 
However, both β-carotene and the subsequent aldehyde and ketone products produced from 
the cleavage reaction are much less polar, and may not extract well into ethyl acetate. 
Assuming the apparent lack of turnover of AtCCD7.2 was due to lack of uptake of the products 
into ethyl acetate, the extraction medium was changed to dichloromethane, a significantly 
more non-polar solvent. On repeating the experiment with dichloromethane extraction, some 
possible product peaks were observed in the HPLC chromatogram. A peak at 3.9 minutes was 
observed, which absorbed at 300 nm, corresponding to the β-ionone product, matching the 
retention time of authentic β-ionone standards (λMAX of β-ionone: 299 nm) (Figure 5.4). 
Additionally, a new small peak was observed at 12.5 minutes, absorbing at 440 nm. However, 
it was unknown whether this peak corresponded to either 9-cis-β-apo-10’-carotenal or 
all-trans-β-apo-10’-carotenal, since authentic standards are not available, or whether it was 
another isomer of β-carotene. 
 It was decided to chemically generate 9-cis-β-carotene from all-trans-β-carotene as it 
was reasoned that the apparent lack of turnover may be due in part to a low concentration of 
substrate (the 9-cis isomer) and the low turnover rate of AtCCD7.2 towards the all-trans 
isomer. Additionally at this point, 10 µL of partially purified AtCCD7.2 was used in assays as 
 
Figure 5.3 – HPLC chromatogram at 440 nm following incubation of commercial all-trans-β-
carotene with AtCCD7.2. No new peaks are visible at 440 nm.  
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opposed to cell free extract (assays contained approximately 125 µg of protein, as determined 
by Bradford assay, following purification (Bradford 1976)). The 9-cis isomer of β-carotene 
was generated via iodine catalysed isomerisation in the presence of ultraviolet light from 
all-trans-β-carotene (Figure 5.5). The isomerisation reaction produces a mixture of different 
 
Figure 5.4 – HPLC chromatogram showing all-trans-β-carotene (A) and β-ionone (B) controls and 
following incubation of all-trans-β-carotene with AtCC7.2 (C). Upon incubation of all-trans-β-
carotene with AtCCD7.2 new peaks at 3.9 minutes (corresponding to the β-ionone) and 12.5 
minutes are visible. 
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geometrical isomers which can be purified via reversed phase HPLC on a C30 column, at 0° C   
(Figure 5.6). Following collection of the appropriate peak (at 23.3 minutes, as described in 
Section 4.3) the solvent was removed under reduced pressure and the 9-cis-β-carotene was 
resuspended in ethanol. Using a known weight of commercially available all-trans-β-carotene, 
the extinction coefficient of β-carotene at 475 nm was calculated as 6.55 x 10-4 M-1 cm-1. This 
extinction coefficient was used to calculate the concentration of 9-cis-β-carotene purified  
(Beer 1852). It should be noted that the 9-cis-β-carotene used was not completely 
geometrically pure due to isomerisation which occurs as discussed in Chapter 4. Other isomers 
present include the all-trans and 15-cis isomers. 
 
Figure 5.5 – Iodine catalysed isomerisation of all-trans-β-carotene to 9-cis-β-carotene (and other 
isomers not shown).  
 
Figure 5.6 – HPLC chromatogram at 475 nm of the purification of 9-cis-β-carotene from a 
geometrical mix of β-carotene isomers. All-trans-β-carotene is still the major isomer present. 
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 After incubation of AtCCD7.2 in the presence of 40 µM 9-cis-β-carotene, a new peak 
was observed in the HPLC chromatogram at approximately 10.5 minutes at 440 nm (Figure 
5.7). Control experiments in the presence of boiled AtCCD7.2 failed to produce a peak (Figure 
5.7). Additionally the appearance of the peak proceeded in a time dependent fashion which 
correlated with the disappearance of the 9-cis-β-carotene (Figure 5.8) and HRMS gave the 
correct molecular formula for β-apo-10’-carotenal (Figure 5.8). However, it was unknown 
whether this peak belongs to the cis or trans isomer. Analysis of the UV spectrum of this peak 
showed a λMAX of 444 nm, in agreement with a value of 447 nm reported by Alder et al. for 9-
cis-β-apo-10’-carotenal (Alder et al. 2012) (Figure 5.8). As a result of this, it was concluded 
that the presence of the peak at 10.5 minutes was due to the action of AtCCD7.2 and belonged 
to 9-cis-β-apo-10’-carotenal. 
 
Figure 5.7 – A: HPLC chromatogram at 440 nm following incubation of 9-cis-β-carotene with 
AtCCD7.2. A new peak corresponding to 9-cis-β-apo-10’-carotenal is visible at 10.5 minutes. B: 
Control assay in the presence of boiled AtCCD7.2. New peaks at 20.2m and 21.8m are proposed to 
arise due to non-specific photochemical isomerisation. 
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 The yield of the peak produced was rather low (≈30%), considering the incubation 
had been at 25° C for one hour, suggesting either inefficiency of the enzyme or a low substrate 
concentration. Other factors considered for the apparent low turnover of the enzyme were 
inhibition of the enzyme by other isomers of β-carotene or a low concentration of substrate. 
Using authentic standards of β-ionone it was known that the β- ionone product eluted at 3.9 
minutes, although it co-eluted with other extraction products which also absorb at 300 nm. 
Additionally, β-ionone is a volatile compound, and it is likely that during evaporation of 
solvent during the extraction process a proportion of the β-ionone is lost, resulting in a 
decreased signal on the HPLC. It was noted, however, that the magnitude of the peak at 3.9 
 
 
Figure 5.8 – Percentage conversion of 9-cis-β-carotene to 9-cis-β-apo-10’-carotenal versus time 
(A), UV-Vis (B) and ESI-MS (C) analysis of the peak at 10.5 minutes from Figure 5.8, confirming 
the identity as 9-cis-β-apo-10’-carotenal. ESI-MS: m/z calculated for C27H36O+H+ 377.2839, found 
377.2840. 
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minutes was larger in the presence of AtCCD7.2 than in the absence of AtCCD7.2, strongly 
suggesting that the β-ionone was indeed produced as expected (Figure 5.9).   
 It was further observed that upon addition of either ethyl acetate or dichloromethane 
to the assay mix there was precipitation of protein, as would be expected. Following 
centrifugation to separate the organic ethyl acetate from the aqueous reaction mixture the 
protein precipitate had formed a layer between the organic and aqueous layers. The precipitate 
layer was coloured orange, suggesting the β-carotene and possibly the products were in the 
precipitate. It was reasoned that the β-carotene and hydrophobic products were co-
precipitating with the protein upon addition of the organic solvent due to the hydrophobic 
environment created by the precipitated protein. This is unsurprising, given the hydrophobic 
nature of the substrate and products, and hence energetically it is more favourable for the 
hydrophobic components to precipitate with the protein. As a result it is likely that little of the 
substrate and products were being extracted into the organic solvents, the outcome being the 
lack of apparent turnover of the enzyme.  
 In order to overcome poor extraction of products, the ionic strength of the assay 
solution was increased following completion of the assay prior to extraction into organic 
solvent. This was achieved through the use of a solution of 4 M pyridinium acetate at pH 5.0, 
 
Figure 5.9 – Comparison of HPLC chromatogram at 300 nm of 9-cis-β-carotene (blue) and 9-cis-
β-carotene plus AtCCD7.2 (orange). The peak at 3.9 minutes is greater in the presence of 
AtCCD7.2, likely due to production of β-ionone. 
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produced by adding pyridine to acetic acid and water (Mihalyi 2014). When added to the assay 
mixture following completion of the assay, the pyridinium acetate increases the ionic strength 
of the solution from effectively zero to 4.01 M. This increased ionic strength not only results 
in denaturation of the proteins but also allows the charged protein molecules to stay in 
solution, preventing co-precipitation of the β-carotene. Subsequent addition of n-butanol 
results in extraction of the enzyme substrates and products. Pyridinium acetate could be 
substituted with 4 M sodium chloride solution pH 7.0 with the same effect. Due to the high 
salt concentrations, the n-butanol extract must be first desalted via C18 solid phase extraction 
cartridges. The substrate and products are then eluted into tertbutylmethylether, which is 
removed under reduced pressure. The residue can then be resuspended in methanol and 
analysed via reversed phase HPLC on a C30 column. 
  Following assays with 9-cis-β-carotene and extraction in pyridinium acetate, a peak 
corresponding to the 9-cis-β-apo-10’-carotenal was consistently detected at 10.5 minutes. It 
was found that enzyme incubations at 25° C with shaking at 180 rpm in the dark resulted in 
good activity of the enzyme. 
5.4 Kinetic Characterisation of A. thaliana CCD7 
 Experiments were performed in order to determine the Michaelis constant (KM) of 
AtCCD7.2. Using the stopped HPLC method, the KM was calculated as 8.7 µM for 
9-cis-β-carotene at pH 7.8 at 25° C (Figure 5.10). This compares moderately well with the 
value of 15.2 µM reported by Schwartz et al. for β-carotene (likely a geometrically impure 
mix, with predominately the all-trans isomer) but differs slightly from the value of 41.1 µM 
reported by Bruno et al. for 9-cis-β-carotene (Schwartz et al. 2004 & Bruno et al. 2014). 
Differences between the three reported values are likely due to the fact that the KM must be 
determined through a stopped HPLC assay, in addition to variations in pH and temperature.  
 During the time course experiment of AtCCD7.2 it was noticed that the amount of 
all-trans-β-carotene and 15-cis-β-carotene decreased versus time, albeit at a slower rate than 
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the 9-cis isomer (Figure 5.11 and 5.12). In addition to this, a new small peak was noticed at a 
retention time of 9.8 minutes, with a λMAX of 457 nm (Figure 5.13). The reported λMAX for 
all-trans-β-apo-10’-carotenal is 452 nm and the all-trans isomer is known to elute before the 
9-cis isomer (Alder et al. 2012). When the 9-cis-β-apo-10’-carotenal was purified (and shown 
to be pure via immediate reinjection to HPLC) and then exposed to heat (40° C) and UV light, 
the peak at 9.8 minutes reappeared following HPLC analysis, demonstrating the 9.8 minute  
 
Figure 5.10 – Lineweaver-Burk plot for the determination of the KM of AtCCD7.2 for 
9-cis-β-carotene at pH 7.8 at 25° C. 
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Figure 5.11 – Graph showing the change in concentration of all-trans-β-carotene (all-trans, green),  
9-cis-β-carotene (9-cis, blue), 15-cis-β-carotene (15-cis, grey), 9-cis-β-apo-10’-carotenal 
(carotenal, orange) and the peak at 9.8 minutes (9.8m peak, yellow) (believed to belong to all-trans-
β-apo-10’-carotenal).  
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Figure 5.12 – Structures of all-trans-β-carotene, 9-cis-β-carotene, 15-cis-β-carotene, 9-cis-β-apo-
10’-carotenal and all-trans-β-apo-10’-carotenal. 
 
 
Figure 5.13 – HPLC chromatogram (A) showing the appearance of a peak at 9.8 minutes on 
following incubation of 9-cis-β-carotene with AtCCD7.2 and the UV absorption spectra (B) of the 
peak at 9.8 minutes believed to correspond to all-trans-β-apo-10’-carotenal. 
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peak is an isomer of 9-cis-β-apo-10’-carotenal (Figure 5.14). As such, the peak at 9.8 minutes 
was assigned to all-trans-β-apo-10’-carotenal. This suggests that AtCCD7.2 is predominantly 
selective for the 9-cis isomer, but is also capable of cleaving other isomers of β-carotene. The 
ability of AtCCD7.2 to cleave different β-carotene isomers as demonstrated here, albeit at 
different rates, explains the observations made by Schwartz et al. that CCD7 is able to cleave 
all-trans-β-carotene (Schwartz et al. 2004).  
5.5 Inhibition of A. thaliana CCD7 
 Application of hydroxamic acids to Arabidopsis thaliana in planta results in a shoot 
branching phenotype, in which there is increased level of branching in the plant. Shoot 
branching is mediated by the hormone strigolactone, the biosynthesis of which requires CCD7  
 
 
Figure 5.14 – HPLC chromatogram showing the immediate reinjection of 9-cis-β-apo-10’-
carotenal following HPLC purification (A). Only the single species is present in the purified 
fraction. Following exposure to heat and light (B) a new peak belonging to the all-trans isomer is 
formed is formed. 
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(Gomez-Roldan et al. 2008, Umehara et al. 2008). In order to investigate the biochemical 
basis of this in planta phenotype, using the HPLC assay detailed above, AtCCD7.2 was 
screened against the hydroxamic acid inhibitors (structures are shown in tables 2.1 to 2.5 and 
3.3 to 3.7), as well as compounds D12H, D13H (synthesised by Paul Sainsbury (Sainsbury 
2014)), abamineSG (provided by Syngenta) and nordihydroguaiartetic acid (NDGA, Sigma) 
(Figure 4.20). 
 All inhibitors were assayed against AtCCD7.2 at a final concentration of 100 µM 
except D12, which was assayed at a final concentration of 10 µM. As with NCED, the 
inhibitors were incubated with the AtCCD7.2 for 10 minutes prior to the addition of 9-cis-β-
carotene, which was added to a final concentration of 40 µM. Assays were incubated at 25° C 
at pH 7.8 for 30 minutes before the assay was stopped and the products extracted as described 
above. 
 At 100 µM, none of the compounds tested showed any inhibition against AtCCD7.2 
in vitro (Figure 5.15). In order to confirm that zero inhibition was not due to degradation of 
the hydroxamic acids, fresh solutions of D2 and D4 were prepared from material provided by 
Syngenta. These solutions at 100 µM also failed to inhibit the cleavage activity. Compound 
D2 was also screened against AtCCD7.2 with one hour pre-incubation, but even with this 
extended time no inhibition was observed. This data is surprising given that using E. coli in 
 
Figure 5.15 – Percentage activity of each inhibitor assayed at 100 µM against AtCCD7.2. D12 is 
at a concentration of 10 µM. 
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vivo assays, partial inhibition of AtCCD7 had been seen at 100 µM of inhibitor and CCD7 is 
one of the targets believed to be responsible for the shoot branching phenotype observed in 
planta with the hydroxamic acids (Sergeant et al. 2009). It is possible that in the in vivo assays 
the hydroxamic acids are inhibiting other enzymes and pathways in E. coli, disrupting the 
expression of either CCD7 or other genes and resulting in the apparent inhibition seen with 
respect to the control. The hydroxamic acids could also be enhancing the levels of carotenoids 
to begin with, leading to erroneous results.  
 In order to investigate possible causes for the lack of inhibition of AtCCD7.2, 
sequence alignment of CCD7 with other members of the CCD enzyme family was performed. 
Alignment of AtCCD7 with LeCCD1a with the ClustalΩ program (Sievers et al. 2011) shows 
that there is only 16.3% identity between the two sequences. Conversely, between LeNCED1 
and LeCCD1a there is 30.7% identity between the sequences and between LeNCED1 and 
ZmNCED1 there is 60.6%, showing that LeNCED1, LeCCD1a and ZmNCED1 are more 
closely related to each other than to AtCCD7. Phylogenetic analysis of a wider selection of 
carotenoid cleavages show that CCD7 clusters away from other members of the family (Figure 
5.16). This suggests there is an ancestral difference between CCD7 and other plant CCDs. On 
the basis of the phylogeny shown in Figure 5.16, CCD7 is more closely related to bacterial 
and cyanobacterial CCDs.  
 The fact that CCD7 appears to be evolutionarily distinct from other members of the 
CCD family and shares little identity with its other members could suggest that CCD7 is 
structurally quite distinct. This structural difference could result in an altered active site 
architecture, which renders the enzyme immune to inhibition by the hydroxamic acids.  
 Interestingly, CCD7 is also not inhibited by inhibitors which do not belong to the 
hydroxamic acid inhibitor family. Both NDGA and the abamine compounds showed no 
inhibition at 100 µM. Abamine and abamineSG have been shown to be reasonably weak 
inhibitors of CCD enzymes and as such strong inhibition against AtCCD7 was not expected. 
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5.6 Conclusions 
 The CCD7 enzyme from A. thaliana has been shown to cleave 9-cis-β-carotene with 
a KM of 8.7 µM. Additionally, AtCCD7 shows a preference for the 9-cis isomer of β-carotene 
over the all-trans isomer, confirming the results of Alder (Alder et al. 2012). 
 None of the hydroxamic acid inhibitors are effective at inhibiting the AtCCD7 
cleavage reaction in vitro. This raises interesting questions regarding the biochemical basis 
for the in planta phenotype observed with the hydroxamic acids affecting lateral shoot 
branching. Neither CCD7 or D27 are inhibited by hydroxamic acids in vitro, and therefore are 
apparently not the in planta target. The phenotype must therefore be due to inhibition of the 
carotenoid cleavage dioxygenases 8 enzyme, or of another enzyme on the strigolactone 
biosynthesis pathway. 
 
Figure 5.16 – Phylogenetic analysis of members of the carotenoid cleavage dioxygenase family 
following ClustalΩ alignment (See Figure 1.9). CCD7 clusters away from other members of the 
CCD enzyme family in plants. LCD – Lignostilbene Cleavage Dioxygenase (or LSD). 
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5.7 Future Work 
 Given that the in vitro data obtained here suggests that CCD7 is not the target of the 
shoot branching phenotype observed in planta, work remains to be done on elucidating what 
the in planta target of the hydroxamic acids is. 
 As with CCD1, it would be of great interest to determine the crystal structure of CCD7 
and to perform detailed mechanistic experiments to help shed further light on the cleavage 
mechanism. 
 Finally, more work would be needed in order to develop an inhibitor which is selective 
for solely CCD7. The development of such an inhibitor would be aided by a crystal structure, 
preferably with bound substrate. A selective inhibitor could be useful agrochemically, but 
would also help to identify other processes mediated by strigolactones.  
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Chapter Six: Expression, Inhibition, Assays and 
Biochemical Characterisation of Arabidopsis thaliana 
Carotenoid Cleavage Dioxygenase 8 
6.1 Introduction 
 Carotenoid cleavage dioxygenase 8 (CCD8) is the third enzyme on the committed 
pathway to strigolactone biosynthesis. CCD8 is predominantly selective for 9-cis-β-apo-10’-
carotenal (produced by CCD7), performing an unusual oxidative cleavage reaction to form a 
compound known as carlactone, which is converted to strigolactone by the remainder of the 
strigolactone biosynthesis pathway (Alder et al. 2012). CCD8 has also been shown to cleave 
all-trans-β-apo-10’-carotenal, albeit at a significantly reduced rate, to form 13-apo-β-
carotenone (Schwartz et al. 2004, Alder et al. 2008) (Figure 6.1).  
 The work detailed within this chapter describes the expression of Arabidopsis 
thaliana CCD8 and assays against hydroxamic acid carotenoid cleavage dioxygenase 
inhibitors in order to determine the biochemical basis of phenotypic effects on shoot branching 
observed in A. thaliana in planta on application of the hydroxamic acid inhibitors D2, D4, D5 
and D6. Biochemical investigations into CCD8 are also discussed.  
 
Figure 6.1 – Schematic of the reaction catalysed by CCD8. 
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6.2 Expression and Assays of A. thaliana CCD8 
  Two E. coli constructs were obtained from Dr Andrew Thompson (University of 
Cranfield) containing CCD8: pGEX-4T-1-AtCCD8.1 (full length CCD8 gene with GST 
fusion tag) and pGEX-4T-1-AtCCD8.2 (truncated gene lacking the first 168 base pairs 
corresponding the chloroplast transit peptide with GST fusion tag) (CCD8 accession number: 
NM_119434). Both the GST-AtCCD8.1 protein (predicted molecular weight based on 
sequence: 90.35 kDa) and GST-AtCCD8.2 protein (predicted molecular weight based on 
sequence: 83.89 kDa) could be overproduced in Escherichia coli following induction with 
1 mM IPTG at 20° C overnight and were purified by glutathione affinity chromatography 
(Figure 6.2). CCD8.2 was additionally cloned into the pET-151 vector and the N-His6-
AtCCCD8.2 protein (predicted molecular weight based on sequence: 61.38 kDa) could also 
be overproduced under the same conditions as GST-CCD8 and was purified via Ni(NTA) 
affinity chromatography (Figure 6.2). In the gel of GST-ATCCD8.1 (Figure 6.2A), additional 
bands at approximately 55 kDa and 25 kDa are due to the chaperone GroEL and cytoplasmic 
glutathione respectively (blue boxes). 
 
Figure 6.2 – 10% SDS-PAGE gels showing expression and purification of GST-AtCCD8.1 (A, 
lanes 1-6), GST-AtCCD8.2 (B, lanes 7-10) and N-His6-AtCCD8.2 (C, lanes 11-15). 1 – Ladder; 2 
– GST-AtCCD8.1 Total protein (TP); 3 - GST-AtCCD8.1 Total soluble protein (TSP); 4 – GST-
AtCCD8.1 Flow through; 5 – GST-AtCCD8.1 Elution fraction 1; 6 – GST-AtCCD8.1 Elution 
fraction 2; 7 – Ladder; 8 – GST-AtCCD8.2 TP; 9 – GST-AtCCD8.2 TSP; 10 – GST-AtCCD8.2 
Elution; 11 – Ladder; 12 – N-His6-AtCCD8.2 TP; 13 – N-His6-AtCCD8.2 TSP; 14 – N-His6-
AtCCD8.2 Elution fraction 1; 15 – N-His6-AtCCD8.2 Elution fraction 2. Molecular weights of 
ladder are in kDa. Molecular weight (Mw, all calculated from sequence) of GST-AtCCD8.1: 90.35 
kDa. Mw of GST-AtCCD8.2: 83.89 kDa. Mw of N-His6-AtCCD8.2: 61.38 kDa. Mass spectrometry 
would be required to definitively prove that AtCCD8 has been produced.  
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The substrate for assays of CCD8, 9-cis-β-apo-10’-carotenal, was generated from 
incubations of AtCCD7.2 with 9-cis-β-carotene (generated from iodine catalysed 
isomerisation of all-trans-β-carotene, see Chapter 5.3). 9-cis-β-apo-10’-carotenal was purified 
via reversed phase HPLC using a C30 column and quantified using the extinction coefficient 
of all-trans-β-apo-8’-carotenal (Ɛ440 nm = 5.1 x 104 M-1 cm-1), since no authentic standard of 
9-cis-β-apo-10’-carotenal is available for the determination of an extinction coefficient. 
Assays of AtCCD8 contained approximately 10 µM of 9-cis-β-apo-10’-carotenal and 190 µg 
of protein containing overproduced CCD8.   
Addition of AtCCD8 to 9-cis-β-apo-10’-carotenal was found to give a disappearance 
in the magnitude of the peak corresponding to 9-cis-β-apo-10’-carotenal relative to an internal 
standard of β-carotene when analysed via HPLC (Figure 6.3). Using this internal standard, the 
Figure 6.3 – HPLC chromatographs at 440 nm of 9-cis-β-apo-10’-carotenal in the absence (A, top) 
and presence (B, bottom) of N-His6-AtCCD8.2. In the presence of N-His6-AtCCD8.2 there is less 
9-cis-β-apo-10’-carotenal with respect to the β-carotene in the sample (4.7:1 9-cis-β-apo-10’-
carotenal : β-carotene versus 6.1:1). 
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ratio of 9-cis-β-apo-10’-carotenal to β-carotene was calculated, with a lower ratio indicating 
turnover of the 9-cis-β-apo-10’-carotenal by CCD8. Incubations of 9-cis-β-apo-10’-carotenal 
with both N-His6-AtCCD8.2 and GST-AtCCD8.2 revealed a decrease in the intensity of the 
9-cis-β-apo-10’-carotenal peak at 440 nm with respect to a β-carotene internal standard 
(Figure 6.3).  
 Activity of AtCCD8.2 could also be observed via continuous UV assays, since 
consumption of the 9-cis-β-apo-10’-carotenal substrate by CCD8 results in a decrease in 
absorbance at 430 nm. The products of the CCD8 cleavage reaction both absorb at a lower 
wavelength (267 nm for the carlactone and calculated 240 nm for the trienal (Williams & 
Fleming 1995)). As such, following incubation of 9-cis-β-apo-10’-carotenal with CCD8, a 
clear colour change from orange to colourless can be observed visually. Observing at 430 nm 
shows a decrease in absorbance on incubation of 9-cis-β-apo-10’-carotenal with CCD8, which 
can be followed on the plate reader (Figure 6.4). Control experiments demonstrated the change 
in absorbance was due to the activity of CCD8 (Figure 6.5). No activity was observed in the 
presence of boiled AtCCD8.2 (Figure 6.5A). Activity was observed in the presence of EDTA 
(Figure 6.5B), which suggests the active site iron is strongly coordinated by the enzyme. 
Additionally, the rate of the cleavage reaction was dependent upon the concentration of 
AtCCD8.2 present (Figure 6.5C). 
 
Figure 6.4 – A: Absorbance change at 430 nm on incubation of 9-cis-β-apo-10’-carotenal with 
AtCCD8.2.  
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 Following incubations of GST-AtCCD8.1, GST-AtCCD8.2 and N-His6-AtCCD8.2 
with 9-cis-β-apo-10’-carotenal at 25° C and analysis via HPLC it was not possible to detect a 
new peak at 267 nm which would correspond to the carlactone product using the same analysis 
method as was used for CCD7 and D27 (Alder et al. 2012)  (Figure 6.6). The product of the 
CCD8 reaction, carlactone, is an enol ether (Figure 6.1), which is likely to be unstable, and 
can readily undergo hydrolysis in mildly acidic aqueous conditions (Figure 6.7). It is likely 
that during the extraction process and analysis, the carlactone is being hydrolysed by water in 
the presence of a protic solvent such as methanol. Breakdown of the carlactone is likely to 
produce an aldehyde and a hemiacetal lactone. The C8 trienal product was also not detected. 
These products are unlikely to be retained on a hydrophobic C30 column, most likely eluting 
immediately after the dead volume. These small compounds are also likely volatile (a sweet 
Figure 6.5 – UV chromatographs of AtCCD8 control reactions. A: 9-cis-β-apo-10’-carotenal with 
boiled AtCCD8.2. B: 9-cis-β-apo-10’-carotenal with AtCCD8.2 and 100 µM EDTA. C: 9-cis-β-
apo-10’-carotenal with 1 x and 2 x concentrations of N-His6-AtCCD8.2. 
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smell can be detected following incubations of AtCCD8 with 9-cis-β-apo-10’-carotenal), and 
so consequentially may be lost during sample preparation.  The retention of carlactone on the 
C30 column may also be weak and extractions from the assay reaction with more polar solvents 
such as ethyl acetate also failed to produce a peak corresponding to the carotenal. 
Figure 6.6 – Comparison of HPLC chromatographs at 267 nm of 9-cis-β-apo-10’-carotenal in the 
absence (A, top) and presence (B, bottom) of AtCCD8.2 using the CCD7/D27 analysis method. No 
new peaks are present.  
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Figure 6.7 – Mechanism of the breakdown of the enol ether carlactone in mild acidic / aqueous 
conditions. The lactone product is possibly stabilised by the cis double bond.  
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 Further analysis was performed using a less hydrophobic C18 column, with a mobile 
phase of water, methanol and tertbutylmethylether (Alder et al. 2012). Via this method a small 
peak at 15.2 minutes at 267 nm was detected in incubations of AtCCD8 with 
9-cis-β-apo-10’-carotenal, as reported by Alder et al. (Figure 6.8). The identity of the peaks at 
 
Figure 6.8 – HPLC chromatograph of incubation of 9-cis-β-apo-10’-carotenal in the absence (A 
and C) and presence (B and D) of N-His6-AtCCD8.2. B and D show enhanced view of the region 
between 12 and 20 minutes, where a new peak is present following incubation of 9-cis-β-apo-10’-
carotenal with AtCCD8.2. 
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15.5 minutes and 16.5 minutes is unknown. Analysis of the UV spectra of this peak at 15.2m 
showed a chromatogram identical to that reported by Alder et al. for carlactone (Figure 6.9). 
However, it was not possible to perform liquid chromatography mass spectrometry (LC-MS) 
directly on this sample due to the nature of the solvents employed. Analysis via low resolution 
mass spectrometry did not reveal a peak which would correspond to carlactone. This molecule 
appears to be very challenging to detect via mass spectrometry. 
In order to perform LC-MS, a mobile phase of solely methanol / water was employed. 
However, using this method it was not possible to discern a new peak in the UV chromatogram 
which would correspond to the carlactone product, and no signals at m/z = 303 could be 
detected in the extracted ion chromatogram, which would correspond to the [M+H]+ signal of 
carlactone. This lack of signal strongly indicates that the carlactone is breaking down during 
the extraction procedure as suggested above. However, sodium borohydride treatment of the 
organic extract of the CCD8 reaction (Figure 6.10), followed by analysis via low resolution 
ESI mass spectrometry revealed peaks with masses of m/z = 209 (the reduced aldehyde 
breakdown product [M+H]+ peak), m/z = 143 (the reduced trienal product [M+H]+ peak) and 
m/z = 379 (unreacted 9-cis-β-apo-10’-carotenal [M+H]+ peak). Although it was not possible 
to obtain high resolution spectra, these data indicate that CCD8 is indeed converting 9-cis-β-
apo-10’-carotenal to carlactone (low resolution spectra are shown in appendix 10.6) 
 
Figure 6.9 – UV chromatogram of the peak at 15.2 minutes from Figure 6.6, possibly belonging to 
carlactone.  
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 Consequentially it can be concluded that AtCCD8 is catalysing the cleavage of 9-cis-
β-apo-10-carotenal, as reported by Alder et al., however, it is not possible to definitively 
confirm the presence of the carlactone product.  
 6.3 Crystallisation of A. thaliana CCD8.2 
 N-His6-AtCCD8.2 was purified via nickel affinity chromatography for the purposes 
of crystallisation of the AtCCD8 protein. Purified N-His6-AtCCD8.2 was added to a panel of 
100 crystallisation buffers provided by Dr Dean Rea (University of Warwick, Life Sciences) 
and allowed to crystallise over a period of 7 days. Crystals were observed for N-His6-
AtCCD8.2 in the presence and absence of addition iron (II) sulfate (1 µM) (Figure 6.11) for 
the buffers Morpheus C2 (small cubes) (10 % w/v PEG 8000, 20 % v/v ethylene glycol, 
 
Figure 6.11 – Image of AtCCD8.2 protein crystal produced from the Morpheus C6 buffer. 
AtCCD8.2 
crystal
 
Figure 6.10 – m/z values of CCD8 reaction products, breakdown products and reduced derivatives. 
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0.03 M of each, 0.1 M MES/Imidazole pH 6.5), Morpheus C6 (single rocks) (10 % w/v PEG 
8000, 20 % v/v ethylene glycol, 0.03 M of each NPS, 0.1 M MOPS/HEPES-Na pH 7.5) and 
Morpheus C10 (rod clusters) (10 % w/v PEG 8000, 20 % v/v ethylene glycol, 0.03 M of each 
NPS, 0.1 M Bicine/Trizma base pH 8.5). Due to time constraints, it was not possible to 
perform further experiments towards obtaining a crystal structure of AtCCD8.  
6.4 Biochemical Characterisation of A. thaliana CCD8 
 CCD8 is proposed to perform an unusual cleavage reaction, inserting three 
equivalents of oxygen, which are all believed to be derived from molecular oxygen, in a single 
reaction, forming carlactone. Currently, there is no kinetic, biochemical or mechanistic data 
on CCD8 in the literature, nor is there a crystal structure of CCD8 available to help probe the 
mechanism.  
 Attempts were made to determine a KM for CCD8 for the substrate 
9-cis-β-apo-10’-carotenal. However, it was observed that at a concentration of substrate above 
15 µM there was a decrease in the rate of the CCD8 reaction (Table 4.1). The rate of the 
reaction at various substrate concentrations was recorded and modelled using analysis 
software (GraphPad) and was found to be consistent with a model of substrate inhibition 
(Figure 6.12). This possibly arises through the enzyme binding a second equivalent of 
substrate in a conformation which is detrimental to the activity of the enzyme. A KM of 9.2 
µM was calculated by the software and specific activity of 2.48 x 10-3 units (µmol s-1) mg-1 
was determined for N-His6-AtCCD8.2. A kcat of 0.18 s-1 was also determined for N-His6-
Substrate Concentration (µM) Reaction Rate (nmol min-1) 
1 0.0 
3 0.0022 
5 0.0163 
7 0.0188 
15 0.0147 
30 0.0 
45 0.0 
60 0.0 
Table 6.1 – Comparison of the rate of the CCD8 reaction at various substrate concentrations. 
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AtCCD8.2. It should be noted that the values of kcat, KM and the specific activity are based on 
the assumption that 80% of protein present was that of N-His6-AtCCD8.2, and that 
concentration of substrate was determined using the extinction coefficient of 
all-trans-β-apo-8’-carotenal. A kcat/KM value of 0.0199 s-1 µM-1 was also determined for N-
His6-AtCCD8.2. This kinetic data suggests that CCD8 is a slow enzyme that does not bind the 
9-cis-β-apo-10’-carotenal substrate tightly. This is consistent with the fact that CCD8 is 
catalysing a complex cleavage reaction.  
In order to investigate the mechanism of AtCCD8, stopped-flow experiments were 
performed on a visit to the group of Prof. Nigel Scrutton (University of Manchester) using a 
 
Figure 6.12 – Modelling of AtCCD8.2 rate data using a model of substrate inhibition by GraphPad. 
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Figure 6.13 – Absorbance change observed over 200 s from stopped flow reaction of 11 µM 
AtCCD8.2 with 11 µM 9-cis-β-apo-10’-carotenal in 100 mM HEPES buffer pH 7.8 with 1 mM 
TCEP. A decrease in absorbance can be observed at 444 nm. 
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1:1 molar ratio of AtCCD8.2 to 9-cis-β-apo-10’-carotenal (Figure 6.13). Following the 
reaction over a period of 200 s using a diode array detector in 100 mM HEPES buffer pH 7.8 
with 1 mM TCEP, a decrease in absorbance at 440 nm can be observed, which represents 
consumption of the 9-cis-β-apo-10’-carotenal substrate by CCD8 (Figure 6.13). Further 
kinetic experiments were performed over a time period of 40 s at a fixed wavelength of 440 nm 
(Figure 6.14). Analysis of the data revealed that decay of the 9-cis-β-apo-10’-carotenal at 
440 nm could be fitted well to a second order exponential (Figure 6.14). This suggests that the 
mechanism of cleavage by CCD8 is a two-step process (Figure 6.15A). 
There is also a slight increase in absorbance at approximately 350 nm during the 
reaction, which could represent the formation of a conjugated intermediate during the reaction 
process (Figure 6.13). However, it was not possible to fit the change at 350 nm to either a 
single or double exponential. No absorbance change could be detected at 267 nm, which would 
 
Figure 6.14 – A: Absorbance change observed over 40 s at 440 nm for reaction of 11 µM 
AtCCD8.2 with 11 µM 9-cis-β-apo-10’-carotenal in 100 mM HEPES buffer pH 7.8 with 1 mM 
TCEP (orange) and fit to a second order exponential (blue). B: Residuals from the fitting of second 
order exponential to absorbance change at 440 nm. 
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correspond to the carlactone product, but this may be hidden in the presence of a high protein 
concentration. Hence the two step mechanism implies the presence of a less UV absorbent 
intermediate in the range of 5-15 seconds (Figure 6.15B).  
  A pH rate profile was performed to determine if any acid-base catalysis was 
occurring during the CCD8 cleavage reaction (Figure 6.16). The pH rate profile analysis 
reveals that there is a sharp decrease in the rate of the CCD8 catalysed reaction below pH 6.0 
and above pH 8.0. The fall in rate at low pH could be due to protonation of a basic residue, 
such as histidine (pKa = 6-8), glutamic acid or aspartic acid (pKa = 4-6) (Bugg 2012). 
Conversely the fall in rate at high pH could be due to the deprotonation of an acidic residue, 
 
 
Figure 6.15 – A: Possible reaction scheme for the CCD8 cleavage reaction involving an enzyme 
bound intermediate. B: Global simulation of CCD8 cleavage reaction showing relative changes in 
the concentrations of substrate, intermediate and product versus time. 
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Figure 6.16 – pH rate profile of the AtCCD8.2 catalysed cleavage of 9-cis-β-apo-10’-carotenal. 
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such as cysteine (pKa = 7.5-9), lysine (pKa = 8.5-10), histidine or even iron bound water (Fe-
OH2). Consequentially, the pH rate profile data strongly suggests that acid-base catalysis is 
required for cleavage of 9-cis-β-apo-10’-carotenal by CCD8.  
 Based on the data of the pH rate profile, group specific reagents were chosen in order 
to determine the nature of residues which may be involved in catalysis. It should be noted that 
group specific reagents will also modify non-catalytic residues, which could perturb the 
activity of the enzyme. CCD8 was incubated for 20 minutes in the presence of a series of 
group specific reagents (Table 6.2) before being assayed as usual. It was observed that CCD8 
was inhibited by iodoacetamide, N-ethyl maleimide (NEM), diethyl pyrocarbonate and 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). The loss of enzyme activity in the 
presence of these chemicals suggests the presence of cysteine (iodoacetamide and NEM), 
histidine (diethyl pyrocarbonate) and aspartic acid or glutamic acid (EDC) residues in or near 
the enzyme active site. It is known that within the CCD enzyme family there are semi-
conserved second shell glutamic acid residues which could well be participating in catalysis 
(Harrison & Bugg 2013, see also Figure 1.9). Histidine could be acting either as an acid or a 
base, or the inhibitory effect could be a result of modification of the histidine residues required 
to coordinate the active site iron, resulting in a loss of ability to coordinate the iron. Cysteine 
could be either acting as an active site acid or in a redox capacity. No loss of activity was 
observed in the presence of succinic anhydride, a group specific reagent for lysine residues.  
Reagent Target Residue 
% Activity after 20 
minutes 
Iodoacetamide Cysteine < 1% 
N-ethyl maleimide Cysteine < 1% 
Diethyl pyrocarbonate Histidine < 1% 
1-Ethyl-3- 
(3-dimethylaminopropyl)carbodiimide 
Aspartic acid / 
Glutamic acid 
< 1% 
Succinic anhydride Lysine > 95% 
Table 6.2 – Comparison of effects observed for different group specific reagents on the AtCCD8 
enzyme reaction. 
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6.5 Discussion of Possible CCD8 Cleavage Mechanisms 
Understanding the CCD8 cleavage mechanism is complicated by the fact that CCD8 
performs an unusual cleavage reaction, apparently cleaving two C-C bonds rather than two 
C=C bonds (although the polyene backbone is a conjugated system, hence electron density is 
spread equally amongst the carbon atoms). As a result, CCD8 must proceed through a non-
standard mechanism, i.e. one unlike the other members of the CCD enzyme family (such as 
those discussed in Chapter 1.6). Experiments with group specific reagents suggest the 
presence of an active site cysteine residue, which could act as a nucleophile, and has the 
Figure 6.17 – Possible mechanism for the CCD8 cleavage reaction. 
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potential to form a stable radical intermediate (Stubbe & van der Donk 1998). A possible 
mechanism for CCD8 is shown in Figure 6.17. 
In this mechanism, following formation of the iron-peroxo intermediate by iron (II) a 
stabilized tertiary radical is formed. One electron transfer from cysteine to iron (III) would 
then occur, creating a cysteinyl radical, which attacks the substrate radical at C13. The less 
hindered group of the substrate is then able to migrate via a Criegee rearrangement (Bugg 
2003), creating an enol ether and secondary cation, which is quenched by the iron bound 
hydroxyl. The hydroxyl group can then eliminate the trienal, which is a good leaving group, 
leaving an enzyme bound covalent intermediate. Homolytic cleavage of the S-C bond forms 
a highly stabilized tertiary radical, which allows a second iron-peroxo intermediate to form at 
C11. This time, the more electron rich group is able to migrate in the Criegee rearrangement 
and again the secondary cation is quenched by the iron bound hydroxyl. Base catalysed 
cyclisation onto the aldehyde then creates a five membered lactol. Finally, oxidation of the 
lactol by the active site cysteine radical and iron (III) restores the active site iron to the iron 
(II) resting state and releases the carlactone product.  
Although there is no definitive proof for the existence of this mechanism, it is 
consistent with the available evidence; that is a two-step acid-base catalysed mechanism 
involving at least three different active site residues. The sequence of cleavages also makes 
sense, given that a cyclisation reaction is required to form the lactone ring, which would first 
require aldehyde formation. Analysis of stopped flow data reveals that the rate constants for 
the first and second reaction steps are 0.43 s-1 and 0.06 s-1 respectively, in close agreement to 
the value of 0.18 s-1 calculated from a continuous UV assay (Section 6.4). As such, this equates 
to a turnover time of 2.3 s and 16 s respectively for the first and second steps. A slow second 
reaction is consistent with this mechanism, as the second half of the reaction requires 
homolytic cleavage of the reasonably stable C-S bond. Sequence alignment of CCD8 
homologs shows that there are a number of conserved cysteine residues in the CCD8 enzyme 
family (Cys217, Cys294, Cys394, Cys395, Cys467 and Cys479 in A. thaliana CCD8) (Figure 6.18).  
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Another CCD8 mechanism has been proposed by Alder et al. (Figure 6.19) (Alder et 
al. 2012). In this mechanism, the 9-cis-β-apo-10’-carotenal substrate undergoes a double 
isomerisation reaction to form 9,11,13-tri-cis-β-apo-10’-carotenel, which then binds to the 
Q8VY26_AtCCD8* MASL----ITTKAMMSHHHVLSSTRITTLYSDNSI-GDQQIKTKPQV--PHRLFARRIFGVTRAV  
G7J3F4_MtCCD8  MAFT----ASPAIIRNPIS--KQNMVVCDMLDNTCRKKFSFRNKGIYKGQHNLRDH--LTVTNVV 
M0TAC6_MaCCD8  MASTLFFLPSPKTTASPSN--------------RL-SVPGFRPPR----LHSLRWRPAVSVRASI 
W5CRG5_TaCCD8  SA--------------------------------------------------------------- 
                *                                                               
Q8VY26_AtCCD8* IN----SAAPSP-LPEKEKVEGERRCHVAWTSVQQENWEGELTVQGKIPTWLNGTYLRNGPGLWN 
G7J3F4_MtCCD8  S--PSRVIAPPPPPEKRSETTGDHQHHVAWTSIPQERWEGELLVQGHIPLWLKGTYIRNGPGMWN 
M0TAC6_MaCCD8  ATKPRPTVVPFDPAVETKQDVGSGRKLAAWTSIRQERWEGELVVEGEIPLWLKGTYLRNGPGIWN 
W5CRG5_TaCCD8  ---------PR--RRGGRGVDGGADELVAWKSIRQERWEGALEVEGKLPTWLDGTYLRNGPGLWD 
                        *           *     .**.*: **.*** * *:*.:* **.***:*****:*:       
Q8VY26_AtCCD8* IGDHDFRHLFDGYSTLVKLQFDGGRIFAAHRLLESDAYKAAKKHNRLCYREFSETPKSVIINKNP 
G7J3F4_MtCCD8  IGDYNFRHLFDGYATLVGLHFEDGRLVAGHRQVESQAYQAAKKNQKICYREFSEVPKAEN----F 
M0TAC6_MaCCD8  IDDYNFRHLFDGYATLVRVCFEHGGVTASHRQIESEAYKAAMTNRRLCYREFSEAPKPTS----F 
W5CRG5_TaCCD8  LGDYGFRHLFDGYATLVRVSFRDGHAVGAHRQIESEAYKAARQHGKVCYREFSEVPKPDS----F 
               :.*:.********:*** : *  *   ..** :**:**:**  : ::*******.**.        
Q8VY26_AtCCD8* FSGIGEIVRLFSGESLTDNANTGVIKLGDGRVMCLTETQKGSILVDHETLETIGKFEYDDVLSDH 
G7J3F4_MtCCD8  LAYVGELANLFSGSSLTDNANTGVVKLGDGRVVCLTETQKGSIVIDPDTLETIGKFDYSDSLG-G 
M0TAC6_MaCCD8  LAYVGELASLFSGASLTDNSNTGVVRLGDGRVVCLTETVKGSVQIDPDTLDTVGRFVYEDNLG-G 
W5CRG5_TaCCD8  KSLVGQLASLFSGNSLTDNSNTGVVRLGDGRVLCLTETVKGSIVVDPDTLDTVSKFEYEDKLG-G 
                : :*::. **** *****:****::******:***** ***: :* :**:*:.:* *.* *.         
Q8VY26_AtCCD8* MIQSAHPIVTETEMWTLIPDLVKPGYRVVRMEAGSNKREVVGRVRCRSGSWGPGWVHSFAVTENY 
G7J3F4_MtCCD8  LIHSAHPIVTDNEFLTLIPDLVKPGYLVARMEPGSNERKVIGRVDCRGGT-SPGWVHSFPVTEHY 
M0TAC6_MaCCD8  LIHSAHPIVTESEFLTLLPDLVRPGYLVVRMEPGSNERKVVGRVNCRGGP-APGWVHSFAVTDRY 
W5CRG5_TaCCD8  LIHSAHPIVTDTEFWTLIPDLIRPGYVVARMDAGSNERQFVGRVDCRGGP-APGWVHSFPVTENY 
               :*:*******:.*: **:***::*** *.**:.***:*:.:*** **.*. .*******.**:.* 
Q8VY26_AtCCD8* VVIPEMPLRYSVKNLLRAEPTPLYKFEWCPQDGAFIHVMSKLTGEVVASVEVPAYVTFHFINAYE 
G7J3F4_MtCCD8  VIVPEMPLRYCAQNLLRAEPTPLYKFQWHPESKAFMHVMCKTSGKIVASVEVPLFVTFHFINAYE 
M0TAC6_MaCCD8  VVVPEMPLRYCVHNLLRAEPTPLYKFEWHPESGSYMHVMSKATGKIVASVEVPPFLTFHFINAYE 
W5CRG5_TaCCD8  VVVPEMPLRYCAANLLRAEPTPLYKFQWHLESGSYMHVMCKASGKIVASVEVPPFVTFHFINAYE 
               *::*******.. *************:*  :. :::***.* :*::******* ::********* 
Q8VY26_AtCCD8* EDKNGDGKATVIIADCCEHNADTRILDMLRLDTLRSSHGHDVLPDARIGRFRIPLDGSKYGKLET 
G7J3F4_MtCCD8  E-EDEDGRVTAVIADCCEHNSNTDILDKLRLQNLRSFNGEDVLPDARVGRFRIPLDGSPYGTLDA 
M0TAC6_MaCCD8  E-VDENGRVTGIIADCCEHNADTSILDILRVQNLRSFTGLDVLPDARVGRFRIPLDGSTRGELLA 
W5CRG5_TaCCD8  E-KDEEGRVTAIIADCCEHNADTSILDNLRLHNLRAFTGEDVLTDARVGRFRIPLDGSPFGELEA 
               *  : :*:.* :********::* *** **:..**:  * ***.***:**********  * * : 
Q8VY26_AtCCD8* AVEAEKHGRAMDMCSINPLYLGQKYRYVYACGAQRPCNFPNALSKVDIVEKKVKNWHEHGMIPSE 
G7J3F4_MtCCD8  ALDPNEHGKGMDMCSINPNYLGLKYRYAYACGAQRPCNFPNTLTKIDLQSERAKNWYEEGAVPSE 
M0TAC6_MaCCD8  ALDPEEHGRGMDMCSINPAYLGKKYRYAYACGARRPCNFPNTLAKIDLVEKKAKNWHEDGAVPSE 
W5CRG5_TaCCD8  ALDPEEHGRGMDMCSINPAHLGKEYRYAYACGARRPCNFPNTLTKIDLVEKTAKNWYEEGAVPSE 
               *::.::**:.******** :** :***.*****:*******:*:*:*: .: .***:*.* :*** 
Q8VY26_AtCCD8* PFFVPRPGATHEDDGVVISIVSEENGGSFAILLDGSSFEEIARAKFPYGLPYGLHGCWIPKD- 
G7J3F4_MtCCD8  PFFVPRPGATKEDDGVVISIISEKNGEGYALVLDGSTFEEIARAKFPYGLPYGLHGCWVPKQ- 
M0TAC6_MaCCD8  PFFVARPGATEEDDGVVISIVSDKNGEGYALMLDGATFEEIARAKFPYGLPYGLHGCWVPKM- 
W5CRG5_TaCCD8  PYFVARPGAVEEDDGVAISMVSAKDGSGYALVLDAKTFKEIARAKFPYGLPYGLHCCWVPRDK 
               *:**.****..*****.**::* ::* .:*::**. :*:******************:*:    
Figure 6.18 – Multiple T-Coffee sequence alignment of CCD8 against selected random hits from a 
BLAST search. Conserved cysteine residues are highlighted in red (based on alignment to top 50 
hits in BLAST search). At – Arabidopsis thaliana; Mt – Medicago truncatula (barrel clover); Ma – 
Musa acuminata (wild banana); Ta – Triticum aestivum (wheat). * refers to functionally 
characterised enzyme. 
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active site in a manner similar to cyclooxygenase. Molecular oxygen is then added across two 
double bonds to form a dioxane intermediate, which undergoes base catalysed rearrangement 
to form an enol ether and an oxygen anion intermediate. A second equivalent of oxygen is 
then added across the same pair of double bonds as before. This structure then rearranges to 
form another oxygen anion, which can then cyclise onto the resulting ester, eliminating the 
trienal and forming carlactone. 
There are several problems with this mechanism, however. Although it is a direct 
route, dioxane formation seems unlikely, as CCD8 bears no sequence similarity to 
cyclooxygenases (van der Donk et al. 2002). Moreover, it is not clear why one isomerase, 
D27, would evolve on the pathway to perform one isomerisation, only for CCD8 to carry out 
two further isomerisation reactions. It is likely that if CCD8 were to catalyse an isomerisation 
as proposed in Figure 6.19, it would require an iron-oxo intermediate, as discussed in Chapter 
4. Such an intermediate would likely form cleavage products, which are not observed. 
 
Figure 6.19 – Proposed mechanism by Alder et al. for the formation of carlactone by AtCCD8. 
Figure from Alder et al. 2012. 
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Additionally, it is likely that CCD8 would also be able to isomerise the 
all-trans-β-apo-10’-carotenal, a process which is also not observed. 
6.6 Inhibition of A. thaliana CCD8 
As discussed, phenotypic effects on lateral shoot branching have been observed in A. 
thaliana on application of the hydroxamic acid compounds D2, D4, D5 and D6, whereby 
application of inhibitor results in an increase in the number of lateral shoots, indicating 
inhibition of the biosynthesis of the shoot branching hormone strigolactone (Sergeant et al. 
2009). 
AtCCD8.2 was initially tested for inhibition against compound D2, using the 
continuous UV method detailed in Section 6.2. Compound D2 was pre-incubated AtCCD8.2 
for varying lengths of time before the enzyme substrate, 9-cis-β-apo-10’-carotenal was added. 
Analysis revealed that, just as with the NCED subfamily, AtCCD8.2 exhibits a time dependent 
inhibitory effect. When pre-incubated for 10 minutes there is 75% inhibition of AtCCD8.2. 
However, following 30 minutes pre-incubation this increases to 100% inhibition of enzyme 
activity (Figure 6.20).  
Therefore the library of hydroxamic acids was screened at a concentration of 100 µM 
against AtCCD8.2 with 30 minutes pre-incubation of inhibitor using the UV assay on the plate 
 
Figure 6.20 – Levels of inhibition observed for compound D2 at 100 µM against AtCCD8.2 with 
varying lengths of pre-incubation of inhibitor with enzyme. 
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reader as described in Section 6.2. Results of the assays are detailed in Tables 6.3 to 6.7 and 
summarised graphically in Figure 6.21. A representative UV assay chromatograph is shown 
in Figure 6.22. 
 
Figure 6.21 – Summary of inhibition data of inhibitors assayed against AtCCD8.2 at 100 µM (A, 
top) and of inhibitors assayed against AtCCD8.2 at 10 µM (B, bottom). 
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Figure 6.22 – Representative UV chromatograph for the reaction of AtCCD8.2 with 
9-cis-β-apo-10’-carotenal in the absence (control, orange) and presence (blue) of 100 µM D2. 
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At a concentration of 100 µM there is complete inhibition with many of the ‘D’ series 
inhibitors. 100% inhibition is seen with compounds D1-D7. Compounds D16 and D17 do not 
show complete inhibition at 100 µM, which may be due to a steric effect as a result of the 
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D
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4-Hydroxy H >95 0 
D
2
 
4-Hydroxy F >95 0 
D
4
 
4-Methoxy F >95 17 
D
5
 3,4-
Dimethoxy 
H >95 9 
D
6
 3,4-
Dimethoxy 
F >95 53 
D
7
 
4-Methoxy F >95 25 
D
1
6
 
4-o-Butyl H 84 --- 
D
1
7
 
4-Acetyl H 90 --- 
D
2
0
 
 
4-Methoxy -- 47 --- 
D
2
1
 
Napthyl -- 92 --- 
D
3
0
 
 
--- -- 70 --- 
D
3
1
 
 
--- -- 52 --- 
D
3
2
 
 
--- -- 47 --- 
Table 6.3 – Inhibition data for compounds D1-D7, D20, D21 and D30-D32 versus AtCCD8.2.  
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larger acetyl and O-butyl substitutions on the phenyl group. None of the inhibitors D1-D7 and 
D15-D17 showed complete inhibition at a concentration of 10 µM. The carboxylated 
inhibitors D20 and D21 showed moderate levels of inhibition at 100 µM. The negative charge 
of the carboxyl may be perturbing interactions within the active site. Fluorinated compounds 
also showed slightly higher levels of inhibition compared to their unflourinated counterparts. 
This is slightly unexpected, since in vitro fluorination should have little effect. It could be that 
the fluorine is adjusting the electron density within the phenyl group to aid interactions within 
the active site, or that the fluorine is acting in a hydrogen bonding capacity. None of the longer 
compounds, D30-D32, showed complete inhibition at 100 µM (70%, 52% and 47% 
respectively). This indicates that the active site may be somewhat restricted in size. 
In contrast to the compounds in Table 6.3, those in Table 6.4 have an ethylene bridge 
between the carboxyl of the hydroxamic acid and the aromatic group (compounds in Table 
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D9 
 
4-Methoxy H >95 54 
D15 4-Methoxy F >95 71 
D10 
 
3,4-Dimethoxy --- >95 0 
D11 4-Methoxy --- >95 0 
D12 
 
3,4-Dimethoxy --- >95 56 
D13 4-Methoxy --- >95 47 
D12H 
 
3,4-Dimethoxy --- 78 --- 
D13H 4-Methoxy --- >95 82 
Table 6.4 – Inhibition data for compounds D9-D13, D12H, D13H and D15 versus AtCCD8.2. 
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6.3 have a methylene bridge). At 100 µM concentration complete inhibition was seen for  
compounds D9-D13, D15 and D13H. The strongest levels of inhibition were observed for 
compounds D13H and D15 (82% and 71% inhibition respectively at 10 µM). The increased 
chain length provided by the ethylene linker may be positioning the aromatic group for a π-π 
stacking interaction in the active site. The long alkyl chain on compounds D10 and D11 may 
perturb inhibition at 10 µM through steric effects. Methoxylated compounds showed higher 
levels of inhibition than hydroxylated ones, suggesting a possible hydrogen bond donor 
interaction. As observed previously, fluorinated analogues showed slightly higher levels of 
inhibition (compounds D15 versus D9).  
Compounds D12, D12H, D13 and D13H all have a protonated N-alkoxy group, 
making them slightly smaller. Loss of a substituent on the N-alkoxy terminus of the 
hydroxamic acid does not have a negative effect on the levels of inhibition seen. This could 
suggest that the inhibition observed is due more to chelation of the active site iron and 
positioning of the other aromatic group, and less to do interactions of the substituents on the 
inhibitor to residues within the active site. Compounds D13 and D13H (4-methoxy) both 
showed greater inhibition than D12 and D12H (3,4-dimethoxy), suggesting a steric effect due 
to the meta substituted methoxy  group. In general, increased inhibition was observed with 4-
methoxy substituted inhibitors than with 3,4-dimethoxy substituted inhibitors, supporting the 
conclusion of a steric clash in the active site.  
Of the ‘F’ series compounds (Table 6.5), 100% inhibition at 100 µM is seen with 
compounds F1-F6. It can again be seen that fluorinated derivatives with a 3,4-dimethoxy 
group showed higher levels if inhibition (albeit marginal). When compared to the equivalent 
‘D’ series compounds, the ‘F’ series compounds showed less inhibition. Although the trend is 
for small compounds to show greater inhibition, it may be that these ‘F’ series compounds are 
too small to bind effectively to the active site. Interestingly, no inhibition at 100 µM is seen 
with compounds F7 and F8, whilst the highest level of inhibition for the ‘F’ series was seen 
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with compound F6, a 3-amino substituted compound. The 3-amino group of F6 may be acting 
as a hydrogen bond donor, enhancing the binding within the active site.  
As with compounds D30-D32, the compounds H1-H4 were also poor inhibitors of 
CCD8. In fact, H1, H2 and H4 showed no inhibition at 100 µM. Compound H3 on the other 
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4-Methoxy H >95 0 
F2 4-Methoxy F >95 0 
F3 3,4-Dimethoxy H >95 1 
F4 3,4-Dimethoxy F >95 4 
F5 3-Chloro H >95 0 
F6 3-Amino H >95 21 
F7 3-Bromo H 0 --- 
F8 3-Chloro-4-Methoxy H 0 --- 
Table 6.5 – Inhibition data for hydroxamic acid compounds F1-F8 versus AtCCD8.2. 
 
In
h
ib
it
o
r 
S
tr
u
ct
u
re
 
A
tC
C
D
8
.2
 
In
h
ib
it
io
n
 a
t 
1
0
0
 µ
M
 
(%
) 
A
tC
C
D
8
.2
 
In
h
ib
it
io
n
 a
t 
1
0
 µ
M
 (
%
) 
H1 
 
0 --- 
H2 
 
0 --- 
H3 
 
>95 41 
H4 
 
0 --- 
Table 6.6 – Inhibition data for hydroxamic acid compounds H1-H4 versus AtCCD8.2. Bn 
represents a benzyl group (CH2Ph). 
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hand showed 41% inhibition at 10 µM, which is unusual for such a large compound. It is not 
immediately clear why H3 is so much more potent with respect to the other members of the H 
series, the only major difference being the addition of an acetyl group, which may be providing 
a hydrogen bonding interaction in the active site. It may be though that hydrolysis of the ester 
in H3 is occurring. This would in effect form a compound similar to D12-D13, which are 
reasonably potent inhibitors of CCD8. 
The hydroxamic acid inhibitor B2 showed no inhibition at 100 µM, further confirming 
the observation that larger compounds are weaker inhibitors of AtCCD8.2. Compound B1, a 
smaller compound, on the other hand showed 94% inhibition at 100 µM. The conjugated triene 
in B1 is likely performing an analogues π-π stacking interaction to the aromatic group in other 
compounds.  
Several non-hydroxamic acid based inhibitors were also assayed against AtCCD8.2. 
Abamine showed 100% inhibition of AtCCD8.2 at 100 µM, whilst the derivative abamineSG 
showed no inhibition. The increased chain length on the ester moiety appears to diminish the 
inhibitory effects, again supporting the observation that larger compounds are weaker 
inhibitors. Compounds E1, E2 and E4 are tertiary amines like abamine and abamineSG. None 
of these compounds showed complete inhibition of AtCCD8.2 at 100 µM. When compared to 
abamine, the loss of the double bond in the structure causes a decrease in the level of 
inhibition, possibly due to weaker π-π interactions within the active site. Finally, the 
compound NDGA showed no inhibition at 100 µM. NDGA is reasonably large, which appears 
to be detrimental to inhibition. It is possible that NDGA could have coordinated to the active 
site iron through either of the two catechol groups. However, this is apparently not observed, 
suggesting that either a hydroxamic acid moiety or tertiary amine is required for inhibition. 
It is suspected that the time dependent inhibitory effect exhibited by CCD8 towards 
the hydroxamic acids is a result of the same reasons detailed for NCED; longer incubation of 
the enzyme with inhibitor allows stronger binding of the inhibitor to the enzyme active site.  
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Based on the inhibition observed in vitro, several conclusions can be made about the features 
of hydroxamic acids which are required for inhibition. In general, smaller compounds are 
better inhibitors of AtCCD8.2 than larger compounds, up to a point. This suggests that the 
active site of AtCCD8.2 may be quite small, preventing larger compounds from binding. 
Compounds with an ethylene bridge on the carboxy terminus of the hydroxamic acid were 
more effective than those with no linker or a methylene linker. Given that the CCD8 cleavage 
reaction is occurring further along the polyene chain of the apocarotenoid (13,14 for the first 
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Table 6.7 – Inhibition data for abamine, abamineSG, NDGA, B1, B2 and E1-4 versus AtCCD8.2.  
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cleavage, compared to a  9,10 cleavage for CCD1/CCD7 and 11,12 for NCED), then the 
increased alkyl chain length in the hydroxamic acids maybe mimicking this effect, effectively 
positioning the phenyl group for a π-π stacking interaction.  
Smaller groups on the N-alkoxy terminus of the hydroxamic acid lend to greater levels 
of inhibition. Larger groups like carboxylates, geranyl substituents and long alkyl chains were 
not well tolerated, whilst smaller groups such as phenyl groups and protons were. Fluorinated 
derivatives are also more effective inhibitors, although it is not clear why. It may be that the 
fluorine substituent is hydrogen bonding to residues within the active site. On the carboxyl 
terminus of the hydroxamic acid a 4-methoxy substitution was preferred. Hydroxyl groups 
and 3,4-dimethoxylation was less well tolerated, suggesting a possible steric interaction within 
the active site and possibly a hydrogen bonding interaction. The hydroxamic acids were more 
potent inhibitors than the tertiary amines. 
It is also interesting to note that compound D15 showed 71% inhibition at a 
concentration of 10 µM, given that D15 has also been shown to exhibit a lateral root branching 
phenotype in A. thaliana (addition of D15 causes a decrease in the number of lateral roots) 
(van Norman et al. 2013). The biochemical basis of this phenotype is unknown and was 
proposed to be due to an unknown carotenoid derived signalling molecule. However, given 
that D15 has shown activity against CCD8, it is possible that the phenotype could be a 
strigolactone mediated process, or due to a signalling molecule derived from 
9-cis-β-apo-10’-carotenal, which would accumulate in planta on inhibition of CCD8. 
Unfortunately, due to limitations with regards to the amount of compound available, it has not 
been possible to test any of the inhibitors in Table 6.4 in planta. 
6.7 Conclusions 
Although it has not been possible to definitively identify the nature of the reaction 
products, AtCCD8 does appear to catalyse the selective cleavage of 9-cis-β-apo-10’-carotenal. 
AtCCD8.2 exhibits substrate inhibition at high concentrations, an effect not observed with any 
Chapter Six: CCD8 
Page | 164  
 
other member of the CCD enzyme family. Such an effect may make labelling experiments and 
the detection of products and intermediates difficult. The mechanism of CCD8 cleavage of 
9-cis-β-apo-10’-carotenal cleavage is still an issue of debate. However, AtCCD8 has been 
shown here to proceed through a two-step reaction, requiring acid-base catalysis and the 
participation of at least different active site residues; a histidine, aspartic acid or glutamic acid 
and a cysteine. Based on this data a possible mechanism for CCD8 has been proposed 
involving a redox active cysteine residue.  
Inhibition has been observed of the CCD8 reaction in the presence of the hydroxamic 
inhibitors. In planta, phenotypic effects on lateral shoot branching were observed with 
compounds D2, D4, D5 and D6. In vitro, 100% inhibition of CCD8 is observed against these 
inhibitors at 100 µM. Some inhibition is also seen at 10 µM. This data would suggests that the 
in planta phenotypic effects on lateral shoot branching are due to inhibition of CCD8. Other 
members of the hydroxamic acid inhibitor family have also been shown to inhibit AtCCD8 
and it has been shown that smaller compounds in general are more effective inhibitors of 
AtCCD8. This could imply that the AtCCD8 active site is quite small, which could have 
implications for the mechanism of CCD8 (Figure 6.23). 
 
Figure 6.23 – Summary of structure-activity relationship data observed for the hydroxamic acid 
inhibitors against AtCCD8.2. 
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6.8 Future Work 
As stated, the mechanism by which CCD8 produces carlactone is still a matter of some 
debate. In order to provide further insight it would be necessary to obtain a crystal structure 
of CCD8, ideally with a bound ligand, which would allow the identification of residues which 
are potentially involved in catalysis. A crystal structure would also help to validate results 
obtained from incubations with group specific reagents. It would also be necessary to identify 
intermediates by mass spectrometry in order to elucidate the CCD8 mechanism. This can be 
performed via rapid quench experiments. If CCD8 does proceed through a radical mechanism 
involving a redox active cysteine, then it may be possible to inhibit the CCD8 reaction via 
incubation with a radical, such as (2,2,6,6-Tetramethyl-piperidin-1-yl)oxyl (TEMPO). Radical 
traps could also be used to probe the mechanism of CCD8.  
 Further work could also be performed with regards to developing a selective inhibitor 
of shoot branching. The compounds D2, D4, D5 and D6 are active in vitro and in planta, but 
have cross reactivity to other members of the CCD enzyme family. Ideally it would be 
advantageous to have an inhibitor which is selective solely for the CCD8 enzyme family. It 
would also be of interest to test further hydroxamic acid inhibitors in planta to investigate 
whether they exhibit either the shoot branching phenotype or lateral root branching phenotype. 
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Chapter Seven: Conclusions and Future Work 
7.1 Conclusions 
 A summary of results is presented in Table 7.1. In their 2009 paper, Sergeant et al. 
reported phenotypic effects on shoot branching upon the application of certain hydroxamic 
acid inhibitors to Arabidopsis thaliana (Sergeant et al. 2009). One such phenotypic effect 
observed was an effect on seed germination, whereby in the presence of the hydroxamic acids 
D2 and D4 in A. thaliana there was a decrease in the time taken for seeds to germinate. This 
effect was believed to be mediated through the inhibition of the enzyme NCED, which is 
involved in the biosynthesis of the plant hormone abscisic acid, which is a promoter of 
Enzyme Conclusions 
Most effective 
inhibitors 
LeCCD1 
CCD1 can be purified by removal of the active site iron. 
Structure-activity analysis has identified key features of 
hydroxamic acid inhibitors required for inhibition. 
D1 (IC50 = 0.9 µM) 
D2 (IC50 = 0.8 µM) 
D3 (IC50 = 0.8 µM) 
LeNCED1 
Tomato NCED1 is inhibited weakly by the hydroxamic 
acids. Structure-activity analysis has identified key 
features of hydroxamic acid inhibitors required for 
inhibition. 
D30 (42% at 100 µM) 
D8 (40% at 100 µM) 
D4 (33% at 100 µM) 
ZmNCED1, 
2, 3A, 3B & 
9 
There is no significant difference between the levels of 
inhibition observed by the Z. mays NCED homologs 
verses hydroxamic acids inhibitors, hence it is not 
possible to identify which homolog is the cause of the 
seed germination phenotype. ZmNCED1 exhibits a time 
dependent inhibition effect towards the hydroxamic 
acids however.  
100% inhibition of 
ZmNCED1 vs. D2 and 
D4 at 100 µM with pre-
incubation 
AtABA2 
ABA2 was cloned and expressed in vitro. However, it 
was not possible to develop a high throughput coupled 
NCED1-ABA2 assay for the screening of inhibitors.  
N/A 
AtCCD7 
CCD7 is not inhibited by the hydroxamic acid 
compounds in vitro and hence is not the cause of the 
shoot branching phenotype observed in planta. 
No inhibition observed 
OsD27 
D27 appears to be a [2Fe2S] protein which isomerises 
β-carotene through a radical mediated mechanism. D27 
shows weak inhibition against the hydroxamic acids and 
hence is not the cause of the shoot branching phenotype 
seen in planta. 
D30 (41% at 100 µM) 
D12H (40% at 100 µM) 
B2 (40% at 100 µM) 
AtCCD8 
AtCCD8 is inhibited by hydroxamic acids at 
concentrations as low as 10 µM and is inhibited by the 
compounds D2, D4, D5 and D6, which exhibit a 
phenotypic effect on seed germination in planta, 
indicating that inhibition of CCD8 is the biochemical 
basis of this phenotype. CCD8 catalyses a two step 
reaction involving acid base catalysis and a possible 
redox active cysteine. 
D13H (82% at 10 µM) 
D15 (71% at 10 µM) 
D12 (56% at 10 µM) 
Table 7.1 – Summary of results. 
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secondary seed dormancy. Despite in vitro data not initially indicating that the target of D2 
and D4 was NCED, through the data illustrated here it can in fact be concluded that it is likely 
that the biochemical basis of the seed germination phenotype is indeed due to inhibition of 
NCED (Figure 7.1). In vitro it was observed that NCED exhibits a time dependent inhibitory 
effect with the hydroxamic acids, whereby pre-incubation of the hydroxamic acid with the 
enzyme is required for inhibition. This is likely to mimic the effect in planta and could well 
be due to oxidation of the active site iron. 
 Attempts were made to develop a high throughout screen for the identification of new 
inhibitors of NCED. To this end, the enzyme following NCED on the abscisic acid 
biosynthesis pathway, ABA2, was cloned and expressed in vitro. It was hoped that since 
ABA2 is an NAD dependent enzyme, the absorbance change at 340 nm could be observed 
 
Figure 7.1 – Schematic of the effects mediated by abscisic acid (A) and strigolactone (B) and the 
points of intervention by the hydroxamic acids. 
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when ABA2 was coupled to NCED. Unfortunately, an unacceptably high background reaction 
of unknown origin prevented development of a coupled high throughput screen.  
 It was also reported by Sergeant et al. that the hydroxamic acids D2, D4, D5 and D6 
had an effect on lateral shoot branching in planta, although the biochemical basis for this 
phenotype was unknown (Sergeant et al. 2009). In order to investigate this the first three 
enzymes on the strigolactone biosynthesis pathway, D27, CCD7 and CCD8, were expressed 
and assayed in vitro. It was observed that there was no inhibition of CCD7 in vitro by the 
hydroxamic acids (Figure 7.1). Some very low level inhibition of D27 was observed for a 
handful of compounds but CCD8 showed 100% inhibition at 100 µM in the presence of 
several of the hydroxamic acids. Additionally, CCD8 was inhibited in vitro by the compounds 
D2, D4, D5 and D6 which showed a phenotype in planta. Some compounds showed inhibition 
in vitro, but did not show an effect in planta (D1, D3 and D7). This is likely to be due to issues 
associated with uptake of molecules into the plant, transport within the plant and metabolism 
of the inhibitors within the plant. Hence it can be concluded that the biochemical basis of the 
shoot branching phenotype is due primarily to inhibition of CCD8. Compound D15 showed 
71% inhibition of AtCCD8 at 10 µM in vitro and has also been shown to exhibit a phenotypic 
effect of lateral root branching in A. thaliana. It is possible that CCD8 is involved in the 
biosynthesis of a signalling molecule which controls this process.  
It is possible, both in the case of the shoot branching phenotype and the seed 
germination phenotype, that the hydroxamic acids are inhibiting other enzymes. However, 
with regards to the non-CCD enzymes investigated during this project, ABA2 and D27, little 
to no inhibition was seen in the presence of the hydroxamic acid inhibitors.  
A library of hydroxamic acid inhibitors was screened against the CCD enzymes 
CCD1, NCED1, CCD7 and CCD8 and it was possible to identify the key features of the 
hydroxamic acids required for the inhibition of these enzymes. CCD1 showed the highest 
levels of inhibition and it is interesting to note that CCD1 shows the highest substrate 
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promiscuity out of all the CCD enzymes. If it has a larger active site that may explain why it 
is most amenable to inhibition by the hydroxamic acids. Time dependent inhibition has been 
observed with regards to the hydroxamic acids towards two members of the CCD enzyme 
family: CCD8 and NCED. This effect may be due to oxidation of iron (II) in the enzyme to 
iron (III), which binds hydroxamic acids more strongly. This effect has also been seen with 
p-hydroxy-phenylpyruvate dioxygenase from A. thaliana (Sergeant et al. 2013).  
 Several observations have also been made with regards to the mechanism of CCD 
enzymes, in particular CCD8. Anecdotally, with the CCD7 cleavage it appears that a degree 
of isomerisation occurs during the cleavage reaction, with a number of other smaller peaks 
evident following separation of the products by HPLC, although these peaks could not be 
definitely identified as isomers of the CCD7 cleavage product. In this regard CCD7 is quite 
similar to the CCD enzyme NinaB (Oberhauser et al. 2008), which also catalyses an 
isomerisation of retinal during the cleavage of β-carotene. With regards to the CCD8 cleavage 
mechanism, although it has not been possible to definitively prove the mechanism of 
carlactone formation, it has been observed that the CCD8 mechanism does utilise acid-base 
catalysis in some form. Moreover, stopped flow analysis has shown that CCD8 uses a two-
step mechanism and at least three different active site residues are required for catalysis. Using 
the data obtained a possible mechanism for CCD8 has been postulated involving a redox active 
cysteine. 
 The enzyme D27 was identified as a β-carotene isomerase by Alder and co-workers 
(Alder et al. 2012), but since its discovery there have been no biochemical investigations of 
the enzyme. Based on observations made here we hypothesise that D27 is an iron-sulfur 
protein, which isomerises all-trans-β-carotene to 9-cis-β-carotene through one electron 
transfer either to or from the β-carotene substrate. D27 also appears to exhibit product 
inhibition, which suggest that in planta, D27 is closely associated with the second enzyme on 
the strigolactone biosynthesis pathway, CCD7. 
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7.2 Future Work 
Based on the structure activity relationships obtained, it would be of interest to 
develop a selective inhibitor for each member of the CCD enzyme family. This would be of 
use in an agrochemical setting as ideally only one enzyme would be inhibited in obtaining a 
given phenotype. It may also be of interest to explore the other enzymes on the abscisic acid 
and strigolactone biosynthesis pathways to determine if they are effected by the hydroxamic 
acid inhibitors, or whether other CCD family members such as CCD4 are inhibited. The 
hydroxamic acid inhibitors developed could also be used to explore the roles of CCDs in other 
organisms in a chemical genetics approach. Applying an inhibitor and observing whether 
phenotype is present could help to identify functions of carotenoid derived molecules.  
Despite the progress made here, there is much work to be done to enable a detailed 
understanding of the biochemistry of the CCD enzyme family. An important step could be 
obtaining a crystal structure of a CCD enzyme with either bound substrate or inhibitor. This 
would be especially useful with regards to elucidation of the CCD8 mechanism. Further work 
to understand the mechanism CCD8 should focus around rapid quench experiments and 
determining the nature of intermediates produced. Finally, more work is required to fully 
understand the mechanism by which D27 works. Experiments such as cyclic voltammetry 
should reveal whether a redox process is occurring during the mechanism whilst advanced 
spectroscopic methods such as electron paramagnetic resonance and Mossbauer spectroscopy 
could be used to determine the nature of the iron containing active site.  
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Chapter Eight: Experimental 
8.1 General Experimental Information 
 All reagents and solvents were, unless otherwise stated, used as received and 
purchased from VWR, Sigma-Aldrich UK, Fischer Scientific, MP Biomedical or Invitrogen. 
All procedures were conducted at room temperature (≈ 23° C) unless specifically stated, all 
biological procedures were conducted under sterile conditions and all solvents used for 
HPLC were of HPLC grade and degassed prior to use.  
 Arabidopsis thaliana CCD7 and CCD8, Solanum lycopersicum CCD1a and NCED1 
and Zea mays NCED1, NCED2, NCED3A, NCED3B and NCED9 were provided by 
Dr Andrew Thompson and Jake Chandler (Cranfield University). A summary of the 
enzymes and accession numbers is shown in Table 8.1.  
Authentic 9’-cis-neoxanthin was obtained by Syngenta from CaroteNature 
(Ostermundigen, Switzerland) and compounds D2, D4, abamine and abamineSG were 
Enzyme Working BL21 Construct Used Accession Number for Enzyme 
LeCCD1a 
pGEX-4T-1-LeCCD1a pRosetta 
BL21 
Q6E4P5 
LeNCED1 
pGEX-4T-1-LeNCED1 pRosetta 
BL21 
O24023  
ZmNCED1 pGEX-4T-1-ZmNCED1 BL21 O24592  
ZmNCED2 pGEX-4T-1-ZmNCED2 BL21 N/A 
ZmNCED3A pGEX-4T-1-ZmNCED3A BL21 N/A 
ZmNCED3B pGEX-4T-1-ZmNCED3B BL21 N/A 
ZmNCED9 pGEX-4T-1-ZmNCED9 BL21 N/A 
AtABA2 pET-200-AtABA2 BL21 Q9C826 
OsD27 pGEX-4T-1-OsD27.1 BL21 C7AU21 
AtCCD7 
pGEX-4T-1-AtCCD7.2 pRosetta 
pBB541 BL21 
Q7XJM2 
AtCCD8 pET-151-AtCCD8.3 pRosetta BL21 Q8VY26  
Table 8.1 – Working bacterial constructs for enzymes used. Accession numbers for ZmNCED2, 
3A, 3B and 9 are not applicable as sequences have not been uploaded to a database. 
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provided by David Brocklehurst (Syngenta, Jealott’s Hill). 
Hydroxamic acids were used from liquid stocks checked via mass spectrometry 
analysis for authenticity before use. Compounds were synthesised and screened against 
LeCCD1a and LeNCED1 by the following: compound A1 was synthesised and assayed by 
Jian-Jun Li. Compound B1 was synthesised and assayed by Christine Fox. Compound B2 
was synthesised and assayed by Peter Harrison. Compounds E1-4 were synthesised by 
Mohsina Khan and assayed by Peter Harrison. Compounds D1-D7 were synthesised and 
assayed by Jian-Jun Li. Compounds D8-D11 were synthesised and assayed by Christine 
Fox. Compounds D14-15 were synthesised and assayed by Peter Harrison. Compounds D16-
D17 were synthesised by Samuel Lowe and assayed by Peter Harrison. Compounds D12-
D13 were synthesised and assayed by Christine Fox. Compounds D12H and D13H were 
synthesised by Paul Sainsbury. Compounds D20-D21 were synthesised and assayed by Peter 
Harrison. Compounds D30-D32 were synthesised and assayed by Sarah Shepherd. 
Compounds H1-H4 were synthesised by Jian-Jun Li and assayed by Peter Harrison 
Compounds F1-F4 were synthesised and assayed by Nicola Brookbank. Compounds F5-F6 
were synthesised by Robert Jenkins and assayed by Peter Harrison. Compound F7-F8 were 
synthesised by Nathaniel Hsueh and assayed by Peter Harrison. 
8.2 Instruments and Equipment 
 Sterilisation of media and equipment for the growth of bacterial strains was 
performed in a Prioclave autoclave according to standard procedures.  
Centrifugation was performed in a Sorval Rc 6 Plus centrifuge with an SLA-3000 or 
SS-34 rotor (for large volumes), an Eppendorf 5810R or 5804R (for 15-50 mL volumes) and 
either a Thermo AccuSpin micro or an Eppendorf Centrifuge 5415R (for samples less than 
2 mL).  
PCR was performed using an Eppendorf Mastercycler Personal. Agarose gel 
electrophoresis was performed using a BioRad Mini-Sub Cell GT system and visualised at 
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260 nm using a UVP Ultraviolet (UV) transilluminator. Fermentas FastRuler low range 
ladder was used to estimate deoxyribonucleic acid (DNA) fragment sizes. 
Overnight cultures were grown in either an Innova 44 or an Innova 4300 shaker. The 
optical density (OD) at 600 nm was recorded with a BioMate3 ultraviolet-visible (UV-Vis) 
spectrometer. Cell lysis was performed with either a Sonics Vibra Cell sonicator at 50 Hz or 
a Constant Systems pneumatic cell disruptor at 20.1 kilo-pound per square inch (kpsi). A GE 
Healthcare AKTA design fast protein liquid chromatograph (FPLC) was used for FPLC 
purification equipped with a P-920 pump and UPC-900 UV monitor. Sodium-dodecyl-
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed using a BioRad 
Mini Protean II electrophoresis system and visualised using bromophenol blue G-250. 
Thermo Scientific PageRuler Plus prestained protein ladder was used for all SDS-PAGE 
gels (unless stated otherwise). 
High-performance liquid chromatography (HPLC) was performed with either an 
Agilent 1100 Series or 1200 Series liquid chromatograph (Agilent Technologies, Santa 
Clara, USA) equipped with a G1311A quaternary pump (both 1100 and 1200) and a 
G1315A photodiode array detector (1100) or a G1314B variable wavelength detector 
(1200). Liquid-chromatography mass spectrometry (LC-MS) was performed with an Agilent 
1200 HPLC system equipped with a G1315A photodiode array detector coupled to a Bruker 
HTC-Ultra electrospray ionisation (ESI) mass spectrometer. Data analysis was performed 
with either Bruker Data Analysis post-processing software or Agilent ChemStation 
(B.01.03). 
 Low resolution ESI was performed using an Agilent 6130B single Quad mass 
spectrometer. High resolution mass spectra were obtained via the departmental Mass 
Spectrometry Service using a Bruker MaXis mass spectrometer or Bruker MicroTOF mass 
spectrometer. 
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 Plate reader assays were performed with either a Tecan (Männedorf, Switzerland) 
GENios Microplate reader (Tecan) or a Tecan infinite 200Pro using Grenier or NUNC 
transparent polystyrene 96 well plates (for UV), PerkinElmer polystyrene white 96 well 
plates (for luminescence) and Grenier black polystyrol 96 well plates (for fluorescence). 
UV-Vis measurements were obtained using either a Varian Cary 1 or Varian Cary50 Bio 
UV-Vis spectrometer.  
8.3 General Buffers and Solutions 
 Buffers and procedures are adapted from Sambrook & Russell, 2001. 
8.3.1 Tris-Borate EDTA (TBE) Buffer 
 70 mM Tris-base, 90 mM boric acid, 8 mM ethylenediaminetetraacetic acid, pH 8.0. 
8.3.2 Luria Broth (LB) 
 1% yeast extract (w/v), 1% tryptone, (w/v), 1% sodium chloride (w/v). For LB agar: 
additional 2% agar (w/v). 
8.3.3 SDS-PAGE Loading Dye 
60 mM Tris-HCl, 10% glycerol (v/v), 2% sodium dodecyl sulfate (w/v), 0.1% 
bromophenol blue (w/v), 1% 2-mercaptoethanol (v/v). 
8.3.4 SDS-PAGE running buffer 
150 mM glycine, 20 mM tris base, 0.8% sodium dodecyl sulfate (w/v). 
8.3.5 SDS-PAGE Staining Solution 
50% distilled water (v/v), 40% methanol (v/v), 10% acetic acid (v/v), 1% Coomassie 
R250 (w/v). 
8.3.6 SDS-PAGE Destaining Solution 
 70% distilled water (v/v), 20% methanol (v/v), 10% acetic acid (v/v). 
8.3.7 Tris Buffer pH 8.8 
 1.5 M Tris-HCl, pH 8.8. 
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8.3.8 Tris Buffer pH 6.8 
 500 mM Tris-HCl, pH 6.8. 
8.3.9 Western Blotting Wet Transfer Buffer 
 25 mM Tris-HCl, 192 mM glycine, 20% methanol (v/v). 
8.3.10 PBST Buffer 
 PBS buffer plus 0.1% Tween-20 (v/v). 
8.3.11 Phosphate Buffered Saline (PBS) 
140 mM sodium chloride, 2.7 mM potassium chloride, 10 mM disodium hydrogen 
phosphate, 1.8 mM potassium dihydrogen phosphate, pH 7.3. 
8.3.12 GST Elution Buffer 
 50 mM Tris-HCl, 20 mM reduced glutathione, pH 8.0. 
8.3.13 N-His6 Wash Buffer 
 50 mM sodium hydrogen phosphate, 300 mM sodium chloride, 20 mM imidazole, 
pH 8.0. 
8.3.14 N-His6 Elution Buffer 
 50 mM sodium hydrogen phosphate, 300 mM sodium chloride, 250 mM imidazole, 
pH 8.0.  
8.3.15 MBP Lysis Buffer 
 PBS buffer plus 25 mM DTT, lysozyme (0.5 mg mL-1), pH 7.4. 
8.3.16 MBP Wash Buffer 
 20 mM Tris-HCl, 200 mM sodium chloride, 1 mM EDTA, 10 mM BME, pH 7.4. 
8.3.17 MBP Elution Buffer 
 20 mM Tris-HCl, 200 mM sodium chloride, 1 mM EDTA, 10 mM BME, 10 mM 
maltose hydrate, pH 7.4. 
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8.3.18 Bis-Tris Buffer 
 100 mM bis-tris, 10% glycerol (v/v), 0.05% Triton X-100 (v/v), pH 6.7. 
8.3.19 MOPS Buffer 
 20 mM MOPS, 80 mM sodium chloride, pH 7.5. 
8.3.20 Potassium Phosphate Buffer 
 100 mM potassium phosphate, pH 7.2 
8.3.21 NCED Assay Buffer 
 PBS buffer plus catalase (1 mg mL-1), 0.05% Triton X-100 (v/v), 20 mM iron 
(II) sulfate, 20 mM sodium ascorbate.  
8.3.22 CCD7 Assay Buffer 
 100 mM HEPES, 0.2 mM iron (II) sulfate, 1 mM tris(2-carboxyethyl)phosphine, 
catalase (1 mg mL-1), 0.05% Triton X-100 (v/v), pH 7.8. 
8.3.23 CCD8 Assay Buffer 
 100 mM HEPES, 1 mM tris(2-carboxyethyl)phosphine, pH 7.8. 
8.3.24 Stopped-Flow Assay Buffer 
 100 mM HEPES, pH 7.8. 
8.4 General Procedures 
8.4.1 Preparation of Chemically Competent E. coli BL21 and E. coli DH5α 
 The method used was adapted from the method of Inoue (Inoue et al. 1990). E. coli 
DH5α and BL21 were obtained either from Life Technologies or New England Biolabs and 
plated onto Luria Broth (LB) agar and grown overnight at 37º C, 180 rpm. A single colony 
was picked and used to inoculate 200 mL of LB media. E. coli was grown at 20º C until OD 
at 600 nm reached 0.6 AU. Cells were harvested at 4220 x g at 4º C for 20 minutes, then 
washed with ice cold 100 mM calcium chloride (2 x 10 mL) with gentle pipetting before 
being incubated on ice for 15 minutes. Cells were pelleted by centrifugation as above and 
resuspended in ice cold 100 mM calcium chloride (1 mL) and left on ice for 30 minutes. 
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Glycerol (50% v/v) was added to a final concentration of 15% (v/v) and cell aliquots 
(100 µL) were snap frozen in liquid nitrogen before being stored at -80º C. 
8.4.2 Transformation of Chemically Competent E. coli BL21 and E. coli DH5α 
 A single aliquot (100 µL) of chemically competent BL21 or DH5α cells was 
defrosted on ice. Plasmid DNA (3 µL, approximately 50–100 ng) was added and mixed by 
gentle pipetting. Cells were incubated on ice for 60 minutes before being heat shocked at 42º 
C for 40 seconds and immediately placed on ice before room temperature LB media was 
added (250 µL). Cells were incubated at 37º C, 180 rpm for 60 minutes and E. coli (2 x 150 
µL) was then plated onto LB agar containing appropriate antibiotic (see Table 8.2) before 
being incubated at overnight at 37º C. 
8.4.3 Overproduction of Proteins in E. coli BL21 
 LB media (10 mL) containing the appropriate antibiotic (see Table 8.2) was 
inoculated with a single colony of E. coli BL21 (containing desired plasmid(s)) and grown 
overnight at 37º C, 180 rpm. LB media (500 mL) containing appropriate antibiotics was 
inoculated with the overnight culture and grown at 37º C, 180 rpm until the OD at 600 nm 
reached 0.6 AU. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final 
concentration of 1 mM. Cultures were incubated overnight at 20º C, 180 rpm. Cells were 
harvested at 4220 x g at 4º C for 15 minutes and either frozen at -20º C or used as described 
in the following chapter.  
 
Antibiotic Final Concentration (µg mL-1) Plasmid(s) Used With 
Ampicillin 100 
pGEX-4T-1 
pET-151 
pMAL-c5e 
Chloramphenicol 35 
pRosetta 
pAC 
Kanamycin 35 
pET-200 
pUC-57-KAN 
Spectinomycin 100 pBB541 
Table 8.2 – Concentrations of antibiotics required for selection of plasmids. 
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8.4.4 Agarose Gel Electrophoresis 
 Agarose (1 g) was dissolved in TBE buffer (100 mL) via heating in a microwave for 
2 minutes. Upon cooling, GelRed (Cambridge Bioscience) (3 µL) was added and the molten 
agarose was added to an appropriate cast with comb. Gels were run at 100 V for 45 -
60 minutes. DNA was visualised at 260 nm. 
8.4.5 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
 Protein samples were analysed using either 8% or 15% SDS-PAGE gels unless 
otherwise stated. To protein samples (5 µL) was added water (15 µl) and SDS-PAGE 
loading dye (5 µL). Samples were boiled for 10 minutes at 100° C before centrifugation at 
20300 x g for 5 minutes. Gels were made using the recipe detailed in Table 8.3 and run at 
200 V for one hour at room temperature. Gels were stained for one hour using SDS-PAGE 
staining solution and destained for 30 minutes with SDS-PAGE destaining solution. 
8.4.6 PCR Screening of Transformants 
 To a single colony of transformed E. coli was added distilled sterile water (3 µL). 
PCR was performed according to the procedure detailed for the particular enzyme with 
appropriate primers. PCR product was analysed via agarose gel electrophoresis. PCR 
reactions consisted of water (39.1 μL), 10 X pfx buffer (Invitrogen) (5.0 μL), 50 mM 
magnesium sulfate (1.0 μL), 10 mM deoxynucleotide triphosphates (dNTPs) (1.5 μL), 10 
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8% 2.3 1.3 1.3 N/A 0.05 0.05 0.003 
15% 1.1 2.5 1.3 N/A 0.05 0.05 0.002 
Stacking 
Gel 
0.68 0.17 N/A 0.13 0.01 0.01 0.001 
Table 8.3 – Recipes for SDS-PAGE gels used.  
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μM forward primer (1.5 μL), 10 μM reverse primer (1.5 μL), pfx tag polymerase (1.0 μL) 
and E. coli colony solution (1.0 μL). 
8.5 Solanum lycopersicum CCD1a 
8.5.1 Preparation of Cell Free Extract and Purification of LeCCD1a 
 Cells were prepared as described in Section 8.4.3 using pGEX-4T-LeCCD1a 
pRosetta E. coli BL21 and were resuspended into PBS buffer (10 mL) with 10% glycerol 
(v/v), 0.05% Triton X-100 (v/v) and 1 mM 2-mercaptoethanol (BME). Lysozyme and 
dithiothreitol (DTT) were added to a final concentration of 25 µg mL-1 and 5 mM 
respectively. Resuspended cells were incubated at room temperature for 20 minutes before 
sonication at 50 Hz and cell disruption at 20.1 kpsi. DNAse I was added to a final 
concentration of 5 µg mL-1 and allowed to incubate at room temperature for 20 minutes. The 
cell free extract was centrifuged at 20300 x g at 4º C for 15 minutes and the supernatant was 
filtered through a 0.2 µm filter. For assays involving cell free extract, the cell free extract 
was used without any further purification. 
To the filtered cell free extract was added 1, 10 phenanthroline to a final 
concentration of 1 mM and the cell free extract was incubated on ice for 15 minutes. The 
solution was added to GST resin (2 mL, GE Life Science) prepared according to the 
manufacturer’s instructions. Cell free extract was passed through the column a total of three 
times before being washed with PBS buffer (25 mL) with 0.05% Triton X-100 (v/v), 10 % 
glycerol (v/v) and 1 mM BME. The apo-protein was eluted into GST elution buffer (10 mL) 
plus 10 % glycerol (v/v), 1 mM BME and 0.05% Triton X-100 (v/v). Apo-protein was then 
concentrated using a 50 kDa centrifugal filter unit before buffer exchange using a PD10 gel 
filtration column (GE Life Sciences) used according to the manufacturer’s instructions. Apo-
protein was eluted into PBS buffer (3.5 mL) plus 10% glycerol (v/v), 1 mM BME and 0.05% 
Triton X-100  (v/v) and concentrated further in a 10 kDa centrifugal filter. Analysis via 
SDS-PAGE was performed using an 8% gel. Apo-protein concentration was determined via 
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the method of Bradford (Bradford 1976). Apo-protein was aliquoted, snap frozen in liquid 
nitrogen and stored at -80º C. 
8.5.2 Assays of LeCCD1a 
 LeCCD1a assays were conducted in a total volume of 200 µL in a 96 well microtiter 
plate. The assay substrate solution was prepared by adding 2% (w/v) ethanolic all-trans-β-
apo-8’-carotenal (5 µL) to 4% (w/v) ethanolic β-octylglucoside (25 µL). The ethanol was 
removed under nitrogen to give an orange residue which was resuspended into PBS buffer 
(150 µL) plus 10% glycerol (v/v) and 10 mM sodium ascorbate. The substrate solution was 
then allowed to incubate at room temperature for 20 minutes. To the assay solution was 
added either cell free extract (50 µL) or purified enzyme (20 µL, ≈40 µg) and the reactions 
were monitored at 485 nm for 60 minutes at room temperature. 
 For assays involving purified apo-LeCCD1a, the apo-protein was allowed to defrost 
on ice before iron (II) sulfate and sodium ascorbate were added to a final concentration of 
1 mM. The protein sample was then allowed to incubate on ice for a further 10 minutes 
before being assayed. 
 Inhibitors were dissolved in either ethanol or dimethyl sulfoxide (DMSO) and a total 
of 2 µL of inhibitor stock was added to the assay to give a final concentration of between 
1 µM to 100 µM.  
8.6 Solanum lycopersicum and Zea mays NCEDs 
8.6.1 Preparation of E. coli BL21 Containing ZmNCEDs 
 E. coli containing the plasmids pGEX-4T-1-ZmNCED1, pGEX-4T-1-ZmNCED2, 
pGEX-4T-1-ZmNCED3A, pGEX-4T-1-ZmNCED3B and pGEX-4T-1-ZmNCED9 were 
obtained from Jake Chandler and Andrew Thompson (Cranfield University). Plasmids were 
extracted from 10 mL overnight cultures using a Thermo Scientific plasmid extraction kit 
according to the manufacturer’s instructions. ZmNCED plasmids were used to transform 
E. coli BL21 according to Section 8.4.2. 
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8.6.2 Preparation of Cell Free Extract and Purification of LeNCED1 and ZmNCEDs 
 Cells were prepared as described in Section 8.4.3 with the appropriate E. coli strain 
and were resuspended into PBS buffer (10 mL) with 10% glycerol (v/v), 0.05% Triton X-
100 (v/v) and 1 mM 2-mercaptoethanol (BME). Lysozyme and DTT were added to a final 
concentration of 25 µg mL-1 and 5 mM respectively. Resuspended cells were incubated at 
room temperature for 20 minutes before sonication at 50 Hz and cell disruption at 20.1 kpsi. 
DNAse I was added to a final concentration of 5 µg mL-1 and allowed to incubate at room 
temperature for 20 minutes. Cell free extract was centrifuged at 20300 x g at 4º C for 15 
minutes and the supernatant was filtered through a 0.2 µm filter. For assays involving cell 
free extract, the cell free extract was used without any further purification. 
 To the filtered cell free extract was then added 1, 10 phenanthroline to a final 
concentration of 1 mM and the cell free extract was incubated on ice for 15 minutes. The cell 
free extract solution was added to 2 mL of GST resin (GE Life Science) prepared according 
to the manufacturer’s instructions. Cell free extract was passed through the column a total of 
three times. The column was washed with PBS buffer (25 mL) with 0.05% Triton X-100 
(v/v), 10 % glycerol (v/v) and 1 mM BME before the protein was eluted into GST elution 
buffer (10 mL) plus 20 mM reduced glutathione, 10 % (v/v) glycerol (v/v), 1 mM BME and 
0.05% Triton X-100 (v/v). Protein was then concentrated using a 50 kDa centrifugal filter 
unit before buffer exchange using a PD10 gel filtration column (GE Life Sciences) 
according to the manufacturer’s instructions. Protein was eluted into PBS buffer (3.5 mL) 
plus 10% glycerol (v/v), 1 mM BME and 0.05% Triton X-100 (v/v) and concentrated further 
in a 10 kDa centrifugal filter. Protein concentration was determined via the method of 
Bradford (Bradford 1976) and protein was analysed via SDS-PAGE using an 8% gel. 
Protein was aliquoted, snap frozen in liquid nitrogen and stored at -80º C. 
8.6.3 Western Blot Analysis of GST-ZmNCED1 
 Following SDS-PAGE, wet transfer from the polyacrylamide gel to Hybond-P 
PVDF nitrocellulose membrane (prepared according to the manufacturer’s instructions (GE 
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Life Sciences)) was performed for one hour at 4º C at 100 V in wet transfer buffer. 
Following transfer, the membrane was blocked in PBST buffer plus 5% milk powder (w/v) 
for one hour at room temperature. The membrane was washed twice in PBST before 
incubation with PBST buffer with 0.02% anti-GST-HRP-conjugate antibody (v/v) for one 
hour at room temperature. The membrane was finally washed briefly with PBST. 
Chemiluminescence was performed using the Amersham ECL Prime Western blotting 
detection kit (GE Life Science) and visualised using a BioRad ChemiDoc system 
8.6.4 Purification of 9’-cis-Neoxanthin 
Fresh organic spinach (≈ 100 g, Tesco) was added to methanol (200 mL) with 
sodium bicarbonate (0.4 g) and butylated hydroxytoluene (0.04 g). Spinach was 
homogenised with a hand blender for five minutes and the resulting solution was filtered 
through a sieve (≈2 mm pore) to give a dark green solution, which was subsequently filtered 
under suction. The filtrate was partitioned between cold saturated sodium chloride (100 mL) 
and cold diethyl ether (200 mL). The ether layer was extracted and the organic layer was 
washed again with cold diethyl ether (200 mL). Combined ether extracts were washed with 
cold sodium chloride (100 mL) and concentrated under reduced pressure to give a dark 
green oil resin. Alumina (10 g) was activated by the addition of distilled water (1.0 mL) and 
petroleum ether (20 mL) and allowed to stir for 5 minutes at room temperature. Activated 
alumina was used to prepare a column and was subsequently washed with petroleum ether 
(50 mL). Resin was resuspended in diethyl ether (2 mL) and petroleum ether (10 mL) and 
applied to the column. The column was eluted with 1 : 1 petroleum ether : diethyl ether (100 
mL), diethyl ether (200 mL) and 5% ethanol in diethyl ether (100 mL) which finally eluted 
the 9’-cis-neoxanthin. Triton X-100 was added to a final concentration of 0.1% (v/v) and 
solvent was removed under reduced pressure to give a yellow solid which was resuspended 
in ethanol (1 mL) and stored in the dark at -20º C. Data: λMAX 416, 440 and 467 nm; HRMS 
(MicroTOF) 601.4251, calc. 601.4244 for C40H56O4. ɛ at 440 nm: 1.33 x 105 M-1 cm-1. 
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8.6.5 HPLC Assays of LeNCED1 and ZmNCEDs 
For assays involving purified apo-LeNCED, the apo-protein was allowed to defrost 
on ice before 1 mM iron (II) sulfate and 1 mM sodium ascorbate were added. The protein 
sample was then allowed to incubate on ice for a further 10 minutes before being assayed. 
For assays involving cell free extract, the cell free extract was pre-incubated with the 
addition of 1.3 mM iron (II) sulfate and 1.3 mM sodium ascorbate. The cell free extract was 
allowed to incubate on ice for 5 minutes before addition to the assay. 
 To NCED assay buffer (130 or 150 μL) was added fresh 9’-cis-neoxanthin extract 
(25 μL, ≈80 µM), cell lysate containing overexpressed NCED enzyme (50 μL) or purified 
LeNCED1 (20 μL, ≈50 µg). Samples were incubated in the dark at room temperature for 
15 minutes. Water (700 μL) was added and the products were extracted into ethyl acetate 
(3 × 700 μL). Ethyl acetate was filtered through cotton wool and removed under nitrogen. 
The residue was dissolved in methanol (300 μL) and 50 μL was injected into a Phenomenex 
HyperClone C18 reverse phase HPLC column (5µ BDS, 130Å, 250 x 4.6 mm) maintained at 
room temperature at a flow rate of 0.5 mL min-1. The column was eluted with 95:5 
acetonitrile : methanol, shifting to 85:10:5 acetonitrile : methanol : ethyl acetate over 20 
minutes. Over the next 5 minutes, the gradient was shifted back to 95:5 acetonitrile : 
methanol and held for a further 20 minutes. C25 product and unreacted 9’-cis-neoxanthin 
were observed at 440 nm. Retention times: 9’-cis-neoxanthin, 10.2 minutes; C25 product, 6.5 
minutes. 
Inhibitors were dissolved in either ethanol or DMSO and a total of 2 µL of inhibitor 
stock was added to the assay to give a final concentration of 100 µM. For time dependent 
inhibition assays, inhibitor was added to assay mix containing LeNCED enzyme for 10 
minutes before the addition of substrate. For other assays, enzyme was added to a mix of 
substrate and inhibitor and water was added to control assays in place of inhibitor. Inhibition 
was calculated from the product formation after 30 minutes, compared with a control assay 
with no inhibitor.  
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8.7 Arabidopsis thaliana ABA2 
8.7.1 Cloning of AtABA2 
 Arabidopsis thaliana ABA2 DNA (sequence optimised) was purchased from 
Genscript cloned into the pUC-57-AtABA2 plasmid. Primers for the AtABA2 gene were 
designed, incorporating a CACC overhang on the 5’ terminus for ligation into the D-TOPO 
pET-200 vector (Invitrogen). The AtABA2 gene was amplified by PCR from pUC57-
AtABA2 using the following primers: Forward 5’ CAC CAT GTC AAC GAA TAC CGA 
ATC CTCT 3’; Reverse 5’ TCA GCG AAA CAC TTT GAA CGA ATG 3’. PCR: 1 cycle of 
94° C for 120 seconds; 35° C cycles of 94° C for 30 seconds, 58° C for 30 seconds, 72° C 
for 60 seconds; 1 cycle of 72° C for 120 seconds. PCR reaction consisted of water (39.1 μL), 
10X pfx buffer (Invitrogen) (5.0 μL), 50 mM magnesium sulfate (1.0 μL), 10 mM dNTPs 
(1.5 μL), 10 μM forward primer (1.5 μL), 10 μM reverse primer (1.5 μL), platinum pfx tag 
polymerase (1.0 μL) and pUC57-AtABA2 (1.0 μL, 0.6 µg). PCR product was separated by 
agarose gel electrophoresis and visualised under UV-light at 260 nm. AtABA2 was excised 
and purified using the Fermentas DNA extraction kit according to the manufacturer’s 
instructions. 
 AtABA2 with CACC overhang was ligated into the D-TOPO pET-200 vector 
according to the manufacturer’s instructions. Plasmid was inserted into TOP10 E. coli 
(Invitrogen) according to the procedure in Section 8.4.2. Colonies were screened by 
sequencing and PCR using primers for AtABA2 gene amplification. Plasmid was extracted 
from an overnight culture (10 mL) using the Fermentas plasmid extraction kit according to 
the manufacturer’s instructions and stored at -20° C. 
pET-200 AtABA2 plasmid was used to transform BL21 E. coli according to the 
procedure detailed in Section 8.4.2. 
8.7.2 Expression and Purification of AtABA2 
 Cells were prepared as described in section 8.4.3 using pET-200-AtABA2 E. coli 
BL21 and were resuspended in N-His6 wash buffer (5 mL) with 25 µg µL-1 lysozyme and 
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100 mM PMSF. Cells were lysed by cell disruption at 20.1 kpsi. Cellular debris was pelleted 
by centrifugation at 20300 x g at 4º C for 15 minutes before the lysate was syringe filtered 
through a 0.2 µm filter. Nickel resin (1 mL, GE Life Science) was prepared according to the 
manufacturer’s instructions. Cell free extract containing overproduced N-His6-AtABA2 was 
loaded onto the nickel resin and allowed to incubate at 4º C for one hour. Resin was added to 
a column and washed with N-His6 wash buffer (20 mL). AtABA2 was eluted into N-His6 
elution buffer (5 mL) before buffer exchange into N-His6 wash buffer using a PD10 column 
(GE Life Science). AtABA2 was then further purified by FPLC. AtABA2 was loaded onto a 
GE Healthcare His tag column (1 mL) at a flow rate of 0.5 mL min-1. Column was washed 
with N-His6 wash buffer (20 mL) at a flow rate of 0.5 mL min-1. Finally, protein was eluted 
into N-His6 elution buffer (10 mL) at a flow rate of 1 mL min-1. Fractions were analysed by 
SDS-PAGE on a 15% gel and protein was concentrated in a 10 kDa centrifugal filter unit 
before buffer exchanged into 20 mM MOPS buffer. AtABA2 was aliquoted into 200 µL 
aliquots and stored at -80° C until required. Protein was quantified via the method described 
by Bradford (Bradford 1976). 
8.7.3 Assays of AtABA2 
 AtABA2 assays were monitored continuously via UV at 340 nm. Assays were 
conducted in a total volume of 1000 µL in potassium phosphate buffer with 100 µM 
nicotinamide adenine dinucleotide (NAD+) and 30 µg mL-1 AtABA2. In the absence of 
authentic xanthoxin substrate, 3,3,5-trimethylcyclohexanol was used at a final concentration 
of 100 µM. 
 Control assays for ABA2 using fluorescence were conducted in a total volume of 
200 µL potassium phosphate buffer using a microtiter plate reader using the same 
concentration of reagents as for UV assays. Samples were excited at 340 nm and the 
emission at 440 nm was observed. 
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8.7.4 Coupled Assays of AtABA2 and NCEDs 
 Coupled assays were conducted in a total volume of either 1000 µL or 200 µL in 
potassium phosphate buffer with 100 mM NAD+, 30 µg mL-1 ABA2, 20-50 µL of cell free 
extract containing overproduced NCED or 20 µL of purified NCED (≈40 µg) and 40 µM 9’-
cis-neoxanthin. Reactions were monitored continuously at 340 nm.  
 Coupled assays using luminescence were conducted using the Promega NAD(P)H 
Glo kit in a 100 µL total volume in a microtiter plate and were monitored using a microtiter 
plate reader. 50 µL of a normal coupled assay mix following the reaction was added to 
50 µL of luminescent reagent and the assay was conducted according to the manufacturer’s 
instructions.  
8.8 Oryza Sativa D27 
8.8.1 Cloning of OsD27.1 and OsD27.2 into pET-151 
 Oryza sativa OsD27.1 (full length sequence, sequence optimised) was purchased 
from Genscript cloned into the pUC-57-KAN-OsD27 plasmid. Primers for the full length 
OsD27 gene (OsD27.1) and truncated peptide lacking the first 120 base pairs corresponding 
to a transit peptide (OsD27.2) were designed, incorporating a CACC overhang on the 5’ 
terminus for ligation into the D-TOPO pET-151 vector (Invitrogen) (Table 8.4). The OsD27 
Construct Primer Sequence (5’-3’)  
pET-151-OsD27.1 
F CAC CAT GGA AAC GAC GAC CCT GGT TC 
R TCA AAT GCT ACA GTT CAC GCC ATG 
pET-151-OsD27.2 
F CAC CGC AGT GAT GGC ACG CCC G 
R TCA AAT GCT ACA GTT CAC GCC 
pMAL-c5e-
OsD27.1 
F GAT  ATC ATG GAA ACG ACG ACC C 
R GGA TCC TCA AAT GCT ACA GTT C 
pGEX-4T-1-
OsD27.1 
F ATC AGT GGA TCC ATG GAA ACG ACG ACC CTG GTT C 
R TAG ACT GAA TTC TCA AAT GCT ACA GTT CAC GCC ATG 
Table 8.4 – Primer sequences used for cloning of OsD27 into pET-151, pMAL-c5e and pGEX-
4T-1 vectors.  
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gene was amplified by PCR from pUC-57-KAN-OsD27 using the primers shown in Table 
8.4. PCR: 1 cycle of 94° C for 120 seconds; 35° C cycles of 94° C for 30 seconds, 58° C for 
30 seconds, 72° C for 60 seconds; 1 cycle of 72° C for 120 seconds. PCR reaction consisted 
of water (39.1 μL), 10X pfx buffer (Invitrogen) (5.0 μL), 50 mM magnesium sulfate (1.0 
μL), 10 mM dNTPs (1.5 μL), 10 μM forward primer (1.5 μL), 10 μM reverse primer (1.5 
μL), platinum pfx tag polymerase (1.0 μL) and pUC-57-KAN-OsD27 (1.0 μL, 0.6 µg). PCR 
products were separated by agarose gel electrophoresis and visualised under UV-light at 260 
nm. OsD27 was excised and purified using the Fermentas DNA extraction kit according to 
the manufacturer’s instructions. 
OsD27 with GACC overhang was ligated into the D-TOPO pET-151 vector 
(Invitrogen) according to the manufacturer’s instructions. Plasmid was inserted into 
chemically competent TOP10 E. coli (Invitrogen) according to the procedure in Section 
8.4.2. Colonies were screened by sequencing and PCR using primers for pET-151-OsD27 
gene amplification (Table 8.4). Plasmid was extracted from an overnight culture (10 mL) 
using the Fermentas plasmid extraction kit according to the manufacturer’s instructions and 
the plasmid was stored at -20° C. 
pET-151-OsD27 plasmid was used to transform pRoestta pBB541 BL21 E. coli 
according to the procedure detailed in Section 8.4.2. 
8.8.2 Cloning of OsD27.1 into pMAL-c5e and pGEX-4T-1 Vector 
 Oryza sativa OsD27.1 (full length sequence, sequence optimised) was purchased 
from Genscript cloned into the pUC-57-KAN-OsD27 plasmid. The OsD27 gene was 
amplified by PCR from pUC-57-KAN-OsD27 using the primers shown in Table 8.4. PCR: 1 
cycle of 94° C for 300 seconds; 35° C cycles of 94° C for 30 seconds, 55° C for 30 seconds, 
72° C for 60 seconds; 1 cycle of 72° C for 120 seconds. PCR reaction consisted of water 
(39.1 μL), 10X pfx buffer (Invitrogen) (5.0 μL), 50 mM magnesium sulfate (1.0 μL), 10 mM 
dNTPs (1.5 μL), 10 μM forward primer (1.5 μL), 10 μM reverse primer (1.5 μL), platinum 
pfx tag polymerase (1.0 μL) and pUC-57-KAN-OsD27 (1.0 μL, 0.6 µg). PCR product was 
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separated by agarose gel electrophoresis and visualised under UV-light at 260 nm. OsD27 
was excised and purified using the Fermentas DNA extraction kit according to the 
manufacturer’s instructions. 
 OsD27.1 PCR product (0.2 µg), pGEX-4T-1 (1 µg) (GE Life Sciences) and pMAL-
c5e vector (1 µg) (New England Biolabs) were digested with the BamHI and EcoRV (for 
pMAL) or BamHI and EcoRI (for pGEX) (Thermo Scientific FastDigest) restriction 
enzymes (1 µL each) in distilled water (to a total volume of 40 µL) and FastDigest green 
buffer (4 µL), incubated at 37° C for one hour. Digestion products were purified via agarose 
gel electrophoresis and extracted using the Fermentas DNA extraction kit according to the 
manufacturer’s instructions. 
 Digested PCR products and vector were ligated with T4 DNA ligase (Invitrogen). 
To vector (pGEX-4T-1 or pMAL-c5e) (20 ng) was added PCR product (100 ng), 10 X 
ligation buffer (Invitrogen, 2 µL), T4 ligase (1 µL) and water (to a total volume of 20 µL). 
The mixture was incubated at 4° C overnight. Ligation mixture (3 µL) was transformed into 
chemically competent E. coli DH5α according to the procedure detailed in section 8.4.2. 
Colonies were screened by sequencing and PCR. Plasmid was extracted from an overnight 
culture (10 mL) using the Fermentas plasmid extraction kit according to the manufacturer’s 
instructions and the plasmid was stored at -20° C. 
pMAL-c5e-OsD27.1 and pGEX-4T-1 plasmids were used to transform pRosetta 
pBB541 BL21 or BL21 E. coli according to the procedure detailed in Section 8.4.2.  
8.8.3 Preparation of Cell Free Extract and Purification of OsD27 from pET vector 
Cells were prepared as described in section 8.4.3 using pET-151-OsD27(.1 or .2) 
E. coli and were resuspended in N-His6 wash buffer (5 mL) with 0.05% Triton X-100 (v/v), 
5 mM DTT and 100 mM PMSF. Cells were lysed by cell disruption at 20.1 kpsi. DNAse I 
was added to a final concentration of 5 µg mL-1 and allowed to incubate at room temperature 
for 20 minutes. Cellular debris was pelleted by centrifugation at 20300 x g at 4º c for 15 
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minutes before the lysate was syringe filtered through a 0.2 µm filter. Cell free extract 
containing overproduced N-His6-OsD27 was loaded onto a HisTrap Gravitrap column (1 
mL, GE Life Science) for a total of three passages. The column was washed with N-His6 
wash buffer (20 mL). OsD27 was eluted into N-His6 elution buffer (5 mL). Protein was then 
concentrated using a 10 kDa centrifugal filter unit before buffer exchange using a PD10 gel 
filtration column (GE Life Sciences) used according to the manufacturer’s instructions. 
Protein was eluted into 100 mM bis-tris buffer pH 6.7 (3.5 mL) plus 10% glycerol (v/v) and 
concentrated further in a 10 kDa centrifugal filter. Protein concentration was determined via 
the method of Bradford (Bradford 1976) and protein was analysed via SDS-PAGE using a 
10% gel. Protein was aliquoted, snap frozen in liquid nitrogen and stored at -80º C. 
8.8.4 Preparation of Cell Free Extract and Purification of OsD27 from pMAL vector 
Cells were prepared as described in section 8.4.3 using pMAL-c5e-OSD27.1 E  coli 
and were resuspended MBP wash buffer (5 mL) with 0.05% Triton X-100 (v/v), 5 mM DTT 
and 100 mM PMSF. Cells were lysed by cell disruption at 20.1 kpsi. DNAse I was added to 
a final concentration of 5 µg mL-1 and allowed to incubate at room temperature for 20 
minutes. Cellular debris was pelleted by centrifugation at 20300 x g at 4º C for 15 minutes 
before the lysate was syringe filtered through a 0.2 µm filter. Cell free extract containing 
overproduced MBP-OsD27 was loaded onto amylose resin (2 mL, New England Biolabs, 
prepared according to the manufacturer’s instructions) and incubated at 4° C for two hours. 
Resin was washed with MBP wash buffer (20 mL) and OsD27 was eluted into MBP elution 
buffer (5 mL) before buffer exchange into N-His6 wash buffer. Protein was then 
concentrated using a 10 kDa centrifugal filter unit before buffer exchange using a PD10 gel 
filtration column (GE Life Sciences) used according to the manufacturer’s instructions. 
Protein was eluted into 100 mM bis-tris buffer pH 6.7 (3.5 mL) plus 10% glycerol (v/v) and 
concentrated further in a 10 kDa centrifugal filter. Protein concentration was determined via 
the method of Bradford (Bradford 1976) and analysed via SDS-PAGE using a 10% gel. 
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8.8.5 Preparation of Cell Free Extract and Purification of OsD27 from pGEX vector 
Cells were prepared as described in Section 8.4.3 with pGEX-4T-1-OsD27.1 and 
were resuspended into PBS buffer (10 mL) with 0.05% Triton X-100 (v/v), 1 mM PMSF and 
5 mM DTT. Resuspended cells were incubated at room temperature for 20 minutes before 
sonication at 50 Hz and cell disruption at 20.1 kpsi. DNAse I was added to a final 
concentration of 5 µg mL-1 and allowed to incubate at room temperature for 20 minutes. Cell 
free extract was centrifuged at 20300 x g at 4º C for 20 minutes and the supernatant was 
filtered through a 0.2 µm filter.  
 The cell free extract solution was added to a 2 mL GST-Gravitrap column (GE Life 
Science) prepared according to the manufacturer’s instructions. Cell free extract was passed 
through the column a total of three times. The column was washed with PBS buffer (25 mL) 
and eluted with GST elution buffer (10 mL) plus 20 mM reduced glutathione. Protein was 
then concentrated using a 10 kDa centrifugal filter unit before buffer exchange using a PD10 
gel filtration column (GE Life Sciences) used according to the manufacturer’s instructions. 
Protein was eluted into 100 mM bis-tris buffer pH 6.7 (3.5 mL) plus 10% glycerol (v/v) and 
concentrated further in a 10 kDa centrifugal filter. Protein concentration was determined via 
the method of Bradford (Bradford 1976) and protein was analysed via SDS-PAGE using an 
8% gel. Protein was aliquoted, snap frozen in liquid nitrogen and stored at -80º C. 
8.8.6 Western Blot Analysis of MBP-OsD27.1 and GST-OsD27.1 
 Following SDS-PAGE, wet transfer from the polyacrylamide gel to Hybond-P 
PVDF nitrocellulose membrane (prepared according to the manufacturer’s instructions (GE 
Life Sciences)) was performed for one hour at 4º C at 100 V in wet transfer buffer. 
Following transfer, the membrane was blocked in PBST buffer plus 5% milk powder (w/v) 
for one hour at room temperature. The membrane was washed twice in PBST before 
incubation with PBST buffer with 0.02% anti-GST-HRP-conjugate antibody (for GST-
OsD27.1, GE Life Sciences) or anti-MBP-HRP-conjugate antibody (for MBP-OsD27, New 
England Biolabs) (v/v) for one hour at room temperature. The membrane was finally washed 
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briefly with PBST. Chemiluminescence was performed using the Amersham ECL Prime 
Western blotting detection kit (GE Life Science) and visualised via autoradiography onto 
Amersham Hyperfilm ECL (GE Life Sciences) and developed with Carestream GBX 
developer and fixer solutions (Kodak) according to the manufacturer’s instructions. 
8.8.7 Isomerisation of β-carotene 
 To a solution of β-carotene (20 mg) dissolved in hexane (20 mL) was added 1 mL of 
iodine (10 mg) in hexane (10 mL) solution. The resulting iodine-β-carotene-hexane solution 
was exposed to UV light (210 nm) for 30 minutes at room temperature.  
9-cis-β-carotene (100 µL injection) was purified via HPLC using a Thermo 
Scientific Acclaim C30 reversed phase column (5 µm, 4.6 x 250 mm) maintained at 4° C at a 
flow rate of 1.0 mL min-1. Column was eluted with 75 : 25 methanol : acetonitrile, shifting to 
25 : 35 : 50 acetonitrile : methanol : tertbutylmethylether (TBME) over 20 minutes. Over the 
next 5 minutes, the gradient was held at 25 : 35 : 50 acetonitrile : methanol : TBME before 
returning to 75 : 25 methanol : acetonitrile for a final five minutes. 9-cis-β-carotene was 
observed at 475 nm. Data: λMAX 448, 474 nm. ɛ at 475 nm: 6.55 x 104 M-1 cm-1. Retention 
time of 9-cis-β-carotene: 24.5 minutes. 
8.8.8 In vitro Assays of OsD27 
 Assays were conducted in a total volume of 200 µL. D27 enzyme (10 µL, 40 µg) 
was preincubated with 1 µM iron (II) sulphate and 1 µm 2-mercaptoethanol for 10 minutes 
on ice prior to the addition of D27 assay buffer (to a total volume of 200 µL) and 9-cis or 
all-trans-β-carotene (20 µM in ethanol). Assays were incubated at 25° C with shaking at 180 
rpm in the dark for 20 minutes. Assays were stopped with the addition of 4:1:4 acetone : 
petroleum ether : diethyl ether (400 µL). The resulting solution was centrifuged at 4220 x g 
for five minutes. The epiphase was collected and removed in a desiccator under reduced 
pressure. The residue was resuspended in methanol (200 µL) and analysed by HPLC (using 
the method in Section 8.8.7). 
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Inhibitors were dissolved in either ethanol or DMSO and a total of 2 µL of inhibitor 
stock was added to the assay to give a final concentration of 100 µM. Inhibitor was added to 
assay mix containing enzyme for 10 minutes before the addition of substrate. Water was 
added to control assays in place of inhibitor. Inhibition was calculated from peak areas 
determined by integration of peaks after 5 minutes, compared with a control assay with no 
inhibitor. 
8.8.9 Mechanistic Assays of OsD27 
 Assays were conducted using the same conditions as described in Section 8.8.8. 
Hydrogen peroxide, 2-mercaptoethanol, sodium dithionite, sodium dithionite / pyridine, lead 
(II) acetate and silver (I) acetate were all used at a final concentration of 100 µM and assays 
performed as described in Section 8.8.8. 
pH rate profile experiments were performed using the same conditions as Section 
8.8.8 with the exception that D27 buffer was replaced. For pH 4.12, 4.65, 5.13, 5.61 and 
5.94 100 mM sodium acetate buffer was used, for pH 6.71 100 mM PBS buffer was used 
and for pH 7.70, 8.19, 8.62, 9.0, 9.62 and 10.3 100 mM tris-HCl was used.  
For oxygen dependence assays, assays were set up as described in Section 8.8.8 in a 
two valved vessel. The system was thoroughly degassed and flushed three times with 
nitrogen. Reactions were performed under an atmosphere of nitrogen. 
UV assays were performed in a total volume of 50 µL in an Eppendorf UVette 
containing approximately 50 µg of protein in 100 mM bis-tris buffer plus 10% glycerol (v/v) 
and 0.1% Triton X-100 (v/v). Hydrogen peroxide, 2-mercaptoethanol, sodium dithionite, 
sodium dithionite / pyridine, lead (II) acetate and silver (I) acetate were all used at a final 
concentration of 100 µM. 
8.8.10 In vivo Assays of OsD27 
pGEX-4T-1-OsD27.1 and pET-151-OsD27.1 were used to transform competent 
pAC-BETA BL21 E. coli (Section 8.4.1 and 8.4.2). LB media (10 mL) containing 
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appropriate the antibiotic (see Table 8.2) was inoculated with a single colony of pGEX-4T-
1-OsD27.1 / pET-151-OsD27.1 pAC-BETA E. coli BL21 (containing desired plasmid(s)) 
and grown overnight at 37º C, 180 rpm. LB media (200 mL) containing appropriate 
antibiotics was inoculated with the overnight culture and grown at 37º C, 180 rpm until OD 
at 600 nm = 0.6 AU. IPTG was added to a final concentration of 1 mM. Cultures were 
incubated overnight at 20º C, 180 rpm, harvested at 4220 x g at 4º C for 15 minutes and then 
resuspended in water (5 mL). Lysozyme was added to give a final concentration of 25 µg 
mL-1. Following incubation at room temperature for 10 minutes, cells were lysed by 
sonication at 50 Hz. n-Butanol (1 mL) was added and the organic phase was collected 
following centrifugation at 4220 x g at 4º C for 10 minutes. The butanol was added to a 100 
mg 1 mL Agilnet Bond Elut C18 solid phase extraction column and centrifuged at 2000 x g at 
4º C for 2 minutes. The column was washed with 10 x 1 mL water before the β-carotene was 
eluted into TBME (1 mL). TBME was removed under reduced pressure and the residue 
resuspended into 200 µL methanol. Samples were analysed via HPLC using a Thermo 
Scientific Acclaim C30 reversed phase column using the same method described in Section 
8.8.7. 
For inhibition assays, D4 was added upon induction with IPTG and inhibitor was 
added to a final concentration of 100 µM. 
8.8.11 Coupled OsD27 / AtCCD7 Assays 
Assays were conducted in a total volume of 200 µL. OsD27.1 enzyme was pre-
incubated with 1 µM iron (II) sulphate and 1 µm 2-mercaptoethanol for 10 minutes on ice. 
OsD27.1 (10 µL, 40 µg) was then added to all-trans-β-carotene (20 µM in ethanol) and 
AtCCD7.2 (10 µL, 30 µg) Assays were incubated at 25° C with shaking at 180 rpm in the 
dark for 20 minutes. Assays were stopped with the addition of 4:1:4 acetone : petroleum 
ether : diethyl ether (400 µL). The resulting solution was centrifuged at 4220 x g for five 
minutes. The epiphase was collected and removed in a desiccator under reduced pressure. 
The residue was resuspended in methanol (200 µL) and analysed by HPLC (Section 8.8.7). 
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Inhibitors (in DMSO or ethanol) were added to a final concentration of 100 µM and pre-
incubated with OsD27.1 and AtCCD7.2 before the addition of all-trans-β-carotene. 
8.9 Arabidopsis thaliana CCD7 
8.9.1 Preparation of E. coli BL21 Containing pBB541 and pGEX-4T-1-AtCCD7 Plasmids 
 Chemically competent pRosetta E. coli BL21 was purchased from Millipore. The 
pBB541 plasmid (Addgene) was transformed into chemically competent pRosetta BL21 via 
the method in Section 8.4.2. Chemically competent pBB541 pRosetta E. coli BL21 was 
prepared from the transformants using the method in Section 8.4.2 and the pGEX-4T-1-
AtCCD7.1 / pGEX-4T-1-AtCCD7.2 plasmids were transformed into the chemically 
competent pBB541 pRosetta E. coli BL21 using the method in Section 8.4.2.  
8.9.2 Preparation of Cell Free Extract and Purification of AtCCD7.1/.2 
Cells were prepared as described in Section 8.4.3 with the appropriate E. coli strain 
and were resuspended into PBS buffer (10 mL) with 0.05% Triton X-100 (v/v), 1 mM PMSF 
and 5 mM DTT. Resuspended cells were incubated at room temperature for 20 minutes 
before sonication at 50 Hz and cell disruption at 20.1 kpsi. DNAse I was added to a final 
concentration of 5 µg mL-1 and allowed to incubate at room temperature for 20 minutes. Cell 
free extract was centrifuged at 20300 x g at 4º C for 20 minutes and the supernatant was 
filtered through a 0.2 µm filter.  
 The cell free extract solution was added to a 2 mL GST-Gravitrap column (GE Life 
Science) prepared according to the manufacturer’s instructions. Cell free extract was passed 
through the column a total of three times. The column was washed with PBS buffer (25 mL) 
and eluted into GST elution buffer (10 mL) plus 20 mM reduced glutathione. Protein was 
then concentrated using a 10 kDa centrifugal filter unit before buffer exchange using a PD10 
gel filtration column (GE Life Sciences) used according to the manufacturer’s instructions. 
Protein was eluted into 100 mM bis-tris buffer pH 6.7 (3.5 mL) plus 10% glycerol (v/v) and 
concentrated further in a 10 kDa centrifugal filter. Protein concentration was determined via 
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the method of Bradford (Bradford 1976) and protein was analysed via SDS-PAGE using an 
8% gel. Protein was aliquoted, snap frozen in liquid nitrogen and stored at -80º C. 
8.9.3 Western Blot Analysis of AtCCD7.2 
 Western blotting was performed as described in Section 8.8.6. 
8.9.4 Assays of AtCCD7.2 
 CCD7 enzyme (preincubated with 1 µM iron (II) sulphate and 1 µm sodium 
ascorbate for 10 minutes on ice) (10 µL, 30 µg) was added to 9-cis or all-trans-β-carotene 
(20 µM) with CCD7 assay buffer (to a total volume of 200 µL). Assay were incubated at 
25° C with shaking at 180 rpm in the dark for 20 minutes. Assays were stopped with the 
addition of 4 M pyridinium acetate or 4 M sodium chloride (200 µL) and ethyl acetate 
(200 µL). The resulting solution was centrifuged at 4220 x g for five minutes. The epiphase 
was collected and added to a 100 mg 1 mL C18 solid phase extraction column (Agilent Bond 
Elut) and centrifuged at 2000 x g.  Columns were washed with 10 x 1 mL of distilled water 
and the products eluted with TBME (600 µL). TBME was removed in a desiccator under 
reduced pressure. The residue was resuspended in methanol (200 µL) and analysed by 
HPLC (100 µL injection) using the method in Section 8.8.7. 9-cis-β-apo-10’-carotenal 
elution at 10.5 minutes. Data: λMAX 444 nm; HRMS (MicroTOF) 377.2839, calc. 377. 2840 
for C27H36O+H+. 
Inhibitors were dissolved in either ethanol or DMSO and a total of 2 µL of inhibitor 
stock was added to the assay to give a final concentration of 100 µM. Inhibitor was added to 
assay mix containing enzyme for 10 minutes before the addition of substrate. Water was 
added to control assays in place of inhibitor. Inhibition was calculated from peak areas 
determined by integration of peaks after 20 minutes, compared with a control assay with no 
inhibitor. 
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8.10 Arabidopsis thaliana CCD8 
8.10.1 Cloning of AtCCD8.2 into pET-151 
Full length AtCCD8 (CCD8.1) was obtained from Dr Andrew Thompson (Cranfield 
University). pGEX-4T-1-AtCCD8.1 was extracted from a 10 mL overnight culture of 
pGEX-4T-1-AtCCD8.1 DH5α E. coli using a Thermo Scientific plasmid extraction kit. 
Primers for the AtCCD8.2 gene were designed, incorporating a CACC overhang on the 5’ 
terminus for ligation into the D-TOPO pET-151 vector. The AtCCD8.2 gene was amplified 
by PCR from pGEX-4T-1-AtCCD8.1 using the following primers: Forward 5’ CAC CGC 
TGT AAT TAA TTC AGC GGC ACC 3’; Reverse 5’ TCA ATC TTT GGG GAT CCA 
GCA AC 3’. PCR: 1 cycle of 94° C for 120 seconds; 35° C cycles of 94° C for 30 seconds, 
58° C for 30 seconds, 72° C for 60 seconds; 1 cycle of 72° C for 120 seconds. PCR reaction 
consisted of water (39.1 μL), 10X pfx buffer (Invitrogen) (5.0 μL), 50 mM magnesium 
sulfate (1.0 μL), 10 mM dNTPs (1.5 μL), 10 μM forward primer (1.5 μL), 10 μM reverse 
primer (1.5 μL), platinum pfx tag polymerase (1.0 μL) and pUC57-AtABA2 (1.0 μL, 0.6 
µg). PCR product was separated by agarose gel electrophoresis and visualised under UV-
light at 260 nm. AtCCD8.2 was excised and purified using the Fermentas DNA extraction 
kit according to the manufacturer’s instructions. 
 AtCCD8.2 with CACC overhang was ligated into the D-TOPO pET-151 vector 
(Invitrogen) according to the manufacturer’s instructions. Plasmid was inserted into TOP10 
E. coli (Invitrogen) according to the procedure in Section 8.4.2. Colonies were screened by 
sequencing and PCR using primers for AtCCD8.2 gene amplification. Plasmid was extracted 
from an overnight culture (10 mL) using the Fermentas plasmid extraction kit according to 
the manufacturer’s instructions and the plasmid was stored at -20° C. 
8.10.2 Preparation of pET-151-AtCCD8.2 pRosetta E. coli BL21 
Chemically competent pRosetta E. coli BL21 was purchased from Millipore. pET-
151-AtCCD8.2 was extracted from a 10 mL overnight culture of pET-151-AtCCD8.2 DH5α 
E. coli using the Thermo Scientific plasmid extraction kit and the pET-151-AtCCD8.2 
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plasmid was used to transform chemically competent pRosetta E. coli BL21 using the 
method in Section 8.4.2. 
8.10.3 Preparation of pGEX-4T-1-AtCCD8.1 E. coli BL21 
Chemically competent E. coli BL21 was prepared according to the method in 
Section 8.4.1. The pGEX-AtCCD8.1 was extracted from a 10 mL overnight culture of 
pGEX-4T-1-AtCCD8.1 DH5α E. coli. The pGEX-4T-1-AtCCD8.1 plasmid was used to 
transform chemically competent BL21 via the method in Section 8.4.2. 
8.10.4 Preparation of pGEX-4T-1-AtCCD8.2 pRosetta pBB541 E. coli BL21 
Chemically competent pRosetta E. coli BL21 was purchased from Millipore. The 
pBB541 plasmid was used to transform chemically competent BL21 via the method in 
Section 8.4.2. Chemically competent pRosetta pBB541 E. coli BL21 was prepared from the 
transformants using the method in Section 8.4.2. pGEX-AtCCD8.2 was extracted from a 10 
mL overnight culture of pGEX-4T-1-AtCCD8.2 DH5α E. coli using the Thermo Scientific 
plasmid extraction kit and the pGEX-4T-1-AtCCD8.2 plasmid was used to transform the 
chemically competent E. coli BL21 pRosetta pBB541 using the method in Section 8.4.2. 
8.10.5 Preparation of Cell Free Extract and Purification of GST-AtCCD8.1/.2 from pGEX 
vector 
Cells were prepared as described in Section 8.4.3 with the appropriate E. coli strain 
and were resuspended into PBS buffer (10 mL) with 0.05% Triton X-100 (v/v), 1 mM PMSF 
and 5 mM DTT. Resuspended cells were incubated at room temperature for 20 minutes 
before sonication at 50 Hz and cell disruption at 20.1 kpsi. DNAse I was added to a final 
concentration of 5 µg mL-1 and allowed to incubate at room temperature for 20 minutes. Cell 
free extract was centrifuged at 20300 x g at 4º C for 20 minutes and the supernatant was 
filtered through a 0.2 µm filter.  
 The cell free extract solution was added to a 2 mL GST-Gravitrap column (GE Life 
Science) prepared according to the manufacturer’s instructions. Cell free extract was passed 
through the column for a total of three passages. The column was washed with PBS buffer 
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(25 mL) and eluted into GST elution buffer (10 mL) plus 20 mM reduced glutathione. 
Protein was then concentrated using a 10 kDa centrifugal filter unit before buffer exchange 
using a PD10 gel filtration column (GE Life Sciences) used according to the manufacturer’s 
instructions. Protein was eluted into 100 mM bis-tris buffer pH 6.7 (3.5 mL) plus 10% 
glycerol (v/v) and concentrated further in a 10 kDa centrifugal filter. Protein concentration 
was determined via the method of Bradford (Bradford 1976) and protein was analysed via 
SDS-PAGE using an 8% gel. Protein was aliquoted, snap frozen in liquid nitrogen and 
stored at -80º C. 
8.10.6 Preparation of Cell Free Extract and Purification of AtCCD8 from pET Vector 
Cells were prepared as described in section 8.4.3 using pET-151-AtCCD8.2 
pRosetta E. coli and was resuspended in N-His6 wash buffer (5 mL) with 0.05% Triton 
X-100 (v/v), 5 mM DTT and 100 mM PMSF. Cells were lysed by cell disruption at 20.1 
kpsi. DNAse I was added to a final concentration of 5 µg mL-1 and allowed to incubate at 
room temperature for 20 minutes. Cellular debris was pelleted by centrifugation at 20300 x g 
at 4 ºc for 15 minutes before the lysate was syringe filtered through a 0.2 µm filter.  
Cell free extract containing overproduced N-His6-OsD27 was loaded onto a HisTrap 
Gravitrap column (1 mL, GE Life Science) and passed through the column a total of three 
times. Column and washed with N-His6 wash buffer (20 mL). OsD27 was eluted into N-His6 
elution buffer (5 mL). Protein was then concentrated using a 10 kDa centrifugal filter unit 
before buffer exchange using a PD10 gel filtration column (GE Life Sciences) used 
according to the manufacturer’s instructions. Protein was eluted into 100 mM bis-tris buffer 
pH 6.7 (3.5 mL) plus 10% glycerol (v/v) and concentrated further in a 10 kDa centrifugal 
filter. Protein concentration was determined via the method of Bradford (Bradford 1976) and 
protein was analysed via SDS-PAGE using a 10% gel. Protein was aliquoted, snap frozen in 
liquid nitrogen and stored at -80º C. 
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8.10.7 Assays of AtCCD8 
The substrate for CCD8 assays, 9-cis-β-apo-10’-carotenal, were obtained from 
incubations of AtCCD7.2 with 9-cis-β-carotene via the same procedure as detailed in 
Section 8.8.4. 9-cis-β-apo-10’-carotenal was extracted from assays with 4 x 400 µL 4:1:4 
acetone : petroleum ether : diethyl ether. The extracts were pooled and reduced under 
pressure. The residue was resuspended in ethanol and used either without further purification 
or was purified via the method detailed in Section 8.8.7. If the internal standard β-carotene 
was required, β-carotene (in ethanol) was added to a final concentration of 5 µM. 
For HPLC assays, samples were performed in a total volume of 200 µL with CCD8 
assay buffer. AtCCD8 (10 µL, 30 µg) was preincubated with 1 µM sodium ascorbate and 
1 µM iron (II) sulphate for 10 minutes on ice before addition of 9-cis-β-apo-10’-carotenal 
(10 µL, 20 µM). Assays were incubated for 10 minutes in the dark at 25° C and were 
stopped with the addition of 4:1:4 acetone : petroleum ether : diethyl ether (400 µL). The 
resulting solution was centrifuged at 4220 x g for five minutes. The epiphase was collected 
and the solvent was removed in a desiccator under reduced pressure. The residue was 
resuspended in methanol (200 µL) and analysed by HPLC using the method in Section 8.8.7. 
HPLC separations using the method of Alder et al. 2012 were performed using a 
Thermo Scientific Acclaim C30 reversed phase column (5 µm, 4.6 x 250 mm) maintained at 
room temperature at a flow rate of 1.0 mL min-1. The column was eluted for 45 minutes 
shifting from 100% solvent system A, 0% solvent system B to 57% A, 43% B. Over the next 
minute, the gradient was shifted to 100% solvent system B and the gradient was maintained 
at 100% B for the next 34 minutes. Over the final 10 minutes the gradient was moved back 
to 100% A. Solvent system A: 30:10:1 methanol : water : TBME. Solvent system B: 1:1 
methanol : TBME. 
HPLC separations using the methanol/water gradient were performed a Phenomenex 
HyperClone C18 reverse phase HPLC column (5µ BDS, 130Å, 250 x 4.6 mm) maintained at 
room temperature at a flow rate of 0.5 mL min-1. Column was eluted with 90% water, 10% 
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methanol shifting to 100% methanol over 30 minutes and maintained at 100% methanol for 
a further 20 minutes before the gradient was returned to 90% water, 10% methanol. 
Inhibitors were dissolved in either ethanol or DMSO and incubated with enzyme at a 
final concentration of 100µM for one hour prior to addition of substrate. Inhibitor was also 
added to buffer such that upon addition of enzyme (containing inhibitor) to the assay mix 
(buffer and enzyme), the inhibitor was at a final concentration of 100 µM. Water was added 
to control assays in place of inhibitor. Inhibition was calculated from loss of 9-cis-β-apo-
10’-carotenal relative to a β-carotene internal standard (5 µM). 
For continuous UV assays reactions were performed in a 96 well microtitFre plate. 
Assays were performed in a total volume of 200 µL with CCD8 assay buffer. AtCCD8 was 
pre-incubated with 1 µM sodium ascorbate and 1 µM iron (II) sulphate for 10 minutes on ice 
9-cis-β-apo-10’-carotenal (10 µL, 20 µM) was added to CCD8 buffer for 10 minutes before 
AtCCD8 (10 µL, 30 µg) was added. Reactions were monitored at 430 nm for 20 minutes. 
Sodium borohydride reduction was performed by adding 5 mg of sodium 
borohydride to 100 µL 100 mM sodium hydroxide solution. 10 µL of this solution was 
added to 200 µL of organic extract from the CCD8 reaction. Analysis was performed by 
ESI-MS. 
8.10.8 Biochemical Characterisation of AtCCD8 
 Stopped flow experiments were performed at the University of Manchester Institute 
of Biotechnology using an Applied Photophysics SX.18MV stopped flow spectrometer with 
a 05169 pbp monochromator. 9-cis-β-apo-10’-carotenal substrate was prepared as described 
in Section 8.9.7, with the exception that prior to the removal of 4:1:4 acetone : petroleum 
ether : diethyl ether under vacuum, 0.04% (v/v) Triton X-100 was added and the residue was 
resuspended into water. Reactions were performed in a 1:1 molar ratio of 9-cis-β-apo-10’-
carotenal:AtCCD8.2 at a concentration of 12 µM in stopped flow assay buffer. For 
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determination of the kinetic parameters k1 and k2, the enzyme was diluted relative to the 
substrate. 
 pH rate profile experiments were performed using the continuous assay described in 
Section 8.9.7 with the exception that D27 buffer was replaced. For pH 4.12, 4.65, 5.13, 5.61 
and 5.94 100 mM sodium acetate buffer was used, for pH 6.71 100 mM PBS buffer was 
used and for pH 7.70, 8.19, 8.62, 9.0, 9.62 and 10.3 100 mM tris-HCl was used.  
 Assays with group specific reagents were performed using the continuous assay 
method described in Section 8.9.7. AtCCD8 was preincubated with group specific reagents 
(Chapter 6.4) at a final concentration of 1 mM and pre-incubated with the enzyme for 10 
minutes before the addition of substrate and monitoring at 430 nm. 
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Chapter Ten: Appendices 
10.1 Full CCD Sequence Alignment 
Full T-Coffee sequence alignment of selected members of the carotenoid cleavage 
dioxygenase enzyme family and other related proteins. Conserved histidine residues are 
marked in red, second shell glutamic acid residues in blue and conflicts in orange. Bt – Bos 
taurus; Hs – Homo sapiens; Zm - Zea mays; At – Arabidopsis thaliana; S. – Synechocystis 
sp.; Dm – Drosophilia melanogaster; Le – Solanum lycopersicum; Ps – Pisum sativum; Pa – 
Persea americana; Bo – Bixa orellana; Cs – Crocus sativum; Mt – Mycobacterium 
tuberculosis; Mm – Mus musculus; Na – Novosphingobium aromaticivorans; Pp – 
Pseudomonas paucimobilis; Gf - Gibberella fujikuroi. 
AN_Q28175|_BtRPE65    1 MSSQVEH--------------------------------------------------------    7  
AN_Q16518|_HsRPE65    1 MSIQVEH--------------------------------------------------------    7  
AN_Q9BYV7|_HsBCO2     1 MFFRVFL-HFI----------------------------------------------------   10  
AN_Q9HAY6|_HsBCO1     1 MDIIFG---------------------------------------------------------    6  
AN_O24592|_ZmNCED1    1 MQGLAPP-TSV----------------------------------------------------   10  
AN_Q45VT7|_ZmCCD1     1 MGTEAEQ-PDMD-----------------------------------S---------------   12  
AN_Q9M9F5|_AtNCED9    1 MTIITII-SGMYIYSLLSQDAHHSQYGQNTNLVLKKPIPKPQTAAFNQESTMASTTLLPSTST   62  
AN_Q9LRR7|_AtNCED3    1 MASFTAT-AAV-----------------------------------SG---------------   12  
AN_Q9C6Z1|_AtNCED5    1 MACSYILTPNP----------------------------------------------------   11  
AN_O49505|_AtNCED2    1 MVSLLTM-PMS----------------------------------------------------   10  
AN_Q9LRM7|_AtNCED6    1 MQHSLRS-DLLP----------------------------------TK---------------   13  
AN_O49675|_AtCCD4     1 MDSVSSS-SFLS-----------------------------------S---------------   12  
AN_O65572|_AtCCD1     1 MAEKLSD-G------------------------------------------------------    8  
AN_Q7XJM2|_AtCCD7     1 MSLPIPP-KFLP-----------------------------------P---------------   12  
AN_Q8VY26|_AtCCD8     1 MASLITT-KAM----------------------------------------------------   10  
AN_P74334|_S.ACO      1 MVTSPPT-SS-----------------------------------------------------    9  
AN_Q9NKW9|_DmNinaB    1 MAAGVFK-SFM----------------------------------------------------   10  
AN_Q6E4P5|_LeCCD1a    1 MGRKEDD-GV-----------------------------------------------------    9  
An_Q8LP16|_PsNCED2    1 MATFTAS-PSN----------------------------------------------------   10  
AN_Q8LP15|_PsNCED3    1 MAPSSLALNSN----------------------------------------------------   11  
AN_Q9AXZ3|_PaNCED1    1 MTTIRQK-PKT-----------------------------------F----------------   11  
AN_Q9AXZ4|_PaNCED3    1 MSMATPT-TTC-----------------------------------GA---------------   12  
AN_C5H805|_LeNCED2    1 ---------------------------------------------------------------    0  
AN_Q70YP8|_BoLCO      1 MQ-------------------------------------------------------------    2  
AN_Q84K96|_CsZCD      1 MQ-------------------------------------------------------------    2  
AN_Q8LP17|_PsCCD1     1 MGSEKKE-N------------------------------------------------------    8  
AN_O06785|_MtCCO      1 MTTAQAA-E------------------------------------------------------    8  
AN_Q99NF1|_MmBCO2     1 MLGPKQS--------------------------------------------------------    7  
AN_Q9JJS6|_MmBCO1     1 MEIIFG---------------------------------------------------------    6  
AN_Q2GA76|_NaCCO      1 MAQFPNT-P------------------------------------------------------    8  
AN_Q53353|_PpLSD      1 MAHFPQT-P------------------------------------------------------    8  
An_O24023|_LeNCED1    1 MATTTSH-ATN----------------------------------------------------   10  
AN_Q5GN50|_GfCarX     1 MKFLQQN-SFTQ-----------------------------------T---------------   12  
cons                  1                                                                   63  
 
AN_Q28175|_BtRPE65    8 ---------------------------------------------------------------    7  
AN_Q16518|_HsRPE65    8 ---------------------------------------------------------------    7  
AN_Q9BYV7|_HsBCO2    11 ---------------------------------------------------------------   10  
AN_Q9HAY6|_HsBCO1     7 ---------------------------------------------------------------    6  
AN_O24592|_ZmNCED1   11 -S-I--HR----HL-PAR----SR---ARASNS------VRFSP----------RAVSSVPPA   41  
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AN_Q45VT7|_ZmCCD1    13 ---------------------------------------------------------------   12  
AN_Q9M9F5|_AtNCED9   63 QF-L--DRTF--S---T----SSS--SSRPKLQSLSFSSTLRNKKLVVPCYVSSSVNKKSSVS  111  
AN_Q9LRR7|_AtNCED3   13 RW-L--GGNH--TQPPL----SSSQSSDLSYCS-----SLPMAS----------RVTRKLNVS   51  
AN_Q9C6Z1|_AtNCED5   12 TK-L--NL---------SFAPSDLD-APSPSSS-VS---FTNTK----------PRRRKLSAN   47  
AN_O49505|_AtNCED2   11 GG-I--KT--------------------WPQAQ-ID---LGFRP----------IKRQPKVIK   36  
AN_Q9LRM7|_AtNCED6   14 TS-P--RS-H--LL-PQ------------P-----------KNA----------NISRRILIN   36  
AN_O49675|_AtCCD4    13 TFSL--HH----S--------------------------LLRRRS---------SSPTLLRIN   34  
AN_O65572|_AtCCD1     9 ---------------------------------------------------------------    8  
AN_Q7XJM2|_AtCCD7    13 LKSPPIHHH------------------------------------------------------   21  
AN_Q8VY26|_AtCCD8    11 MS-H--HH----VL-S------ST----RIT--------TLYSD------------------N   29  
AN_P74334|_S.ACO     10 ----PS---------------------------------------------------------   11  
AN_Q9NKW9|_DmNinaB   11 ---------------------------------------------------------------   10  
AN_Q6E4P5|_LeCCD1a   10 ---------------------------------------------------------------    9  
An_Q8LP16|_PsNCED2   11 TW-I--NTKS--SS--------------RTNSS-----SILLNKK---------RSTSKNTIS   40  
AN_Q8LP15|_PsNCED3   12 TW-A--TTTNKPQF-PQSFSISSSS-STSFNDK-ST---LKLKK----------PNRKMLLLQ   55  
AN_Q9AXZ3|_PaNCED1   12 ---------------TI----H-----------------------------------------   14  
AN_Q9AXZ4|_PaNCED3   13 GDLL--QNPK--LL-PI----SKN--LSRPKNF-I---MLKHNTP----------LIQCCSHS   50  
AN_C5H805|_LeNCED2    1 ---------------------------------------------------------------    0  
AN_Q70YP8|_BoLCO      3 ---------------------------------------------------------------    2  
AN_Q84K96|_CsZCD      3 ---------------------------------------------------------------    2  
AN_Q8LP17|_PsCCD1     9 ---------------------------------------------------------------    8  
AN_O06785|_MtCCO      9 ---------------------------------------------------------------    8  
AN_Q99NF1|_MmBCO2     8 ---------------------------------------------------------------    7  
AN_Q9JJS6|_MmBCO1     7 ---------------------------------------------------------------    6  
AN_Q2GA76|_NaCCO      9 ---------------------------------------------------------------    8  
AN_Q53353|_PpLSD      9 ---------------------------------------------------------------    8  
An_O24023|_LeNCED1   11 TW-I--KTKL--SM-PS----SKE--FGFASNS-I---SLLKNQ----------HNRQSLNIN   47  
AN_Q5GN50|_GfCarX    13 SMSQPH--E------------------------------------------------------   19  
cons                 64                                                                  126  
 
AN_Q28175|_BtRPE65    8 ---------------------------------------------------------------    7  
AN_Q16518|_HsRPE65    8 ---------------------------------------------------------------    7  
AN_Q9BYV7|_HsBCO2    11 ---------------------------------------------------------------   10  
AN_Q9HAY6|_HsBCO1     7 ---------------------------------------------------------------    6  
AN_O24592|_ZmNCED1   42 ECL-QAPFHKPVADLPAPSRK---P----------AAIAVPGHAAAP---------RKAEGGK   81  
AN_Q45VT7|_ZmCCD1    13 ------------------------------H-RNDGVVVV------------------P---A   23  
AN_Q9M9F5|_AtNCED9  112 SSL-QS---------PTF--K---PPS-WKKLCNDVTNLIPK----------------TTNQN  142  
AN_Q9LRR7|_AtNCED3   52 SAL-HTP---PALHFPKQSSN---SP---------AIVVKPK---------------AKESNT   83  
AN_Q9C6Z1|_AtNCED5   48 SVS-DTP---NLLNFPNY--------------P--SPNPII-----------------PEKDT   73  
AN_O49505|_AtNCED2   37 CTV-QID----VTELTKK------RQL-FT--P--RTTATP-----------------PQHNP   66  
AN_Q9LRM7|_AtNCED6   37 P-F-------KIPTLPDLTS-----P---------VP--SP---------------VKLKPTY   60  
AN_O49675|_AtCCD4    35 SAVVEER---SPITNPSDNNDRRNKPKTLHN-RTNHTLVS------------------S---P   72  
AN_O65572|_AtCCD1     9 -----------------------------------SSIIS------------------V---H   15  
AN_Q7XJM2|_AtCCD7    22 ----QTP---PPLAPPRAAIS----------------ISIPD-----------------TGLG   44  
AN_Q8VY26|_AtCCD8    30 S------------------IG--------------DQQIK------------------T---K   39  
AN_P74334|_S.ACO     12 -----QR---SYS--------------------------------------------------   16  
AN_Q9NKW9|_DmNinaB   11 ---------------------------------------------------------------   10  
AN_Q6E4P5|_LeCCD1a   10 ------------------------------E-RIEGGVVV------------------V---N   20  
An_Q8LP16|_PsNCED2   41 CSL-QT-----TLPFPKKYQP-QSTNT-------TTTTLIPTRETKPNLPS---NTKPLHKQE   86  
AN_Q8LP15|_PsNCED3   56 CAV-HSP---SVLDYPKQSYK---QPL-INK-ENDTETIIH-----------------KPKES   92  
AN_Q9AXZ3|_PaNCED1   15 SSL-HSS---PVLHLPKLLTT-TTTPL-HEK-SQRELG-----------------LILQEPNR   53  
AN_Q9AXZ4|_PaNCED3   51 PSS-SSA---AVLHLPPKQPT-KSKPS-IKK-GEKSSTLTPSIEKNPGSHQVKTDQSGPNRVG  106  
AN_C5H805|_LeNCED2    1 ---------------------------------------------------------------    0  
AN_Q70YP8|_BoLCO      3 ---------------------------------------------------------------    2  
AN_Q84K96|_CsZCD      3 ---------------------------------------------------------------    2  
AN_Q8LP17|_PsCCD1     9 -----------------------------------GVILE------------------V---E   15  
AN_O06785|_MtCCO      9 ---------------------------------------------------------------    8  
AN_Q99NF1|_MmBCO2     8 ---------------------------------------------------------------    7  
AN_Q9JJS6|_MmBCO      7 ---------------------------------------------------------------    6  
AN_Q2GA76|_NaCCO      9 ---------------------------------------------------------------    8  
AN_Q53353|_PpLSD      9 ---------------------------------------------------------------    8  
An_O24023|_LeNCED1   48 SSL-QAP---PILHFPKQSSN-YQTPK-------NNTISHPKQENN----------NSSSSST   88  
AN_Q5GN50|_GfCarX    20 ----DVS---PAI--------------------------------------------------   25  
cons                127                                                                  189  
 
AN_Q28175|_BtRPE65    8 -----------------------------------------------------PA-GGYKKLF   16  
AN_Q16518|_HsRPE65    8 -----------------------------------------------------PA-GGYKKLF   16  
AN_Q9BYV7|_HsBCO2    11 ------RSHSATAVDFLPVMVH-RL--PVFKRYMG-NTPQKKAVFGQCR----GL-PCVAPLL   58  
AN_Q9HAY6|_HsBCO1     7 -------------------------------------------------------------R-    7  
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AN_O24592|_ZmNCED1   82 KQLNLFQRAAAAALDAFEEGFV-ANVLE------R-PHGLPS------TA--DPA-VQIAGNF  127  
AN_Q45VT7|_ZmCCD1    24 PR--PRKGLASWALDLLESLAV-RL--------------GHD------KT--KPL-HWLSGNF   60  
AN_Q9M9F5|_AtNCED9  143 PKLNPVQRTAAMVLDAVENAMI-SH--E------RRRHPHPK------TA--DPA-VQIAGNF  187  
AN_Q9LRR7|_AtNCED3   84 KQMNLFQRAAAAALDAAEGFLV-SH--E------K-LHPLPK------TA--DPS-VQIAGNF  127  
AN_Q9C6Z1|_AtNCED5   74 SRWNPLQRAASAALDFAETALL-RR--E------R-SKPLPK------TV--DPR-HQISGNY  117  
AN_O49505|_AtNCED2   67 LRLNIFQKAAAIAIDAAERALI-SH--E------Q-DSPLPK------TA--DPR-VQIAGNY  110  
AN_Q9LRM7|_AtNCED6   61 PNLNLLQKLAATMLDKIESSIVIPM--E------Q-NRPLPK------PT--DPA-VQLSGNF  105  
AN_O49675|_AtCCD4    73 PKLRPEMTLATALFTTVEDVIN-TF---------I-DPPSRP------SV--DPK-HVLSDNF  115  
AN_O65572|_AtCCD1    16 PR--PSKGFSSKLLDLLERLVV-KL--------------MHD------AS--LPL-HYLSGNF   52  
AN_Q7XJM2|_AtCCD7    45 RTGTILDESTSSA----------------------------------------FR-DYQSLFV   66  
AN_Q8VY26|_AtCCD8    40 P--QVPHRLFARRIFGVTRAVI-NS--A------A-PSPLPE------KEKVEGE-RRCHVAW   83  
AN_P74334|_S.ACO     17 -----------------------------------------------------PQ-DWLRGYQ   25  
AN_Q9NKW9|_DmNinaB   11 ------RDFFAVK-------------------------------YDEQRN--DPQAERLDGNG   34  
AN_Q6E4P5|_LeCCD1a   21 PK--PRRGITAKAIDLLEWGIV-KL--------------MHD------SS--KPL-HYLQGNF   57  
An_Q8LP16|_PsNCED2   87 QKWNLLQQAAATTLDFVETTLI-KQ--E------S-KHPLPK------TS--DPR-VQIAGNF  130  
AN_Q8LP15|_PsNCED3   93 SQWNPLQKAAAIALNMFESALL-SR--E------L-QYPLPK------TS--DPR-IQIAGNF  136  
AN_Q9AXZ3|_PaNCED1   54 AKWNFFQRAAAVALDTVEDSFI-SGVLE------R-RHPLPK------TS--DPA-VQISGNF   99  
AN_Q9AXZ4|_PaNCED3  107 PNWNIFQRTAAFALDAIEEKLI-ARVLE------R-RHPLPK------TA--DPE-VQIAGNF  152  
AN_C5H805|_LeNCED2    1 ---------------------------------------------------------------    0  
AN_Q70YP8|_BoLCO      3 ---------------------------------------------------------------    2  
AN_Q84K96|_CsZCD      3 ---------------------------------------------------------------    2  
AN_Q8LP17|_PsCCD1    16 PK--PSNGFTSKAVDLLEKIIV-KL--------------FYD------SS--LPH-HWLSGNF   52  
AN_O06785|_MtCCO      9 ------------------------------------------------SQ----N-PYLEGFL   18  
AN_Q99NF1|_MmBCO2     8 ------------------------------------------------------L-PCIAPLL   15  
AN_Q9JJS6|_MmBCO1     7 -------------------------------------------------------------Q-    7  
AN_Q2GA76|_NaCCO      9 ---------------------------------------------------------SFTGFN   14  
AN_Q53353|_PpLSD      9 ---------------------------------------------------------GFSGTL   14  
An_O24023|_LeNCED1   89 SKWNLVQKAAAMALDAVESALT-KH--E------L-EHPLPK------TA--DPR-VQISGNF  132  
AN_Q5GN50|_GfCarX    26 -----------------------------------------------------RH-PYLTGNF   34  
cons                190                                                                  252  
 
AN_Q28175|_BtRPE65   17 ------------E-TVE-ELS-SPLTAHVTGRIPLWLT-GSLLRCGPGLFEV-GS-EPFYHLF   61  
AN_Q16518|_HsRPE65   17 ------------E-TVE-ELS-SPLTAHVTGRIPLWLT-GSLLRCGPGLFEV-GS-EPFYHLF   61  
AN_Q9BYV7|_HsBCO2    59 ------------T-TVE-EAP-RGISARVWGHFPKWLN-GSLLRIGPGKFEF-GK-DKYNHWF  103  
AN_Q9HAY6|_HsBCO1     8 --------------NRK-EQL-EPVRAKVTGKIPAWLQ-GTLLRNGPGMHTV-GE-SRYNHWF   51  
AN_O24592|_ZmNCED1  128 ------------A-PVG-ERP-PVHELPVSGRIPPFID-GVYARNGANPCFD-P--VAGHHLF  171  
AN_Q45VT7|_ZmCCD1    61 ------------A-PVVEETP-PAPNLTVRGHLPECLN-GEFVRVGPNPKFA-P--VAGYHWF  105  
AN_Q9M9F5|_AtNCED9  188 ------------F-PVP-EKP-VVHNLPVTGTVPECIQ-GVYVRNGANPLHK-P--VSGHHLF  231  
AN_Q9LRR7|_AtNCED3  128 ------------A-PVN-EQP-VRRNLPVVGKLPDSIK-GVYVRNGANPLHE-P--VTGHHFF  171  
AN_Q9C6Z1|_AtNCED5  118 ------------A-PVP-EQS-VKSSLSVDGKIPDCID-GVYLRNGANPLFE-P--VSGHHLF  161  
AN_O49505|_AtNCED2  111 ------------S-PVP-ESS-VRRNLTVEGTIPDCID-GVYIRNGANPMFE-P--TAGHHLF  154  
AN_Q9LRM7|_AtNCED6  106 ------------A-PVN-ECP-VQNGLEVVGQIPSCLK-GVYIRNGANPMFP-P--LAGHHLF  149  
AN_O49675|_AtCCD4   116 ------------A-PVLDELP-PTDCEIIHGTLPLSLN-GAYIRNGPNPQFL-P--RGPYHLF  160  
AN_O65572|_AtCCD1    53 ------------A-PIRDETP-PVKDLPVHGFLPECLN-GEFVRVGPNPKFD-A--VAGYHWF   97  
AN_Q7XJM2|_AtCCD7    67 ------------S-QRS-ETIEPVVIKPIEGSIPVNFPSGTYYLAGPGLFTD-DH-GSTVHPL  113  
AN_Q8VY26|_AtCCD8    84 ------------T-SVQ-QEN-WEGELTVQGKIPTWLN-GTYLRNGPGLWNI-GD-HDFRHLF  128  
AN_P74334|_S.ACO     26 ------------S--QP-QEW-DYWVEDVEGSIPPDLQ-GTLYRNGPGLLEI-GD-RPLKHPF   69  
AN_Q9NKW9|_DmNinaB   35 RLYPNCSSDVWLRSCER-EIV-DPIEGHHSGHIPKWIC-GSLLRNGPGSWKV-GD-MTFGHLF   92  
AN_Q6E4P5|_LeCCD1a   58 ------------A-PTD-ETP-PLNDLVVQGHLPECLN-GEFVRVGPNPKFA-P--VAGYHWF  101  
An_Q8LP16|_PsNCED2  131 ------------A-PVP-EHP-VTQNLPITGKLPKGID-GVYLRNGANPLHE-P--VAGHHFF  174  
AN_Q8LP15|_PsNCED3  137 ------------A-PVP-EQP-VVHSLPVTGKIPRCVN-GVYVRNGANPMFE-P--VSGHHLF  180  
AN_Q9AXZ3|_PaNCED1  100 ------------A-PVD-EHP-VQHHLPVSGRIPRCLD-GVYLRNGANPLLE-P--VAGHHFF  143  
AN_Q9AXZ4|_PaNCED3  153 ------------A-PVA-EHP-VQHGIPVAGRIPRCLD-GVYVRNGANPLFE-P--IAGHHFF  196  
AN_C5H805|_LeNCED2    1 --------------------------------------------------------------F    1  
AN_Q70YP8|_BoLCO      3 ---------------------------------------------------------------    2  
AN_Q84K96|_CsZCD      3 ---------------------------------------------------------------    2  
AN_Q8LP17|_PsCCD1    53 ------------A-PVKDETP-PVKDLTVQGHLPDCLN-GEFVRVGPNPKFS-P--VAGYHWF   97  
AN_O06785|_MtCCO     19 ------------A-PVS-TEV-TATDLPVTGRIPEHLD-GRYLRNGPNPVAEVD--PATYHWF   63  
AN_Q99NF1|_MmBCO2    16 ------------T-TAE-ETL-SAVSARVRGHIPEWLN-GYLLRVGPGKFEF-GK-DRYNHWF   60  
AN_Q9JJS6|_MmBCO1     8 --------------NKK-EQL-EPVQAKVTGSIPAWLQ-GTLLRNGPGMHTV-GE-SKYNHWF   51  
AN_Q2GA76|_NaCCO     15 ------------T-PSR-IEA-DIADLAHEGTIPQGLN-GAFYRVQPDPQFP-PR-LDDDIAF   59  
AN_Q53353|_PpLSD     15 ------------R-PLR-IEG-DILDIEIEGEVPPQLN-GTFHRVHPDAQFP-PR-FEDDQFF   59  
An_O24023|_LeNCED1  133 ------------A-PVP-ENP-VCQSLPVTGKIPKCVQ-GVYVRNGANPLFE-P--TAGHHFF  176  
AN_Q5GN50|_GfCarX    35 ------------A-PIH-KTT-NLTPCTYSGCIPPELTGGQYVRNGGNPVSH-QDLGKDAHWF   81  
cons                253                                                                  315  
 
AN_Q28175|_BtRPE65   62 DGQALLHKFDFK--EGHV------T-YHRRFIRTDAYVRAM--TEKRIVITE--------FGT  105  
AN_Q16518|_HsRPE65   62 DGQALLHKFDFK--EGHV------T-YHRRFIRTDAYVRAM--TEKRIVITE--------FGT  105  
AN_Q9BYV7|_HsBCO2   104 DGMALLHQFRMA--KGTV------T-YRSKFLQSDTYKANS--AKNRIVISE--------FGT  147  
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AN_Q9HAY6|_HsBCO1    52 DGLALLHSFTIR--DGEV------Y-YRSKYLRSDTYNTNI--EANRIVVSE--------FGT   95  
AN_O24592|_ZmNCED1  172 DGDGMVHALRIR--NGAAE-----S-YACRFTETARLRQER--AIGRPVFPKA-------IGE  217  
AN_Q45VT7|_ZmCCD1   106 DGDGMIHAMRIK--DGKA------T-YVSRYVKTARLKQEE--YFGGAKFMK--------IGD  149  
AN_Q9M9F5|_AtNCED9  232 DGDGMVHAVRFD--NGSV------S-YACRFTETNRLVQER--ECGRPVFPKA-------IGE  276  
AN_Q9LRR7|_AtNCED3  172 DGDGMVHAVKFE--HGSA------S-YACRFTQTNRFVQER--QLGRPVFPKA-------IGE  216  
AN_Q9C6Z1|_AtNCED5  162 DGDGMVHAVKIT--NGDA------S-YSCRFTETERLVQEK--QLGSPIFPKA-------IGE  206  
AN_O49505|_AtNCED2  155 DGDGMVHAVKIT--NGSA------S-YACRFTKTERLVQEK--RLGRPVFPKA-------IGE  199  
AN_Q9LRM7|_AtNCED6  150 DGDGMIHAVSIGF-DNQV------S-YSCRYTKTNRLVQET--ALGRSVFPKP-------IGE  195  
AN_O49675|_AtCCD4   161 DGDGMLHAIKIH--NGKA------T-LCSRYVKTYKYNVEK--QTGAPVMPNV-------FSG  205  
AN_O65572|_AtCCD1    98 DGDGMIHGVRIK--DGKA------T-YVSRYVKTSRLKQEE--FFGAAKFMK--------IGD  141  
AN_Q7XJM2|_AtCCD7   114 DGHGYLRAFHIDGNKRKA------T-FTAKYVKTEAKKEEH--DPVT----------------  151  
AN_Q8VY26|_AtCCD8   129 DGYSTLVKLQFD--GGRI------F-AAHRLLESDAYKAAK--KHNRLCYREFSETPKSVIIN  180  
AN_P74334|_S.ACO     70 DGDGMVTAFKFPG-DGRV------H-FQSKFVRTQGYVEEQ--KAGKMIYRGV-------FGS  115  
AN_Q9NKW9|_DmNinaB   93 DCSALLHRFAIR--NGRV------T-YQNRFVDTETLRKNR--SAQRIVVTE--------FGT  136  
AN_Q6E4P5|_LeCCD1a  102 DGDGMIHGLRIK--DGKA------T-YVSRYVRTSRLKQEE--FFGGAKFMK--------VGD  145  
An_Q8LP16|_PsNCED2  175 DGDGMVHAVKFT--NGSV------S-YSCRFTETHRLAQEK--ALGRPVFPKA-------IGE  219  
AN_Q8LP15|_PsNCED3  181 DGDGMVHAVTMN--DGVA------S-YACRFTETERLVQER--ELGRAMFPKA-------IGE  225  
AN_Q9AXZ3|_PaNCED1  144 DGDGMVHSVSLR--QGTA------S-YACRFTETHRLVQER--AIGRPVFPKA-------IGE  188  
AN_Q9AXZ4|_PaNCED3  197 DGDGMIHAVRFR--NGSA------S-YSCRYTETRRLVQER--QLSRPIFPKA-------IGE  241  
AN_C5H805|_LeNCED2    2 DGDGMVHAVTVE--NGSV------S-YSCRFTETERLVQER--ELGHPVFPKA-------IGE   46  
AN_Q70YP8|_BoLCO      3 ---------------------------------------------------------------    2  
AN_Q84K96|_CsZCD      3 ---------------------------------------------------------------    2  
AN_Q8LP17|_PsCCD1    98 DGDGMIHGLRIK--DGKA------S-YVSRFVKTSRFKQEE--YFNGSKFMK--------IGD  141  
AN_O06785|_MtCCO     64 TGDAMVHGVALR--DGKA------RWYRNRWVRTPAVCA----ALGEPISAR-----------  103  
AN_Q99NF1|_MmBCO2    61 DGMALLHQFRME--RGTV------T-YKSKFLQSDTYKANS--AGGRIVISE--------FGT  104  
AN_Q9JJS6|_MmBCO1    52 DGLALLHSFSIR--DGEV------F-YRSKYLQSDTYIANI--EANRIVVSE--------FGT   95  
AN_Q2GA76|_NaCCO     60 NGDGMITRFHIH--DGQV------D-FRQRWAKTDKWKLEN--AAGKALFGAY-------RNP  104  
AN_Q53353|_PpLSD     60 NGDGMVSLFRFH--DGKI------D-FRQRYAQTDKWKVER--KAGKSLFGAY-------RNP  104  
An_O24023|_LeNCED1  177 DGDGMVHAVQFK--NGSA------S-YACRFTETERLVQEK--ALGRPVFPKA-------IGE  221  
AN_Q5GN50|_GfCarX    82 DGDGMLSGVAFR--KASIDGKTIPE-FVNQYILTDLYLSRKTTSIASPIMPSI-------TTL  134  
cons                316                                                                  378  
 
AN_Q28175|_BtRPE65  106 CAFPDPCK-NIFSRFFSYF--RG---------------VEVTDNALVNIYPV-GEDYYACTET  149  
AN_Q16518|_HsRPE65  106 CAFPDPCK-NIFSRFFSYF--RG---------------VEVTDNALVNVYPV-GEDYYACTET  149  
AN_Q9BYV7|_HsBCO2   148 LALPDPCK-NVFERFMSRFELPG-------------KAAAMTDNTNVNYVRY-KGDYYLCTET  195  
AN_Q9HAY6|_HsBCO1    96 MAYPDPCK-NIFSKAFSYL--SH-------------TIPDFTDNCLINIMKC-GEDFYATSET  141  
AN_O24592|_ZmNCED1  218 LHGH---S-GI-ARLALFY-ARAACG--------LVDPSAGTGVANAGLVYF-NGRLLAMSED  265  
AN_Q45VT7|_ZmCCD1   150 LKGF---F-GL-FMVQMQQ-LRKKFK--------VLDFTYGFGTANTALIYH-HGKLMALSEA  197  
AN_Q9M9F5|_AtNCED9  277 LHGH---L-GI-AKLMLFN-TRGLFG--------LVDPTGGLGVANAGLVYF-NGHLLAMSED  324  
AN_Q9LRR7|_AtNCED3  217 LHGH---T-GI-ARLMLFY-ARAAAG--------IVDPAHGTGVANAGLVYF-NGRLLAMSED  264  
AN_Q9C6Z1|_AtNCED5  207 LHGH---S-GI-ARLMLFY-ARGLFG--------LLNHKNGTGVANAGLVYF-HDRLLAMSED  254  
AN_O49505|_AtNCED2  200 LHGH---S-GI-ARLMLFY-ARGLCG--------LINNQNGVGVANAGLVYF-NNRLLAMSED  247  
AN_Q9LRM7|_AtNCED6  196 LHGH---S-GL-ARLALFT-ARAGIG--------LVDGTRGMGVANAGVVFF-NGRLLAMSED  243  
AN_O49675|_AtCCD4   206 FNGV---TASV-ARGALTA-ARVLTG--------QYNPVNGIGLANTSLAFF-SNRLFALGES  254  
AN_O65572|_AtCCD1   142 LKGF---F-GL-LMVNVQQ-LRTKLK--------ILDNTYGNGTANTALVYH-HGKLLALQEA  189  
AN_Q7XJM2|_AtCCD7   152 -------------DTWRFT-HRGPFSVLK-GGKRFGNTKVMKNVANTSVLKW-AGRLLCLWEG  198  
AN_Q8VY26|_AtCCD8   181 KNPF---S-GI-GEIV---------R--------LFSGESLTDNANTGVIKLGDGRVMCLTET  221  
AN_P74334|_S.ACO    116 QPAG---G-W--------------LKTIF--------DLRLKNIANTNITYW-GDRLLALWEG  151  
AN_Q9NKW9|_DmNinaB  137 AAVPDPCH-SIFDRFAAIF--RP---------------DSGTDNSMISIYPF-GDQYYTFTET  180  
AN_Q6E4P5|_LeCCD1a  146 LKGL---F-GL-FTVYMQM-LRTKLK--------VLDISYGNSTANTALVYH-HGKLLALSEA  193  
An_Q8LP16|_PsNCED2  220 LHGH---S-GI-ARLMLYY-ARSLCG--------LVDGTHGMGVANAGLVYF-NNRLLAMSED  267  
AN_Q8LP15|_PsNCED3  226 LHGH---S-GI-ARLMLFY-ARSLCG--------IVDHRRGSGVANAGLVYF-DGKLLAMSED  273  
AN_Q9AXZ3|_PaNCED1  189 LHGH---S-GI-ARLLLFY-ARTATG--------LVDGSSGTGVATAGLVYF-NRHLLAMSED  236  
AN_Q9AXZ4|_PaNCED3  242 LHGH---S-GI-ARLLLFY-TRGLFG--------LVNADEGMGVANAGLVYF-NRRLLAMSED  289  
AN_C5H805|_LeNCED2   47 LHGH---S-GI-ARLLLFY-ARGVFG--------LVDHSHGTGVANAGLVFF-NNRLLAMSED   94  
AN_Q70YP8|_BoLCO      3 -----------------------------------VEPTRGIGLANTSLQFS-NGRLHALCEY   29  
AN_Q84K96|_CsZCD      3 -----------------------------------VDPTKGIGLANTSLQFS-NGRLHALCEY   29  
AN_Q8LP17|_PsCCD1   142 LKGL---F-GL-LMVNMQM-LRAKLK--------ILDVSYGHGTANTALVYH-HQKLLALSEG  189  
AN_O06785|_MtCCO    104 PHPR---T-GI-I----------------------------EGGPNTNVLTH-AGRTLALVEA  132  
AN_Q99NF1|_MmBCO2   105 LALPDPCK-SIFERFMSRF-----------------EPPTMTDNTNVNFVQY-KGDYYMSTET  148  
AN_Q9JJS6|_MmBCO1    96 MAYPDPCK-NIFSKAFSYL--SH-------------TIPDFTDNCLINIMKC-GEDFYATTET  141  
AN_Q2GA76|_NaCCO    105 LTDD---E-AV-K------------G--------E-----IRSTANTNAFVF-GGKLWAMKED  136  
AN_Q53353|_PpLSD    105 LTDD---A-SV-Q------------G--------M-----IRGTANTNVMVH-AGKLYAMKED  136  
An_O24023|_LeNCED1  222 LHGH---S-GI-ARLMLFY-ARGLFG--------LVDHSKGTGVANAGLVYF-NNRLLAMSED  269  
AN_Q5GN50|_GfCarX   135 VNPL---S-TM-FQIMFAT-FRTIFLVILSNLPGSQQAIKRISVANTAVLYH-DGRALATCES  190  
cons                379                                           .                  *   441  
 
AN_Q28175|_BtRPE65  150 NFITK--V-N-PETLETIKQVDLCN------------------------YVSV----------  174  
AN_Q16518|_HsRPE65  150 NFITK--I-N-PETLETIKQVDLCN------------------------YVSV----------  174  
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AN_Q9BYV7|_HsBCO2   196 NFMNK--V-D-IETLEKTEKVDWSK------------------------FIAV----------  220  
AN_Q9HAY6|_HsBCO2   142 NYIRK--I-N-PQTLETLEKVDYRK------------------------YVAV----------  166  
AN_O24592|_ZmNCED1  266 DLPYHVRVAD-DGDLETVGRYDFDG------------------------QLG-----------  292  
AN_Q45VT7|_ZmCCD1   198 DKPYVVKVLE-DGDLQTLGLLDYDK------------------------RLK-----------  224  
AN_Q9M9F5|_AtNCED9  325 DLPYHVKVTQ-TGDLETSGRYDFDG------------------------QLK-----------  351  
AN_Q9LRR7|_AtNCED3  265 DLPYQVQITP-NGDLKTVGRFDFDG------------------------QLE-----------  291  
AN_Q9C6Z1|_AtNCED5  255 DLPYQVRVTD-NGDLETIGRFDFDG------------------------QLS-----------  281  
AN_O49505|_AtNCED2  248 DLPYQLKITQ-TGDLQTVGRYDFDG------------------------QLK-----------  274  
AN_Q9LRM7|_AtNCED6  244 DLPYQVKIDG-QGDLETIGRFGFDD------------------------QID-----------  270  
AN_O49675|_AtCCD4   255 DLPYAVRLTE-SGDIETIGRYDFDG------------------------KLA-----------  281  
AN_O65572|_AtCCD1   190 DKPYVIKVLE-DGDLQTLGIIDYDK------------------------RLT-----------  216  
AN_Q7XJM2|_AtCCD7   199 GEPYEI---E-SGSLDTVGRFNVENNGCESC--------------DDDDSSDRDLSGHDIWDT  243  
AN_Q8VY26|_AtCCD8   222 QKGSI--LVD-HETLETIGKFEYDD------------------------VLSD----------  247  
AN_P74334|_S.ACO    152 GQPHRL---E-PSNLATIGLDDLGG------------------------ILAEG---------  177  
AN_Q9NKW9|_DmNinaB  181 PFMHR--I-N-PCTLATEARICTTD------------------------FVGV----------  205  
AN_Q6E4P5|_LeCCD1a  194 DKPYALKVLE-DGDLQTLGMLDYDK------------------------RLT-----------  220  
An_Q8LP16|_PsNCED2  268 DIPYHVRVTP-NGDLTTVCRYDFND------------------------QLK-----------  294  
AN_Q8LP15|_PsNCED3  274 DLPYELQITP-YGDLKTVGRYSFLD------------------------QLH-----------  300  
AN_Q9AXZ3|_PaNCED1  237 DLPYHVRVTS-SGDLETVGRFDFMG------------------------QLN-----------  263  
AN_Q9AXZ4|_PaNCED3  290 DLPYHVRITP-SGDLKTVGRHDFDN------------------------QLR-----------  316  
AN_C5H805|_LeNCED2   95 DVPYHVQVLP-SGDLQTVGRYNFDD------------------------QLK-----------  121  
AN_Q70YP8|_BoLCO     30 DLPYVVRLSPEDGDISTVGRIENNV------------------------S-T-----------   56  
AN_Q84K96|_CsZCD     30 DLPYVVRLSPEDGDISTVGRIENNV------------------------S-T-----------   56  
AN_Q8LP17|_PsCCD1   190 DKPYAIKVFE-DGDLQTLGMLDYDK------------------------RLG-----------  216  
AN_O06785|_MtCCO    133 GVV---NYEL-TDELDTVGPCDFDG------------------------TLH-----------  156  
AN_Q99NF1|_MmBCO2   149 NFMNK--V-D-IEMLERTEKVDWSK------------------------FIAV----------  173  
AN_Q9JJS6|_MmBCO1   142 NYIRK--I-D-PQTLETLEKVDYRK------------------------YVAV----------  166  
AN_Q2GA76|_NaCCO    137 SP-AL--VMD-PATMETFGFEKFGG------------------------KMTG----------  161  
AN_Q53353|_PpLSD    137 SP-CL--IMD-PLTLETEGYTNFDG------------------------KLQS----------  161  
An_O24023|_LeNCED1  270 DLPYHVKVTP-TGDLKTEGRFDFDG------------------------QLK-----------  296  
AN_Q5GN50|_GfCarX   191 GPPMRI---Q-LPSLDTVGWFDGVEAEGEPEISQAGSDDSPFGGSGIFSFMK-----------  238  
cons                442               :                                                  504  
 
AN_Q28175|_BtRPE65  175 -----------------NGA--TAHPHIENDGTVYNIGNCFG----KNFSIAYNIV----K--  208  
AN_Q16518|_HsRPE65  175 -----------------NGA--TAHPHIENDGTVYNIGNCFG----KNFSIAYNIV----K--  208  
AN_Q9BYV7|_HsBCO2   221 -----------------NGA--TAHPHYDLD----------G----TAYNMGNSFG----P--  244  
AN_Q9HAY6|_HsBCO1   167 -----------------NLA--TSHPHYDEA----------G----NVLNMGTSIV----E--  190  
AN_O24592|_ZmNCED1  293 -----------------CAM--IAHPKLDPA---------TG----ELHALSYDV----IK--  317  
AN_Q45VT7|_ZmCCD1   225 -----------------HSF--TAHPKVDPF---------TD----EMFTFGYSH----E---  248  
AN_Q9M9F5|_AtNCED9  352 -----------------STM--IAHPKIDPE---------TR----ELFALSYDV----VS--  376  
AN_Q9LRR7|_AtNCED3  292 -----------------STM--IAHPKVDPE---------SG----ELFALSYDV----VS--  316  
AN_Q9C6Z1|_AtNCED5  282 -----------------SAM--IAHPKIDPV---------TK----ELFALSYDV----VK--  306  
AN_O49505|_AtNCED2  275 -----------------SAM--IAHPKLDPV---------TK----ELHALSYDV----VK--  299  
AN_Q9LRM7|_AtNCED6  271 -----------------SSV--IAHPKVDAT---------TG----DLHTLSYNV----LK--  295  
AN_O49675|_AtCCD4   282 -----------------MSM--TAHPKTDPI---------TG----ETFAFRYGP----V---  305  
AN_O65572|_AtCCD1   217 -----------------HSF--TAHPKVDPV---------TG----EMFTFGYSH----T---  240  
AN_Q7XJM2|_AtCCD7   244 AADLLKPILQGVFKMPPKRF--LSHYKVDGR---------RK----RLLTVTCNAEDMLLP--  289  
AN_Q8VY26|_AtCCD8   248 ------------------HMIQSAHPIVTE-----------T----EMWTLIPDL----VK--  271  
AN_P74334|_S.ACO    178 -----------------QPL--SAHPRIDPA---------STFDGGQPCYVTFSIKS--SL--  208  
AN_Q9NKW9|_DmNinaB  206 -----------------VNH--TSHPHVLPS----------G----TVYNLGTTMT----R--  229  
AN_Q6E4P5|_LeCCD1a  221 -----------------HSF--TAHPKVDAV---------TG----EMFTFGYAH----T---  244  
An_Q8LP16|_PsNCED2  295 -----------------STM--IAHPKVDPV---------DK----NLYALSYDV----VQ--  319  
AN_Q8LP15|_PsNCED3  301 -----------------STM--IAHPKIDPI---------SG----ELFALSYEV----A---  324  
AN_Q9AXZ3|_PaNCED1  264 -----------------SAM--IAHPKLDPA---------SG----ELFALSYNV----IK--  288  
AN_Q9AXZ4|_PaNCED3  317 -----------------SSM--IAHPKLDPE---------SG----ELFSLSYDV----AR--  341  
AN_C5H805|_LeNCED2  122 -----------------STM--IAHPKIDPV---------SG----ELFALSYDV----VQ--  146  
AN_Q70YP8|_BoLCO     57 -----------------KST--TAHPKTDPV---------TG----ETFSFSYGP----I---   80  
AN_Q84K96|_CsZCD     57 -----------------KST--TAHPKTDPV---------TG----ETFSFSYGP----I---   80  
AN_Q8LP17|_PsCCD1   217 -----------------HNF--TAHPKVDPF---------TG----EMFTFGYSH----T---  240  
AN_O06785|_MtCCO    157 -----------------GGY--TAHPQRDPH---------TG----ELHAVSYSF----AR--  181  
AN_Q99NF1|_MmBCO2   174 -----------------NGA--TAHPHYDPD----------G----TAYNMGNSYG----P--  197  
AN_Q9JJS6|_MmBCO1   167 -----------------NLA--TSHPHYDEA----------G----NVLNMGTSVV----D--  190  
AN_Q2GA76|_NaCCO    162 -----------------QTF--TAHPKVDPK---------TG----NMVAIGYAA----SGLC  188  
AN_Q53353|_PpLSD    162 -----------------QTF--CAHPKIDPV---------TG----NLCAFAYGA----KGLM  188  
An_O24023|_LeNCED1  297 -----------------STM--IAHPKLDPV---------SG----ELFALSYDV----IQ--  321  
AN_Q5GN50|_GfCarX   239 -----------------EWT--TGHPKVDPV---------TG----EMLLYHNT-----FM--  262  
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AN_Q16518|_HsRPE65  209 IPPLQADKED-----PISKS----------EIV------VQ--FPCSDRFKPSYVHSFGLTPN  248  
AN_Q9BYV7|_HsBCO2   245 YG-FSYKVIRVP---PEKVDL-GE-TIHGVQVI------CS--IASTEKGKPSYYHSFGMTRN  293  
AN_Q9HAY6|_HsBCO1   191 KGKTKYVIFKIPATVPEGKKQ-GKSPWKHTEVF------CS--IPSRSLLSPSYYHSFGVTEN  244  
AN_O24592|_ZmNCED1  318 RPYLKYFYFR-----PDGTKS-D---------D------VE--I---PLEQPTMIHDFAITEN  354  
AN_Q45VT7|_ZmCCD1   249 PPYCTYRVIN-----KEGAML-D---------P------VP--I---TIPESVMMHDFAITEN  285  
AN_Q9M9F5|_AtNCED9  377 KPYLKYFRFT-----SDGEKS-P---------D------VE--I---PLDQPTMIHDFAITEN  413  
AN_Q9LRR7|_AtNCED3  317 KPYLKYFRFS-----PDGTKS-P---------D------VE--I---QLDQPTMMHDFAITEN  353  
AN_Q9C6Z1|_AtNCED5  307 KPYLKYFKFS-----PEGEKS-P---------D------VE--I---PLASPTMMHDFAITEN  343  
AN_O49505|_AtNCED2  300 KPYLKYFRFS-----PDGVKS-P---------E------LE--I---PLETPTMIHDFAITEN  336  
AN_Q9LRM7|_AtNCED6  296 KPHLRYLKFN-----TCGKKT-R---------D------VE--I---TLPEPTMIHDFAITEN  332  
AN_O49675|_AtCCD4   306 PPFLTYFRFD-----SAGKKQ-R---------D------VP--I--FSMTSPSFLHDFAITKR  343  
AN_O65572|_AtCCD1   241 PPYLTYRVIS-----KDGIMH-D---------P------VP--I---TISEPIMMHDFAITET  277  
AN_Q7XJM2|_AtCCD7   290 RSNFTFCEYD-----SEFKLI-Q---------T------KE--F---KIDDHMMIHDWAFTDT  326  
AN_Q8VY26|_AtCCD8   272 -PGYRVVRME-----AGSNKR-E------VVGR------VRCRS---GSWGPGWVHSFAVTEN  312  
AN_P74334|_S.ACO    209 SSTLTLLELD-----PQGKLL-R---------Q------KT--E---TFPGFAFIHDFAITPH  245  
AN_Q9NKW9|_DmNinaB  230 SG-PAYTILCFP---HGEQMF-ED-----AHVV------AT--LPCRWKLHPGYMHTFGLTDH  274  
AN_Q6E4P5|_LeCCD1a  245 PPYITYRVIS-----KDGIMQ-D---------P------VP--I---TIPEPIMMHDFAITEN  281  
An_Q8LP16|_PsNCED2  320 KPYLKYFRFD-----SNGVKS-P---------D------VE--I---PLAEPTMMHDFAITEN  356  
AN_Q8LP15|_PsNCED3  325 RPYLKYFRFS-----PDGKKS-P---------D------VE--I---RLSVPTMIHDFAITEN  361  
AN_Q9AXZ3|_PaNCED1  289 KPFLKFFKFT-----SDGKKS-P---------D------VE--I---PIDQPTMIHDFVITEN  325  
AN_Q9AXZ4|_PaNCED3  342 KPYLKYFHFA-----PDGWKS-P---------D------VE--I---PLDRPTMIHDFAITEN  378  
AN_C5H805|_LeNCED2  147 KPYLKSFKFS-----PDGEKS-P---------D------VE--I---PLDVPTMMHDFAITES  183  
AN_Q70YP8|_BoLCO     81 QPYVTYSRYD-----CDDKKSGP---------D------VP--I--FSFKEPSFVHDFAITEH  119  
AN_Q84K96|_CsZCD     81 QPYVTYSRYD-----CDGKKSGP---------D------VP--I--FSFKEPSFVHDFAITEH  119  
AN_Q8LP17|_PsCCD1   241 APYVTYRVIS-----KDGFMQ-D---------P------VP--I---TISDPVMMHDFAITEN  277  
AN_O06785|_MtCCO    182 GHRVQYSVIG-----TDGHAR-R---------T------VD--I---EVAGSPMMHSFSLTDN  218  
AN_Q99NF1|_MmBCO2   198 RG-SCYNIIRVP---PKKKEP-GE-TIHGAQVL------CS--IASTEKMKPSYYHSFGMTKN  246  
AN_Q9JJS6|_MmBCO1   191 KGRTKYVIFKIPATVPDSKKK-GKSPVKHAEVF------CS--ISSRSLLSPSYYHSFGVTEN  244  
AN_Q2GA76|_NaCCO    189 TDDVTYMEVS-----PEGELV-R---------E------VW--F---KVPYYCMMHDFGITED  225  
AN_Q53353|_PpLSD    189 TLDMAYIEIS-----PTGKLL-K---------E------IP--F---QNPYYCMMHDFGVTED  225  
An_O24023|_LeNCED1  322 KPYLKYFRFS-----KNGEKS-N---------D------VE--I---PVEDPTMMHDFAITEN  358  
AN_Q5GN50|_GfCarX   263 PPYVHCSVLP-----KSNEKA-P---------GHRLVNQPV--L---GVSGARMMHDFGASRS  305  
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AN_Q28175|_BtRPE65  249 YIVFVETPVKINLF--K-FL---SS-WSLWGANYMD---------------------------  277  
AN_Q16518|_HsRPE65  249 YIVFVETPVKINLF--K-FL---SS-WSLWGANYMD---------------------------  277  
AN_Q9BYV7|_HsBCO2   294 YIIFIEQPLKMNLW--K-IA---TS-KI-RGKAFSD---------------------------  321  
AN_Q9HAY6|_HsBCO1   245 YVIFLEQPFRLDIL--K-MA---TA-YI-RRMSWAS---------------------------  272  
AN_O24592|_ZmNCED1  355 LVVVPDHQVVFKLQ--E-ML---RG-G--------S---------------------------  375  
AN_Q45VT7|_ZmCCD1   286 YSIFMDLPLLFRPK--E-MV---KN-G--------E---------------------------  306  
AN_Q9M9F5|_AtNCED9  414 FVVIPDQQVVFRLP--E-MI---RG-G--------S---------------------------  434  
AN_Q9LRR7|_AtNCED3  354 FVVVPDQQVVFKLP--E-MI---RG-G--------S---------------------------  374  
AN_Q9C6Z1|_AtNCED5  344 FVVIPDQQVVFKLS--D-MF---LG-K--------S---------------------------  364  
AN_O49505|_AtNCED2  337 FVVIPDQQVVFKLG--E-MI---SG-K--------S---------------------------  357  
AN_Q9LRM7|_AtNCED6  333 FVVIPDQQMVFKLS--E-MI---RG-G--------S---------------------------  353  
AN_O49675|_AtCCD4   344 HAIFAEIQLGMRMNMLDLVL---EG-G--------S---------------------------  367  
AN_O65572|_AtCCD1   278 YAIFMDLPMHFRPK--E-MV---KE-K--------K---------------------------  298  
AN_Q7XJM2|_AtCCD7   327 HYILFANRVKLNPI--G-SIAAMCG-M--------S---------------------------  350  
AN_Q8VY26|_AtCCD8   313 YVVIPEMPLRYSVK--N-LL---RA-E--------P---------------------------  333  
AN_P74334|_S.ACO    246 YAIFLQNNVTLNGL--P-YLFGLRGAG--------E---------------------------  270  
AN_Q9NKW9|_DmNinaB  275 YFVIVEQPLSVSLT--E-YI---KA-QL-GGQNLSA---------------------------  302  
AN_Q6E4P5|_LeCCD1a  282 YAIMMDLPLCFRPK--E-MV---KK-N--------K---------------------------  302  
An_Q8LP16|_PsNCED2  357 FVVVPDQQVVFKLG--E-MI---RG-G--------S---------------------------  377  
AN_Q8LP15|_PsNCED3  362 YVVIPDHQVVFKLE--E-MI---KG-C--------S---------------------------  382  
AN_Q9AXZ3|_PaNCED1  326 FVIIPDQQVVFKLQ--E-MI---RG-G--------S---------------------------  346  
AN_Q9AXZ4|_PaNCED3  379 FVVIPDQQVVFKLE--E-MI---RG-G--------S---------------------------  399  
AN_C5H805|_LeNCED2  184 YVVIPDQQVVFKLQ--E-MI---KG-G--------S---------------------------  204  
AN_Q70YP8|_BoLCO    120 YAVFPDIQIVMKPA--E-IV---RG-R--------R---------------------------  140  
AN_Q84K96|_CsZCD    120 YAVFPDIQIVMKPA--E-IV---RG-R--------R---------------------------  140  
AN_Q8LP17|_PsCCD1   278 YSIFMDLPLYFRPK--E-MV---KN-K--------T---------------------------  298  
AN_O06785|_MtCCO    219 YVVIYDLPVTFDPM--Q-VV---PA-S--------VPRWLQRPARLVIQSVLGRVRIPDPIAA  266  
AN_Q99NF1|_MmBCO2   247 YIIFVEQPVKMKLW--K-II---TS-KI-RGKPFAD---------------------------  274  
AN_Q9JJS6|_MmBCO1   245 YVVFLEQPFKLDIL--K-MA---TA-YM-RGVSWAS---------------------------  272  
AN_Q2GA76|_NaCCO    226 YLVLHIVPSIGSWE--R-LE---QG-K--------P---------------------------  246  
AN_Q53353|_PpLSD    226 YAVFAVMPLLSSWD--R-LE---QR-L--------P---------------------------  246  
An_O24023|_LeNCED1  359 FVVIPDQQVVFKMS--E-MI---RG-G--------S---------------------------  379  
AN_Q5GN50|_GfCarX   306 HTIIMDLPLSLDPL--N-TM---KG-K--------E---------------------------  326  
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AN_Q28175|_BtRPE65  278 ------------C----FESNE----TMGVWLHIADKKR-KKYINN---KY----R--TSPFN  310  
AN_Q16518|_HsRPE65  278 ------------C----FESNE----TMGVWLHIADKKR-KKYLNN---KY----R--TSPFN  310  
AN_Q9BYV7|_HsBCO2   322 ------------G----ISWEP----QCNTRFHVVEKRT-GQLLPG---RY----Y--SKPFV  354  
AN_Q9HAY6|_HsBCO1   273 ------------C----LAFHR----EEKTYIHIIDQRT-RQPVQT---KF----Y--TDAMV  305  
AN_O24592|_ZmNCED1  376 ------------P----VVLD----KEKTSRFGVLPKHA-ADASEM---AW----VD-VPDCF  409  
AN_Q45VT7|_ZmCCD1   307 ------------FI---YKFD----PTKKGRFGILPRYA-KDDKLI---RW----FQ-LPNCF  341  
AN_Q9M9F5|_AtNCED9  435 ------------P----VVYD----EKKKSRFGILNKNA-KDASSI---QW----IE-VPDCF  468  
AN_Q9LRR7|_AtNCED3  375 ------------P----VVYD----KNKVARFGILDKYA-EDSSNI---KW----ID-APDCF  408  
AN_Q9C6Z1|_AtNCED5  365 ------------P----VKYD----GEKISRFGILPRNA-KDASEM---VW----VE-SPETF  398  
AN_O49505|_AtNCED2  358 ------------P----VVFD----GEKVSRLGIMPKDA-TEASQI---IW----VN-SPETF  391  
AN_Q9LRM7|_AtNCED6  354 ------------P----VIYV----KEKMARFGVLSKQD-LTGSDI---NW----VD-VPDCF  387  
AN_O49675|_AtCCD4   368 ------------P----VGTD----NGKTPRLGVIPKYA-GDESEM---KW----FE-VPGFN  401  
AN_O65572|_AtCCD1   299 ------------MI---YSFD----PTKKARFGVLPRYA-KDELMI---RW----FE-LPNCF  333  
AN_Q7XJM2|_AtCCD7   351 ------------PMVSALSLNP---SNESSPIYILPRFS-D--KYSRGGRDWRVPVEVSSQLW  395  
AN_Q8VY26|_AtCCD8   334 ------------T----PLYKFEWCPQDGAFIHVMSKL-T--GEVV---AS----VE-VPAYV  369  
AN_P74334|_S.ACO    271 ------------C----VQFHP----DKPAQIILVPRDG----GEI---KR----IP-VQAGF  301  
AN_Q9NKW9|_DmNinaB  303 ------------C----LKWFE----DRPTLFHLIDRVS-GK--LV---QT----YE-SEAFF  334  
AN_Q6E4P5|_LeCCD1   303 ------------LA---FTFD----ATKKARFGVLPRYA-NNEALI---RW----FE-LPNCF  337  
An_Q8LP16|_PsNCED2  378 ------------P----VVYD----KEKVSRFGVLSKNA-ENASEM---KW----ID-APECF  411  
AN_Q8LP15|_PsNCED3  383 ------------P----VIFD----GAKKSRFGVLPKYA-KDASSI---IW----VD-SPDTF  416  
AN_Q9AXZ3|_PaNCED1  347 ------------P----VVYD----KKKTARFGILLKTA-ADSNGL---RW----ID-APDCF  380  
AN_Q9AXZ4|_PaNCED3  400 ------------P----VVYD----KNKTSRFGILPKYA-PDASEM---IW----VD-APDCF  433  
AN_C5H805|_LeNCED2  205 ------------P----VIYD----KNKKSRFGILPKNA-ENSENI---IW----VE-SAETF  238  
AN_Q70YP8|_BoLCO    141 ------------M----IGPD----LEKVPRLGLLPRYA-TSDSEM---RW----FD-VPGFN  174  
AN_Q84K96|_CsZCD    141 ------------M----IGPD----LEKVPRLGLLPRYA-TSDSEM---RW----FD-VPGFN  174  
AN_Q8LP17|_PsCCD1   299 ------------LI---FSFD----STKKARFGVLPRYA-KDDKHI---RW----FE-LPNCF  333  
AN_O06785|_MtCCO    267 LGNRMQGHSDRLP----YAWN----PSYPARVGVMPREG-GN-EDV---RW----FD-IEPCY  311  
AN_Q99NF1|_MmBCO2   275 ------------G----ISWEP----QYNTRFHVVDKHT-GQLLPG---MY----Y--SMPFL  307  
AN_Q9JJS6|_MmBCO1   273 ------------C----MSFDR----EDKTYIHIIDQRT-RKPVPT---KF----Y--TDPMV  305  
AN_Q2GA76|_NaCCO    247 ------------H----FGFD----TTMPVHLGIIPRRDGVRQEDI---RW----FT-RDNCF  281  
AN_Q53353|_PpLSD    247 ------------F----FGFD----TTLPCYLGILPRN-G-DARDL---RW----FK-TGNCF  279  
An_O24023|_LeNCED1  380 ------------P----VVYD----KNKVSRFGILDKYA-KDGSDL---KW----VE-VPDCF  413  
AN_Q5GN50|_GfCarX   327 ------------V----VAYDP----TKPSRFGVFPRHL-P--SSV---RW----FH-TAPCC  358  
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AN_Q28175|_BtRPE65  311 LFHHINTYEDHE--------F-L-IV--D-LCC-------------------WKGFEF-V---  337  
AN_Q16518|_HsRPE65  311 LFHHINTYEDNG--------F-L-IV--D-LCC-------------------WKGFEF-V---  337  
AN_Q9BYV7|_HsBCO2   355 TFHQINAFEDQG--------C-V-II--D-LCC-------------------QDNGRT-L---  381  
AN_Q9HAY6|_HsBCO1   306 VFHHVNAYEEDG--------C-I-VF--D-VIA-------------------YEDNSL-Y---  332  
AN_O24592|_ZmNCED1  410 CFHLWNAWEDEA--T-G---E-V-VV--I-GSC-------------------MTPADS-I---  438  
AN_Q45VT7|_ZmCCD1   342 IFHNANAWEEGD--------E-V-VL--I-TCR-------------------LENPDLDKVNG  372  
AN_Q9M9F5|_AtNCED9  469 CFHLWNSWEEPE--T-D---E-V-VV--I-GSC-------------------MTPPDS-I---  497  
AN_Q9LRR7|_AtNCED3  409 CFHLWNAWEEPE--T-D---E-V-VV--I-GSC-------------------MTPPDS-I---  437  
AN_Q9C6Z1|_AtNCED5  399 CFHLWNAWESPE--T-D---E-V-VV--I-GSC-------------------MTPADS-I---  427  
AN_O49505|_AtNCED2  392 CFHLWNAWESPE--T-E---E-I-VV--I-GSC-------------------MSPADS-I---  420  
AN_Q9LRM7|_AtNCED6  388 CFHLWNAWEERTEEG-D---PVI-VV--I-GSC-------------------MSPPDT-I---  419  
AN_O49675|_AtCCD4   402 IIHAINAWDEDD--G-N---S-V-VL--I-APN-------------------IMSIEH-T---  430  
AN_O65572|_AtCCD1   334 IFHNANAWEEED--------E-V-VL--I-TCR-------------------LENPDLDMVSG  364  
AN_Q7XJM2|_AtCCD7   396 LIHSGNAYETRE--DNG---D-L-KIQIQASACSYRWFDFQKMFGYDWQSNKLDPSVM-N---  447  
AN_Q8VY26|_AtCCD8   370 TFHFINAYEEDK--N-GDGKA-TVII--A-DCC-------------------EHNADTRI---  403  
AN_P74334|_S.ACO    302 VFHHANAFEEN-----G---K-I-IL--D-SIC-------------------YNSLPQ-V---  328  
AN_Q9NKW9|_DmNinaB  335 YLHIINCFERDG--------H-V-VV--D-ICS-------------------YRNPEM-I---  361  
AN_Q6E4P5|_LeCCD1a  338 IFHNANAWEEGD--------E-V-VL--I-TCR-------------------LVNPDLDMVNG  368  
An_Q8LP16|_PsNCED2  412 CFHLWNAWEEPE--N-D---E-V-VV--I-GSC-------------------MTPADS-I---  440  
AN_Q8LP15|_PsNCED3  417 CFHLWNAWEEPE--A-D---E-I-VV--I-GSC-------------------MTPPDS-I---  445  
AN_Q9AXZ3|_PaNCED1  381 CFHLWTAWEEPE--T-D---Q-V-VV--I-GSC-------------------MTPPDS-I---  409  
AN_Q9AXZ4|_PaNCED3  434 CFHLWNAWEEPE--S-G---E-V-VV--V-GSC-------------------MTPPDS-I---  462  
AN_C5H805|_LeNCED2  239 CFHLWNAWEEPE--T-D---E-V-IV--I-GSC-------------------MTPPDS-I---  267  
AN_Q70YP8|_BoLCO    175 MVHVVNAWEEEG--G-E---V-V-VI--V-APN-------------------VSPIEN-A---  203  
AN_Q84K96|_CsZCD    175 MVHVVNAWEEEG--G-E---V-V-VI--V-APN-------------------VSPIEN-A---  203  
AN_Q8LP17|_PsCCD1   334 IFHNANAWEEED--------E-I-VL--I-TCR-------------------LENPNLDVVGG  364  
AN_O06785|_MtCCO    312 VYHPLNAYSECR--N-G--AE-V-LV--L-DVV-------------------RYS--R-M---  339  
AN_Q99NF1|_MmBCO2   308 TYHQINAFEDQG--------C-I-VI--D-LCC-------------------QDDGRS-L---  334  
AN_Q9JJS6|_MmBCO1   306 VFHHVNAYEEDG--------C-V-LF--D-VIA-------------------YEDSSL-Y---  332  
AN_Q2GA76|_NaCCO    282 ASHVLNAWQEGT--K--------IHF--V-TCE-------------------AKNNMFPF---  309  
AN_Q53353|_PpLSD    280 VGHVMNAFNDGT--K--------VHI--D-MPV-------------------SRNNSFPF---  307  
An_O24023|_LeNCED1  414 CFHLWNAWEEAE--T-D---E-I-VV--I-GSC-------------------MTPPDS-I---  442  
AN_Q5GN50|_GfCarX   359 IFHTANTWDSQS--SEG---E-L-SVNLL-ACR-------------------MTSSTL-V---  390  
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AN_Q28175|_BtRPE65  338 -Y-NYS---------YLA-------------NLR-----------------------------  347  
AN_Q16518|_HsRPE65  338 -Y-NYL---------YLA-------------NLR-----------------------------  347  
AN_Q9BYV7|_HsBCO2   382 ---EVY---------QLQ-------------NLR-----------------------------  390  
AN_Q9HAY6|_HsBCO1   333 ---QLF---------YLA-------------NLN-----------------------------  341  
AN_O24592|_ZmNCED1  439 -F-N------E----SDE-------------RLE-----------------------------  447  
AN_Q45VT7|_ZmCCD1   373 YQ-S------D----KLE-------------NFG-----------------------------  382  
AN_Q9M9F5|_AtNCED9  498 -F-N------E----HDE-------------TLQ-----------------------------  506  
AN_Q9LRR7|_AtNCED3  438 -F-N------E----SDE-------------NLK-----------------------------  446  
AN_Q9C6Z1|_AtNCED5  428 -F-N------E----CDE-------------QLN-----------------------------  436  
AN_O49505|_AtNCED2  421 -F-N------E----RDE-------------SLR-----------------------------  429  
AN_Q9LRM7|_AtNCED6  420 -F-S------E----SGE-------------PTR-----------------------------  428  
AN_O49675|_AtCCD4   431 -L-E-----------RMD-------------LVH-----------------------------  438  
AN_O65572|_AtCCD1   365 KV-K------E----KLE-------------NFG-----------------------------  374  
AN_Q7XJM2|_AtCCD7   448 -L-NR----------GDD-------------KLL-----------------------------  456  
AN_Q8VY26|_AtCCD8   404 -L-DML---------RLD-------------TLR-----------------------------  413  
AN_P74334|_S.ACO    329 -D-TD----------GDFR----ST---NFDNLD-----------------------------  343  
AN_Q9NKW9|_DmNinaB  362 ---NCM---------YLE-------------AIA-----------------------------  370  
AN_Q6E4P5|_LeCCD1a  369 AV-K------E----KLE-------------NFC-----------------------------  378  
An_Q8LP16|_PsNCED2  441 -F-N------E----CDE-------------SLK-----------------------------  449  
AN_Q8LP15|_PsNCED3  446 -F-N------E----SDE-------------NLK-----------------------------  454  
AN_Q9AXZ3|_PaNCED1  410 -F-N------E----SNQ-------------SLK-----------------------------  418  
AN_Q9AXZ4|_PaNCED3  463 -F-N------E----NEE-------------SLK-----------------------------  471  
AN_C5H805|_LeNCED2  268 -F-N------E----CNE-------------NLK-----------------------------  276  
AN_Q70YP8|_BoLCO    204 -I-D-----------RFD-------------LLH-----------------------------  211  
AN_Q84K96|_CsZCD    204 -I-D-----------RFD-------------LLH-----------------------------  211  
AN_Q8LP17|_PsCCD1   365 AV-K------E----KLD-------------NFS-----------------------------  374  
AN_O06785|_MtCCO    340 -F-D------RDRRGPGG-------------DSR-----------------------------  352  
AN_Q99NF1|_MmBCO2   335 ---DLY---------QLQ-------------NLR-----------------------------  343  
AN_Q9JJS6|_MmBCO1   333 ---QLF---------YLA-------------NLN-----------------------------  341  
AN_Q2GA76|_NaCCO    310 -FPDVHGAPFN----GME-------------AM------------------------------  324  
AN_Q53353|_PpLSD    308 -F-DVHGA-------PFD-------------PVA-----------------------------  319  
An_O24023|_LeNCED1  443 -F-N------E----CDE-------------GLK-----------------------------  451  
AN_Q5GN50|_GfCarX   391 -Y-TA----------GNIRPPVRSRCTQARVWSDEREETACRYKEAPALESPGESTGLADYFP  441  
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AN_Q28175|_BtRPE65  348 ----------------------EN---WEEVKKNARK--A-PQPEVR------RYVLPLNI--  374  
AN_Q16518|_HsRPE65  348 ----------------------EN---WEEVKKNARK--A-PQPEVR------RYVLPLNI--  374  
AN_Q9BYV7|_HsBCO2   391 ----------------------KAGEGLDQV-HNSAA--K---SFPR------RFVLPLNV--  417  
AN_Q9HAY6|_HsBCO1   342 ----------------------QD---FKEN-SRLTS--V---PTLR------RFAVPLHV--  365  
AN_O24592|_ZmNCED1  448 ------------S----------V---LTEIRLDART--G-R--STR------R---------  465  
AN_Q45VT7|_ZmCCD1   383 ------------N----------E---LYEMRFNMKT--G-A--ASQ------K---------  400  
AN_Q9M9F5|_AtNCED9  507 ------------S----------V---LSEIRLNLKT--G-E--STR------R---------  524  
AN_Q9LRR7|_AtNCED3  447 ------------S----------V---LSEIRLNLKT--G-E--STR------R---------  464  
AN_Q9C6Z1|_AtNCED5  437 ------------S----------V---LSEIRLNLKT--G-K--STR------R---------  454  
AN_O49505|_AtNCED2  430 ------------S----------V---LSEIRINLRT--R-K--TTR------R---------  447  
AN_Q9LRM7|_AtNCED6  429 ------------V----------E---LSEIRLNMRT--K-E--SNR------K---------  446  
AN_O49675|_AtCCD4   439 ------------A----------L---VEKVKIDLVT--G-I--VRR------H---------  456  
AN_O65572|_AtCCD1   375 ------------N----------E---LYEMRFNMKT--G-S--ASQ------K---------  392  
AN_Q7XJM2|_AtCCD7   457 ------------P----------H---LVKVSMTLDS-TG-N--CNS------C---------  475  
AN_Q8VY26|_AtCCD8   414 ------------SSHGHDVLPDAR---IGRFRIPLDG--S-K--YGKLETAVEA---------  447  
AN_P74334|_S.ACO    344 -----------PG----------Q---LWRFTI--DPAAA-T--VEK------Q---------  362  
AN_Q9NKW9|_DmNinaB  371 ----------------------NMQ--TNPN-YATLF--R---GRPL------RFVLPLGTIP  397  
AN_Q6E4P5|_LeCCD1a  379 ------------N----------E---LYEMRFNMKS--G-A--ASQ------K---------  396  
An_Q8LP16|_PsNCED2  450 ------------S----------V---LSEIRLNLKT--G-K--STR------R---------  467  
AN_Q8LP15|_PsNCED3  455 ------------S----------V---LSEIRLNLKT--G-K--STR------R---------  472  
AN_Q9AXZ3|_PaNCED1  419 ------------S----------V---LTEIRLNLKT--G-L--SSR------R---------  436  
AN_Q9AXZ4|_PaNCED3  472 ------------S----------I---LTEIRLNTRT--G-E--STR------R---------  489  
AN_C5H805|_LeNCED2  277 ------------S----------V---LSEIRLNLKT--G-E--STR------R---------  294  
AN_Q70YP8|_BoLCO    212 ------------V----------S---VEMARIELKS--G-S--VPR------T---------  229 
AN_Q84K96|_CsZCD    212 ------------V----------S---VEMARIELKS--G-S--VSR------T---------  229  
AN_Q8LP17|_PsCCD1   375 ------------N----------E---LYEMRFNMKT--G-E--ASQ------K---------  392  
AN_O06785|_MtCCO    353 ------------P----------S---LDRWTINLAT--G-A--VTA------E---------  370  
AN_Q99NF1|_MmBCO2   344 ----------------------KAGEGLDQV-YELKA--K---SFPR------RFVLPLDV--  370  
AN_Q9JJS6|_MmBCO1   342 ----------------------KD---FEEK-SRLTS--V---PTLR------RFAVPLHV--  365  
AN_Q2GA76|_NaCCO    325 ----------------------SH---PTDWVVDMAS--NGE--DFA-G---IV---------  345  
AN_Q53353|_PpLSD    320 ------------G--------QGF---LTRWTVDMAS--NGD--SFE-K---TE---------  342  
An_O24023|_LeNCED1  452 ------------S----------V---LSEIRLNLKT--G-K--STR------K---------  469  
AN_Q5GN50|_GfCarX   442 ITAESDDYDQCRL----------Y---YYEFDLAMESRNH-V--KSQ------W---------  473  
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AN_Q28175|_BtRPE65  375 ----------------DK----ADTGK------------------------------------  381  
AN_Q16518|_HsRPE65  375 ----------------DK----ADTGK------------------------------------  381  
AN_Q9BYV7|_HsBCO2   418 ----------------SLN---APEGD------------------------------------  425  
AN_Q9HAY6|_HsBCO1   366 ----------------DKN---AEVGT------------------------------------  373  
AN_O24592|_ZmNCED1  466 -------AVLP-P-SQ-----------------------------------------------  472  
AN_Q45VT7|_ZmCCD1   401 -------QLS-----------------------------------------------------  403  
AN_Q9M9F5|_AtNCED9  525 -------PVIS----E-----------------------------------------------  529  
AN_Q9LRR7|_AtNCED3  465 -------PIISNE-DQ-----------------------------------------------  472  
AN_Q9C6Z1|_AtNCED5  455 -------TIIP-G-SV-----------------------------------------------  461  
AN_O49505|_AtNCED2  448 -------SLLV-N--E-----------------------------------------------  453  
AN_Q9LRM7|_AtNCED6  447 -------VIVT----------------------------------------------------  450  
AN_O49675|_AtCCD4   457 -------PIS-----------------------------------------------------  459  
AN_O65572|_AtCCD1   393 -------KLS-----------------------------------------------------  395  
AN_Q7XJM2|_AtCCD7   476 -------DVEP-LNGW-----------------------------------------------  483  
AN_Q8VY26|_AtCCD8   448 -------EKH-----------------------------------------------------  450  
AN_P74334|_S.ACO    363 -------------LMV-----------------------------------------------  365  
AN_Q9NKW9|_DmNinaB  398 PASIAKRGLVK-S-FSLAGLSAPQVSRTMKHSVSQYADITYMPTNGKQATAGEESPKRDAKRG  458  
AN_Q6E4P5|_LeCCD1   397 -------KLS-----------------------------------------------------  399  
An_Q8LP16|_PsNCED2  468 -------AIIQ-E-SE-----------------------------------------------  474  
AN_Q8LP15|_PsNCED3  473 -------SIVP----------------------------------------------------  476  
AN_Q9AXZ3|_PaNCED1  437 -------EIDP---SR-----------------------------------------------  442  
AN_Q9AXZ4|_PaNCED3  490 -------TIID-P-QK-----------------------------------------------  496  
AN_C5H805|_LeNCED2  295 -------QLPS-P-SD-----------------------------------------------  301  
AN_Q70YP8|_BoLCO    230 -------LLS-----------------------------------------------------  232  
AN_Q84K96|_CsZCD    230 -------LLS-----------------------------------------------------  232  
AN_Q8LP17|_PsCCD1   393 -------KLS-----------------------------------------------------  395  
AN_O06785|_MtCCO    371 -------CRD-----------------------------------------------------  373  
AN_Q99NF1|_MmBCO2   371 ----------------SVD---AAEGK------------------------------------  378  
AN_Q9JJS6|_MmBCO1   366 ----------------DKD---AEVGS------------------------------------  373  
AN_Q2GA76|_NaCCO    346 -------KLS-----------------------------------------------------  348  
AN_Q53353|_PpLSD    343 -------RLF-----------------------------------------------------  345  
An_O24023|_LeNCED1  470 -------SIIENP-DE-----------------------------------------------  477  
AN_Q5GN50|_GfCarX   474 -------------ALS-----------------------------------------------  476  
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AN_Q28175|_BtRPE65  382 --------NLVTLPNTTATAILCSDETIWLEPEVLFS---GPRQAFEFPQINYQKYGGKPYTY  433  
AN_Q16518|_HsRPE65  382 --------NLVTLPNTTATAILCSDETIWLEPEVLFS---GPRQAFEFPQINYQKYCGKPYTY  433  
AN_Q9BYV7|_HsBCO2   426 --------NLSPLSYTSASAVKQADGTIWCSHENLHQEDLEKEGGIEFPQIYYDRFSGKKYHF  480  
AN_Q9HAY6|_HsBCO1   374 --------NLIKVASTTATALKEEDGQVYCQP-------EFLYEGLELPRVNYA-HNGKQYRY  420  
AN_O24592|_ZmNCED1  473 ------------------------------------------QVNLEVGMVNRN-LLGRETRY  492  
AN_Q45VT7|_ZmCCD1   404 ------------------------------------------VSAVDFPRVNES-YTGRKQRY  423  
AN_Q9M9F5|_AtNCED9  530 ------------------------------------------QVNLEAGMVNRN-LLGRKTRY  549  
AN_Q9LRR7|_AtNCED3  473 ------------------------------------------QVNLEAGMVNRN-MLGRKTKF  492  
AN_Q9C6Z1|_AtNCED5  462 ------------------------------------------QMNLEAGMVNRN-LLGRKTRY  481  
AN_O49505|_AtNCED2  454 ------------------------------------------DVNLEIGMVNRN-RLGRKTRF  473  
AN_Q9LRM7|_AtNCED6  451 ------------------------------------------GVNLEAGHINRS-YVGRKSQF  470  
AN_O49675|_AtCCD4   460 ------------------------------------------ARNLDFAVINPA-FLGRCSRY  479  
AN_O65572|_AtCCD1   396 ------------------------------------------ASAVDFPRINEC-YTGKKQRY  415  
AN_Q7XJM2|_AtCCD7   484 ------------------------------------------NKPSDFPVINSS-WSGKKNKY  503  
AN_Q8VY26|_AtCCD8   451 ------------------------------------------GRAMDMCSINPL-YLGQKYRY  470  
AN_P74334|_S.ACO    366 ------------------------------------------SRCCEFPVVHPQ-QVGRPYRY  385  
AN_Q9NKW9|_DmNinaB  459 RYEEENLVNLVTMEGSQAEAFQGTN-GIQLRPEM------LCDWGCETPRIYYERYMGKNYRY  514  
AN_Q6E4P5|_LeCCD1   400 ------------------------------------------ESAVDFPRINEN-YTGRKQRY  419  
An_Q8LP16|_PsNCED2  475 ------------------------------------------HMNLEAGMVNKN-KLGRKTQF  494  
AN_Q8LP15|_PsNCED3  477 ------------------------------------------QMNLEAGMVNRN-RLGRKTRF  496  
AN_Q9AXZ3|_PaNCED1  443 ------------------------------------------HLNLEVGMVNRN-RLGRGPGV  462  
AN_Q9AXZ4|_PaNCED3  497 ------------------------------------------PLNLEAGMVNRN-RLGRKTRF  516  
AN_C5H805|_LeNCED2  302 ------------------------------------------QVNLEAGMVNRN-KLGRKTQF  321  
AN_Q70YP8|_BoLCO    233 ------------------------------------------AENLDFGVIHRG-YSGRKSRY  252  
AN_Q84K96|_CsZCD    233 ------------------------------------------AENLDFGVIHRG-YSGRKSRY  252  
AN_Q8LP17|_PsCCD1   396 ------------------------------------------ASTVDFPRVNES-YTGRKQRY  415  
AN_O06785|_MtCCO    374 ------------------------------------------DRAQEFPRINET-LVGGPHRF  393  
AN_Q99NF1|_MmBCO2   379 --------NLSPLSYSSASAVKQGDGEIWCSPENLHHEDLEEEGGIEFPQINYGRFNGKKYSF  433  
AN_Q9JJS6|_MmBCO1   374 --------NLVKVSSTTATALKEKDGHVYCQP-------EVLYEGLELPRINYA-YNGKPYRY  420  
AN_Q2GA76|_NaCCO    349 ------------------------------------------DTAAEFPRIDDR-FTGQKTRH  368  
AN_Q53353|_PpLSD    346 ------------------------------------------DRPDEFPRIDER-YATRAYRH  365  
An_O24023|_LeNCED1  478 ------------------------------------------QVNLEAGMVNRN-KLGRKTEY  497  
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AN_Q5GN50|_GfCarX   477 ------------------------------------------AIPFEFPSVRPD-REMQEARY  496  
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AN_Q28175|_BtRPE65  434 AYGLGLNH--F-----------V-PDRLCKLNVKT----------------------------  454  
AN_Q16518|_HsRPE65  434 AYGLGLNH--F-----------V-PDRLCKLNVKT----------------------------  454  
AN_Q9BYV7|_HsBCO2   481 FYGCGFRH--L-----------V-GDSLIKVDVVN----------------------------  501  
AN_Q9HAY6|_HsBCO1   421 VFATGVQW-SP-----------I-PTKIIKYDILT----------------------------  442  
AN_O24592|_ZmNCED1  493 AYLAVAEP-WP-----------K-VSGFAKVDLST----------------------------  514  
AN_Q45VT7|_ZmCCD1   424 VYCTILDS-IA-----------K-VTGIIKFDLHA----------------------------  445  
AN_Q9M9F5|_AtNCED9  550 AYLALTEP-WP-----------K-VSGFAKVDLST----------------------------  571  
AN_Q9LRR7|_AtNCED3  493 AYLALAEP-WP-----------K-VSGFAKVDLTT----------------------------  514  
AN_Q9C6Z1|_AtNCED5  482 AYLAIAEP-WP-----------K-VSGFAKVDLST----------------------------  503  
AN_O49505|_AtNCED2  474 AFLAIAYP-WP-----------K-VSGFAKVDLCT----------------------------  495  
AN_Q9LRM7|_AtNCED6  471 VYIAIADP-WP-----------K-CSGIAKVDIQN----------------------------  492  
AN_O49675|_AtCCD4   480 VYAAIGDP-MP-----------K-ISGVVKLDVSK----------------------------  501  
AN_O65572|_AtCCD1   416 VYGTILDS-IA-----------K-VTGIIKFDLHA----------------------------  437  
AN_Q7XJM2|_AtCCD7   504 MYSAASSG-TRS--EL---PHFP-FDMVVKFDLDS----------------------------  531  
AN_Q8VY26|_AtCCD8   471 VYACGAQRPCN-----------F-PNALSKVDIVE----------------------------  493  
AN_P74334|_S.ACO    386 VYMGAAHH-ST--------GNAP-LQAILKVDLES----------------------------  410  
AN_Q9NKW9|_DmNinaB  515 FYAISSDV-DA-----------VNPGTLIKVDVWN----------------------------  537  
AN_Q6E4P5|_LeCCD1   420 VYGTTLNS-IA-----------K-VTGVIKFDLHA----------------------------  441  
An_Q8LP16|_PsNCED2  495 AYLALAEP-WP-----------K-VSGFAKVDLFS----------------------------  516  
AN_Q8LP15|_PsNCED3  497 AYLAVAEP-WP-----------K-VSGFAKVDLES----------------------------  518  
AN_Q9AXZ3|_PaNCED1  463 SLSSHCRP-WP-----------K-VSGFAKVDLST----------------------------  484  
AN_Q9AXZ4|_PaNCED3  517 AYLAIAEP-WP-----------K-VSGIAKVDLGT----------------------------  538  
AN_C5H805|_LeNCED2  322 AYLAIAEP-WP-----------K-VSGFAKVDLST----------------------------  343  
AN_Q70YP8|_BoLCO    253 AYLGVGDP-MP-----------K-IRGVVKVDFEL----------------------------  274  
AN_Q84K96|_CsZCD    253 AYLGVGDP-MP-----------K-IRGVVKVDFEL----------------------------  274  
AN_Q8LP17|_PsCCD1   416 VYGTTLDS-IA-----------K-VTGIIKFDLHA----------------------------  437  
AN_O06785|_MtCCO    394 AYTVGIEG-GF--LVGA--GAAL-STPLYKQDCVT----------------------------  422  
AN_Q99NF1|_MmBCO2   434 FYGCGFRH--L-----------V-GDSLIKVDVTN----------------------------  454  
AN_Q9JJS6|_MmBCO1   421 IFAAEVQW-SP-----------V-PTKILKYDILT----------------------------  442  
AN_Q2GA76|_NaCCO    369 GWFLEMDMKRPVELRGGSAGGLL-MNCLFHKDFET----------------------------  402  
AN_Q53353|_PpLSD    366 GWMLILDTEKPYEAPGGA-FYAL-TNTLGHIDLAT----------------------------  398  
An_O24023|_LeNCED1  498 AYLAIAEP-WP-----------K-VSGFAKVNLFT----------------------------  519  
AN_Q5GN50|_GfCarX   497 IYGCSTST-SCFGVALG--RADK-VDLLVKMDAKTLIQRGKKMNATSITGCVDRRSVCEILQE  555  
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AN_Q28175|_BtRPE65  455 ----KE-------------TWVW-QEPDSYPSEPIFVSHP-D-----ALEEDDGVVLSVVVSP  493  
AN_Q16518|_HsRPE65  455 ----KE-------------TWVW-QEPDSYPSEPIFVSHP-D-----ALEEDDGVVLSVVVSP  493  
AN_Q9BYV7|_HsBCO2   502 ----KT-------------LKVW-REDGFYPSEPVFVPAP-G-----TNEEDGGVILSVVITP  540  
AN_Q9HAY6|_HsBCO1   443 ----KS-------------SLKW-REDDCWPAEPLFVPAP-G-----AKDEDDGVILSAIVST  481  
AN_O24592|_ZmNCED1  515 ----GE-------------LTKFEYGEGRFGGEPCFVPMDPAA--AHPRGEDDGYVLTFVHDE  558  
AN_Q45VT7|_ZmCCD1   446 ----EPESGVKVLEVGGNVQGIYDLGPGRFGSEAIFVPKHPG----VSGEEDDGYLIFFVHDE  500  
AN_Q9M9F5|_AtNCED9  572 ----GE-------------IRKYIYGEGKYGGEPLFLPSG-D------GEEDGGYIMVFVHDE  610  
AN_Q9LRR7|_AtNCED3  515 ----GE-------------VKKHLYGDNRYGGEPLFLPGE-G------GEEDEGYILCFVHDE  553  
AN_Q9C6Z1|_AtNCED5  504 ----GE-------------VKNHFYGGKKYGGEPFFLPRGLE-----SDGEDDGYIMSFVHDE  544  
AN_O49505|_AtNCED2  496 ----GE-------------MKKYIYGGEKYGGEPFFLPGNSGN---GEENEDDGYIFCHVHDE  538  
AN_Q9LRM7|_AtNCED6  493 ----GT-------------VSEFNYGPSRFGGEPCFVPEG-E------GEEDKGYVMGFVRDE  531  
AN_O49675|_AtCCD4   502 ----GDRD--------DCTVARRMYGSGCYGGEPFFVARDPGN---PEAEEDDGYVVTYVHDE  549  
AN_O65572|_AtCCD1   438 ----EAETGKRMLEVGGNIKGIYDLGEGRYGSEAIYVPRE-T------AEEDDGYLIFFVHDE  489  
AN_Q7XJM2|_AtCCD7   532 ----NL-------------VRTWSTGARRFVGEPMFVPKNSVE---EGEEEDDGYIVVVEYAV  574  
AN_Q8VY26|_AtCCD8   494 ----KK-------------VKNW-HEHGMIPSEPFFVPRP-G-----ATHEDDGVVISIVSEE  532  
AN_P74334|_S.ACO    411 ----GT-------------ETLRSFAPHGFAGEPIFVPRPG------GVAEDDGWLLCLIYKA  450  
AN_Q9NKW9|_DmNinaB  538 ----KS-------------CLTW-CEENVYPSEPIFVPSP-D-----PKSEDDGVILASMVLG  576  
AN_Q6E4P5|_LeCCD1a  442 ----EPETGKSQLEVGGNVQGIFDLGPGRFGSEAVFVPSRPG----TEREEDDGYLIFFVHDE  496  
An_Q8LP16|_PsNCED2  517 ----GE-------------VKKYLYGENRFGGEPLFLPNE-D-----SENEDDGYILTFVHDE  556  
AN_Q8LP15|_PsNCED3  519 ----GE-------------VKKHSYGDGRFGGEPFFLPTRRSGRCEYENEEDGGYIMALVHDE  564  
AN_Q9AXZ3|_PaNCED1  485 ----GE-------------VTKFIYGEQCYGGEPYFVSRDPV------APEDDGYVLSFMHDE  524  
AN_Q9AXZ4|_PaNCED3  539 ----GE-------------VNRFVYGERQFGGEPYFIPREPS----TSGREDDGYVVSFMHDE  580  
AN_C5H805|_LeNCED2  344 ----GE-------------IKKHIYGDKRYGGEPLFLPRNVN-----SEKEDDGYILAFCHDE  384  
AN_Q70YP8|_BoLCO    275 ----AGRG--------ECVVARREFGVGCFGGEPFFVPASSKK---SGGEEDDGYVVSYLHDE  322  
AN_Q84K96|_CsZCD    275 ----AGRG--------ECVVARREFGVGCFGGEPFFVPASSKK---SGGEEDDGYVVSYLHDE  322  
AN_Q8LP17|_PsCCD1   438 ----EPDSGKTKLEVGGNVQGLYDLGPGRFGSEAVYVPRVPG----TDSEEDDGYLIFFVHDE  492  
AN_O06785|_MtCCO    423 ----GS-------------STVASLDPDLLIGEMVFVPNP-S-----ARAEDDGILMGYGWHR  462  
AN_Q99NF1|_MmBCO2   455 ----KT-------------LRVW-REEGFYPSEPVFVPVP-G-----ADEEDSGVILSVVITP  493  
AN_Q9JJS6|_MmBCO1   443 ----KS-------------SLKW-SEESCWPAEPLFVPTP-G-----AKDEDDGVILSAIVST  481  
AN_Q2GA76|_NaCCO    403 ----GR-------------EQHWWCGPVSSLQEPCFVPRA-K-----DAPEGDGWIVQVCNRL  442  
AN_Q53353|_PpLSD    399 ----GK-------------SSSWWAGPRCAIQEPCFIPRS-P-----DAPEGDGYVIALVDDH  438  
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An_O24023|_LeNCED1  520 ----GE-------------VEKFIYGDNKYGGEPLFLPRDPN-----SKEEDDGYILAFVHDE  560  
AN_Q5GN50|_GfCarX   556 QRKDDP-------------IYIFRLPPNHYAQEPRFVPRAC------STEEDDGYLLFYVFDE  599  
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AN_Q28175|_BtRPE65  494 GA----------GQKPAYLLILNAKDLSE--VARAE--VEINI-------PVTFHGLFKK---  532  
AN_Q16518|_HsRPE65  494 GA----------GQKPAYLLILNAKDLSE--VARAE--VEINI-------PVTFHGLFKK---  532  
AN_Q9BYV7|_HsBCO2   541 NQ----------NE-SNFILVLDAKNFEE--LGRAE--VPVQM-------PYGFHGTFIP---  578  
AN_Q9HAY6|_HsBCO1   482 DP----------QK-LPFLLILDAKSFTE--LARAS--VDVDM-------HMDLHGLFITDMD  522  
AN_O24592|_ZmNCED1  559 R----------AGT--SELLVVNAADMRL--EATVQ--LPSRV-------PFGFHGTFITGQE  598  
AN_Q45VT7|_ZmCCD1   501 N----------TGK--SEVNVIDAKTMSADPVAVVE--LPNRV-------PYGFHAFFVTEDQ  542  
AN_Q9M9F5|_AtNCED9  611 E----------KVK--SELQLINAVNMKL--EATVT--LPSRV-------PYGFHGTFISKED  650  
AN_Q9LRR7|_AtNCED3  554 K----------TWK--SELQIVNAVSLEV--EATVK--LPSRV-------PYGFHGTFIGADD  593  
AN_Q9C6Z1|_AtNCED5  545 E----------SWE--SELHIVNAVTLEL--EATVK--LPSRV-------PYGFHGTFVNSAD  584  
AN_O49505|_AtNCED2  539 E----------TKT--SELQIINAVNLKL--EATIK--LPSRV-------PYGFHGTFVDSNE  578  
AN_Q9LRM7|_AtNCED6  532 E----------KDE--SEFVVVDATDMKQ--VAAVR--LPERV-------PYGFHGTFVSENQ  571  
AN_O49675|_AtCCD4   550 V----------TGE--SKFLVMDAKSPELEIVAAVR--LPRRV-------PYGFHGLFVKESD  591  
AN_O65572|_AtCCD1   490 N----------TGK--SCVTVIDAKTMSAEPVAVVE--LPHRV-------PYGFHALFVTEEQ  531  
AN_Q7XJM2|_AtCCD7   575 S----------VER--CYLVILDAKKIGE-SDAVVS--SVNKVYIAKINYIICVHSFYFDRNI  622  
AN_Q8VY26|_AtCCD8   533 N----------G-G--SFAILLDGSSFEE--IARAK--FPYGL-------PYGLHGCWIPK--  569  
AN_P74334|_S.ACO    451 D----------LHR--SELVILDAQDITAPAIATLK--LKHHI-------PYPLHGSWAQ---  489  
AN_Q9NKW9|_DmNinaB  577 GL----------NDRYVGLIVLCAKTMTE--LGRCDFHTNGPV-------PKCLHGWFAPN--  618  
AN_Q6E4P5|_LeCCD1   497 N----------TGK--SAVNVIDAKTMSAEPVAVVE--LPKRV-------PYGFHAFFVTEEQ  538  
An_Q8LP16|_PsNCED2  557 K----------EWK--SEIQIVNAVNLKL--EACIP--LPSRV-------PYGFHGTFIHSKE  596  
AN_Q8LP15|_PsNCED3  565 R----------RCK--SELQIVNAVNLEV--EATVK--LPSRV-------PYGFHGTFVEAKD  604  
AN_Q9AXZ3|_PaNCED1  525 K----------TAR--SELLIVNAITMQL--EASVK--LPSRV-------PYGFHGTFISSKD  564  
AN_Q9AXZ4|_PaNCED3  581 K----------TSR--SELLILNAMNMRL--EASVM--LPSRV-------PYGFHGTFISSRD  620  
AN_C5H805|_LeNCED2  385 K----------TWK--SELQIVNAMTLEL--EATVK--LPSRV-------PYGFHGTFISSKD  424  
AN_Q70YP8|_BoLCO    323 G----------KGE--SSFVVMDARSAQLEILAEVV--LPRRV-------PYGFHGLFVTDKD  364  
AN_Q84K96|_CsZCD    323 G----------KGE--SSFVVMDARSPELEILAEVV--LPRRV-------PYGFHGLFVTEAE  364  
AN_Q8LP17|_PsCCD1   493 N----------TGK--SFVHVIDAKRMSAEPVAVVE--LPQRV-------PYGFHAFFVTEDQ  534  
AN_O06785|_MtCCO    463 G----------RDE--GQLLLLDAQTLES--IATVH--LPQRV-------PMGFHGNWAP---  499  
AN_Q99NF1|_MmBCO2   494 NQ----------SE-SNFLLVLDAKSFTE--LGRAE--VPVQM-------PYGFHGTFVP---  531  
AN_Q9JJS6|_MmBCO1   482 DP----------QK-LPFLLILDAKSFTE--LARAS--VDADM-------HLDLHGLFIPDAD  522  
AN_Q2GA76|_NaCCO    443 E----------EQR--SDLLIFDALDIEKGPVATVN--IPIRL-------RFGLHGNWANADE  484  
AN_Q53353|_PpLSD    439 V----------ANY--SDLAIFDAQHVDQGPIARAK--LPVRI-------RQGLHGNWADASR  480  
An_O24023|_LeNCED1  561 K----------EWK--SELQIVNAMSLKL--EATVK--LPSRV-------PYGFHGTFINAND  600  
AN_Q5GN50|_GfCarX   600 SQLLPSGDCPPSAT--SELWILDAKNMRD-VVAKVR--LPQRV-------PYGLHGTWFSSQD  650  
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AN_Q28175|_BtRPE65  533 ---------------------------------------------------------------  532  
AN_Q16518|_HsRPE65  533 ---------------------------------------------------------------  532  
AN_Q9BYV7|_HsBCO2   579 ---------------------------------------------------------------  578  
AN_Q9HAY6|_HsBCO1   523 WDTKKQAASEE---------------QRDR----ASDCHGAP---------------------  545  
AN_O24592|_ZmNCED1  599 LE---------------------------------------AQ--------------------  602  
AN_Q45VT7|_ZmCCD1   543 LA---------------------------------------RQA-------------------  547  
AN_Q9M9F5|_AtNCED9  651 LS---------------------------------------KQ--------------------  654  
AN_Q9LRR7|_AtNCED3  594 LA---------------------------------------KQ--------------------  597  
AN_Q9C6Z1|_AtNCED5  585 ML---------------------------------------N---------------------  587  
AN_O49505|_AtNCED2  579 LV---------------------------------------D---------------------  581  
AN_Q9LRM7|_AtNCED6  572 LK---------------------------------------EQ--------------------  575  
AN_O49675|_AtCCD4   592 L----------------------------------------N---------------------  593  
AN_O65572|_AtCCD1   532 LQ---------------------------------------EQ--------------------  535  
AN_Q7XJM2|_AtCCD7   623 AF-------------------------------------------------------------  624  
AN_Q8VY26|_AtCCD8   570 ---------------------------------------------------------------  569  
AN_P74334|_S.ACO    490 ---------------------------------------------------------------  489  
AN_Q9NKW9|_DmNinaB  619 ---------------------------------------------------------------  618  
AN_Q6E4P5|_LeCCD1a  539 IQ---------------------------------------EQ--------------------  542  
An_Q8LP16|_PsNCED2  597 LE---------------------------------------K---------------------  599  
AN_Q8LP15|_PsNCED3  605 LT-------------------------------------------------------------  606  
AN_Q9AXZ3|_PaNCED1  565 LA---------------------------------------N---------------------  567  
AN_Q9AXZ4|_PaNCED3  621 LA---------------------------------------K---------------------  623  
AN_C5H805|_LeNCED2  425 LQ---------------------------------------N---------------------  427  
AN_Q70YP8|_BoLCO    365 LL---------------------------------------N---------------------  367  
AN_Q84K96|_CsZCD    365 LL---------------------------------------S---------------------  367  
AN_Q8LP17|_PsCCD1   535 LQ---------------------------------------EQ--------------------  538  
AN_O06785|_MtCCO    500 ---------------------------------------------------------------  499  
AN_Q99NF1|_MmBCO2   532 ---------------------------------------------------------------  531  
AN_Q9JJS6|_MmBCO1   523 WNAVKQTPAETQEVENSDHPTDPTAPELSHSENDFTAGHGGS---------------------  564  
AN_Q2GA76|_NaCCO    485 IGLAE----------------------------------KVL---------------------  492  
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AN_Q53353|_PpLSD    481 LA---------------------------------------V---------------------  483  
An_O24023|_LeNCED1  601 LA---------------------------------------N---------------------  603  
AN_Q5GN50|_GfCarX   651 IE---------------------------------------SQRSVESLRSLEVVQRKKEEWV  674  
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AN_Q28175|_BtRPE65  533 ---------------------S  533  
AN_Q16518|_HsRPE65  533 ---------------------S  533  
AN_Q9BYV7|_HsBCO2   579 ---------------------I  579  
AN_Q9HAY6|_HsBCO1   546 --------------------LT  547  
AN_O24592|_ZmNCED1  603 --------------------AA  604  
AN_Q45VT7|_ZmCCD1   548 -------------------EGQ  550  
AN_Q9M9F5|_AtNCED9  655 -------------------ALC  657  
AN_Q9LRR7|_AtNCED3  598 --------------------VV  599  
AN_Q9C6Z1|_AtNCED5  588 --------------------QA  589  
AN_O49505|_AtNCED2  582 --------------------QL  583  
AN_Q9LRM7|_AtNCED6  576 --------------------VF  577  
AN_O49675|_AtCCD4   594 --------------------KL  595  
AN_O65572|_AtCCD1   536 -------------------TLI  538  
AN_Q7XJM2|_AtCCD7   625 -----------------HLSHK  629  
AN_Q8VY26|_AtCCD8   570 ---------------------D  570  
AN_P74334|_S.ACO    490 ---------------------T  490  
AN_Q9NKW9|_DmNinaB  619 --------------------AI  620  
AN_Q6E4P5|_LeCCD1a  543 -------------------AKL  545  
An_Q8LP16|_PsNCED2  600 --------------------QE  601  
AN_Q8LP15|_PsNCED3  607 --------------------FQ  608  
AN_Q9AXZ3|_PaNCED1  568 --------------------QA  569  
AN_Q9AXZ4|_PaNCED3  624 --------------------QA  625  
AN_C5H805|_LeNCED2  428 --------------------QV  429  
AN_Q70YP8|_BoLCO    368 --------------------QA  369  
AN_Q84K96|_CsZCD    368 --------------------QQ  369  
AN_Q8LP17|_PsCCD1   539 -------------------AKF  541  
AN_O06785|_MtCCO    500 --------------------TT  501  
AN_Q99NF1|_MmBCO2   532 ---------------------I  532  
AN_Q9JJS6|_MmBCO1   565 --------------------SL  566  
AN_Q2GA76|_NaCCO    493 --------------------AA  494  
AN_Q53353|_PpLSD    484 --------------------AA  485  
An_O24023|_LeNCED1  604 --------------------QA  605  
AN_Q5GN50|_GfCarX   675 NSGGQIRKSWMVLREKLEKAVG  696  
cons               1324                        1345  
10.2 Zea mays NCED Sequences 
Sequences of the GST-tagged Z. mays NCEDs 1, 2, 3A, 3B and 9. Main sequence is 
shown in red. GST tag is shown in black.  
10.2.1 ZmNCED1 
Accession number for ZmNCED1: ZMU95953. 
 258 ATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTT 
   1  M  S  P  I  L  G  Y  W  K  I  K  G  L  V  Q  P  T  R  L  L  
 318 TTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAA 
  21  L  E  Y  L  E  E  K  Y  E  E  H  L  Y  E  R  D  E  G  D  K  
 378 TGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGAT 
  41  W  R  N  K  K  F  E  L  G  L  E  F  P  N  L  P  Y  Y  I  D  
 438 GGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAAC 
  61  G  D  V  K  L  T  Q  S  M  A  I  I  R  Y  I  A  D  K  H  N  
 498 ATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTG 
  81  M  L  G  G  C  P  K  E  R  A  E  I  S  M  L  E  G  A  V  L  
 558 GATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTT 
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 101  D  I  R  Y  G  V  S  R  I  A  Y  S  K  D  F  E  T  L  K  V  
 618 GATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAA 
 121  D  F  L  S  K  L  P  E  M  L  K  M  F  E  D  R  L  C  H  K  
 678 ACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGAT 
 141  T  Y  L  N  G  D  H  V  T  H  P  D  F  M  L  Y  D  A  L  D  
 738 GTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAA 
 161  V  V  L  Y  M  D  P  M  C  L  D  A  F  P  K  L  V  C  F  K  
 798 AAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCA 
 181  K  R  I  E  A  I  P  Q  I  D  K  Y  L  K  S  S  K  Y  I  A  
 858 TGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGAT 
 201  W  P  L  Q  G  W  Q  A  T  F  G  G  G  D  H  P  P  K  S  D  
 918 CTGGTTCCGCGTGGATCCGCCTCCAATTCCGTCAGGTTCTCGCCGCGCGCCGTCAGCTCC 
 221  L  V  P  R  G  S  A  S  N  S  V  R  F  S  P  R  A  V  S  S  
 978 GTGCCGCCCGCCGAGTGCCTCCAAGCGCCGTTCCACAAGCCCGTCGCCGACCTGCCGGCG 
 241  V  P  P  A  E  C  L  Q  A  P  F  H  K  P  V  A  D  L  P  A  
1038 CCGTCCAGGAAGCCCGCCGCCATTGCCGTCCCAGGGCACTCCGCGGCGCCGAGGAAAGCG 
 261  P  S  R  K  P  A  A  I  A  V  P  G  H  S  A  A  P  R  K  A  
1098 GACGGCGGCAAGAAGCAGCTCAACTTGTTCCAGCGCGCCGCGGCGGCCGCGCTCGACGCG 
 281  D  G  G  K  K  Q  L  N  L  F  Q  R  A  A  A  A  A  L  D  A  
1158 TTCGAGGAAGGGTTCGTGGCCAACGTCCTGGAGCGGCCCCACGGGCTGCCCAGCACGGCC 
 301  F  E  E  G  F  V  A  N  V  L  E  R  P  H  G  L  P  S  T  A  
1218 GACCCGGCCGTGCAGATCGCCGGCAACTTCGCGCCCGTCGGGGAGAGCCCGCCCGTGCAC 
 321  D  P  A  V  Q  I  A  G  N  F  A  P  V  G  E  S  P  P  V  H  
1278 GAGCTCCCCGTCTCCGGCCGCATCCCGCCCTTCATCGACGGGGTCTACGCGCGCAACGGC 
 341  E  L  P  V  S  G  R  I  P  P  F  I  D  G  V  Y  A  R  N  G  
1338 GCCAACCCCTGCTTCGACCCCGTCGCCGGGCACCACCTCTTCGACGGCGACGGCATGGTG 
 361  A  N  P  C  F  D  P  V  A  G  H  H  L  F  D  G  D  G  M  V  
1398 CACGCGCTGCGGATACGCAACGGCGCCGCCGAGTCCTACGCCTGCCGCTTCACGGAGACC 
 381  H  A  L  R  I  R  N  G  A  A  E  S  Y  A  C  R  F  T  E  T  
1458 GCGCGCCTGCGCCAGGAGCGCGCGATCGGCCGCCCCGTCTTCCCCAAGGCCATTGGCGAG 
 401  A  R  L  R  Q  E  R  A  I  G  R  P  V  F  P  K  A  I  G  E  
1518 CTGCACGGGCACTCCGGGATCGCGCGCCTCGCCCTGTTCTACGCGCGCGCCGCGTGCGGC 
 421  L  H  G  H  S  G  I  A  R  L  A  L  F  Y  A  R  A  A  C  G  
1578 CTCGTGGACCCCTCGGCCGGCACCGGCGTGGCCAACGCCGGCCTCGTCTACTTCAACGGC 
 441  L  V  D  P  S  A  G  T  G  V  A  N  A  G  L  V  Y  F  N  G  
1638 CGCCTGCTCGCCATGTCCGAGGACGACCTCCCCTACCACGTCCGCGTGGCGGACGACGGC 
 461  R  L  L  A  M  S  E  D  D  L  P  Y  H  V  R  V  A  D  D  G  
1698 GACCTCGAGACCGTCGGCCGCTACGACTTCGACGGGCAGCTCGGCTGCGCCATGATCGCG 
 481  D  L  E  T  V  G  R  Y  D  F  D  G  Q  L  G  C  A  M  I  A  
1758 CACCCCAAGCTGGACCCGGCCACCGGGGAGCTCCACGCGCTCAGCTACGACGTCATCAAG 
 501  H  P  K  L  D  P  A  T  G  E  L  H  A  L  S  Y  D  V  I  K  
1818 AGGCCGTACCTCAAGTACTTCTACTTCAGGCCCGACGGCACCAAGTCCGACGACGTGGAG 
 521  R  P  Y  L  K  Y  F  Y  F  R  P  D  G  T  K  S  D  D  V  E  
1878 ATCCCGCTGGAGCAGCCTACGATGATCCACGACTTCGCCATCACCGAGAACTTCGTGGTT 
 541  I  P  L  E  Q  P  T  M  I  H  D  F  A  I  T  E  N  F  V  V  
1938 GTGCCCGACCACCAGGTGGTGTTCAAGCTCCAGGAGATGCTGCGCGGCGGGTCGCCCGTG 
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 561  V  P  D  H  Q  V  V  F  K  L  Q  E  M  L  R  G  G  S  P  V  
1998 GTGCTGGACAAGGAGAAGACGTCGCGGTTCGGCGTGCTCCCCAAGCACGCCGCGGACGCG 
 581  V  L  D  K  E  K  T  S  R  F  G  V  L  P  K  H  A  A  D  A  
2058 TCGGAGATGGCGTGGGTGGACGTGCCGGACTGCTTCTGCTTCCACCTGTGGAACGCGTGG 
 601  S  E  M  A  W  V  D  V  P  D  C  F  C  F  H  L  W  N  A  W  
2118 GAGGACGAGGCGACGGGCGAGGTGGTGGTGATCGGCTCCTGCATGACCCCCGCCGACTCC 
 621  E  D  E  A  T  G  E  V  V  V  I  G  S  C  M  T  P  A  D  S  
2178 ATCTTCAACGAGTCCGACGAGCGCCTGGAGAGCGTGCTGACGGAGATCCGCCTGGACGCG 
 641  I  F  N  E  S  D  E  R  L  E  S  V  L  T  E  I  R  L  D  A  
2238 CGCACGGGCCGGTCCACGCGCCGCGCCGTCCTGCCGCCGTCGCAGCAGGTGAACCTGGAG 
 661  R  T  G  R  S  T  R  R  A  V  L  P  P  S  Q  Q  V  N  L  E  
2298 GTGGGCATGGTGAACCGCAACCTGCTGGGCCGCGAGACCCGGTACGCGTACCTCGCGGTG 
 681  V  G  M  V  N  R  N  L  L  G  R  E  T  R  Y  A  Y  L  A  V  
2358 GCGGAGCCGTGGCCCAAGGTGTCGGGCTTCGCCAAGGTGGACCTGTCCACGGGCGAGCTC 
 701  A  E  P  W  P  K  V  S  G  F  A  K  V  D  L  S  T  G  E  L  
2418 ACCAAGTTCGAGTACGGCGAGGGCCGGTTCGGCGGCGAGCCATGCTTCGTGCCCATGGAC 
 721  T  K  F  E  Y  G  E  G  R  F  G  G  E  P  C  F  V  P  M  D  
2478 CCGGCCGCGGCCCACCCGCGCGGCGAGGACGACGGGTACGTGCTCACCTTCGTCCACGAC 
 741  P  A  A  A  H  P  R  G  E  D  D  G  Y  V  L  T  F  V  H  D  
2538 GAGCGCGCCGGCACGTCGGAGCTACTTGTGGTCAATGCCGCCGACATGCGGCTGGAGGCC 
 761  E  R  A  G  T  S  E  L  L  V  V  N  A  A  D  M  R  L  E  A  
2598 ACGGTCCAGCTGCCGTCCCGCGTGCCCTTCGGCTTCCACGGCACCTTCATCACGGGCCAG 
 781  T  V  Q  L  P  S  R  V  P  F  G  F  H  G  T  F  I  T  G  Q  
2658 GAGCTCGAGGCCCAGGCGGCCTGA 
 801  E  L  E  A  Q  A  A  * 
 
10.2.2 ZmNCED2 
258 ATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTT 
   1  M  S  P  I  L  G  Y  W  K  I  K  G  L  V  Q  P  T  R  L  L  
 318 TTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAA 
  21  L  E  Y  L  E  E  K  Y  E  E  H  L  Y  E  R  D  E  G  D  K  
 378 TGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGAT 
  41  W  R  N  K  K  F  E  L  G  L  E  F  P  N  L  P  Y  Y  I  D  
 438 GGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAAC 
  61  G  D  V  K  L  T  Q  S  M  A  I  I  R  Y  I  A  D  K  H  N  
 498 ATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTG 
  81  M  L  G  G  C  P  K  E  R  A  E  I  S  M  L  E  G  A  V  L  
 558 GATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTT 
 101  D  I  R  Y  G  V  S  R  I  A  Y  S  K  D  F  E  T  L  K  V  
 618 GATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAA 
 121  D  F  L  S  K  L  P  E  M  L  K  M  F  E  D  R  L  C  H  K  
 678 ACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGAT 
 141  T  Y  L  N  G  D  H  V  T  H  P  D  F  M  L  Y  D  A  L  D  
 738 GTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAA 
 161  V  V  L  Y  M  D  P  M  C  L  D  A  F  P  K  L  V  C  F  K  
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 798 AAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCA 
 181  K  R  I  E  A  I  P  Q  I  D  K  Y  L  K  S  S  K  Y  I  A  
 918 TGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGAT 
 201  W  P  L  Q  G  W  Q  A  T  F  G  G  G  D  H  P  P  K  S  D  
 978 CTGGTTCCGCGTGGATCCGCAGCGGCAGCGGCCAACTCGGTCTTCAGCGCGCCGCCCGCA 
 221  L  V  P  R  G  S  A  A  A  A  A  N  S  V  F  S  A  P  P  A  
1038 GCCGTGCGCTACGCCGCGCCGCCCAAGCCGGCGGCGCCCATTGCGCCAGTGCCCGCTCCG 
 241  A  V  R  Y  A  A  P  P  K  P  A  A  P  I  A  P  V  P  A  P  
1098 GCGCCGGCGGCGGGCGGCGAGAAAGGCCTGAGCTTCCTGCAGCGCGCGGCGTCGGCGGCG 
 261  A  P  A  A  G  G  E  K  G  L  S  F  L  Q  R  A  A  S  A  A  
1158 CTGGACGCGTTCGAATCCGGCGTGATCGCGGGCCTCCTGGAGCGTCCCCGCGCGCTGCCC 
 281  L  D  A  F  E  S  G  V  I  A  G  L  L  E  R  P  R  A  L  P  
1218 CGGTCGGCGGACCCGGCCGTGCAGATCGCCGGCAACTTCGCCCCCGTCGGCGAGCAGCCG 
 301  R  S  A  D  P  A  V  Q  I  A  G  N  F  A  P  V  G  E  Q  P  
1278 CCCGTGCGGTCGCTGCCCGTGTCGGGCCGCATCCCGCCCTTCATCTCCGGCGTGTACGCG 
 321  P  V  R  S  L  P  V  S  G  R  I  P  P  F  I  S  G  V  Y  A  
1338 CGCAACGGCGCCAACCCCTGCTTCGACCCCGCCGCGGGGCACCACCTGTTCGACGGCGAC 
 341  R  N  G  A  N  P  C  F  D  P  A  A  G  H  H  L  F  D  G  D  
1398 GGCATGGTGCACGCGGTCCGCATCCGCAACGGCGCCGCGGAGTCGTACGCGTGCCGCTTC 
 361  G  M  V  H  A  V  R  I  R  N  G  A  A  E  S  Y  A  C  R  F  
1458 ACCGAGACGGCGCGGCTCCGGCAGGAGCGCGCCCTGGGGCGGGCCGTGTTCCCCAAGGCC 
 381  T  E  T  A  R  L  R  Q  E  R  A  L  G  R  A  V  F  P  K  A  
1518 ATCGGCGAGCTGCACGGCCACTCCGGGATCGCGCGCCTGGCGCTCTTCTACGCGCGCGGC 
 401  I  G  E  L  H  G  H  S  G  I  A  R  L  A  L  F  Y  A  R  G  
1578 CTCTGCGGCCTCGTCGACGCGTCCCGCGGCACGGGCGTCGCCAACGCCGGCCTCGTCTAC 
 421  L  C  G  L  V  D  A  S  R  G  T  G  V  A  N  A  G  L  V  Y  
1638 TTCAACGGCCGCCTGCTGGCCATGTCCGAGGACGACCTACCGTACCAGGTGCGCGTGACC 
 441  F  N  G  R  L  L  A  M  S  E  D  D  L  P  Y  Q  V  R  V  T  
1698 GCCGACGGGGACCTCCGCACCGTCGGGCGCTACGACTTCGAAGGGCAGCTCGGGTGCGCC 
 461  A  D  G  D  L  R  T  V  G  R  Y  D  F  E  G  Q  L  G  C  A  
1758 AGCATGATCGCGCACCCCAAGCTGGACCCGGCCTCCGGCGACCTCTTCGCGCTCAGCTAC 
 481  S  M  I  A  H  P  K  L  D  P  A  S  G  D  L  F  A  L  S  Y  
1818 GACGTCATCCGGCGGCCCTACCTGAGGTACTTCTACTTCCGGCCCGACGGCACCAAGTCC 
 501  D  V  I  R  R  P  Y  L  R  Y  F  Y  F  R  P  D  G  T  K  S  
1878 GACGACGTGGAGATCCCGCTGGAGCAGCCGACCATGATCCACGACTTCGCCATCACGGAG 
 521  D  D  V  E  I  P  L  E  Q  P  T  M  I  H  D  F  A  I  T  E  
1938 CGGTTCGTGGTGGTGCCCGACCACCAGGTGGTGTTCAAGCTCGGCGAGATGCTCCGCGGC 
 541  R  F  V  V  V  P  D  H  Q  V  V  F  K  L  G  E  M  L  R  G  
1998 GGGTCCCCCGTGGTGCTGGACCAGGGCAAGACGTCCCGCTTCGGCGTGCTGCCCAAGTAC 
 561  G  S  P  V  V  L  D  Q  G  K  T  S  R  F  G  V  L  P  K  Y  
2058 GCGCGCGACGCGTCGGAGATGGTGTGGGTGGACGTGCCGGACTGCTTCTGCTTCCACCTG 
 581  A  R  D  A  S  E  M  V  W  V  D  V  P  D  C  F  C  F  H  L  
2118 TGGAACGCGTGGGAGGAGCCCGGCACGGGGGAGGTGGTGGTGGTCGGGTCCTGCATGACC 
 601  W  N  A  W  E  E  P  G  T  G  E  V  V  V  V  G  S  C  M  T  
2178 CCCGCCGACTCCATCTTCAACGACGACGGCGGCGAGGACGGGCGGCTCCAGAGCGTGCTG 
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 621  P  A  D  S  I  F  N  D  D  G  G  E  D  G  R  L  Q  S  V  L  
2238 ACCGAGATCCGGCTGGACACGCGCACGGGCGCGTCCACGCGCCGCGCCGTGCTGCCTCCG 
 641  T  E  I  R  L  D  T  R  T  G  A  S  T  R  R  A  V  L  P  P  
2298 TCGGCGCAGGTGAACCTGGAGGTCGGGATGGTGAACCGCAACATGGTGGGGCGGAGGACG 
 661  S  A  Q  V  N  L  E  V  G  M  V  N  R  N  M  V  G  R  R  T  
2358 CGGTACGCGTACCTGGCCGTGGCGGAGCCGTGGCCCAAGGTGTCCGGGTTCGCCAAGGTG 
 681  R  Y  A  Y  L  A  V  A  E  P  W  P  K  V  S  G  F  A  K  V  
2418 GACCTGGACACGGGCGACCTCGTCCGGTTCGACTACGGCGACGGCCGCTTCGGCGGGGAG 
 701  D  L  D  T  G  D  L  V  R  F  D  Y  G  D  G  R  F  G  G  E  
2478 CCCTGCTTCGTGCCCACCGAGGGCGCGCCGGCGCGCGGCGAGGACGACGGCTACATCCTG 
 721  P  C  F  V  P  T  E  G  A  P  A  R  G  E  D  D  G  Y  I  L  
2538 TCCCTCGTCCGCGACGAGCGGGCGGGCACGTCGGAGCTCCTGGTAGTGAACGCCGCCGAC 
 741  S  L  V  R  D  E  R  A  G  T  S  E  L  L  V  V  N  A  A  D  
2598 ATGCGGCTGGAGGCCACGGTCCAGCTACCCTCCCGCGTGCCCTATGGCTTCCACGGCACC 
 761  M  R  L  E  A  T  V  Q  L  P  S  R  V  P  Y  G  F  H  G  T  
2658 TTCATCGGCGAACGGGAGCTAGAGGCCCAGGCCTGA 
 781  F  I  G  E  R  E  L  E  A  Q  A  * 
 
10.2.3 ZmNCED3A 
515 ATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTT 
   1  M  S  P  I  L  G  Y  W  K  I  K  G  L  V  Q  P  T  R  L  L  
 575 TTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAA 
  21  L  E  Y  L  E  E  K  Y  E  E  H  L  Y  E  R  D  E  G  D  K  
 635 TGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGAT 
  41  W  R  N  K  K  F  E  L  G  L  E  F  P  N  L  P  Y  Y  I  D  
 695 GGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAAC 
  61  G  D  V  K  L  T  Q  S  M  A  I  I  R  Y  I  A  D  K  H  N  
 755 ATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTG 
  81  M  L  G  G  C  P  K  E  R  A  E  I  S  M  L  E  G  A  V  L  
 815 GATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTT 
 101  D  I  R  Y  G  V  S  R  I  A  Y  S  K  D  F  E  T  L  K  V  
 875 GATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAA 
 121  D  F  L  S  K  L  P  E  M  L  K  M  F  E  D  R  L  C  H  K  
 935 ACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGAT 
 141  T  Y  L  N  G  D  H  V  T  H  P  D  F  M  L  Y  D  A  L  D  
 995 GTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAA 
 161  V  V  L  Y  M  D  P  M  C  L  D  A  F  P  K  L  V  C  F  K  
1055 AAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCA 
 181  K  R  I  E  A  I  P  Q  I  D  K  Y  L  K  S  S  K  Y  I  A  
1115 TGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGAT 
 201  W  P  L  Q  G  W  Q  A  T  F  G  G  G  D  H  P  P  K  S  D  
1175 CTGGTTCCGCGTGGATCCGCCGCCGCTCCCAAGTGGAACCCGCTCCAGCGGCTCGCCGCG 
 221  L  V  P  R  G  S  A  A  A  P  K  W  N  P  L  Q  R  L  A  A  
1235 GCGGCGCTCGACGCGCTGGAGGAGGGGCTCGTCGCGGGCGTCCTCGAGCGCGCGCACCCG 
 241  A  A  L  D  A  L  E  E  G  L  V  A  G  V  L  E  R  A  H  P  
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1295 CTGCCACGGACCGCCGACCCGGCCGTCCAGATCGCCGGCAACTACGCGCCCGTCGGGGAG 
 261  L  P  R  T  A  D  P  A  V  Q  I  A  G  N  Y  A  P  V  G  E  
1355 CGCCCGCCCACCGGCGAGCTGCCCGTGTCCGGCCGCGTCCCGGCGTGCCTCGACGGCGTG 
 281  R  P  P  T  G  E  L  P  V  S  G  R  V  P  A  C  L  D  G  V  
1415 TACGTCCGCAACGGCGCCAACCCGCTCCACGCGCCGCGCGCGGGGCACCACCTCTTCGAC 
 301  Y  V  R  N  G  A  N  P  L  H  A  P  R  A  G  H  H  L  F  D  
1475 GGCGACGGCATGCTGCACGCCGTGCGGCTCCGCGGGGGCCGCGCCGAGTCGTACGCGTGC 
 321  G  D  G  M  L  H  A  V  R  L  R  G  G  R  A  E  S  Y  A  C  
1535 CGGTTCACGGAGACGGCGCGGCTCAGGCAGGAGCGCGCCATCGGCAGGGCCGTGTTCCCC 
 341  R  F  T  E  T  A  R  L  R  Q  E  R  A  I  G  R  A  V  F  P  
1595 AAGGCCATCGGCGAGCTGCACGGCCACTCGGGCGTGGCGCGCCTGCTCCTCTTCGGCGCC 
 361  K  A  I  G  E  L  H  G  H  S  G  V  A  R  L  L  L  F  G  A  
1655 CGCTCCCTCTGCGGCGTGCTCGACGCGTCCCAGGGGATCGGGGTCGCCAACGCCGGCCTG 
 381  R  S  L  C  G  V  L  D  A  S  Q  G  I  G  V  A  N  A  G  L  
1715 GTGTACCACAACAACCGCCTCCTCGCCATGTCGGAGGACGACCTCCCCTACCACGTGCGC 
 401  V  Y  H  N  N  R  L  L  A  M  S  E  D  D  L  P  Y  H  V  R  
1775 GTCACCGCCGACGGCGACCTCGAGACCGCCGGGCGCTACGACTTCGGCGGCCAGCTCGAC 
 421  V  T  A  D  G  D  L  E  T  A  G  R  Y  D  F  G  G  Q  L  D  
1835 ACCGCCATGATCGCGCACCCCAAGCTGGACCCGGCCACCGGCGAGCTCTTCGCGCTCAGC 
 441  T  A  M  I  A  H  P  K  L  D  P  A  T  G  E  L  F  A  L  S  
1895 TACAATGTCGTGTCCAAGCCGTTCCTCAAGTACTTCTACTTCACCGCCGACGGCCGCAAG 
 461  Y  N  V  V  S  K  P  F  L  K  Y  F  Y  F  T  A  D  G  R  K  
1955 TCCCCCGACGTCGAGATCCCCGTGGACGCGCCCACCATGATGCACGACTTCGCCGTCACC 
 481  S  P  D  V  E  I  P  V  D  A  P  T  M  M  H  D  F  A  V  T  
2015 GAGAACCACGCCATCATCCCGGACCAGCAGATCGTGTTCAAGCTCCAGGAGATGGTGCTG 
 501  E  N  H  A  I  I  P  D  Q  Q  I  V  F  K  L  Q  E  M  V  L  
2075 GGCGGCTCCCCCGTGGTGTACGACAGGAACAAGACCGCGCGGTTCGGGGTGCTGCCGAAG 
 521  G  G  S  P  V  V  Y  D  R  N  K  T  A  R  F  G  V  L  P  K  
2135 CGCGCCACCGACGCGTCGCGGCTGCGGTGGGTGGACGTCCCCGACTGCTTCTGCTTCCAC 
 541  R  A  T  D  A  S  R  L  R  W  V  D  V  P  D  C  F  C  F  H  
2195 CTCTGGAACGCGTGGGAGGACGAGGCCACGGGCGAGGTCGTGGTGATCGGGTCCTGCATG 
 561  L  W  N  A  W  E  D  E  A  T  G  E  V  V  V  I  G  S  C  M  
2255 ACCCCCGCGGACGCCGTGTTCAACGAGTCCGCCGCCGGCGAGGAGAGCTTCCGCAGCGTG 
 581  T  P  A  D  A  V  F  N  E  S  A  A  G  E  E  S  F  R  S  V  
2315 CTGTCGGAGATCCGGCTGGACCCGCGCACCGGCACGTCCTCGCGGCGCGCGGTCCTGAGC 
 601  L  S  E  I  R  L  D  P  R  T  G  T  S  S  R  R  A  V  L  S  
2375 GACGCCGACCAGGTGAACCTGGAGGCCGGCATGGTGAACCGGCAGCTGCTGGGCAGGAGG 
 621  D  A  D  Q  V  N  L  E  A  G  M  V  N  R  Q  L  L  G  R  R  
2435 ACGCGCTACGCCTACCTCGCCATCGCCGAGCCGTGGCCCAAGGTGTCGGGCTTCGCCAAG 
 641  T  R  Y  A  Y  L  A  I  A  E  P  W  P  K  V  S  G  F  A  K  
2495 GTGGACCTCGAGGCCGGCACCGTCGACAAGTTCATCTACGGCGACGGCCGGTACGGCGGC 
 661  V  D  L  E  A  G  T  V  D  K  F  I  Y  G  D  G  R  Y  G  G  
2555 GAGCCCTGCTTCGTGCCGCGCCCCGACGCCCCCGCGGGCGCCGCGGAGGACGACGGCTAC 
 681  E  P  C  F  V  P  R  P  D  A  P  A  G  A  A  E  D  D  G  Y  
2615 GTGCTGTGCTACGTGCACGACGAGGCCCGCGGTGCGTCGGAAATGCTCGTCGTCAACGCC 
 701  V  L  C  Y  V  H  D  E  A  R  G  A  S  E  M  L  V  V  N  A  
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2675 CGCGACATGCGGGCCGAGGCCGCCGTCAAGCTGCCGGGCCGCGTCCCGTACGGGTTGCAC 
 721  R  D  M  R  A  E  A  A  V  K  L  P  G  R  V  P  Y  G  L  H  
2735 GGCACGTTCATCGCCGGCAAGGAGCTGCAGCGGCAGGCCTAG 
 741  G  T  F  I  A  G  K  E  L  Q  R  Q  A  * 
 
10.2.4 ZmNCED3B 
 258 ATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTT 
   1  M  S  P  I  L  G  Y  W  K  I  K  G  L  V  Q  P  T  R  L  L  
 318 TTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAA 
  21  L  E  Y  L  E  E  K  Y  E  E  H  L  Y  E  R  D  E  G  D  K  
 378 TGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGAT 
  41  W  R  N  K  K  F  E  L  G  L  E  F  P  N  L  P  Y  Y  I  D  
 438 GGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAAC 
  61  G  D  V  K  L  T  Q  S  M  A  I  I  R  Y  I  A  D  K  H  N  
 498 ATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTG 
  81  M  L  G  G  C  P  K  E  R  A  E  I  S  M  L  E  G  A  V  L  
 558 GATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTT 
 101  D  I  R  Y  G  V  S  R  I  A  Y  S  K  D  F  E  T  L  K  V  
 618 GATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAA 
 121  D  F  L  S  K  L  P  E  M  L  K  M  F  E  D  R  L  C  H  K  
 678 ACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGAT 
 141  T  Y  L  N  G  D  H  V  T  H  P  D  F  M  L  Y  D  A  L  D  
 738 GTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAA 
 161  V  V  L  Y  M  D  P  M  C  L  D  A  F  P  K  L  V  C  F  K  
 798 AAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCA 
 181  K  R  I  E  A  I  P  Q  I  D  K  Y  L  K  S  S  K  Y  I  A  
 858 TGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGAT 
 201  W  P  L  Q  G  W  Q  A  T  F  G  G  G  D  H  P  P  K  S  D  
 918 CTGGTTCCGCGTGGATCCGCGGCCGCCAAGTGGAACCCGCTCCAGCGGCTCGCCGCGGCG 
 221  L  V  P  R  G  S  A  A  A  K  W  N  P  L  Q  R  L  A  A  A  
 978 GCGCTCGACGCGCTGGAGGAGGGGCTCGTGGCGGGCGTCCTGGAGCGCGCGCACCCGCTG 
 241  A  L  D  A  L  E  E  G  L  V  A  G  V  L  E  R  A  H  P  L  
1038 CCACGGACCGCCGACCCGGCCGTCCAGATCGCCGGCAACTACGCGCCCGTCGGGGAGCGC 
 261  P  R  T  A  D  P  A  V  Q  I  A  G  N  Y  A  P  V  G  E  R  
1098 CCGCCCAGCGGCGAGCTCCCGGTGTCCGGCCGCGTCCCGGCGTGCCTCGACGGCGTGTAC 
 281  P  P  S  G  E  L  P  V  S  G  R  V  P  A  C  L  D  G  V  Y  
1158 GTCCGCAACGGCGCCAACCCGCTCCACGCGCCGCGCGCGGGGCACCACCTCTTCGACGGC 
 301  V  R  N  G  A  N  P  L  H  A  P  R  A  G  H  H  L  F  D  G  
1218 GACGGCATGCTGCACGCCGTGCGGCTCCGCGGGGGCCGCGCCCAGTCCTACGCGTGCCGG 
 321  D  G  M  L  H  A  V  R  L  R  G  G  R  A  Q  S  Y  A  C  R  
1278 TTCACGGAGACGGCGCGGCTCCGGCAGGAGCGCGCCCTCGGCAGGGCCGTCTTCCCCAAG 
 341  F  T  E  T  A  R  L  R  Q  E  R  A  L  G  R  A  V  F  P  K  
1338 GCCATCGGCGAGCTGCACGGCCACTCCGGCGTGGCGCGCCTGCTCCTCTTCGGGGCCCGC 
 361  A  I  G  E  L  H  G  H  S  G  V  A  R  L  L  L  F  G  A  R  
1398 TCCCTCTGCGGCGTGCTCGACGCGTCGCAGGGGATCGGGGTCGCCAACGCCGGCCTGGTG 
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 381  S  L  C  G  V  L  D  A  S  Q  G  I  G  V  A  N  A  G  L  V  
1458 TACCATAACAACCGCCTCCTCGCCATGTCGGAGGACGACCTCCCGTACCACGTGCGCGTC 
 401  Y  H  N  N  R  L  L  A  M  S  E  D  D  L  P  Y  H  V  R  V  
1518 ACCGCCGACGGCGACCTCGAGACCGCCGGGCGCTACGACTTCGGCGGCCAGCTCGACGCC 
 421  T  A  D  G  D  L  E  T  A  G  R  Y  D  F  G  G  Q  L  D  A  
1578 GCAATGATCGCGCACCCCAAGCTGGACCCGGCCACCGGCGAGCTCTTCGCGCTCAGCTAC 
 441  A  M  I  A  H  P  K  L  D  P  A  T  G  E  L  F  A  L  S  Y  
1638 AATGTCGTGTCCAGGCCCTTCCTCAAGTACTTCTACTTCACCGCCGACGGCCGCAAGTCC 
 461  N  V  V  S  R  P  F  L  K  Y  F  Y  F  T  A  D  G  R  K  S  
1698 CCCGACGTCGAGATCCCCGTCGACGCGCCCACCATGATGCACGACTTCGCCGTCACCGAG 
 481  P  D  V  E  I  P  V  D  A  P  T  M  M  H  D  F  A  V  T  E  
1758 AACCACGCCATCATCCCCGACCAGCAGATCGTGTTCAAGCTCCAGGAGATGGTGCTGGGC 
 501  N  H  A  I  I  P  D  Q  Q  I  V  F  K  L  Q  E  M  V  L  G  
1818 GGCTCCCCCGTGGTGTACGACAGGAACAAGACCGCGCGGTTCGGTGTGCTGCCGAAGCGC 
 521  G  S  P  V  V  Y  D  R  N  K  T  A  R  F  G  V  L  P  K  R  
1878 GCCACCGACGCGTCGCGGCTGCAGTGGGTGGACGTCCCCGACTGCTTCTGCTTCCACCTC 
 541  A  T  D  A  S  R  L  Q  W  V  D  V  P  D  C  F  C  F  H  L  
1938 TGGAACGCGTGGGAGGACGAGGCCACGGGCGAGATCGTGGTGATCGGGTCCTGCATGACC 
 561  W  N  A  W  E  D  E  A  T  G  E  I  V  V  I  G  S  C  M  T  
1998 CCGGCCGACGCCGTGTTCAACGAGTCCGCCGGCGAGGAGAGCTTCCGCAGCGTGCTGTCG 
 581  P  A  D  A  V  F  N  E  S  A  G  E  E  S  F  R  S  V  L  S  
2058 GAGATCCGCCTGGACCCGCGCACCGGCACGTCCTCGCGGCGCGCGGTCCTGAGCGACGCC 
 601  E  I  R  L  D  P  R  T  G  T  S  S  R  R  A  V  L  S  D  A  
2118 GACCAGGTGAACCTGGAGGCCGGCATGGTGAACCGGCAGCTGCTGGGCAGGAAGACGCGC 
 621  D  Q  V  N  L  E  A  G  M  V  N  R  Q  L  L  G  R  K  T  R  
2178 TACGCCTACCTCGCCATCGCCGAGCCGTGGCCCAAGGTGTCGGGCTTCGCCAAGGTGGAC 
 641  Y  A  Y  L  A  I  A  E  P  W  P  K  V  S  G  F  A  K  V  D  
2238 CTCGAGGCCGGCACCGTGGAGAAGTTCGTCTACGGCGAGGGCCGGTACGGCGGCGAGCCC 
 661  L  E  A  G  T  V  E  K  F  V  Y  G  E  G  R  Y  G  G  E  P  
2298 TGCTTCGTGCCGCGCCCGGACGCCCCGGCCGCGGAGGATGACGGGTACGTGCTGTGCTAC 
 681  C  F  V  P  R  P  D  A  P  A  A  E  D  D  G  Y  V  L  C  Y  
2358 GTGCACGACGAGGGCCGCGGCGCGTCGGAAATGCTCGTCGTCAACGCCCGCGACATGCGG 
 701  V  H  D  E  G  R  G  A  S  E  M  L  V  V  N  A  R  D  M  R  
2418 GCCGAGGCCGCCGTGAAGCTGCCGAGCCGCGTCCCGTACGGGTTGCACGGCACGTTCATC 
 721  A  E  A  A  V  K  L  P  S  R  V  P  Y  G  L  H  G  T  F  I  
2478 GCCGGCAAGGAGCTGCAGCGGCAGGCCTAG 
 741  A  G  K  E  L  Q  R  Q  A  * 
10.2.5 ZmNCED9 
258 ATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTT 
   1  M  S  P  I  L  G  Y  W  K  I  K  G  L  V  Q  P  T  R  L  L  
 318 TTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAA 
  21  L  E  Y  L  E  E  K  Y  E  E  H  L  Y  E  R  D  E  G  D  K  
 378 TGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGAT 
  41  W  R  N  K  K  F  E  L  G  L  E  F  P  N  L  P  Y  Y  I  D  
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 438 GGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAAC 
  61  G  D  V  K  L  T  Q  S  M  A  I  I  R  Y  I  A  D  K  H  N  
 498 ATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTG 
  81  M  L  G  G  C  P  K  E  R  A  E  I  S  M  L  E  G  A  V  L  
 558 GATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTT 
 101  D  I  R  Y  G  V  S  R  I  A  Y  S  K  D  F  E  T  L  K  V  
 618 GATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAA 
 121  D  F  L  S  K  L  P  E  M  L  K  M  F  E  D  R  L  C  H  K  
 678 ACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGAT 
 141  T  Y  L  N  G  D  H  V  T  H  P  D  F  M  L  Y  D  A  L  D  
 738 GTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAA 
 161  V  V  L  Y  M  D  P  M  C  L  D  A  F  P  K  L  V  C  F  K  
 798 AAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCA 
 181  K  R  I  E  A  I  P  Q  I  D  K  Y  L  K  S  S  K  Y  I  A  
 858 TGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGAT 
 201  W  P  L  Q  G  W  Q  A  T  F  G  G  G  D  H  P  P  K  S  D  
 918 CTGGTTCCGCGTGGATCCGCCTCCAACTCCGTCAGGTTCTCGCCGCGCGCCGTCCGCTCC 
 221  L  V  P  R  G  S  A  S  N  S  V  R  F  S  P  R  A  V  R  S  
 978 GTGCCGCACGAGTGCCTCCAGGCGCCGTTCCACGCCGACCTGCCGGCACCGTCCAAGAAG 
 241  V  P  H  E  C  L  Q  A  P  F  H  A  D  L  P  A  P  S  K  K  
1038 CCCACCGCCATTGCCGTCCCGAGGCACGCCGCGGCGCCGCGCAAGTCTGGCGGCGGCGGC 
 261  P  T  A  I  A  V  P  R  H  A  A  A  P  R  K  S  G  G  G  G  
1098 GGCAAGAAGCAGCTCAACCTATTCCAGCGCGCGGCGGCGGCCGCGCTCGACGCGTTCGAG 
 281  G  K  K  Q  L  N  L  F  Q  R  A  A  A  A  A  L  D  A  F  E  
1158 GAGGGGTTCGTGGCCAACGTCCTCGAGCGGCCCCGCGGGCTGCCCAGCACGGCCGACCCA 
 301  E  G  F  V  A  N  V  L  E  R  P  R  G  L  P  S  T  A  D  P  
1218 GCCGTGCAGATCGCCGGCAACTTCGCGCCCGTCGGGGAGAGGCTGCCCGTGCATCGGCTC 
 321  A  V  Q  I  A  G  N  F  A  P  V  G  E  R  L  P  V  H  R  L  
1278 CCCGTCTCCGGCCGCATCCCGCCCTTCATCAGCGGCGTCTACGCGCGCAACGGCGCCAAC 
 341  P  V  S  G  R  I  P  P  F  I  S  G  V  Y  A  R  N  G  A  N  
1338 CCCTGCTTCGACCCCGTCGCCGGGCACCACCTCTTCGACGGCGACGGCATGGTGCACGCG 
 361  P  C  F  D  P  V  A  G  H  H  L  F  D  G  D  G  M  V  H  A  
1398 CTGCGGATACGCGACGGCGTCGCCGAGTCCTACGCCTGCCGCTTCACCGAGACCGCGCGC 
 381  L  R  I  R  D  G  V  A  E  S  Y  A  C  R  F  T  E  T  A  R  
1458 CTGACCCAGGAGCGCGCGGTCGGCCGCCCCGTCTTCCCCAAGGCCATCGGCGAGCTGCAC 
 401  L  T  Q  E  R  A  V  G  R  P  V  F  P  K  A  I  G  E  L  H  
1518 GGCCACTCCGGGATCGCGCGCCTCGCCCTGTTCTACGCGCGCGCCGCGTGCGGCCTCGTC 
 421  G  H  S  G  I  A  R  L  A  L  F  Y  A  R  A  A  C  G  L  V  
1578 GACCCCTCGGCCGGCACCGGCGTCGCCAACGCCGGACTCGTCTACTTCAACGGCCGCCTC 
 441  D  P  S  A  G  T  G  V  A  N  A  G  L  V  Y  F  N  G  R  L  
1638 CTCGCCATGTCCGAGGACGACCTGCCGTACCACGTCCGCGTCGCGGACGACGGCGACCTC 
 461  L  A  M  S  E  D  D  L  P  Y  H  V  R  V  A  D  D  G  D  L  
1698 GAGACCGTCGGCCGCTACGACTTCGACGGCCAGCTCGGCTGCCCCATGATCGCGCACCCC 
 481  E  T  V  G  R  Y  D  F  D  G  Q  L  G  C  P  M  I  A  H  P  
1758 AAGCTGGACCCGGCCACCGGGGAGCTGCACGCGCTCAGCTACGAGGTCGTCAGGAGGCCC 
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 501  K  L  D  P  A  T  G  E  L  H  A  L  S  Y  E  V  V  R  R  P  
1818 TACCTCAAGTACTTCTACTTCAGGCCCGACGGCACCAAGTCCGACGACGTGGAGATCCCG 
 521  Y  L  K  Y  F  Y  F  R  P  D  G  T  K  S  D  D  V  E  I  P  
1878 CTGGCCCAGCCCACCATGATCCACGACTTCGCCATCACCGAGAACTTGGTCGTGGTGCCC 
 541  L  A  Q  P  T  M  I  H  D  F  A  I  T  E  N  L  V  V  V  P  
1938 GACCACCAGGTGGTGTTCAAGCTGCAGGAGATGCTGCGCGGCGGGTCGCCCGTGGTGCTG 
 561  D  H  Q  V  V  F  K  L  Q  E  M  L  R  G  G  S  P  V  V  L  
1998 GACAGGGAGAAGACGTCGCGCTTCGGCGTCCTCCCGAAGCGCGCCGCGGACGCGTCGGAG 
 581  D  R  E  K  T  S  R  F  G  V  L  P  K  R  A  A  D  A  S  E  
2058 ATGGCGTGGGTGGACGTGCCGGACTGCTTCTGCTTCCACCTGTGGAACGCGTGGGAGGAC 
 601  M  A  W  V  D  V  P  D  C  F  C  F  H  L  W  N  A  W  E  D  
2118 GAGGCGACGGGCGAGGTGGTGGTGATCGGCTCCTGCATGACCCCCGCCGACTCCATCTTC 
 621  E  A  T  G  E  V  V  V  I  G  S  C  M  T  P  A  D  S  I  F  
2178 AACGAGTCGGACGTGCGGCTCGAGAGCGTGCTGACGGAGATCCGGCTGGACGCGCGCACG 
 641  N  E  S  D  V  R  L  E  S  V  L  T  E  I  R  L  D  A  R  T  
2238 GGCCGGTCGACGCGCCGCGCCGTCCTGCCGCCGTCGCGGCAGGTGAACCTGGAGGTGGGC 
 661  G  R  S  T  R  R  A  V  L  P  P  S  R  Q  V  N  L  E  V  G  
2298 ATGGTGAACCGCAACCTCCTGGGGCGCAGGACGCGGTACGCGTACCTCGCGGTGGCCGAG 
 681  M  V  N  R  N  L  L  G  R  R  T  R  Y  A  Y  L  A  V  A  E  
2358 CCGTGGCCCAAGGTCTCGGGCTTCGCCAAGGTGGACCTGGCCACGGGCGAGCTCGCCAGG 
 701  P  W  P  K  V  S  G  F  A  K  V  D  L  A  T  G  E  L  A  R  
2418 TTCGAGTACGGCGAGGGCCGGTTCGGCGGCGAGCCCTGCTTCGTGCCCATGGACCCCGCC 
 721  F  E  Y  G  E  G  R  F  G  G  E  P  C  F  V  P  M  D  P  A  
2478 GCGGCCCACCCGCGCGGCGAGGACGACGGGCACGTGCTCGCCTTCGTCCACGACGAGCGC 
 741  A  A  H  P  R  G  E  D  D  G  H  V  L  A  F  V  H  D  E  R  
2538 GCCGGCACGTCCGAGCTCCTGGTGGTCAATGCCGCCGACATGCGGCTGGAGGCCACCGTC 
 761  A  G  T  S  E  L  L  V  V  N  A  A  D  M  R  L  E  A  T  V  
2598 CGGCTCCCGTCCCGCGTGCCCTTCGGCTTCCACGGCACCTTCATCACGGGCGCGGAGCTC 
 781  R  L  P  S  R  V  P  F  G  F  H  G  T  F  I  T  G  A  E  L  
2658 GAGGCCCAGGCCTGA 
 801  E  A  Q  A  * 
10.3 Arabidopsis thaliana ABA2 Optimised Sequence 
Accession number of native A. thaliana ABA2 sequence: BT003412. Optimised 
sequence contains no introns. His tag is shown in black. Main ABA2 sequence is shown in 
red. 
297 ATGCGGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTGGACAGCAA 
   1  M  R  G  S  H  H  H  H  H  H  G  M  A  S  M  T  G  G  Q  Q  
 357 ATGGGTCGGGATCTGTACGACGATGACGATAAGGATCATCCCTTCACCATGTCAACGAAT 
  21  M  G  R  D  L  Y  D  D  D  D  K  D  H  P  F  T  M  S  T  N  
 417 ACCGAATCCTCTTCTTACTCATCTCTGCCGAGCCAACGCCTGCTGGGCAAAGTCGCTCTG 
  41  T  E  S  S  S  Y  S  S  L  P  S  Q  R  L  L  G  K  V  A  L  
 477 ATTACGGGTGGTGCGACCGGCATTGGTGAATCTATCGTTCGTCTGTTCCATAAACACGGC 
  61  I  T  G  G  A  T  G  I  G  E  S  I  V  R  L  F  H  K  H  G  
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 537 GCTAAAGTGTGCATTGTTGATCTGCAGGATGACCTGGGCGGTGAAGTGTGTAAATCCCTG 
  81  A  K  V  C  I  V  D  L  Q  D  D  L  G  G  E  V  C  K  S  L  
 597 CTGCGTGGCGAATCAAAAGAAACCGCATTTTTCATTCATGGTGATGTCCGCGTGGAAGAT 
 101  L  R  G  E  S  K  E  T  A  F  F  I  H  G  D  V  R  V  E  D  
 657 GACATCTCAAACGCCGTGGATTTCGCAGTTAAAAATTTTGGTACGCTGGACATTCTGATC 
 121  D  I  S  N  A  V  D  F  A  V  K  N  F  G  T  L  D  I  L  I  
 717 AACAATGCTGGTCTGTGCGGTGCACCGTGTCCGGATATCCGTAACTATAGCCTGTCTGAA 
 141  N  N  A  G  L  C  G  A  P  C  P  D  I  R  N  Y  S  L  S  E  
 777 TTCGAAATGACCTTTGACGTTAATGTCAAAGGCGCCTTTCTGTCCATGAAACACGCGGCC 
 161  F  E  M  T  F  D  V  N  V  K  G  A  F  L  S  M  K  H  A  A  
 837 CGCGTTATGATTCCGGAGAAAAAAGGTAGTATCGTCTCCCTGTGCTCAGTGGGTGGTGTG 
 181  R  V  M  I  P  E  K  K  G  S  I  V  S  L  C  S  V  G  G  V  
 897 GTTGGTGGTGTTGGTCCGCATTCTTATGTCGGTAGTAAACACGCAGTGCTGGGTCTGACG 
 201  V  G  G  V  G  P  H  S  Y  V  G  S  K  H  A  V  L  G  L  T  
 957 CGTTCGGTTGCAGCTGAACTGGGCCAACATGGTATTCGCGTCAACTGTGTGAGCCCGTAC 
 221  R  S  V  A  A  E  L  G  Q  H  G  I  R  V  N  C  V  S  P  Y  
1017 GCTGTGGCGACCAAACTGGCCCTGGCACACCTGCCGGAAGAAGAACGTACGGAAGATGCC 
 241  A  V  A  T  K  L  A  L  A  H  L  P  E  E  E  R  T  E  D  A  
1077 TTTGTGGGCTTCCGCAACTTTGCGGCCGCAAACGCAAATCTGAAAGGTGTTGAACTGACG 
 261  F  V  G  F  R  N  F  A  A  A  N  A  N  L  K  G  V  E  L  T  
1137 GTTGATGACGTCGCTAATGCGGTCCTGTTCCTGGCCTCGGATGACAGCCGCTACATCAGC 
 281  V  D  D  V  A  N  A  V  L  F  L  A  S  D  D  S  R  Y  I  S  
1197 GGTGATAACCTGATGATCGACGGCGGCTTCACCTGCACCAACCATTCGTTCAAAGTGTTT 
 301  G  D  N  L  M  I  D  G  G  F  T  C  T  N  H  S  F  K  V  F  
1257 CGCTGA 
 321  R  * 
 
10.4 Oryza Sativa D27 Optimised Sequence 
Accession number of native sequence: FJ641055. Optimised sequence contains no 
introns. His tag is shown in black. Main ABA2 sequence is shown in red. For GST tagged 
construct, GST tag is the same as shown for Z. mays NCED sequences. Truncated protein 
lacks the first 120 base pairs of the red sequence. 
  1 ATGCGGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTGGACAGCAA 
  1  M  R  G  S  H  H  H  H  H  H  G  M  A  S  M  T  G  G  Q  Q  
 61 ATGGGTCGGGATCTGTACGACGATGACGATAAGGATCATCCCTTCACCATGGAAACGACG 
 21  M  G  R  D  L  Y  D  D  D  D  K  D  H  P  F  T  M  E  T  T  
121 ACCCTGGTTCTGCTGCTGCCGCATGGTGGTGCTGGCGGTGTGCGTCCGGCTGCTGCTGCA 
 41  T  L  V  L  L  L  P  H  G  G  A  G  G  V  R  P  A  A  A  A  
181 ACGGCGAAGCGTAGCTATGTTATGCGTCGCTGCTGTTCTACCGTCCGTGCAGTGATGGCA 
 61  T  A  K  R  S  Y  V  M  R  R  C  C  S  T  V  R  A  V  M  A  
241 CGCCCGCAGGAAGCCCCGGCAAGTGCTCCGGCGAAAAAGACCGAAACGGCGGCCATGATG 
 81  R  P  Q  E  A  P  A  S  A  P  A  K  K  T  E  T  A  A  M  M  
301 TCCACCGTTCAAACCGAAACGGCAGCTGCGCCGCCGGCTACGGTCTATCGTGATAGTTGG 
101  S  T  V  Q  T  E  T  A  A  A  P  P  A  T  V  Y  R  D  S  W  
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361 TTTGACAAACTGGCCATTGGTTACCTGTCACGCAACCTGCAGGAAGCATCGGGCCTGAAA 
121  F  D  K  L  A  I  G  Y  L  S  R  N  L  Q  E  A  S  G  L  K  
421 AATGAAAAGGATGGTTACGAAAGCCTGATTGACGCCGCACTGGCAATTAGTCGTATCTTT 
141  N  E  K  D  G  Y  E  S  L  I  D  A  A  L  A  I  S  R  I  F  
481 TCCCTGGATAAACAGTCAGAAATCGTGACCCAAGCTCTGGAACGCGCGCTGCCGTCGTAT 
161  S  L  D  K  Q  S  E  I  V  T  Q  A  L  E  R  A  L  P  S  Y  
541 ATTCTGACCATGATCAAGGTTATGATGCCGCCGAGCCGTTTCTCTCGCGAATACTTTGCT 
181  I  L  T  M  I  K  V  M  M  P  P  S  R  F  S  R  E  Y  F  A  
601 GCGTTCACCACGATTTTCTTTCCGTGGCTGGTTGGCCCGTGCGAAGTCATGGAAAGCGAA 
201  A  F  T  T  I  F  F  P  W  L  V  G  P  C  E  V  M  E  S  E  
661 GTGGAAGGTCGTAAAGAAAAGAACGTGGTTTATATCCCGAAATGTCGCTTTCTGGAATCT 
221  V  E  G  R  K  E  K  N  V  V  Y  I  P  K  C  R  F  L  E  S  
721 ACCAACTGCGTCGGCATGTGTACGAATCTGTGCAAAATTCCGTGTCAGAAGTTCATCCAA 
241  T  N  C  V  G  M  C  T  N  L  C  K  I  P  C  Q  K  F  I  Q  
781 GATAGCCTGGGTATGAAAGTGTACATGAGCCCGAATTTTGAAGACATGTCTTGCGAAATG 
261  D  S  L  G  M  K  V  Y  M  S  P  N  F  E  D  M  S  C  E  M  
841 ATCTTCGGTCAGCAACCGCCGGAAGATGACCCGGCCCTGAAACAGCCGTGTTTCCGTACC 
281  I  F  G  Q  Q  P  P  E  D  D  P  A  L  K  Q  P  C  F  R  T  
901 AAGTGCGTTGCGAAGCAGAATCATGGCGTGAACTGTAGCATTTGA 
301  K  C  V  A  K  Q  N  H  G  V  N  C  S  I  * 
 
10.5 Sequence of Arabidopsis thaliana CCD7 
Accession number of native sequence: NM_130064. Sequence of CCD7.1 and 
CCD7.2 differs from that of NM_130064 from base pair 1793. Sequence of CCD7 used during 
this investigation is shown below. GST-tag is shown in black. Main CCD7 sequence is shown 
in red. Truncated protein lacks the first 93 base pairs of the red sequence. 
   1  M  S  P  I  L  G  Y  W  K  I  K  G  L  V  Q  P  T  R  L  L  
 318 TTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAA 
  21  L  E  Y  L  E  E  K  Y  E  E  H  L  Y  E  R  D  E  G  D  K  
 378 TGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGAT 
  41  W  R  N  K  K  F  E  L  G  L  E  F  P  N  L  P  Y  Y  I  D  
 438 GGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAAC 
  61  G  D  V  K  L  T  Q  S  M  A  I  I  R  Y  I  A  D  K  H  N  
 498 ATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTG 
  81  M  L  G  G  C  P  K  E  R  A  E  I  S  M  L  E  G  A  V  L  
 558 GATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTT 
 101  D  I  R  Y  G  V  S  R  I  A  Y  S  K  D  F  E  T  L  K  V  
 618 GATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAA 
 121  D  F  L  S  K  L  P  E  M  L  K  M  F  E  D  R  L  C  H  K  
 678 ACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGAT 
 141  T  Y  L  N  G  D  H  V  T  H  P  D  F  M  L  Y  D  A  L  D  
 738 GTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAA 
 161  V  V  L  Y  M  D  P  M  C  L  D  A  F  P  K  L  V  C  F  K  
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 798 AAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCA 
 181  K  R  I  E  A  I  P  Q  I  D  K  Y  L  K  S  S  K  Y  I  A  
 858 TGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGAT 
 201  W  P  L  Q  G  W  Q  A  T  F  G  G  G  D  H  P  P  K  S  D  
 918 CTGGTTCCGCGTGGATCCGGATTAATGTCTCTCCCTATCCCGCCGAAATTTCTTCCACCG 
 221  L  V  P  R  G  S  G  L  M  S  L  P  I  P  P  K  F  L  P  P  
 978 CTAAAATCTCCACCGATTCATCATCACCAAACTCCGCCACCGCTTGCACCTCCACGAGCC 
 241  L  K  S  P  P  I  H  H  H  Q  T  P  P  P  L  A  P  P  R  A  
1038 GCAATATCAATATCTATACCAGACACCGGTTTAGGACGTACCGGTACCATCCTCGACGAG 
 261  A  I  S  I  S  I  P  D  T  G  L  G  R  T  G  T  I  L  D  E  
1098 TCCACGTCTTCAGCTTTCCGTGATTACCAATCTTTATTCGTGTCACAACGTTCCGAGACT 
 281  S  T  S  S  A  F  R  D  Y  Q  S  L  F  V  S  Q  R  S  E  T  
1158 ATCGAACCGGTCGTAATTAAACCAATCGAAGGTTCAATACCGGTTAACTTCCCTTCCGGT 
 301  I  E  P  V  V  I  K  P  I  E  G  S  I  P  V  N  F  P  S  G  
1218 ACATACTACTTAGCCGGTCCAGGACTATTTACTGACGACCATGGCTCAACGGTTCATCCT 
 321  T  Y  Y  L  A  G  P  G  L  F  T  D  D  H  G  S  T  V  H  P  
1278 TTAGACGGTCACGGTTATCTCCGTGCGTTTCACATCGACGGTAACAAACGGAAAGCCACT 
 341  L  D  G  H  G  Y  L  R  A  F  H  I  D  G  N  K  R  K  A  T  
1338 TTCACGGCGAAGTACGTTAAAACGGAAGCTAAAAAAGAAGAGCACGATCCTGTAACTGAC 
 361  F  T  A  K  Y  V  K  T  E  A  K  K  E  E  H  D  P  V  T  D  
1398 ACGTGGCGGTTCACTCATAGAGGTCCTTTCTCGGTGTTGAAAGGAGGGAAGAGATTTGGA 
 381  T  W  R  F  T  H  R  G  P  F  S  V  L  K  G  G  K  R  F  G  
1458 AACACGAAAGTGATGAAAAACGTGGCTAATACTAGCGTTTTGAAATGGGCTGGGCGATTG 
 401  N  T  K  V  M  K  N  V  A  N  T  S  V  L  K  W  A  G  R  L  
1518 CTTTGTTTATGGGAAGGTGGTGAACCGTACGAGATTGAATCTGGATCGTTGGATACCGTC 
 421  L  C  L  W  E  G  G  E  P  Y  E  I  E  S  G  S  L  D  T  V  
1578 GGAAGATTTAACGTCGAGAACAACGGTTGTGAATCTTGTGATGATGATGATTCTTCCGAC 
 441  G  R  F  N  V  E  N  N  G  C  E  S  C  D  D  D  D  S  S  D  
1638 AGAGATTTATCTGGTCATGATATATGGGACACAGCCGCAGATTTGTTGAAACCCATACTT 
 461  R  D  L  S  G  H  D  I  W  D  T  A  A  D  L  L  K  P  I  L  
1698 CAAGGTGTATTTAAGATGCCACCGAAACGGTTCTTGTCACATTACAAAGTCGACGGTCGA 
 481  Q  G  V  F  K  M  P  P  K  R  F  L  S  H  Y  K  V  D  G  R  
1758 AGAAAAAGACTTTTAACGGTCACTTGCAACGCTGAAGATATGCTTTTACCTCGAAGCAAC 
 501  R  K  R  L  L  T  V  T  C  N  A  E  D  M  L  L  P  R  S  N  
1818 TTCACATTTTGTGAGTATGATTCGGAATTCAAGTTGATACAAACGAAAGAATTCAAGATC 
 521  F  T  F  C  E  Y  D  S  E  F  K  L  I  Q  T  K  E  F  K  I  
1878 GATGATCATATGATGATTCATGATTGGGCATTCACGGATACTCACTACATACTCTTTGCC 
 541  D  D  H  M  M  I  H  D  W  A  F  T  D  T  H  Y  I  L  F  A  
1938 AACCGAGTCAAGCTTAATCCAATAGGTTCCATAGCGGCTATGTGCGGAATGTCACCAATG 
 561  N  R  V  K  L  N  P  I  G  S  I  A  A  M  C  G  M  S  P  M  
1998 GTATCAGCGTTATCGTTAAACCCAAGCAACGAGAGTTCTCCGATTTATATTCTCCCTAGG 
 581  V  S  A  L  S  L  N  P  S  N  E  S  S  P  I  Y  I  L  P  R  
2058 TTTTCTGATAAATATTCTAGGGGAGGTCGAGACTGGAGAGTTCCTGTCGAAGTGTCTTCT 
 601  F  S  D  K  Y  S  R  G  G  R  D  W  R  V  P  V  E  V  S  S  
2118 CAATTATGGCTAATACACTCCGGAAACGCTTATGAGACTAGAGAGGATAACGGCGATTTA 
 621  Q  L  W  L  I  H  S  G  N  A  Y  E  T  R  E  D  N  G  D  L  
2178 AAGATTCAGATACAAGCTTCCGCTTGTTCTTACCGATGGTTCGATTTCCAGAAAATGTTT 
 641  K  I  Q  I  Q  A  S  A  C  S  Y  R  W  F  D  F  Q  K  M  F  
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2238 GGCTATGATTGGCAAAGCAACAAGCTGGATCCTTCTGTTATGAATCTAAACCGTGGCGAC 
 661  G  Y  D  W  Q  S  N  K  L  D  P  S  V  M  N  L  N  R  G  D  
2298 GACAAACTACTCCCTCATCTAGTTAAGGTGTCTATGACTTTGGACTCTACCGGAAACTGC 
 681  D  K  L  L  P  H  L  V  K  V  S  M  T  L  D  S  T  G  N  C  
2358 AATAGTTGTGATGTAGAGCCTCTAAACGGGTGGAACAAGCCGTCAGATTTTCCGGTTATA 
 701  N  S  C  D  V  E  P  L  N  G  W  N  K  P  S  D  F  P  V  I  
2418 AACTCATCCTGGTCCGGAAAAAAGAACAAGTACATGTACTCTGCTGCCTCGTCGGGAACT 
 721  N  S  S  W  S  G  K  K  N  K  Y  M  Y  S  A  A  S  S  G  T  
2478 CGAAGTGAACTTCCCCATTTTCCATTCGACATGGTCGTGAAATTTGACTTAGACTCAAAC 
 741  R  S  E  L  P  H  F  P  F  D  M  V  V  K  F  D  L  D  S  N  
2538 CTCGTCCGTACTTGGTCTACCGGAGCTAGAAGATTCGTTGGTGAGCCCATGTTTGTCCCA 
 761  L  V  R  T  W  S  T  G  A  R  R  F  V  G  E  P  M  F  V  P  
2598 AAAAACTCTGTTGAAGAAGGAGAAGAAGAGGACGATGGTTACATTGTCGTGGTCGAGTAT 
 781  K  N  S  V  E  E  G  E  E  E  D  D  G  Y  I  V  V  V  E  Y  
2658 GCGGTTTCGGTGGAGAGATGTTACCTAGTGATTTTGGATGCTAAGAAGATCGGTGAATCC 
 801  A  V  S  V  E  R  C  Y  L  V  I  L  D  A  K  K  I  G  E  S  
2718 GATGCGGTCGTGTCGAGGTTAGAGGTTCCGAGGAATTTGACGTTTCCGATGGGTTTTCAT 
 821  D  A  V  V  S  R  L  E  V  P  R  N  L  T  F  P  M  G  F  H  
2778 GGTTTATGGGCTAGCGACTGA 
 841  G  L  W  A  S  D  * 
 
10.6 Low Resolution Mass Spectrometry Spectrum for CCD8 Cleavage 
Reaction Breakdown Products 
Spectra were obtained via direct infusion using a Bruker HTC-Ultra electrospray 
ionisation mass spectrometer and trapped using an ion trap.  
10.6.1 Spectra for all-trans-β-apo-10’-carotenol 
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10.6.2 Spectra for (3E)-4-(2,6,6-Trimethylcyclohex-1-en-1-yl)2-methyl-but-3-en-1-ol 
10.6.3 Spectra for 4-methylhept-2,4-en-1,7-diol 
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